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The relationship between psychotic disorders and substance use is 
well established but complex. High rates of psychosis and greater risk of 
negative outcomes have been found in Black Caribbean and Black African 
groups. In addition research within the general population has shown 
important ethnic differences in patterns of substance use disorders 
(SUD). An under researched issue is the impact of SUDs on treatment 
and outcomes for people suffering from psychosis and whether this 
impact differs by ethnic group.   
 
METHOD 
This PhD study aimed to investigate the prevalence, correlates and 
experiences of comorbid SUDs in patients with an 8-12 year history of 
psychosis with special attention to Black African and Black Caribbean 
groups. The study comprised two phases. The first phase utilised data 
from the AESOP-10 follow-up study of 325 epidemiologically based White 
British, Black Caribbean and Black African individuals who originally 
presented to psychiatric services in London and Nottingham between 
1997 and 2000 with a psychotic disorder. The second phase was a 
qualitative study that  purposefully selected a sub-sample of patients 
from the AESOP London cohort.   
 
 AIMS AND HYPOTHESES 
It was hypothesised that there would be higher rates of SUDs in 
Black Caribbean and lower rates in Black African ethnic groups compared 
to White groups and that irrespective of ethnicity comorbidity will be 
associated various negative factors. The second phase  aimed to describe 
the experiences of mental illness, SUDs and treatment experiences in all 




The quantitative study found that Black African patients had a 
significantly lower prevalence of SUDs than White patients (Comorbid 
DUD: OR 0.090, CI 0.025-0.327, p=0.000; Comorbid AUD: OR 0.066, CI 
0.013-0.322, p=0.001). Black Caribbean patients with drug use disorders 
and White British patients with alcohol use disorders were more likely to 
have negative outcomes however many these findings failed to reach 
statistical significance.  
 
Findings from the qualitative study highlighted the use of numerous 
devices and mechanism in account giving. Several thematic constructions 
were uncovered including lay models of illness aetiology, perceptions of a 
causal relationship between illness experiences and substance use, 
perceptions of a relationship between cannabis and paranoia, perceptions 
of cannabis use as non-problematic and the importance of the role health 
services (particularly talking based therapies), family and mastery play in 
the treatment and recovery process.  
 
CONCLUSIONS 
Mixed method design involving large longitudinal epidemiological 
and qualitative studies are an appropriate way of investigating the 
relationship between psychosis and substance use disorders. Patients 
with comorbid SUDs may be more likely to have subsequent relapses and 
hospital admissions over the course of their illness, however the 
likelihood of this may differ for different ethnic groups and type of 
substances used. Talking based treatments which focus on lay models of 
aetiology, mastery of symptoms and cannabis use and involve the 
patients larger social networks are likely to be of benefit to this 
population. Further epidemiological and qualitative research into the 









The idea to investigate the ethnic differences in comorbid psychosis and 
substance use disorders was developed from my long standing interest in 
the dual diagnosis and discussions with my first (Dr. Craig Morgan) and 
second (at that time Dr. Paul Fearon) PhD supervisors. The review of the 
literature in Chapters 2 and 3 as well as the systematic review of 
ethnicity and comorbidity in Chapter 4 was my own work.  
 
 
Data for the baseline Aetiology and Ethnicity of Schizophrenia and Other 
Psychoses (ÆSOP) study was collected between 1997 and 2000, the 
method for this study is outlined in Chapter 6. This data was collected by 
a team of researchers in South East London and Nottingham headed by 
Professor Robin Murray and Professor Peter Jones respectively. I was not 
involved in the collection of this data. During my PhD I worked as part of 
a team of researchers in London headed by Dr. Paul Fearon, Dr. Paola 
Dazzan and Dr. Craig Morgan to trace and re-contact participants in the 
original London cohort (AESOP-10). The method for this is presented in 
Chapter 6. As part of the team of researchers I was jointly responsible for 
the interviewing and examination of clinical case notes for London 
participants using the main outcome schedules (including the SCAN 
diagnostic interview and the WHO Life Chart). I was involved in 
consensus diagnosis meetings in London attended by the principle 
investigators and other members of the research team. This data was 
utilised for Phase One of the PhD study and is summarised in Chapter 8. 
 
The design for Phase Two of the PhD was developed after discussions 
with my first supervisor Dr. Craig Morgan. I developed a detailed 
proposal for the study, along with additional study documents 
(participant information sheet, participant consent form and interview 
topic guide) for submission to NRES Bexley and Greenwich Research 
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Ethics Committee (REC Reference 08/H0809/8). On 9th May 2008 the 
Ethics Committee awarded me a favourable ethical opinion for the Phase 
Two Qualitative study (see appendix 1). Participants for Phase Two were 
identified through the AESOP-10 study by me and other members of the 
research team (see Chapter 6). I was solely responsible for all data 
collection (qualitative interviews) and data analyses for the qualitative 
study. All data analyses and summaries of results for both phases of this 
PhD (Chapters 8 and 9) were my own work. The PhD thesis presented 
here was written and edited after comments from my first (Dr. Craig 
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CHAPTER 1: INTRODUCTION 
 
There is a well-established association between the presence of 
mental health problems and drug and alcohol use disorders (Mueser et 
al., 1992; Strathdee et al., 2002; Weaver et al., 2002; Farrell et al. 
2004), but the aetiological relationship between the two is complex and 
little is understood despite recent advances in the understanding of how 
certain substances can increase risk of mental disorder, notably psychotic 
illness (Mueser et al., 1992; Strawkowski, et al.,1993; Cantor-Graae et 
al., 2001) 
 
High rates of psychosis have been well documented in Black 
Caribbean and Black African groups (Sharpley et al., 2001) and there are 
numerous studies showing these groups are at greater risk of compulsory 
admission to hospital (Bhui et al., 2003; Morgan et al., 2004; Morgan et 
al., 2005), and more likely to be treated in secure and forensic settings 
(Bhui et al., 2003; Morgan et al., 2004).  However, reasons for this 
remain unclear (Morgan et al., 2004).  
 
An under-researched issue is the impact of substance use disorders 
on treatment and outcomes for people suffering from psychosis.  This is 
in spite of evidence suggesting that comorbidity is associated with 
increased psychiatric admissions and poor outcomes (including worsening 
psychiatric symptoms, increased use of institutional services, poor 
medication adherence and contact with the criminal justice system) in 
both mental health and drug abuse treatment services (Hunt et al. , 
2002).  
 
Since the 1980s there has also been evidence indicating that most of 
the serious drug-related problems are in areas of high unemployment 
and social deprivation (Haw, 1985; Pearson, 1987a & 1987b; Peck & 
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Plant, 1986), where the majority of young Black and minority ethnic 
groups live.  
 
Studies investigating the epidemiological patterns of substance abuse 
have found important differences according to ethnicity. Substance use, 
abuse or dependence among Black Caribbeans often centres on crack-
cocaine use and cannabis use, although low levels of substance use have 
been found in Black African populations (Aust, 2003).  
 
 
1.1 RATIONALE FOR THE INVESTIGATION AND STRUCTURE 
OF THE THESIS  
 
Given the potential service implications, this is an issue that merits 
much more research. A recent study has shown that Black British groups 
being treated for psychosis were significantly more likely to be diagnosed 
as having comorbid cannabis use and Black African groups were 
significantly more likely to be diagnosed with abusing stimulants and 
opiates than White groups (Afuwape et al., 2006). Despite finding ethnic 
differences in the prevalence of comorbidity, this study was a cross-
sectional community-based study which used case manager ratings of 
substance abuse/dependence in patients with established illness.   
 
There is a need for robust longitudinal population-based studies, 
which can explore the various interactions ethnicity may have with 
comorbid diagnosis. This study will estimate the prevalence of comorbid 
psychosis and substance abuse/dependence in different ethnic groups 
giving special attention to Black African and Black Caribbean populations. 
Using a mixed method design, it will also explore in detail the relationship 
between comorbid diagnosis and various clinical and psychosocial 
outcomes as well as service provision and the perceived quality of care in 





1.1.1 Aims, hypotheses and research questions 
 The PhD study is nested within the larger MRC funded AESOP-10 
(Aetiology and Ethnicity in Schizophrenia and Other Psychoses) follow-up 
study which looked at the course and outcome of psychosis in an 
ethnically-diverse cohort of psychiatric patients being followed-up 8-12 
years after their first presentation to services.  
 
 The overall objectives of the PhD study were: 
 
1) To make a theoretical and methodological contribution to 
the understanding of the relationship between comorbidity 
of psychosis and substance use disorder and ethnicity. 
2) To estimate the prevalence and correlates of comorbidity 
of psychosis and substance use disorder in different ethnic 
groups.  
3) To describe service responses to, and the perceived quality 
of care of patients with, comorbid diagnoses from different 
ethnic populations, giving special attention to Black 
Caribbean and Black African groups. 
 
 To achieve these objectives two hypotheses were tested in the first 
quantitative phase of the study. This study hypothesises that: 
 
1) The prevalence of comorbid substance use disorders in 
individuals with an 8-12 year history of psychosis will differ 
according to ethnic group.  More specifically, rates of 
comorbidity will be higher in Black Caribbean, and lower in 
Black African, patients than White patients.  
 
2) In all ethnic groups, comorbid substance use disorder will be 
associated with:  
   a) more frequent relapses and  
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 b) more compulsory admissions  
independent of potential confounders, including age, gender, 
diagnosis and study centre. 
 
 Although the study hypothesised that poorer outcomes will be 
evident in patients from all three ethnic groups with comorbidity 
compared to those that only have a psychotic illness, it is likely that a 
greater prevalence of comorbid psychosis and substance use disorders in 
the Black Caribbean group will show a higher risk for poor outcomes than 
in White or Black African groups over the 8-12 year follow-up period.   
 
 The second, qualitative phase of the study, which purposefully 
selected a sub-sample of patients from the AESOP-10 cohort, 
investigated the following research questions: 
 
1) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
‘psychosis’ and drug and alcohol use 8-12 years after their 
first episode?  
2) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
mental health and substance abuse treatment services? 
3) What is the perceived role (if any) of family, friends and 
other social support networks in the treatment process for 
‘psychosis’ and substance use disorder? 
 
In other words the second arm of the study aimed to both describe if 
and how the problem of comorbidity differs for ethnic minorities in 
psychotic populations and to identify conceptualisations of illness and 
substance use. The study also aimed to explore the impact comorbidity 
might have on attitudes towards the perceived usefulness of treatment 
approaches (namely hospitalisation and community treatment) and the 




It should be noted that although the AESOP-10 study included 
patients from all ethnic backgrounds, the first half of the PhD study 
focuses on three broad ethnic groups: White, Black Caribbean and Black 
African. This is because firstly the numbers in other ethnic categories 
were too small to be compared separately and were too diverse to be 
combined. Secondly, previous research has tended to focus on crude 
categorisations and comparisons of ethnic differences and so a basis for 
comparison needed to be established in this study. 
 
 
1.1.2 Thesis outline 
The thesis falls into four main sections. Figure 1 summarises the 
aims and objectives of each chapter. The first part forms the background 
to the PhD study and includes a review of epidemiological and 
anthropological literature in the areas of comorbidity, service utilisation of 
patients with dual diagnosis and constructions of the lived experience of 
comorbidity.  
 
Chapter 2 builds on the concepts discussed in section 1.2 and 
details the characteristics and correlates of first-episode psychotic 
patients with comorbid substance use disorders, their outcomes and the 
basis for consideration of the role ethnicity may play in prevalence and 
outcome.  
 
Chapter 3 follows on from this by presenting the findings from a 
systematic review of current literature on ethnicity and comorbidity with 
particular attention given to ethnic differences in prevalence and ethnicity 
as a risk factor for comorbid diagnosis.  
 
Chapter 4 discusses the limitations of epidemiological literature in 
understanding the construction of experience in patients with comorbid 
psychosis and substance use. It discusses models of health beliefs and 
how they may relate to lay understandings of comorbidity.  
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 Overview of rationale for the PhD study 
 Summary of thesis concepts 
 Outline of thesis structure 
CHAPTER 2 
 Overview of epidemiological research in comorbid substance 
use disorders in first episode psychosis populations 
 Provide a summary of why ethnicity should be of interest in 
epidemiological research in this area.  
 Provide a summary of the limitations of this research 
CHAPTER 3 
 Summary of a systematic review 
investigating ethnic differences in the 
prevalence and outcomes of comorbid  
CHAPTER 4 
 Discussion of the limitations of epidemiological research in understanding 
the experience in patients with comorbid psychosis and substance use.  
 Overview of models of help seeking and health beliefs and how they may 
relate to lay understandings of comorbidity. 
 Overview of literature concerning patient constructions of comorbidity 
CHAPTERS 5, 6 & 7 
  Critical discussion of the theoretical and methodical approaches to 
mixed method design and the appropriateness of these for 
addressing the aims and objectives of the PhD study 
  Overview of the methodological structure and design of the PhD 
study 
 Overview of the analytical structure and design of the PhD study 
 
CHAPTERS 8 & 9 
 Summary of the findings from the quantitative 
(Phase One) and qualitative (Phase Two) arms of 
the PhD study 
CHAPTER 10 
 Discussion of the strengths and limitations of the 
PhD study 
 Discussion of the findings from both arms of the 
study in relation to previous research 
 Discussion of future research areas highlighted by 
the qualitative study and implications of the 
findings from the PhD as a whole 
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The second part of the thesis gives an overview of the 
methodological aspects of the PhD study. Chapter 5 discusses the 
theoretical considerations for conducting mixed-method health services 
research and gives an overview of the ontological and epistemological 
framework within which the PhD study is situated. Chapter 6 then 
describes the method that was used to address the hypotheses and 
research questions.  It gives an overview of the AESOP-10 study which 
the quantitative phase of the PhD was situated within as well as detailing 
the selection, sampling, recruitment and interviewing of a sub-sample of 
AESOP-10 patients for the second qualitative phase of the study. Chapter 
7 moves onto the analytical structure for the epidemiological first phase 
as well as the qualitative second phase of the PhD study. 
 
The third section of this thesis provides a detailed summary of the 
findings of both phases of the study. Chapter 8 summarises the 
quantitative findings and Chapter 9 summarises the qualitative findings. 
The thesis’ final part draws on the background literature, methodological 
considerations and findings for both arms of the study. Chapter 10 is a 
full discussion of the findings of both arms in relation to what we already 
know and predicted and then highlights the potential clinical applications 
of these findings as well as the limitations of the study. This Chapter 




1.2 DEFINING CONCEPTS 
 
1.2.1 Psychosis  
Psychosis is an umbrella construct which includes a range of 
disorders (Ross, 2005) which are characterised by the primary presence 
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of what psychiatry terms positive symptoms such as hallucinations and 
delusions. 
 
In current classification systems (World Health Organisation (WHO) 
International Statistical Classification of Diseases and Related Health 
Problems (ICD-10) and American Psychological Association Diagnostic 
and Statistical Manual of Mental Disorders, 4th Edition) the following 
diagnoses are grouped under the umbrella of psychosis: schizophrenia, 
schizotypal disorder, schizophreniform, persistent delusional disorders, 
acute and transient psychotic disorders, induced delusional disorder, 
schizoaffective disorders, other nonorganic psychotic disorders, shared 
psychotic disorder, brief psychotic disorder and unspecified nonorganic 
psychosis.  
 
Conceptualisation of psychosis in this thesis was largely 
determined by the nature of the sample and the measures completed 
upon them. In other words the thesis is concerned with individuals who 
presented to psychiatric services for the first time with evidence of 
psychotic symptoms regardless of their diagnosis between 1997 and 
2000. Patients were recruited according to the Screening Schedule for 
Psychosis (Jablensky et al., 1992) (for overview of AESOP study methods 
see section 6.3) and had to fulfil the criteria for either A or B below with 
no evidence of an organic cause. 
 
A. At least one of the following: 
 Hallucinations or pseudo-hallucinations in any modality 
 Delusions 
 Marked thought and speech disorder (e.g. incoherence, 
irrelevance, thought blocking, neologisms incomprehensibility of 
speech etc.) other than simple retardation or acceleration 
 Marked psychomotor disorder (e.g. negativism, mutism or stupor, 
catatonic excitement, constrained attitudes or unnatural postures 
maintained for long periods etc.) other than simple retardation or 
acceleration 
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 Emergence or marked exacerbation of bizarre and grossly 
inappropriate behaviour (e.g. talking or giggling to self, acts 




B. At least two of the following: 
 Marked reduction or loss of interests, initiative and drive, leading 
to serious deterioration of the performance of usual activities and 
tasks 
 Emergence or marked exacerbation of social withdrawal (active 
avoidance of communication with other people) 
 Severe excitement, purposeless destructiveness or aggression 
 Episodic or persistent states of overwhelming fear or severe 
anxiety 
 Gross and persistent self-neglect 
 
 
1.2.2 Comorbidity and Dual Diagnosis  
According to current classification systems (ICD-10 and DSM-IV 
TR) in psychology and psychiatry, mental disorders are diagnosed 
according to operationalised diagnostic criteria and the diagnosis of one 
disorder does not necessarily preclude the diagnosis of another. 
Comorbidity is defined in general terms as the co-occurrence of two or 
more mental disorders. More specifically within psychiatry, comorbidity is 
most commonly used to describe the overlap of two or more psychiatric 
disorders (Boyd et al., 1984).  
 
Comorbidity between substance use disorders and other mental 
disorders has gained increasing prominence in psychiatry and psychology 
within the past few decades and is sometimes referred to as ‘dual 
diagnosis’ with both terms being used interchangeably (Wittchen et al., 
1996). In practice, comorbidity is specifically restricted to include severe 
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mental illness (SMI) – psychosis, schizophrenia, bipolar affective illness 
and substance use disorder (Todd et al., 2004).  
 
The chronology of disorders in comorbid diagnosis is important in 
determining aetiology (which I touch on in Chapter 4) as comorbidity can 
occur when a substance use disorder is primary and dominant, but 
underlined by at least one other psychiatric disorder or the mental 
disturbance may be considered the primary condition (Franey & Quirk, 
1996).  
 
For a comorbid diagnosis DSM-IV and DSM-IV TR make clear 
distinctions between an independent psychotic disorder (e.g. bipolar 
disorder, schizophrenia etc.) and substance-induced syndromes (e.g. 
delirium, dementias etc.). Most substance-induced psychotic symptoms 
are considered to be short-lived and to resolve after a period of sustained 
abstinence along with other symptoms of substance intoxication and 
withdrawal (Rounsaville, 2007). This however is likely to be challenged 
by mounting evidence that marijuana use may be a contributing cause of 
schizophrenia (Arseneault et al., 2004). 
 
Definitions of comorbidity have sometimes been loosely applied in 
epidemiological studies to include co-occurring substance use (Barnes et 
al., 2006) and have focused on current (Cantor-Graae et al., 2001) as 
well as lifetime diagnoses (Kavanagh et al., 2004). However, this study 
uses the tight definition of co-occurring diagnoses of a psychotic disorder 
and lifetime substance abuse or dependence according to DSM-IV.  
 
Drugs: 
 Substance abuse (Maladaptive use leading to any of the following: 
(1) failure to fulfil major role obligations due to substance; (2) 
substance leading to, or exacerbating,  social or interpersonal 
problems; (3) recurrent abuse when physically hazardous (e.g. 
driving) or substance-related legal problems). 
 Substance dependence (Maladaptive use leading to 3 of the 
following: (1) increased tolerance; (2) symptoms of withdrawal; 
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(3) substance taken in larger amounts over a longer period than 
originally intended ;(4) persistent desire, or unsuccessful attempts, 
to cut down; (5) much time spent in activities to obtain the 
substance or recovering from effects; (6) impairment of social, 
occupational or recreational activities due to substance; (7) 
persistent use despite harmful physical or psychological effects. 
 
Alcohol: 
 Alcohol abuse (Maladaptive use leading to any of the following: (1) 
failure to fulfil major role obligations due to alcohol; (2) substance 
leading to, or exacerbating, social or interpersonal problems; (3) 
recurrent abuse when physically hazardous (e.g. driving) or 
alcohol-related legal problems). 
 Alcohol dependence (Maladaptive use leading to 3 of the following: 
(1) increased tolerance; (2) symptoms of withdrawal; (3) alcohol 
taken in larger amounts over a longer period than originally 
intended; (4) persistent desire, or unsuccessful attempts, to cut 
down; (5) much time spent drinking the substance or recovering 
from effects; (6) impairment of social, occupational or recreational 
activities due to alcohol; (7) persistent use despite harmful 
physical or psychological effects of alcohol. 
 
The term substance use disorder is used throughout the thesis but it 
should be noted that this includes substance abuse and dependence.  
 
Patients characterised as having a diagnosis of comorbidity will have 
been diagnosed with a psychotic disorder around their initial episode of 
illness and will have met criteria for a substance use disorder (substance 







1.2.3 Race, ethnicity and culture  
Race, culture and ethnicity have multiple and sometimes ambiguous 
meanings, which often overlap with political concepts of nationality and 
immigration status (Singh, 1997). Fernando, (1991) has argued that race 
is socially perceived as permanent and genetically determined. Singh 
(1997) summarises ethnicity and culture in the following ways: 
 
 An ethnic group refers to a group of people that share language, 
customs and a recent common ancestry and definitions of ethnicity 
encompass biological and non-biological differences between 
groups (for example physical appearance, self-identification, values 
and attitudes, language, behaviour and knowledge of that ethnic 
groups history). 
 Culture involves the shared characteristics of a society for example 
traditions, language, social roles. These characteristics are 
transmitted across generations by non-biological means.  
 
The main differences between race, ethnicity and culture are that race 
is generally considered unchangeable while culture is considered 
changeable and ethnicity is considered partially changeable (Fernando, 
1991). 
 
Traditionally the term race was used in social and scientific arenas 
(Huxley & Haddon, 1935). However, after the Second World War 
arguments that social rather than biological inequalities were responsible 
for differences in populations led to the term ethnicity replacing race in 
socio-political discourse and scientific and medical research (Singh, 
1997). This thesis is concerned with the concept of ethnicity and its 
relationship to both psychotic and substance use disorders.  
 
Although ethnicity has been widely studied in sociological and 
anthropological fields since the late 1960s, ethnicity, ethnic groupings 
and ethnic diversity remain highly contested concepts (Brown & Langer, 
2010). There is no universally accepted definition of ethnicity but it is 
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generally conceptualised as a sense of group belonging, based on 
common ideas, history, culture, language, experience and values (e.g. 
Glazer & Moynihan, 1975; Anderson, 1983; Horowitz, 1985; Bates, 
2006). 
 
Singh argues that in Britain, Caucasian (now associated with the term 
White), Asian and Afro Caribbean are considered the main ethnic groups 
and that all of these groups are heterogeneous and socially perceived 
(Singh, 1997). In addition self-assigned ethnicity (where the participant 
assigns themselves to an ethnic category that most represents their 
identity) has become popular in social science research because it 
reduces observer bias. However, research that offers participants a 
limited range of ethnic categories (albeit popular ones), as Singh notes 
may force respondents to ‘pigeonhole themselves in artificially chosen 
constructs.’ (Singh, 1997, p. 306).  
 
Despite epidemiological studies using self-defined ethnicity variables 
to uncover patterns of aetiology and outcome by reducing it to mutually 
exclusive ethnic categories, Brown and Langer argue that as long as the 
interpretation of results acknowledges the limitations of this kind of 
categorisation, quantitative analysis can provide a useful and systematic 
form of comparison (Brown & Langer, 2010). 
 
In both phases of the PhD study information relating to ethnicity was 
based on data collected from the AESOP baseline study. Ethnicity for all 
people who took part in this study, was defined according to the self-
report criteria used in 2001 UK census. The criteria employed by the UK 
Office of National Statistics (ONS) census in 2001 included 16 categories: 
a) White British;  
b) White Irish;  
c) Other White;  
d) Mixed: White and Black Caribbean;  
e) Mixed: White and Black African;  
f) Mixed: White and Asian; 
g) Other Mixed; 
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h) Indian;  
i) Pakistani;  
j) Bangladeshi;  
k) Other Asian; 
l) Black Caribbean;  
m) Black African;  
n) Black Other;  
o) Chinese; and  
p) Other. 
 
The qualitative phase of the PhD study included a description of 




The following PhD study aims to make a theoretical and methodological 
contribution to the understanding of the relationship between comorbidity 
of psychosis and substance use disorder and ethnicity. It also aims 
through a mixed design to estimate the prevalence and correlates of 
comorbidity in different ethnic groups as well as uncover patient 
perceptions of psychotic illness, substance use and service responses 
within different ethnic populations. 
 
The chapters that follow provide essential background literature and a 
detailed overview of the PhD study’s theoretical and methodological 
structure. This is followed by a summary of the findings from both phases 
of the study and finally a discussion of these findings in relation to the 








Chapter Summary 1.   
Chapter Summary 
 
Aims of the Chapter: 
 
To provide a brief overview of the rationale for the PhD study. To summarise the 





 There is a need for robust longitudinal population-based studies, which 
can explore the various interactions ethnicity may have with comorbid 
diagnosis 
 Psychosis is an umbrella construct which includes a range of disorders 
and was largely defined by the PhD study sample. 
 Comorbidity in this study is defined as: the co-occurring diagnoses of a 
psychotic disorder and lifetime substance abuse or dependence according 
to DSM-IV 
 Definitions of ethnicity in this study were self-reported and based on 




CHAPTER 2:  EPIDEMIOLOGY OF COMORBID 
SUBSTANCE USE DISORDERS IN FIRST 




The aim of this chapter (as well as the proceeding two chapters) is 
to build on the rationale for the PhD study by providing an overview of 
some of the most prominent epidemiological research in the area of 
comorbid substance use disorders in first episode psychosis populations. 
The chapter begins with outlining study estimates of prevalence and risk 
for comorbidity and moves onto summarising the relationship between 
comorbidity and outcome. Turning next to the aims and objectives of the 
PhD study the chapter addresses the question why ethnicity should be of 
interest in epidemiological research in this area. Finally a summary of the 
limitations of this research is given. 
 
2.2 COMORBID SUBSTANCE USE DISORDERS IN FEP 
2.2.1 Prevalence, correlates and risk 
Co-occurring substance use is common among people with 
psychotic disorders and has important implications for the course and 
treatment of psychosis. Several epidemiological studies have examined 
the prevalence and correlates of substance use disorders in people in 
their first episode of psychosis (FEP). Typically, higher rates of substance 
use disorders have been reported in FEP patients when compared to the 
general population. Findings however vary significantly between studies 
and countries.  
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The highest rates of substance use disorders have been reported in 
the USA, although ranges have been found from 10% to as high as 70% 
(Mueser et al., 1990). Canada on the other hand has prevalences 
between 35% and 45%, (Archie et al., 2007; Van Mastrigt S., Addington 
J. & Addington D., 2004).  
 
Epidemiological research into the prevalence of comorbidity in 
Australia have reported prevalences of substance use disorders of 
roughly 40%, (Kavanagh et al., 2004; Lambert et al., 2005), while closer 
to home prevalences reported in Europe range from 14% to 23%, 
(Cantwell et al., 1999; Hambrecht & Hafner , 2000; Sorbara et al., 2003; 
Larsen et al., 2006).  
 
Some of the lowest rates found were from Singapore (6%) (Verma 
et al., 2002).  
 
In the UK specifically a systematic review of rates of comorbid 
substance misuse and psychosis in UK studies between 1986 and 2007 
by Carra and Johnson (2009) showed ranges of prevalence between 12% 
(Virgo et al., 2001) and 75% (Gaite et al., 2002) across various 
treatment settings. For example, in inpatient settings prevalences ranged 
from 20% (Sanders et al., 1993) to 50% (Phillips & Johnson, 2003).  
 
Differences in prevalence may have been due to the way substance 
misuse data was collected. For example, in CMHT caseloads, rates of 
alcohol and drug misuse taken from staff reports estimated around 12% 
and 13% respectively (Miles et al., 2003; Virgo, Bennett G., Higgins D., 
Bennett L. & Thomas P., 2001; Weaver et al., 2001), whereas diagnostic 
interviews ranged from 16% to 27% (Barnes et al., 2006; Cantwell et al., 
1999) and consensus rating methods ranged between 20% and 26% 
(Menezes et al., 1996; Weaver et al., 2003; Wright et al., 2000). 
 
While it is clear that prevalence of comorbidity is high in psychotic 
populations the observed variation in prevalence across countries and 
studies could be due to methodological inconsistencies between studies, 
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but also to cultural and environmental differences between countries, 
especially in substance availability (Mazzoncini et al., 2009). 
 
Substance use has also been found to be a risk factor for the onset 
of schizophrenia (Smith et al., 2004; Semple et al., 2005) and the use of 
cannabis in adolescence has been reported to increase the risk of 
developing symptoms of schizophrenia in adulthood (Tsapakis et al., 
2003). Cannabis use specifically has been found to increase the risk of 
both the incidence of psychosis in the general population and a poor 
prognosis for those with an established vulnerability to psychotic disorder 
(Van Os et al., 2002).   
 
In a Cambridgeshire study age of first use of cannabis, cocaine, 
ecstasy and amphetamine was found to be significantly associated with 
age at first psychotic symptom (Barnett et al., 2007). Prevalence of the 
types of substances used by people with psychosis also vary across 
studies, however cannabis is consistently reported as the most frequently 
used illicit substance (Cantwell et al., 1999; Regier et al., 1990). 
Evidence suggests an increased risk of cannabis exposure prior to onset 
of psychosis (Moore et al., 2007) though the frequency of poly-drug use 
can make it difficult to disentangle the effects of each individual 
substance (Addington J. & Addington D., 2007).  
 
In an Australian study of first admission for psychosis Sara, 
Burgess, Malhi, Whiteford and Hall (2013) found that diagnoses of drug-
induced psychoses were more strongly associated with stimulants than 
with cannabis.  They also found that, compared to patients with cannabis 
diagnoses alone, those with both cannabis and stimulant disorders were 
older, more likely to have a diagnosis of drug-induced psychosis and 
more likely to have comorbid alcohol disorders (Sara et al. , 2013).  
 
Comorbid substance use has also been associated with 
unemployment, less desirable living conditions (Drake, Osher & Wallach, 
1991), a lower educational level (Dixon L., 1999), more family problems 
and single relationship status (Dixon, McNary & Lehman, 1995). 
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However, reliable clinical correlates of substance use in patients with 
psychosis have yet to be identified (Mazzoncini et al., 2009).  
 
Some studies have also reported that substance misusers are more 
likely to have an acute mode of illness onset, a shorter duration of 
untreated psychosis (DUP) (Morgan et al., 2006) and to be admitted 
compulsorily at first contact with psychiatric services (Wade D., Harrigan 
S., McGorry P. D., Burgess P. M. & Whelan G., 2007; Dean et al., 2007).  
 
It should be noted, however, that a major limitation of previous 
studies in this area is their small sample sizes and inconsistent 




2.3 COMORBIDITY AND FOLLOW-UP IN FEP 
  
There is a small collection of epidemiological research which looks at 
the clinical, social and service use outcomes of patients with comorbid 
substance use disorders and FEP. Most follow-up studies have tended to 
range from twelve months to five years after the initial episode of illness 
and have focused on reduction of psychotic symptoms, reduction of 
substance use, global function and likelihood or readmission. 
 
 
2.3.1 The relationship between comorbidity and clinical/social 
outcomes in psychosis 
Studies have revealed similar motives for substance use in 
psychotic populations as in the general population with “coping” and 
“enhancement” motives found to lead to substance use problems and 
dependence (Spencer, Castle & Mitchie, 2002).  
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Comorbidity has typically been associated with more severe 
psychotic symptomatology (Margolese, Negrete, Tempier & Gill, 2006), 
more hospitalisations (Haywood et al., 1995), poorer treatment 
compliance (Owen et al., 1996; Miller, 2008), higher relapse rates 
(Lambert et al., 2005; Malla et al., 2008; Lambert et al., 2008) and 
higher costs for mental health services (Bartels et al., 1993) than 
patients with a single psychotic disorder. On-going substance abuse has 
also been shown to be related to levels of depression (Margolese et al., 
2006). 
 
Few studies have identified interventions that reduce cannabis use 
for example and improve clinical outcome amongst this population. 
Interestingly patients with comorbidity who were treated for their 
psychiatric illness have been found to show a reduction in psychotic 
symptom scores over 12 months, even when their substance use 
remained largely unchanged (Margolese et al., 2006). Integrated 
treatment for both conditions however has not been proven to be so 
successful.  
 
In a recent multi-centre, randomised-controlled trial of a group 
psychological intervention (based on CBT and Motivational Interviewing) 
for psychosis with comorbid cannabis dependence Lawlor et al. (2012) 
found that at 3-month and 1-year follow-ups no intervention effect on 
cannabis use, symptoms, global functioning, insight or attitude to 
treatment was found.  
 
Although the intervention improved subjective quality of life at 3 
months and this effect was sustained at 1 year, neither psychotic 
diagnosis nor type of substance abuse diagnosis was found to be related 
to outcomes for dual diagnosis treatments.  However, dual diagnosis 
treatments was found to be successful in reducing hospitalisation and 
homelessness (Xie, McHugo, Helmstetter & Drake, 2005).   
 
Substance-abuse-only-focused-treatment has in some studies been 
found to be successful, with significant improvements in proximal 
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outcomes (e.g. approach to coping) and in distal outcomes (e.g. 
psychiatric symptoms, substance use frequency etc.) up to 5-years later 
(Boden & Moos, 2013). 
 
A study looking at the role of medication in patients with co-
occurring psychosis and substance use disorder (Hunt & Bergen, 2002) 
found that patients who were compliant with antipsychotic medication, 
but also abused substances, were readmitted to hospital sooner (within 
10 months of first admission). Over a four year period, non-compliant 
substance abusing patients made up 57% of all readmissions, leading to 
the conclusion that any benefit from antipsychotic medication compliance 
in reducing readmission was counteracted by on-going substance abuse. 
 
A recently published Barcelona-based study investigating the 
influence of substance use disorders on readmission risk in inpatients 
with first-episode psychosis found that a quick screening self-report scale 
for cannabis and cocaine use disorders was a significant predictor 
(compared to urinary analysis) for predicting readmission in the first five 
years after initial episode  (Batalla et al., 2013). This study highlights the 
need for more longitudinal research examining screening tests for 
substance use in the early phases of psychotic illness to be conducted to 
evaluate their benefits in preventing early readmission in first-episode 
psychosis. 
 
In a systematic review of substance use disorders in first-episode 
psychosis Wisdom, Manuel and Drake (2011) found that few studies 
examined mental health outcome as well as substance use outcome. Only 
including studies examining FEP, as well as comorbid substance abuse, 
dependence and substance use disorder, the authors identified nine 
studies that described outcomes from psychiatric-only treatment for 
individuals with co-occurring disorders and five studies that described 
outcomes from integrated treatments. 
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Reprinted from: “Substance Use Disorder Among People With First-Episode Psychosis: A Systematic Review of Course and Treatment” by Jennifer P. Wisdom, Jennifer I. 
Manuel & Robert E. Drake, 2011, Psychiatric Services, 62:9, p. 1009. doi: 10.1176/appi.ps.62.9.1007.
Study Substance use outcome Mental health outcome Functional outcome 
 
Without specialised substance abuse treatment 
   Archie et al., 2007  Improvementa No change No change 
   Baeza et al., 2009  Mixed findings Improvement Not assessed 
   Grech et al., 2005  Improvement Mixed findings Not assessed 
   Harrison et al., 2008 Improvement Mixed findings No change 
   Kovasznay et al., 1997  Observational only No change Observational only 
   Lambert et al., 2005        
   and Hinton et al., 2007   
Improvement Improvement Not assessed 
   Turkington et al., 2009  Improvement Observational only Observational only 
   Verdoux et al., 2001  Improvement Not assessed Not assessed 
With specialised substance abuse treatment 
   Addington et al., 2001 Improvement No change Mixed findings 
   Carr et al., 2009  Improvement Not assessed Not assessed 
   Edwards et al., 2006  No change No change No change 
   Gleeson et al., 2009  No change Improvement No change 
   Kavanagh et al., 2004  No change Not assessed Not assessed 
 
 
a “Improvement” indicates the intervention group demonstrated a statistically significant increase in positive outcomes or a decrease in negative outcomes 
compared with the comparison or control group.  “Mixed findings” indicates improvement on some measures of the outcome and no difference or negative 
findings on other measures of the outcome.  
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The findings as to the effectiveness of substance abuse treatment 
for comorbid patients were mixed. As Table 1 shows, several of the 
cohort FEP studies documented significant reductions in both drug 
(mainly cannabis) and alcohol use in the absence of specialised substance 
abuse treatments.  
 
Some studies found that clients diagnosed as having substance 
dependence or greater depression (Turkington et al., 2009) at baseline 
were more vulnerable to persistent substance use disorders, but only a 
few studies compared patients with substance use cessation to those with 
substance use continuation. Wisdom et al. (2011) found in one study 
significant differences in involuntary hospitalisations and arrests between 
drug abusers and non-abusers at baseline; however these differences 
were no longer significant at follow-up (Archie et al., 2007). An 
interesting finding was that in many of the studies patients who adopted 
abstinence reduced their rates of relapse and hospitalisation, whereas 
those who continued to abuse substances experienced increased rates of 
relapse and hospitalisation. 
 
Apart from the lack of power in any of these studies, Wisdom et al. 
(2011) argue that a possible explanation of these findings is that a 
significant proportion of patients who were using or abusing alcohol and 
other drugs may have reduced their substance use or became abstinent 
when they experienced a first episode of psychosis as a result of the 
traumatic experience of a psychotic experience itself and/or the 
education they received about preventing relapses (Drake et al., 2011).  
 
Alternatively, they argue that while treating psychosis some 
reduction in substance abuse was attained through the common 
therapeutic elements typically found in treatments for psychosis and 
substance abuse (e.g. assertive outreach, comprehensiveness, long-term 
perspective, shared decision making, stage wise treatment and 
pharmacotherapy); a clear rationale for integrated treatments for dual 




2.4 WHY IS ETHNICITY OF INTEREST? 
2.4.1 Ethnic differences in risk for psychosis and pathways to 
care in psychotic populations 
Research in FEP populations has shown considerable ethnic 
differences not only in incidence but also in pathways to mental health 
service care.  
 
Much of this research has focused on differences between Black 
(Caribbean and African) and White patients. Early research examining 
incidence rates in psychotic disorders in ethnic minorities showed growing 
evidence of elevated rates of schizophrenia and other psychotic illnesses 
(Hutchinson, Mallett & Fletcher, 1999) and mania (Sharpley et al., 2001) 
amongst African-Caribbeans.  
 
The same pattern was observed in more recent studies examining 
first and second generation immigrants from several ethnic backgrounds 
who both had an elevated risk for non-affective and affective psychoses.  
Although this varied by ethnicity, the risk of psychoses in first and second 
generations of the same ethnicity were estimated to be roughly the same 
(Coid et al. , 2008).  
 
There is also mounting evidence of ethnic differences in the 
pathways to and utilisation of mental health services (Rwegellera, 1980). 
A three-centre UK-based study (which forms the foundation of this PhD 
study) of first-episode psychosis suggested that Black Caribbeans are 
less likely to seek help from a GP, as well as less likely to be referred to 
specialist services when they do; a finding which has significant 
implications for early detection of psychosis at a primary care level 
(Morgan et al., 2004).  
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In addition, numerous UK-based studies have found that Black 
Caribbean and Black African patients are more likely than White patients 
to come into contact with mental health services in a compulsory 
capacity. These contacts often involve the police and other criminal 
justice agencies (Bhui et al., 2003) and appear to follow more coercive 
and complex routes to psychiatric care (Commander et al., 1999).  
 
An early study has shown that Black Caribbeans may also 
experience longer periods of untreated psychosis (Harrison et al., 1989) 
however subsequent research has found not this to be the case (Cole et 
al., 1995; Morgan et al., 2006). 
 
 
2.4.2 The relationship between ethnicity and clinical/social 
outcomes in psychosis 
Unlike research around ethnic differences at first presentation of 
psychotic illness, research over the last decade regarding ethnic 
differences in outcomes of patients with FEP has been mixed.  
 
A systematic review of outcome and ethnicity in FEP populations 
(Chorlton, McKenzie, Morgan & Doody, 2011) showed considerable 
variations in findings. Focusing on follow-up studies ranging from four 
years nine months to ten years after first admission, the review included 
all studies with FEP populations between 1950 and 2010 using 
prospective and retrospective methodologies.  
 
One study found that Black Caribbeans tended to be sporadic 
attendees of community services compared to other ethnic groups 
(McGovern & Cope, 1991). However, several studies have found that 
contact with services at follow-up did not differ by ethnic group (Goater 
et al., 1999; McGovern et al., 1994; Mohan et al., 2006).  
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While some studies reported that Black Caribbean patients were 
more likely to have experienced multiple compulsory admissions 
compared to white patients (Takei et al., 1998; McGovern et al., 1994), 
two others reported no association between type of hospital admission 
and ethnicity (Goater et al., 1999; Harrison et al., 1999).  
 
Again findings for length of admission were mixed. A handful of 
studies reported no association between ethnicity and length of 
admission (Callan, 1996; Harrison et al., 1999; McGovern et al., 1994) or 
total time as an inpatient (Harvey et al., 1990; McKenzie et al., 1995 & 
2001). Others however reported that length of time as an inpatient was 
higher in Black Caribbean groups compared to White groups (Harrison et 
al., 1999) and Black Caribbean patients with schizophrenia had a 
significantly higher median length of hospital admissions compared with 
White patients in others (Takei et al., 1998). 
 
With regard to social functioning, and with the exception of one 
study which reported that Black Caribbeans had higher levels of 
employment than Asian and White groups during the follow-up period 
(Birchwood et al., 1992), most studies reported no significant association 
between social functioning and ethnicity (Harrison et al., 1999; McGovern 
et al., 1994; McKenzie et al., 1995, 2001; Sugarman, 1992),  ‘social 
recovery’ and ethnicity (Harvey et al., 1990) and ethnicity and social 
circumstances at outcome, including employment (Goater et al., 1999; 
McGovern et al., 1994; McKenzie et al., 1995) and type of 
accommodation (Goater et al., 1999; McGovern et al., 1994; McKenzie et 
al., 1995). 
 
Chorlton et al. (2011) also found that the studies included in the 
review reported no significant differences between course of psychotic 
symptoms and ethnicity (Goater et al., 1999; Harrison et al., 1999), 
between symptom recovery between episodes and ethnicity (Birchwood 
et al., 1992) or between ethnicity and positive symptoms (McGovern et 
al., 1994).  
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With the exception of one study that found higher rates of negative 
symptoms in White patients (Callan, 1996), the majority of studies that 
examined negative symptoms found no significant differences in 
frequency among ethnic groups (Goater et al., 1999; Harrison et al., 
1999; McGovern et al., 1994; McKenzie et al., 1995; Perera et al., 1991; 
Takei et al., 1998). 
 
There are two things that are noteworthy when interpreting the 
usefulness of these results. Firstly, Chorlton et al. (2011) highlight the 
severe heterogeneity of the studies selected for inclusion with differences 
in definition of FEP, method of data collection, length of follow-up and 
follow-up rate, sample size, categorisation of ethnicity, adjustment for 
confounding variables, geographical area and types of assessments used 
to measure outcome. Secondly, despite a predominance of negative 
findings for the ethnic differences in clinical and social outcome in 
psychotic populations, it is unclear whether ethnic differences may occur 
when individuals have comorbid substance use disorders. 
 
 
2.4.3 Ethnic differences in the prevalence of substance use in the 
general population 
In addition to ethnic differences in the prevalence of psychotic 
disorders in the general population and pathways to mental health care 
there are well-documented differences in the prevalence of substance use 
in the general population (Karlsen, Rogers & McCarthy, 1998; Canning et 
al., 1999; Galea, Nandi & Vlahov, 2004) with people from non-White 
ethnic backgrounds being significantly more likely to abuse cocaine 
(Vivancos et al., 2006) and people from White backgrounds more likely 
to abuse alcohol (Grant et al., 2004).  
 
In minority  ethnic populations, studies have shown higher levels 
of drug use among African Caribbeans than among Indians and 
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Pakistanis/Bangladeshis and these differences were amplified in people 
aged between 16 and 29 years (Ramsey & Spiller, 1997).  
 
A study by Leitner et al. (1993) found that in one geographical 
location over half the White respondents had taken illicit drugs compared 
to only one third of the Black respondents. Substance use among Black 
Caribbeans often centres on crack-cocaine use and cannabis use, 
although low levels of substance use have been found in Black African 
populations (Aust & Smith, 2003).   
 
Interestingly findings from the 2001/2002 British Crime Survey 
have shown that prevalence of cannabis use in the previous year was 
higher in the Black Caribbean than in the White British population (Black 
Caribbean 17% vs. White British 11%). However, lifetime ever 
prevalence of cannabis use was roughly the same in both ethnic groups 
(Black Caribbean 33% vs. White British 30%), (Aust & Smith (2003).  
 
The prevalence of heroin use in the Black Caribbean community 
has been estimated to range between 2% and 4% (Castleton & Francis, 
1996) and alcohol consumption and alcohol-related problems in UK Black 
Caribbeans has been reported to be comparatively lower than in Whites 
(Balarajan & Yuen, 1986). Khat (a drug with stimulant properties) has 
been found to be widely used in some African communities, such as UK 
Somali (Williams & Nutt, 2005). 
 
More recently a paper by Wanigaratne, Dar, Abdulrahim & Strang 
(2003) which reviewed the relationship between ethnicity and drug use in 
the UK noted findings from the British Crime Survey which indicated that 
drug use is more widespread among Whites than within any other ethnic 
group. National reports have shown that in general, overall drug use has 
been found to be lower among minority ethnic groups than among White 
groups. Reported cannabis use prevalence has found to be highest in 
groups from mixed ethnic backgrounds in a number of studies, however, 
when adjusted for age this groups drug use levels are similar to those in 
the White population (UK Drug Policy Commission, 2010). 
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Other findings from the UK Drug Policy Commission (2010) have 
shown poly drug use is most common among White groups, compared 
with other ethnic groups. National and local records of treatment 
services, and some small scale studies, indicate that the types of drugs 
that cause individuals to seek help vary between different communities. 
For example, among the Asian community the most common reason for 
seeking treatment is problematic use of heroin, whereas almost half of 
people from White, Mixed and Black ethnic groups report alcohol use 
prior to entering treatment compared with only about a third of those of 
Asian background. 
 
Wanigaratne et al. (2003) have critiqued much of the research 
around ethnicity and illicit drug use for having small sample sizes in 
select groups (such as university students) that may not be 
representative of larger populations. The lack of valid conceptual and 
operational definitions alcohol or drug use (Wanigaratne et al., 2003), 
inconsistent use of the terms ethnicity, minority and race (McKenzie & 
Snowcroft, 1994) as well as credible and accurate measurement of such 
concepts have been identified as a problem in these studies. The UK Drug 
Policy Commission (2010) suggests caution in interpretation of these 
findings as much of this evidence comes from qualitative studies and 
discussions with users and community members and may not be 
completely representative. 
 
Nevertheless, these findings may suggest not only ethnic differences 
in substance use disorders in the general population but that similar 
patterns may also be evident in psychotic populations, compromising a 
good prognosis for both disorders in minority groups.   
 
2.4.4 Ethnicity and social disadvantage 
Bhui et al., (2005) argue that “Race” is socially constructed with 
little biological validity. They also argue that race as a risk factor may not 
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fully explain ethnic differences in health and health outcome. Recent 
research has focused on uncovering the socio-economic mechanisms that 
underpin the relationship between ethnicity and both mental illness and 
substance use or use disorders.  
 
A study by Morgan et al., (2008) has shown that patients with 
psychosis had significantly more social disadvantage (social disadvantage 
indicated by level of education, employment status, living arrangements, 
housing, relationship status and social networks) than controls. They also 
found White British and Black Caribbean cases, relative to their 
respective controls, both experienced significantly raised levels of social 
disadvantage and isolation. However, on several of the indicators, social 
disadvantage and isolation were more prevalent in the Black Caribbean 
population (current unemployment, living in rented housing, living alone, 
being single and never having had a long term relationship).  
 
In addition social disadvantage and isolation have been explored as 
possible explanations for ethnic differences in the risk and prevalence of 
substance use in minority populations. The extent to which the strength 
of the association between social disadvantage and drug abuse directly 
relates to Black and ethnic minority groups however is yet to be properly 
established (Wanigaratne et al., 2003). 
 
Recent examination of drug and alcohol use in the UK (The U.K. 
Drug Policy Commission, 2010), however has uncovered several reasons 
for ethnic differences. For example, peer pressure has been observed as 
an important reason why young people use drugs. Studies have 
suggested that drug use in young minority populations may be in part 
due to young people growing up under the influence of western culture 
and trends may seek to distance themselves from ‘traditional’ cultural 
values in order to ‘fit in’ (Fountain, 2009). Other research has suggested 
that BME communities may be at risk of drug use because they often live 
in disadvantaged and deprived areas, where drug markets thrive 
(Bashford et al., 2003). 
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Similarly several minority ethnic groups, in particular refugees and 
asylum seekers, often face high levels of unemployment, isolation and 
social exclusion (Nabuzoka and Badhadhe, 2000). Limited opportunities 
can lead to frustration, boredom and anxiety increasing the likelihood of 
drug use (Bashford et al., 2003). High levels of cannabis use within Black 
ethnic communities have also been explained in terms of: perceptions 
that cannabis is a safer drug; a history of cannabis use within the family; 
for Rastafarians, cannabis use is a spiritual act and part of the ‘culture’ of 
the movement (Fernandez, 2002; Sharp & Budd, 2005; Fountain et al., 
2009a-e). 
 
Figure 2 highlights how ethnicity might be linked to social 
disadvantage and risk factors for mental illness and substance use 
disorders. Here, ethnicity which is combines biological or physical 
attributes as well as the cultural/social or religious attributes, is a risk 
factor for various forms of social disadvantage. This social disadvantage 
in turn is a risk factor for mental illness and/or substance use disorders. 
 
What we also see from the figure below is that social disadvantage 
might play only part of the mediating role in the relationship between 
ethnicity and poor health outcomes such as mental illness or substance 
use disorders. Acculturation has been defined as a multidimensional 
concept reflecting complex processes of adaptation to a new country, 
society and culture (Ortega et al., 2000). It has been found to impact on 
risk of mental disorder (Ortega and Rosenheck, 2000) and substance use 
disorders (Amaro et al., 1990), though results have not been entirely 















Acculturation, assessed through preferences for spoken and 
written language, personal assessment of nationality, and personal and 
parental nativity (e.g. Burnam et al., 1987; Ortega and Rosenheck, 
2000) has been investigated by Ortega et al., (2000). Comparing three 
Hispanic ethnic sub groups (Mexican American, Puerto Rican and Other 
Hispanic), the study found that Mexican Americans who spoke English as 
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a first language at home as a child were more likely to have 3 or more 
disorders (including psychiatric and substance use disorders) compared 
with those who did not speak English. Similarly persons from ‘other’ 
Hispanic ethnic groups that were U.S. born or whose current language at 
home was English were more likely to have any psychiatric or substance 
use disorder.  
 
The above study concluded that acculturated Hispanics of different 
nationalities have an increased risk for both psychiatric and substance 
use disorders than their less acculturated counterparts. 
What these studies suggest is that while ethnicity may be a 
predictor of risk for certain psychiatric disorders, outcomes in mental 
illness and increased rates of substance use disorders in the general 
population, this relationship should be considered within the wider 




2.5 CONSIDERATIONS AND LIMITATIONS OF PREVIOUS 
EPIDEMIOLOGICAL RESEARCH 
2.5.1 Additional risk for poor outcomes? 
From the research described previously it is clear that substance 
use is highly prevalent in psychotic populations and that patients with a 
comorbid substance use disorder are more likely to have negative 
outcomes; such as more frequent hospital admissions and more 
psychotic relapses.  
 
It is also clear that patients from Black Caribbean ethnic groups 
are at increased risk of having a psychotic disorder and of using certain 
illicit substances. What isn’t clear is whether increased risk of psychosis 
and certain types of substance use in the general population equates to 
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increased risk of substance use disorders in psychotic populations in 
patients from a Black Caribbean ethnic background. 
 
Additionally, if we know that comorbidity is related to poorer 
outcome (such as compulsory admission and illness relapse) in psychotic 
populations and that outcome in patients with psychosis also differs by 
ethnicity, can we infer that certain ethnic groups with a comorbid 
diagnosis will have an even more elevated risk of negative outcome 
compared to others? 
 
 
2.5.2 Methodological considerations 
As with many epidemiological studies of first-episode psychosis 
study sample size is often a problem. This is even more the case when 
studies have sought to uncover ethnic differences. When we look 
specifically at studies of pathways to care there is a difficulty in 
interpreting findings because previous contacts with services (that may 
or may not have resulted in treatment) may confound results. In 
addition, the data sources (most often case notes), and heterogeneity of 
instruments used to collect details of psychopathology and service use 
makes comparisons between studies and general conclusions difficult. 
 
When studies have estimated prevalence of comorbidity they have 
relied on the ability of practitioners to identify, classify and record details 
of patients with comorbid substance use problems.  However, as I will 
discuss in the next chapter, there is often no consensus on how they 
define ‘dual diagnosis’ (Todd, 2004).  
 
When we examine studies that have sought to investigate ethnic 
differences we see that categorisations are often crude, ill-defined and 
inconsistent and as Morgan et al. (2004), notes the choice of ethnic 
categorisation may obscure important differences between groups 





Despite methodological inconsistencies in the measurement of 
comorbidity, we can see from this literature that rates of comorbid 
substance use disorder in psychotic populations vary by country with 
prevalences estimated as high as 70%. Furthermore comorbidity is 
associated with various negative outcomes including more frequent 
relapses and more frequent hospitalisation. Few studies have found 
beneficial interventions for people with dual diagnoses despite integrated 
treatment approaches. 
 
People from minority ethnic groups are at an increased risk for 
psychotic disorders compared to whites. They are also more likely to use 
certain illicit drugs suggesting that there might be an increased likelihood 
for comorbid diagnoses among minority ethnic populations, specifically 
people with Black Caribbean ethnicity. This notion forms the rationale for 
the systematic review outlined in the next chapter. 
 
Chapter Summary 2.  
Chapter Summary 
 
Aims of the Chapter: 
 
To build on the rationale for the PhD study by providing a critical review of 
epidemiological research in the area of comorbid substance use disorders in first 
episode psychosis (FEP).  In relation to the aims and objectives of the PhD study 
the chapter addressed the question why ethnicity should be of interest in 




 Prevalence’s of comorbidity vary between countries 
 Comorbidity is associated with various negative outcomes 
 People from minority ethnic groups are at an increased risk for psychotic 
disorders compared to whites 
 There are ethnic differences in the types of illicit substances used. 
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CHAPTER 3:  ETHNICITY AND COMORBID 




As discussed  in Chapter 2, reports have shown high rates of 
psychosis among the Black Caribbean and Black African populations 
(Sharpley M. S., Hutchinson G., McKenzie K. et al., 2001), not to mention 
numerous studies showing these groups to be at greater risk of 
compulsory admission to hospital (Morgan et al., 2004; Morgan et al., 
2005; Bhui et al., 2003).   
 
Prevalence of illicit drug use in the general population has been 
observed to differ between and within ethnic groups as well (Aust & 
Smith, British Crime Survey 2001/2002), with suggestions that drug use 
in Black African groups is lower than in Black Caribbean or White ethnic 
groups and that drug use between Black Caribbean and White groups are 
similar (Aust & Smith, 2003). 
 
As we saw in section 2.2 studies have documented comorbidity to 
be associated with a greater likelihood of admission to hospital and 
poorer outcomes (including worsening psychiatric symptoms; increased 
use of institutional services; poor medication adherence; and contact with 
the criminal justice system) in both mental health and drug abuse 
treatment services (Hunt et al., 2002).  
 
Much of the epidemiological evidence surrounding comorbidity 
comes from the USA (Carra et al., 2009). The Epidemiologic Catchment 
Area (ECA) being one of the largest studies of this type, found that 47% 
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of people with schizophrenia had a comorbid substance use disorder, with 
odds of meeting criteria for such a disorder 4.6 times higher for 
individuals with schizophrenia than for the rest of the US population 
(Regier et al., 1990). It has been reported that Black psychiatric patients 
are more likely to receive a comorbid psychiatric diagnosis compared to 
Whites (Febrega et al., 1989), however this was not found in the ECA 
study (Regier et al., 1990). 
 
However, there is very little evidence regarding the relationship 
between comorbid psychosis and substance use disorders and ethnicity 
internationally or in the UK. Consequently very little is known about the 
prevalence, characteristics of and outcomes for these groups which have 
implications for policy and practice in the mental health and substance 
abuse treatment fields. The purpose of this review is to investigate 
whether there is evidence of ethnic differences in the prevalence and 





3.2.1 Search strategies 
Literature searches were conducted within the following four 
sources. A search term strategy was used for searching each source (see 
appendix 2).  
 
1. Electronic databases1: 
OVID Databases (EMBASE, OVID MEDLINE In-Process and other non-
indexed citations, OVID MEDLINE, AGRIS, Social Policy and Practice and 
                                                 
1
 Each database was searched from the earliest dates available 
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PsychInfo) were searched. Web of Knowledge (Inpspec, Medline, Web of 
Science, Biosis citation index and previews, and Journal citation reports), 
was also searched.  
 
2. Web based sources 
Searches were conducted using the web based search engine Google 
Scholar. Google Scholar is considered one of the major academic search 
engines (Jean-François, Laetitia & Stefan, 2013). It uses a ranking 
algorithm in a similar "way researchers do, weighing the full text of each 
article, the author, the publication in which the article appears, and how 
often the piece has been cited in other scholarly literature"(Google 
Scholar). Research into the ranking on this search engine has shown that 
Google Scholar puts high weight on citation counts (Beel & Gipp, 2009a) 
and words included in a document's title (Beel & Gipp, 2009b).  
 
This means the first search results are often highly cited articles. 
Because of the strength of the search engine and the high number of 
possible hits that can be obtained, a more conservative collection of 
search terms were used for web searches.  Search results were found to 
be duplicated after the first few search result pages. No further review of 
results pages were conducted when duplication became clear. Google 
Scholar search results report the title and the first few sentences within 
the paper that contain the keywords being searched for. These sentences 
may or may not include part of the abstract but provide enough 
information to determine whether a paper should be downloaded in full 
text to be scrutinized further. 
 
The internet has improved the visibility of ‘grey literature’ however 
in addition to these electronic databases, the website Scirus (a website 
which included grey literature) was also searched using the same search 
term strategy as the web searches. 
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3. Reference lists of eligible papers 
Once a sample of eligible full text papers had been sampled from the 
electronic database and web searches, the reference lists of those papers 
were reviewed and papers that were considered relevant to the topic area 
were obtained in full text for further screening for eligibility. 
 
4. Personal contacts:  
Key authors in the areas of comorbidity and ethnic differences in mental 
health were consulted for additional information on any published and 
unpublished studies in this area (Dr. Sarah Afuwape and Dr. Dinesh 
Bhugra).   
 
 
3.2.2 Search terms 
Psychosis is an umbrella term for several psychiatric diagnoses 
including Schizophrenia, Schizoaffective disorder, Bipolar and Psychotic 
Depression. To be as inclusive as possible several terms relating to 
psychosis and substance use disorders were used when searching 
electronic databases and web searches.  A full overview of the search 
terms used as part of the search strategy can be found in Appendix 2.  
 
Terms were  linked together using the boleon term ‘and’ and wild 
cards (the use of an asterix * to replace unknown characters of a word 
that shares the same core or stem as another word e.g. schizo* would 
also include schizophrenia and schizoaffective), were used where 
necessary.  
 
Searches conducted in the electronic databases were done in 
stages: each database was searched individually; each term (which was 
expanded to include all formations) was entered individually and then 
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combined with other related terms to narrow down the results further. 
This process was continued until all relevant term variations for psychosis 
and substance use disorder and ethnicity were combined. The OVID 
databases allow for abstracts as well as titles of search results to be 
displayed. Both titles and abstracts for OVID databases were screened 
manually for relevance and eligibility (see below). All papers considered 




3.2.3 Study inclusion criteria and method for determining 
eligibility 
Comorbidity can be defined in many ways (see section 1.2.2). This 
review was interested in literature concerned with the comorbidity or dual 
diagnosis of patients with a diagnosed psychotic illness and a co-
occurring substance use disorder (namely substance misuse, diagnosed 
abuse or dependence of alcohol or illicit drugs).  
The inclusion criteria for the review were as follows: 
a) Study participants (or a sub sample of participants) had a 
diagnosis (either ICD-9 or -10, or DSM III IIIR, or IV), of psychosis 
(schizophrenia, schizoaffective disorder or bipolar disorder with 
psychotic features, other non-organic psychotic disorder) as well as 
comorbid substance (alcohol or illicit drug), misuse, diagnosable 
abuse or dependence 
b) Analyses reported ethnic differences in the prevalence, outcome or 
patient characteristics of the sample. 
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To be as inclusive as possible, studies that investigated comorbid 
substance misuse were included as well as those studies that identified 
diagnosable drug use disorders.  
 
Studies investigating bipolar disorder were included as long as their 
sample (or part of their sample), were psychotic. This information about 
the sample was usually ascertained during review of the full text 
document. Studies which focused on mental illness in general were 
excluded unless they documented (e.g. through comparison) ethnic 
differences in the prevalence or risk of a comorbid psychotic illness with 
co-occurring substance use disorder.  
 
As highlighted in the previous chapters, as well as the methodological 
considerations of this review, defining comorbidity can be problematic. 
Many epidemiological studies examine comorbid substance ‘use’ and 
either do not distinguish between those who have problematic use or a 
diagnosable substance use disorder or alternatively use the terms 
interchangeably (Barnes et al., 2006). This makes comparability of 
findings in this area problematic.  
 
The exclusion criteria for the review were as follows: 
 
a) Studies which investigated psychopathology other than psychosis 
b) Studies that investigated non-problematic substance use or 
included non-problematic substance use in their definition of 
comorbidity 
c) Studies which did not report differences in prevalence, outcome or 
sample characteristics by ethnicity 
 
All titles and abstracts produced by the searches were screened for 
relevance to the topic area. Full text documents were then obtained for 
all publications that were considered to be eligible. As mentioned above 
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the reference lists of papers that were considered eligible were also 
screened for relevance and full text papers obtained. Those papers where 
then subjected to screening for eligibility and a final sample of eligible 
papers was produced. This type of method is advocated by the Cochrane 
collaboration in their handbook for conducting systematic reviews 
(Higgins and Green, 2008). 
 
It should be noted that this review is not a meta-analysis but a 
narrative review with interpretation of evidence.  The number of papers 
identified was small and the definitions of both ethnicity and comorbidity 
were so varied that it was impossible to conduct a meta-analysis.  
 
 
3.2.4 Papers excluded from the review 
Ninety-one papers did not meet the eligibility criteria and 
subsequently were not included in the review (see Figure 3). Reasons for 
exclusion were varied. Seventy-two studies were excluded because they 
focused on comorbid Axis I mental illness and comorbid substance use 
disorders and did not present data on psychotic illness comorbidity 
separately and/or they did not present findings by ethnic group. Fourteen 
studies were excluded because their focus was on Bipolar disorder and as 
with the general Axis I mental illnesses did not present findings on 
patients with psychotic illnesses. Several studies (n=4) after review of 
the full text papers were found to be investigating comorbid non-
problematic substance use or failed to report a consistent operationalised 
concept of comorbidity and so were excluded.  
One of the papers obtained was a systematic review of comorbid 
psychosis and substance use disorders (Carra et al., 2009). Although the 
review by Carra et al. (2009) had similar inclusion criteria, several papers 
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included did not meet this reviews inclusion criteria. Subsequently this 








Figure 3: Flowchart showing stages for obtaining final sample of 






Fourteen studies were identified. Four studies were conducted in the 
UK, seven studies were conducted in the US, two studies were conducted 
in Europe, and one study was a systematic review of studies conducted in 
three different locations around the world.  None of the studies were 
conducted in a substance abuse population. Three studies were 
conducted in services for dually diagnosed patients; Two studies were 
general population based; and the remaining studies were conducted 
among psychotic populations. 
 
From a detailed analysis of all the eligible papers the collective 
findings can be categorised into six different areas: ethnic differences in 
the estimated prevalence of comorbidity; ethnicity as a risk factor for 
comorbidity; ethnic differences in drug choice; ethnic differences in 
psychiatric diagnosis and symptom severity of patients with comorbidity; 
ethnic differences in treatment outcome; and ethnic differences in 
experiences of services. 
 
 
3.3.1 Ethnic differences in the prevalence and correlates of 
comorbid substance use disorders in psychotic populations 
Evidence relating to ethnic differences in the prevalence of 
comorbid substance use disorders in psychotic populations was mixed. 
The earliest paper obtained from searches for this review was an 
American report by Rosenthal et al. (1992). The paper examined patterns 
in demographics, symptoms and substance abuse in patients with co-
occurring substance use disorders and schizophrenia. The paper reported 
on three studies.  
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The first study looked at number of cases that met DSM-III criteria 
for substance use disorder (PSUD) in schizophrenic inpatients. The 
second study analysed data on schizophrenic admissions to a dual 
diagnosis unit and the third study assessed the benefits of integrated 
outpatient treatment in an early model of a dual diagnosis program – The 
Combined Psychiatric and Addictive Disorders Program (COPAD) at Beth 
Israel Medical Center (BIMC) in New York. 
 
For the first study, all 1792 psychiatric hospital admissions were 
examined over a one year period (1985). Six hundred and two patients 
were identified as suffering from a schizophrenic disorder, and of those 
24.3% (n=146) were deemed to a have a co-occurring substance (drugs 
and ethanol) use disorder (dual diagnosis group). This dual diagnosis 
group consisted of three ethnic groups with nearly equal proportions of 
Black (34.2%), Caucasian (37%), and Hispanic (28.1%) patients.  
 
A group of 146 non-substance abusing schizophrenic patients 
admitted immediately subsequent to each dual diagnosis admission was 
selected for comparison. A greater proportion of Hispanics were found 
among the dual diagnosis group than among the non-abusing 
schizophrenic group; the reverse was found for Caucasian patients. These 
patterns were not observed for African-Americans in abusing and non-
abusing groups. 
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Measure of  
Comorbidity 
Ethnic Distribution 
of Exposed Samplea / Prevalence of 









and key informant) 
Alcohol misuse 
(11.7%; n=18)  
Drug misuse 
(19.5%; n=30) 
Diagnosis of psychotic disorder according to 
ICD-10 and co-occurring substance (drug) 
misuse 
Substance b:  
Non-African-Caribbean (32.0%) and-
African-Caribbean (6.9%). 
















Diagnosis of psychotic illness (schizophrenia 
or schizoaffective disorder, bipolar affective 
disorder, or delusional disorder) according to 
ICD-10 and co-occurring abuse, dependence 
or dependence with institutionalisation of 
drugs and/or alcohol. 
 
 
Alcohol onlya: White 68%; Black 23%; and 
other 9% 
Cannabis onlya: White17%; Black 79%; and 
Other 3% 
Alcohol onlyb: White, 15%, n=101; Black 
Caribbean, 5%, n=11; Black African, 14%, 
n=11; Black British 23% n=27 
Cannabis onlyb: White, n=42, 6%; Black 
Caribbean, n=15, 7%; Black African, n=12, 
10%; Black British, n=46, 40% 
Stimulant onlyb: White, n=25, 4%; Black 
Caribbean, n=6, 3%; Black African, n=5, 
4%; and Black British, n=13, 11% 




Self report 100% Diagnosis of Schizophrenia, Bipolar Affective 
Disorder, Severe Personality Disorder, and 
problematic or harmful use of psychoactive 
substances including prescription drugs or 
Substancea: White British (n=3); Black 
Caribbean (n=2); Somalian (n=2); 
Ethiopian (n=1); and Mixed Ghanaian and 
Scottish (n=1) 
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Measure of  
Comorbidity 
Ethnic Distribution 
of Exposed Samplea / Prevalence of 














Study 1: 24.3% 
(n=146) 
Study 3: 100% 
(n=30) 
Diagnosis of substance (drugs and ethanol) 
use disorder and schizophrenia according to 
DSM-III criteria 
Study 1a: Caucasian (37%), Black (34.2%), 
and Hispanic (28.1%) 
Study 3a: White (Caucasian) (33.3%); Black 






Case note review of 
administrative data 






Diagnosis of a primary psychotic disorder 
(Schizophrenia, Schizoaffective Disorder; 
Bipolar Affective Disorder with psychotic 
symptoms; Unipolar Major Depression with 
Psychotic Symptoms; Atypical Psychotic 
Disorder) with co-occurring Alcohol abuse or 
Drug abuse according to DSM-III-R. 
Alcohol onlya:  Black (30%); White (26%); 









100% (n=100) Diagnosis of schizophrenic type disorders 
(schizophrenia or schizoaffective) with co-
occurring substance use disorder according 
to DSM-III-R 
Substancea:  White (n=69) and Ethnic 
(n=31) 
 








Not specified Diagnosis of schizophrenia, schizoaffective 
disorder, or bipolar disorder with a co-
occurring diagnosis of substance (drug or 
alcohol) abuse or dependence according to 
Not specified 
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Measure of  
Comorbidity 
Ethnic Distribution 
of Exposed Samplea / Prevalence of 
Exposure within Ethnic Groupsb  





Case note review of 
administrative data 
based on routine 
clinical assessment 
27% (n= 18,842) Diagnosis of Schizophrenia and co-occurring 
substance use disorders/substance abuse 
Substanceb: African American (38%); 
Hispanic (23%); 
White (22%) 





Case note review of 
administrative data 









Diagnosis of schizophrenia with co-occurring 
substance related and alcohol related mental 
disorders mental disorders according to ICD-
9-CM (drug psychoses; drug dependence; 
non-dependent abuse of drugs; alcohol 
psychoses; alcohol dependence syndrome; 
and alcohol abuse). 
Drug onlya:  African American/Black 
(63.7%); Caucasian/White (27.2%) 
Alcohol onlya:  African American/Black 
(64.7%); Caucasian/White (23.9%) 
Other 
Cantor-Graae 










rating and case note 
review 
48.2% (n=42) Diagnoses of schizophrenia and co-occurring 
diagnosis of substance abuse or dependence 
according to DSM-IV 
Not specified 
Veen et al. FEP  Routine clinical 26%; n=47 Diagnosis of psychotic disorder Drug onlyb: Dutch (23%); Moroccans 
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Measure of  
Comorbidity 
Ethnic Distribution 
of Exposed Samplea / Prevalence of 











schizoaffective disorder, mood disorder with 
psychotic features, delusional disorder, brief 
psychotic disorder, shared psychotic disorder 
or psychotic disorder not otherwise 
specified) according to DSM IV with co-
occurring substance (drug) misuse in the 
previous year. 
(17%); Surinamese (27%); Turkish (30%); 
Others (33%) 















and relatives) and 
case note review 
Not Applicable Diagnosis of schizophrenia or schizoaffective 
disorder and co-occurring substance abuse 
or dependence according to DSM-IV 
Cannabis onlyb: Australia (45.5%); India 
(0%); Sarawak (0.8%) 
Other drug onlyb: Australia (26.5%); India 
(0.0%); Sarawak (2.6%) 
Alcohol onlyb: Australia (40.7%); India 
(0.8%); Sarawak (10.5%) 
 
 
*Patients with both psychosis and substance use disorder as defined by the study. **unduplicated cases for 2003 only
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The second study focused on sociodemographic and clinical 
characteristics of a sample of 457 consecutive admissions to a Psychiatric 
Substance Abuse Inpatient Unit during 1989. Of these, 106 (23%) 
inpatients were diagnosed with DSM-IIIR schizophrenia (or 
schizoaffective disorder). Although examination of the ethnic distribution 
of the sample was conducted: Caucasian (29.8%); Black (28.9%); 
Hispanic (33.0%); and Asian (<2%), these analyses were not conducted 
on the subsample of dual diagnosis patients with schizophrenic (or 
psychotic) disorder. 
  
The third study which assessed the COPAD program conducted at 
the Psychiatric Substance Abuse inpatient unit of BIMC compared 
integrated and non-integrated outpatient treatment of PSUD 
schizophrenic patients. The inclusion criteria for the programme were: 
patients aged between 18-50 years; a Research Diagnostic Criteria 
diagnosis of schizophrenia-continuum disorder, concurrent DSMIII-R 
psychoactive substance abuse/dependence (PSUD) and an expressed 
desire for substance abuse treatment. Thirty patients took part in the 
program. Similarly to the first study the sample was split equally between 
three ethnic groups; White (Caucasian) (33.3%); Black (36.3%); and 
Hispanic (30.0%). No further analyses were conducted with regard to 
sensitivity of diagnosis, symptom severity, patterns of substance abuse 
or treatment outcomes.  
 
Although this early paper shows higher prevalence of Hispanic 
patients in substance abusing schizophrenic populations compared with 
non-substance abusing schizophrenic populations, several critiques 
however can be made. Firstly, the first and third studies did not conduct 
statistical tests to see if ethnic differences were significant. In addition, 
the non-abusing group (control group) in the first study was not selected 
randomly.  
 
The authors note that since the diagnostic criteria and methods of 
data collection differed between studies, comparability is limited. For 
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example, they highlight that while routine clinical assessment and 
standardized structured interviews were used consistently between 
studies to determine schizophrenia spectrum disorders, the measures 
used to determine substance abuse were not. Study One revealed that 
11% of schizophrenics were DSM-III substance abuse/dependence 
diagnosed while Study Three yielded a 90% dual diagnosis sample. 
 
An early 90s US study investigated the effects of race and 
comorbidity on clinical diagnosis in patients with psychosis (Strakowski et 
al., 1993). Retrospective clinical review of 231 case records of a large 
public hospital in Tennessee USA was conducted. They found that 173 
patients (74.9%), met criteria for a primary psychotic disorder according 
to DSM-III-R criteria in discharge summaries. Comorbidity was defined as 
a non-primary diagnosis of an Axis I or Axis II disorder and was 
categorised into three groups: Drug abuse; Alcohol abuse; and any other 
psychiatric disorder. 
 
Comorbid drug abuse was diagnosed in 20.2% (n=35) of patients 
and comorbid alcohol abuse was diagnosed in 27.2% (n=47) patients. 
There were no statistically significant differences in the prevalence of 
comorbid alcohol (Black patients, 30.4%; White patients, 25.6%) and 
drug (Black patients, 23.2%; White patients, 18.8%) abuse between 
Black and White patients.  
 
Further analyses were done on a sub-sample of patients who had 
been discharged from their first hospitalisation (n=39). Analyses were 
performed on this sub-sample, examining ethnic differences for those 
with and without a schizophrenic psychotic disorder in terms of 
comorbidity. Although ethnic differences in prevalence of comorbid 
alcohol (for example Black Schizophrenics, 42.9% vs. White 
Schizophrenics, 20.0%) and comorbid drug abuse (for example Black 
non-Schizophrenics, 0% vs. White non-Schizophrenics 25%) between 
these two psychotic groups was observed, the numbers were too small of 




Jerrell and Wilson (1996 & 1997) examined ethnic differences in 
White and ethnic minority clients’ psychosocial functioning, psychiatric 
and substance abuse symptomatology from a clinical trial examining the 
relative cost effectiveness of three specialized interventions for dual 
disorders (Behavioural skills training, case management, and a 12-step 
recovery model).  Clients in the study were adults, aged between 18 to 
59, who had an Axis I DSM-III-R diagnosis with a co-occurring substance 
disorder and had undergone psychiatric treatment one or more times in 
an inpatient facility. 
 
They found that White clients made up the biggest proportion of 
service users (n=92, 70%). Ethnic minority clients fell into 4 different 
groups: Hispanics n=26 (20%); African-Americans n=8 (6%); Asian 
Americans n=3 (2%); and Native Americans n=3 (2%). These groups 
however were combined into one ‘Ethnic’ group for the purpose of 
analyses.  
 
Separate analyses of ethnic differences in the prevalence of 
schizophrenic type disorders (schizophrenia or schizoaffective) with 
comorbid substance use disorders versus other Axis I disorders with 
comorbid substance use disorder were conducted. Schizophrenic type 
disorders were present in 75.0% of White comorbid groups (n=69) and 
77.5% of Ethnic comorbid groups (n=31) (p=0.76). No statistical 
differences were present showing equivalent prevalence’s between the 
two groups. Additional analyses on ethnic differences in the whole sample 
(age, gender, drug severity, service use, functioning and treatment arm 
outcomes) were conducted. However these analyses were not performed 
separately for the schizophrenia type comorbid group. 
 
A UK study by Cantwell et al. (1999) looked at the prevalence and 
pattern of substance use and misuse in first-episode psychosis. Between 
1992 and 1994 all patients aged between 16-64 presenting to secondary 
care services for the first time with psychotic symptoms were examined. 
Patients who met criteria for substance withdrawal or intoxication states 
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were excluded. In total 168 patients were included in the study. Data on 
substance use and misuse were collected using a combination of the 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (or where 
an interview with the patient was not possible the Item Group Checklist), 
and the Personal and Psychiatric History Schedule (PPHS) 
 
Substance use was categorised in three ways; any drug use (use 
of illicit drugs at least once a month in the year before inclusion in the 
study); any drug misuse (daily use for a period of at least 2 weeks in the 
same year); and alcohol misuse (daily use for a period of at least 2 
weeks in the same year associated with evidence of significant 
psychological, social harm or dependence). An analysis on each drug that 
was misused was also conducted. 
 
Of 168 patients included in the study only 18 (11.7%) met criteria 
for alcohol misuse and 30 (19.5%) for drug misuse. Substance related 
psychosis was reported in 13 patients and 92% of those patients were 
White (n=12). The prevalence of comorbid substance use was equivalent 
in White, African-Caribbean and other ethnic groups (9/29 African-
Caribbean users v. 48/125 non-African-Caribbean users). However 
substance misusers were less likely to be of African-Caribbean ethnicity 
(2/29 African-Caribbean compared with 40/125 non-African-Caribbean 
x2=7.48, P<0.007; OR 0.16, 95% CI 0.02-0.73).  
 
The concern with these findings is that the number of patients in 
the African-Caribbean group was very small and might be considered too 
small for valid statistical analysis. The small number of non-White 
patients in the sample may have been due to the geographical location of 
the study population (Nottingham).  
 
The findings from this study highlight one of the reasons why 
smaller studies have tended to collapse ethnic minority groups into one 
category and compare them to patients native to the study’s country. 
Another point to be considered is that African-Caribbean’s were compared 
to a heterogeneous group of ‘non-African-Caribbeans’, who do not 
 70 
necessarily share the same social, cultural or economic experiences. 
Additionally the findings cannot be compared to studies that examine 
differences between White (Caucasian) native and African or Caribbean 
immigrant groups. Cannabis and alcohol were the most commonly 
misused substances yet Cantwell et al. (1999) note that although use of 
other substances was not uncommon, misuse as defined by their criteria 
was rare. Suggesting the possibility of too restrictive criteria which may 
have led to an under-diagnosis of comorbidity. 
 
A first incidence of psychotic illness study was conducted in The 
Hague, Netherlands (Selten, Slaets & Kahh, 1997; Selten & Sijben, 1994; 
Selten, Veen, Feller et al., 2001). All individuals aged between 15 and 54 
years old who made contact with a physician for a suspected psychotic 
illness between April 1997 and April 1999 were included. The aim of the 
study was to compare the risk of first contact with services for a 
psychotic disorder between the native Dutch (those who were born and 
whose parents were born in the Netherlands), and immigrant 
populations.   
 
Immigrants (both first and second generation) were divided into 
four ethnic groups: Turkish; Moroccan; Surinamese; and other.  The only 
patients excluded from the study were those who were diagnosed with 
substance induced psychosis and patients who were illegally resident in 
The Hague or had been resident there for less than six months.  Veen et 
al. (2002) reported on information collected on substance use as part of 
the study. Based on definitions used in the earlier UK study by Cantwell 
et al. (1999) substance use was split into two types; any substance use; 
and any substance misuse. Cannabis misuse was also analysed 
separately.  
 
The final study sample consisted of 179 subjects. One hundred and 
ten (61%) patients were diagnosed with schizophrenic disorders (DSM-
IV: 295.x), 21 (12%) with mood disorders with psychotic features (DSM-
IV: 296.x4) and 50 (28%) with other nonorganic psychotic disorders 
(DSM-IV: 297.1, 298.8, 298.9). 
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The study observed that 23% of Native Dutch (Caucasian) 
psychosis patients had substance misuse. The lowest prevalence of 
substance misuse was found in Moroccan patients (17%) and the highest 
prevalence in the ‘Other’ ethnic group of patients (33%). Despite this, no 
significant differences in the prevalence of any substance use, any 
substance misuse or cannabis misuse were found between immigrants 
and Dutch national patients. One of the methodological critiques of this 
study (as with many epidemiological studies in this area), is that 
substance use and misuse was assessed using verbal information from 
the patients, key informants and the responsible clinician and not a 
structured measure of substance misuse which may have led to some 
measurement bias. 
 
Another study published in 2003 by Copeland et al. (2003) 
assessed racial differences in the prescription of antipsychotic medication 
among schizophrenic veterans receiving care through the Department of 
Veterans Affairs. Outpatient pharmacy records from the National VA 
Psychoses Registries for a year period (October 1998 to September 1999) 
were examined. 
 
Patients were included in the study if they had been diagnosed 
with schizophrenia, if they were given prescriptions for antipsychotic 
medication as outpatients (n=69,787), and if valid data regarding race 
and age (age ≥18) were available. The diagnosis of schizophrenia was 
obtained from administrative data for outpatient visits and inpatient stays 
and patient’s race was recorded on the database as “observed” race. The 
ethnic breakdown for the sample included 5,955 Hispanic patients 
(8.5%), 21,032 African American patients (30.1%), and 42,800 White 
patients (61.3%). The category “Hispanic black” (0.6%) was considered 
too small for separate analyses so was combined with “Hispanic White” 
(7.9%). Patients were considered to have comorbid diagnosed substance 
abuse if it was noted in either inpatient or outpatient records on at least 
two occasions.  
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The study found that around 27% of the patients had a diagnosis 
of substance use or dependence during the study period. In line with the 
Ahuja et al. (2007) study substance use disorders were more common 
among African American patients (38%) than Hispanic (23%) or White 
patients (22%) (χ2=2001.6; d.f.=2, p<0.0001). Although it was found 
that having a comorbid diagnosis of substance abuse increased the 
likelihood of receiving certain antipsychotics they failed to identify 
whether these increased likelihoods were the same in different ethnic 
groups.  
 
A UK based study by Miles et al. (2003) investigated the 
characteristics of a group of patients with a comorbid psychotic illness 
and substance use disorder. Data was collected as part of the 
Comorbidity Dual Diagnosis Study (COMO), a randomized controlled trial 
of a case manager training intervention focused on knowledge and 
attitudes about dual diagnosis and on clinical and social outcomes of the 
case manager’s clients.  
 
Thirteen community mental health teams (CMHTs) took part and 
case managers were randomly allocated to either an experimental group 
who received training immediately or a control group who received 
training after 18 months. Patients with an ICD-10 diagnosis (made by 
psychiatrists and recorded in case notes) of a psychotic disorder as well 
as a rating of comorbid drug or alcohol abuse or dependence were 
included in the study (Miles et al., 2003; Afuwape et al., 2006). 
Screening of all patients was done by case managers using the Clinician 
Alcohol Use Scale (CAUS) and the Clinician Drug Use Scale (CDUS) and 
patients who were rated as at least abusing or dependent on at least one 
substance met the study criteria for dual diagnosis. 
 
Of the 1,560 clients on the caseloads of these case managers, 
1,271 had a clinical diagnosis of psychotic illness. Eighteen percent of 
cases with a psychotic illness (n= 233) met the criteria for dual 
diagnosis. Of those 233 patients only 69% (n=160) agreed to be 
interviewed, however in addition to the CAUS and the CDUS the Alcohol 
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Use Disorders Identification Test (AUDIT), was completed by case 
managers for all patients giving detailed information about patterns of 
substance use.  
 
Categorisation into substance abuse groups was based on ‘best 
available information’ for all sources. For those who were interviewed 
(and admitted substance use) self-reported substance misuse was used 
whereas case manager recorded substance abuse/dependence was used 
in all other cases. After sensitivity analysis of case manager and patient 
reported drug abuse only 213 patients remained in the dual diagnosis 
sample. 
 
Substance abuse/dependence was categorised into four different 
groups for the main analyses: Alcohol only; cannabis only; stimulant 
only; and cannabis and alcohol. Analysis of Variance and Kruskal Wallis 
test were completed and on significant results post hoc Bonferroni 
contrasts were used to compare pairs of subgroups. Significant 
differences were found by ethnicity (F=21.228, d.f.=3, p<0.001; n=210). 
Post hoc tests confirmed that patients in the alcohol-only subgroup were 
more likely to be White European (White 68%, Black 23%; and other 
9%), whereas those in the cannabis-only subgroup were more likely to 
be ‘black’ (Black Caribbean, Black African, or Black British) (White17%, 
Black 79% and Other 3%). Differences in ethnicity were still significant 
when the analyses were repeated first with the subgroups based on the 
case managers’ ratings and then with the subgroups based on patients’ 
self-reported substance use. 
  
Despite being one of the first studies in the UK to look at ethnic 
differences in comorbidity psychosis and substance use disorder 
populations and more importantly considered to have tight definitions of 
this type of comorbidity, a few methodological criticisms can be made of 
this study. For patient self-reported drug comorbidity (namely not 
alcohol), any reported use in the previous month was considered 
potentially problematic and used in analysis. The rationale behind this 
being that persons with severe mental illness may be vulnerable to 
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adverse effects of even low levels of drug use (Mueser et al., 1992; 
Drake et al., 2001) (Miles et al., 2003).  
 
Interestingly when they compared patient and case manager 
reports, the majority of patients remained in the same category when the 
case manager ratings were used as opposed to the patients’ self-reports 
as the basis of classification (82 % (n=46) in the alcohol-only group; 
55% (n=17) in the alcohol and cannabis group; 71% (n=15) in the 
cannabis-only group; 62% (n=24) in the stimulants-only group; and 77% 
(n=10) in the other substance group). This suggests low sensitivity and 
specificity of the CDUS and CAUS scales which were used as a screening 
tool for inclusion to the study. 
 
As part of the same study Afuwape et al. (2006) looked at the 
differences in prevalence or dual diagnosis between each of the Black 
ethnic subgroups and White patients using the ratings from the CAUS and 
CDUS. Black British patients (23%, n=27) had the highest prevalence 
alcohol abuse only comorbidity (White, 15%, n=101; Black Caribbean, 
5%, n=11; Black African, 14%, n=11), (p<0.001). The same pattern was 
found for prevalence of cannabis abuse only comorbidity (p<0.001), 
(White, n=42 (6%); Black Caribbean, n=15 (7%); Black African, n=12 
(10%); Black British, n=46 (40%)), as well as stimulant abuse only 
comorbidity (White, n=25 (4%); Black Caribbean, n=6 (3%); Black 
African, n=5 (4%); and Black British, n=13 (11%)).  
 
Afuwape et al. (2006) also examined sociodemographic differences 
in White and Black subgroups.  Black African (mean age=33) and Black 
British (mean age=32) patients were significantly younger than White 
(mean age = 40) and Black Caribbean (mean age=43) patients. Black 
Caribbean patients had the longest mean contact with services with 83% 
having their first contact with services last more than five years 
compared with only 36% in the Black African group having been in 
contact for the same length of time (p<0.001). There were no other 
significant socio-demographic differences between White and any of the 
Black subgroup patients. 
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In 2007 Ahuja et al. (2007) reported on a study investigating 
ethnic differences in the clinical diagnosis of schizophrenic disorders 
(according to ICD-9) and associated comorbidities among inpatient 
discharges (n=24,810) in Louisiana hospitals between 2000 and 2003. 
The Louisiana Hospital Inpatient Discharge Database (LAHIDD) which has 
data on all inpatient discharges in the catchment area was used.  
 
Each inpatient may have had multiple admissions over the three 
years, so analysis was divided into two types: number of discharges; and 
number of patients (unduplicated discharge analysis). Forty-four percent 
of patients (i.e. unduplicated discharges) with schizophrenic illness had a 
Black/African American ethnicity compared with 31% who had a 
White/Caucasian ethnicity (n=10,214). 
 
Data on comorbidities was only available for the 2003 discharges 
(n=6,848) as the file structure of the database would not allow analyses 
of more than one year at a time. Primary diagnosis at discharge was 
recorded along with the possibility for up to eight comorbidities to be 
recorded as ‘other diagnoses’. Incidents of substance (drug) related 
mental disorders and alcohol related mental disorders according to ICD-9 
(drug psychoses, drug dependence, non-dependent abuse of drugs, 
alcohol psychoses, and alcohol dependence syndrome and alcohol abuse) 
found in one or more of the eight ‘other’ diagnoses were selected for 
analysis.  
 
Of the 6, 848 discharges for with a schizophrenic illness in 2003 
Ahuja et al. (2007) found that 54.7% of discharges were from Black 
(Black or African American) patients compared with 31.9% from White 
(Caucasian) patients. At patient level (unduplicated discharges) 53.2% of 
patients with a schizophrenic illness were Black and 34.0% were White 
(n=3,950). Of all 2003 patients discharged with a schizophrenic illness 
1,082 (27.4%) had a comorbid substance related mental disorder 
recorded as one the eight ‘other’ diagnoses and 394 (10%) discharges 
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had an alcohol related mental disorder recorded as a comorbidity in one 
of the eight ‘other’ diagnosis.  
 
When the ethnic distribution of discharges and patients with co-
occurring substance and alcohol use disorders were examined they found 
that 64.1% of discharges with substance related comorbidity were from 
patients with a Black ethnic grouping and 24.8% were from a White 
ethnic grouping. For those discharges with an alcohol related 
comorbidity, 63.4% were from a Black ethnic group compared with 
23.5% from a White ethnic group (n=6,848). Looking at the ethnic 
distribution at patient level they found that 63.7% of patients with 
substance related comorbidity were Black and 27.2% were White. For 
alcohol related comorbidity, again a similar pattern was found with 
64.7% of patients coming from a Black ethnic group and 23.8% of 
patients coming from a White ethnic group (n=3,950). 
 
As a survey of all inpatient discharges in one geographical area 
these findings could tell us something about rates of comorbidity in the 
inpatient population, however as with some of the other studies reviewed 
here (e.g. Rosenthal et al., 1992; Jerrell & Wilson, 1996 & 1997) no 
statistical analysis was done to determine whether prevalence of 
comorbidity within each ethnic group differed. Between group analysis of 
prevalence of comorbid substance and alcohol related mental disorders is 
needed to truly ascertain if belonging to a Black ethnic group carries 
more risk of comorbidity.  
 
Additionally there was a high proportion of missing and inaccurate 
data which may also have contributed to selection bias. The authors 
acknowledge that data on ethnicity was in some instances poor. Data on 
cases where hospitals did not follow up to determine patient ethnicity and 
left the discharge record blank were coded as missing and individual 
patients were sometimes coded as being from two different ethnic groups 
in different discharge summaries (532 cases had their race changed).  
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Unlike many epidemiological studies in this area, drug or alcohol 
induced psychoses was not excluded. There are many clinical differences 
between organic or substance induced psychosis and non-organic 
psychotic disorders. Substance induced psychosis by definition is a 
secondary psychotic disorder to substance intoxication and does not 
share the same clinical characteristics, illness course or outcomes as 
comorbid psychosis and substance use disorders (Caton et al., 2005). 
 
A more recent study (McLean et al., 2012), explored clinical 
phenotypes contrasted demographic and clinical correlates in trans-ethnic 
schizophrenia populations from Australia, India and Sarawak, Malaysia.  
The study conducted by The Genetics Research group at the Queensland 
Centre for Mental Health Research (QCMHR) recruited three cohorts of 
individuals with psychosis for genetic analyses. McLean et al. (2012) 
studied demographic and clinical characteristics of schizophrenia in three 
ethnic groups: Caucasian Australians (n=821); Tamil Brahmin and 
proximal caste groups from Tamil Nadu, India (n=520); and Iban of 
Sarawak, Malaysia (n=298). McLean et al. (2012) proposed cultural 
explanations for any differences in prevalence or characteristic of 
schizophrenia. 
 
Inclusion criteria were consistent for all three sites: all probands 
and relatives who had a DSM-IV (APA, 1994) diagnosis of schizophrenia 
or schizoaffective disorder. For the Australian site and the Sarawak site 
ethnicity was self-reported (Caucasian and Iban respectively). Patients 
were considered eligible for inclusion at the Indian site if they were a 
member of the Brahmin caste from Tamil, Kerala, Karnataka, or Andhra 
Pradesh, or a member of a geographically proximal caste groups from 
Tamil Nadu (Mudaliars, Chettiars and Dalits). In addition ethnicity was 
confirmed through genetic analysis across all three samples. 
 
Despite the Sarawak sample being based on treated rates of 
schizophrenia, and the Australian and Indian samples being 
opportunistically recruited, the similarities in the recruitment methods 
across all three sites still made comparison of these groups valuable. 
 78 
Trained clinicians used the semi-structured DIGS (Nurnberger et al., 
1994) to obtain relevant information about the diagnosis of psychotic, 
mood, and substance-use disorders in accordance with DSM-IV criteria.  
Comorbidity was grouped in three ways: Lifetime DSM-IV alcohol abuse 
or dependence, lifetime DSM-IV cannabis abuse or dependence, and 
lifetime DSM-IV other drug abuse or dependence. 
 
The study found significant site differences for alcohol, cannabis, 
and other drug abuse/dependence after controlling for sex. A lifetime 
diagnosis of alcohol abuse/dependence was found in 40.7% (n=333) of 
Australian patients compared with 0.8% (n=3) in Indian patients and 
10.5% (n=28) in Sarawak patients (χ2=265.53; d.f.=2, p<0.0001). For 
patients with a lifetime diagnosis of cannabis abuse/dependence a similar 
trend was found (χ2=397.06; d.f.=2, p<0.0001): Australia (n=372, 
45.5%); India (n=0, 0%); and Sarawak (n=2, 0.8%). Additionally 
analyses were performed comparing those with a lifetime diagnosis of 
other drug abuse/dependence. Again Australian patients (n=216, 26.5%) 
had the highest prevalence (χ2=185.94; d.f.=2, p<0.0001), followed by 
patients from Sarawak (n=0, 0%) and Indian patients (n=7, 2.6%). 
 
It is noteworthy that the authors suggest possible explanations for 
these differences in the samples. Firstly, they suggest that the small 
rates of alcohol and drug use in the Indian sample may well be explained 
by the socio-cultural practices of schizophrenic population, with psychosis 
patients continuing to live with family members, thus limiting their access 
to illicit substances. Secondly McLean et al. (2012) argue that Caste may 
also play a role in this finding. It has been reported that there is a 
disinclination in the Tamil Brahmin community to use substances such as 
alcohol, although cannabis use has been noted (Sharma, 1996). Thirdly, 
a critique of this large study can be made on grounds of selection bias. 
McLean et al. (2009) state that there were high rates of patients 
recruited from hostels in the Australian sample which also may go toward 
explaining high rates of substance abuse and dependence in that sample 




3.3.2 Ethnicity as a risk factor for comorbid substance use 
The UK Cantwell et al. study (1999) found that while non Afro-
Caribbean ethnicity was not a risk factor for comorbid substance use it 
was a risk factor (alongside younger age and male gender) for comorbid 
substance misuse (x2=31.632, 3 d.f., p < 0.0001) (Cantwell et, 1999).  
 
In a Swedish study of all patients seen at a psychiatric clinic 
(either as in- or out-patient, n=87) between January 1 and May 31 1998, 
Cantor-Graae et al. (2001) found that non-Swedish ethnicity (defined as 
patients who were born outside of Sweden or who had at least one 
parent born outside of Sweden first- or second-generation immigrant), 
was associated with a life time history of substance abuse (p < 0.05). 
They do note however that although non-Swedish ethnicity was a 
potential risk factor, the implications of these findings are difficult to 
interpret in such an ethnically diverse sample. 
 
The Veen et al. (2002) study found that, after controlling for age 
and sex, the odds for having comorbid substance misuse for Moroccan 
patients was less than half the odds of Dutch nationals. Equally ‘Other’ 
ethnicity was nearly twice as likely as Dutch nationals to have substance 
misuse. However confidence intervals were fairly wide and overall ethnic 
differences in odds of for having substance misuse did not reach 
statistical significance (Moroccans OR 0.4 CI=0.1–1.2; Surinamese OR 
1.2, CI=0.4–3.6; Turkish OR 0.8, CI=0.2–3.7; Others OR 1.8, CI=0.7–
4.8). They found a similar finding for cannabis misuse however the 
results were not presented in the paper. 
 
The Comorbidity Dual Diagnosis Study (Miles et al., 2003; Afuwape 
et al., 2006) investigated whether certain Black ethnicity sub-groups had 
a greater or lesser risk of having comorbidity (Afuwape et al., 2003). 
Despite the higher prevalence of cannabis use among Black British 
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patients the risk for having comorbid abuse or dependence in this group 
(OR=1.3) was relatively close to that in the White group (OR=1).  
 
 
3.3.3 Ethnic differences in choice of drug 
Afuwape et al. (2006) as part of the UK COMO study (Miles et al., 
2003; Afuwape et al., 2006), also examined ethnic differences in primary 
drug of abuse. The study found that patients from Black British groups 
were significantly more likely to be rated as abusing cannabis compared 
to patients from White groups (OR=4.8, 95% CI=2.9-8.1).  Black African 
patients were significantly more likely to be rated as abusing ‘other 
substances’ (including hallucinogens, amphetamines, opiates, illicit 
benzodiazepines and khat) (OR=2.9, CI=1.2-7.2). Black Caribbean 
patients were significantly less likely to have a comorbid alcohol diagnosis 
than patients from White groups. (OR=0.3, CI=0.1-0.5).  No other 
significant differences between White and Black groups with regard to 
case managers’ ratings of co-occurring substance abuse was found. 
 
 
3.3.4 Ethnic differences in psychiatric diagnosis and symptom 
severity of patients with comorbidity 
Previous research has shown that Black patients are more likely to 
be diagnosed with schizophrenia (Strakowski et al., 1993; Neighbors et 
al., 1989; Jones & Gray, 1986; Marquez et al., 1985; Lawson et al., 
1991; Mukherjee et al., 1983; Adebimp, 1981; Lawson, 1986) and less 
likely to be diagnosed with an affective disorder (Baker & Bell, 1999). 
Ethnic differences in mental health diagnosis in comorbid populations is 
under-reported and the studies in this review that did report it yielded 
conflicting results. 
 
Jerrell and Wilson (1996 & 1997) in their clinical trial examining 
the relative cost effectiveness of three specialized interventions for dual 
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disorders (see above) found no significant difference in psychiatric 
diagnosis between White and ethnic groups (p=0.76). However the 
sample size of ethnic minorities was fairly small (n=40). 
 
However, one of the key authors in comorbid mental health and 
substance use disorders reporting on findings from a study conducted by 
the New Hampshire study group (Mueser et al., 2001) found patterns of 
psychiatric diagnosis between ethnic groups of comorbid patients similar 
to those in the general psychiatric population. The study examined 
differences between two cohorts of patients (New Hampshire and 
Connecticut) with dual disorders who were recruited using similar 
eligibility criteria and assessed with the same measures with a dual 
diagnosis (Psychiatric and substance-use diagnoses were based on the 
SCID).  
 
In New Hampshire, 225 psychiatric outpatients were recruited into 
the New Hampshire study between 1989 and 1991. In Connecticut, 199 
outpatients were recruited into the Connecticut study between 1993 and 
1998. Patients were eligible for inclusion in both study sites if they had a 
DSM-III-R diagnosis of schizophrenia, schizoaffective disorder, or bipolar 
disorder (New Hampshire n=225; Connecticut n=166). 
 
Data on comorbid substance use disorders were collected and 
defined as ‘substance (alcohol or drug) abuse or dependence diagnosis 
within the past six months according to DSM-III-R or DSM-IV criteria 
(excluding nicotine and caffeine). Several measures of substance abuse 
(Addiction Severity Index (McLellan et al., 1992); Alcohol Use Scale and 
the Drug Use Scale (Drake et al., 1990; Mueser et al., 1995); and the 
Substance Abuse Treatment Scale (McHugo et al., 1995), were used to 
evaluate both the types and amounts of substances used.  
 
Analyses on the ethnic distribution of patients could only be done 
using the Connecticut sample due to underrepresentation of minority 
groups in the New Hampshire sample. A sub-sample of 108 African 
American patients was compared to sub-sample of 53 White patients. 
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African American dual diagnosis patients were less likely to be diagnosed 
with bipolar disorder and more likely to be diagnosed with schizophrenia 
(p < 0.01) compared with White patients (Mueser et al., 2001). 
 
Only a few of the studies examined ethnic differences in 
symptomatology. The Jerrell and Wilson (1996 & 1997) studies, found 
ethnic minority clients self-reported slightly more psychiatric symptoms 
but this difference did not achieve statistical significance. There were no 
differences in alcohol/drug abuse severity.  
 
The Afuwape et al. (2006) paper reporting on findings of the UK 
COMO study found that Black British (82%) and Black Caribbean (84%) 
groups had a significantly higher prevalence (p=0.02) of schizophrenia 
diagnoses in the comorbid sample than in the White (69%) or Black 
African groups (55%) but numbers with diagnoses other than 
schizophrenia were too small for meaningful comparisons. Black Africans 
tended to be perceived by clinical staff as suffering from more severe and 
persistent symptomatology and impaired psychosocial functioning. 
However no significant differences in symptom severity by ethnic group 
were found (Afuwape et al., 2006) 
 
 
3.3.5 Ethnic differences in treatment outcome  
Data on ethnic differences in clinical or psychosocial outcome in 
comorbid populations was limited. The Jerrell and Wilson (1996 & 1997) 
studies which examined ethnic differences in outcomes of three 
treatments for dual diagnosis found that the overall outcomes (including 
change in functioning and symptom severity scores) of ethnic clients 
were equivalent to those of White clients at 6 months. The individual 
treatment groups were significantly different on five outcomes, but only 
two (substance use symptoms and costs) of those five were ethnic group 
differences. Drug and alcohol symptoms were lower in the Behavioural 
Skills group especially for ethnic clients (p=0.03).  The reduction in 
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intensive mental health service costs (for acute and sub-acute services) 
was greater in the 12-Step group, especially for ethnic clients (p=0.01) 
(Jerrell & Wilson, 1996 & 1997). 
 
 
3.3.6 Ethnic differences in experiences of services 
As part of the UK COMO study, Afuwape et al. (2006) found 
differences by ethnic group for hospital admissions in the 18 months prior 
to admission with more comorbid Black African patients having been 
admitted at least once. However, when adjusted for age, this just failed 
to reach statistical significance.  In their study comorbid Black British 
patients had the longest time in hospital (mean days over 18 month 
period=105) and were more likely to be detained under the Mental 
Health Act during the past 18 months (p=0.03). Black Caribbean patients 
had smallest number of admissions (p=0.30). Despite the marked ethnic 
differences in experience of services they found no significant difference 
between ethnic groups on their satisfaction with services (Afuwape et al., 
2006). 
 
One study found that there were no significant ethnic differences 
(p= 0.34) in service use history in the year prior to study entry (number 
of days in 24-hour care both acute and sub-acute) (Jerrell & Wilson, 1996 
& 1997). However anecdotal evidence from the study showed that young 
African Americans were noted (by clinical staff) to be difficult to place in 
temporary accommodation during the study because of a combination of 
fear of increased risk of violent behaviour and culturally 
inappropriate/unprepared shelters. 12 step recovery programs not 
participating in the study were also seen as inaccessible to this client 
group because the majority of them were not culturally sensitive. They 
also found that ethnic clients received less supportive treatment services 
during the first 6 months of the intervention program. 
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A qualitative study by Warfa et al. (2006) interviewed nine dually 
diagnosed young men aged between 18-35 from a range of local 
voluntary agencies and statutory services in East London. Broadly, the 
study aimed at exploring service user perceptions of service effectiveness 
within three different ethnic groups with comorbid mental health and 
substance use problems (White British; Black African; and African 
Caribbean).  It also aimed to identify the role culture and ethnicity play in 
the treatment of service users with comorbidity, uncover perceptions 
about the adequacy of services and identify gaps in the training needs of 
social and mental health professionals working with dually diagnosed 
patients from service user perspectives. 
 
Diagnoses (which were self-reported) and symptoms varied across 
ethnic groups. Patient histories were generally characterized by frequent 
hospitalisation, separation from family, education problems. The 
participants reported varying degrees of service effectiveness and they 
tended to measure this through the services ability to address social and 
cultural needs. Migration related stress emerged as a common theme and 
was in one case explained in terms of their onset of symptoms. 
 
The study found that mental health issues were addressed more 
thoroughly than substance abuse issues. Some participants mentioned 
that they used support services which were often culturally specific and 
felt that mental health services would be improved if they became more 
culturally aware.  Additional services utilised included Somali support 
services, Ethiopian community centres and spiritual services which were 
accessible during their hospital stay. For those participants who used 
counselling services or alternative spiritual or cultural support services, 
these services or groups were seen as being an integral part of their 
healthcare. 
  
All of the subjects in this study received pharmacological treatment 
for their dual diagnosis, with the majority having been hospitalized. The 
majority of participants reported that they were encouraged by their 
healthcare providers to stop using drugs or alcohol; however they rarely 
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reported specific advice or a specific intervention to deal with their abuse 
(Warfa et al., 2006). 
 
 
3.4 CONCEPTUAL ISSUES/METHODOLOGICAL ISSUES 
 
If we are to interpret the findings above it is important to outline 
some of the conceptual and methodological issues associated with 
research in this area. 
 
3.4.1 Differences in study population and difficulties in measuring 
differences in small samples 
It can be argued that many studies in mental health sometimes fail 
to recruit large enough numbers of comorbid patients to either make 
accurate generalisations or to obtain statistical significance. Three of the 
studies (Cantwell et al., 1999; Strakowski et al., 1992; Afuwape et al., 
2006) that reported ethnic differences in the prevalence of comorbidity 
had what might be considered small sample sizes meaning either 
statistical significance was not achieved or if it was the findings should be 
interpreted with caution. There is also the problem of performing 
analyses on sub groups (for example women or young people) of these 
small comorbid samples. 
 
Furthermore the population sample from which several of the 
studies drew their exposed sample from differed considerably. Three of 
the studies were conducted in services for dually diagnosed patients and 
two were conducted within the general population. Even though the 
remaining studies were conducted among psychotic populations, there a 
marked differences within this group. Six studies investigated psychotic 
populations, two of which examined first-episode psychosis while five 
studies looked at patients with schizophrenia. Comparing evidence on 
prevalence, characteristics and outcomes of ‘comorbid’ patients between 
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studies where there is no standard group of interest is difficult, especially 
when there are clear differences between these diagnostic groups even 
without comorbid substance use. 
 
Most of the samples in the above studies have a higher proportion 
of male patients. The Jerrell and Wilson study did manage to highlight 
some of the more complex challenges in treating female dually diagnosed 
patients, as well as patients from younger age groups. Nevertheless, 
prevalence and outcome measures for these sub-groups within White and 
non-White populations and treatment samples are under-researched. 
 
Warfa et al. (2006) was the only qualitative study. It stands to 
reason that studies like these are never going to measure prevalence 
rates but despite this the sample was very low and the authors 
acknowledge that the nine patients may not be representative of the 
three ethnic groups. The study also focused on the experiences of male 




3.4.2 Conceptualising and measuring ethnicity 
The Warfa et al. (2006) study was the only study to look at some 
of the more complex cultural issues associated with ethnicity and its 
impact on or interaction with treatment outcomes.  This is in contrast to 
studies which have chosen to focus on differences based on nationality 
(Veen et al., 2002), ignoring any likely cultural differences between, for 
example, first and second generation patients.  
 
Although their analysis of the interaction between ethnicity and 
treatment outcomes was not limited to a simplistic ‘White group’ vs. 
‘homogeneous ethnic group’ comparison as the Jerrell and Wilson study 
(1996 & 1997) was, Veen et al.’s (2002) conceptualisation of ethnicity 
was based mainly on immigration (Dutch nationals vs. Dutch 
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immigrants). Operationalising ethnicity this way fails to illuminate some 
of the more complex elements to race and ethnicity as well as any 
similarities second or even third generation immigrant groups may have 
had with Dutch nationals in terms of identity, cultural values and 
attitudes.  
 
The Ahuja et al. (2007) study is another example of the problem of 
not using standardised categorisation of ethnicity. In this study the 
‘Black’ group consisted of ‘Black’ and ‘African American’.  The term ‘Black’ 
was not unpacked or scrutinized; it may well have been that patients who 
were observed to have dark skin were categorised as ‘Black’ and included 
with patients that self-defined as African American. The problem with this 
is that ‘Black’ is a heterogeneous group and may have included Native 
Africans, Caribbean’s, dark skinned middle easterners as well as patients 
of mixed heritage. Additionally Carra et al. (2009) highlight the need to 
disaggregate ‘Black’ ethnic groups within comorbidity research, 
particularly as British born Black patients tend to have much higher 
prevalence’s of comorbid substance abuse. 
 
In most of the studies measures of ethnicity were far from 
sensitive, sometimes using the crude ‘Black’ category for non-White 
clients. The paper by Afuwape et al. (2006) which examined ethnic 
differences in a sample of dual diagnosis patients from the COMO study 
did manage to highlight some of the differences within Black patient 
groups (Black African, Black Caribbean and Black British) despite not 
obtaining significance on many of the relationship tests.   
 
One criticism though is that during their screening process any 
patient that was of mixed parentage (i.e. one parent was Black and the 
other parent was White) who identified themselves as Black was put in 
the Black British Category. They do not detail the percentage of mixed 
parentage patients in this category or where they placed mixed 
parentage patients that did not identify themselves as Black. With 
increasing numbers of children from mixed parentage backgrounds it is 
important to make a distinction between this subgroup and Black and 
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White groups, even when patients align themselves with one particular 
group. 
 
The Copeland et al. (2003) study also illustrates how defining 
ethnicity can be problematic. Firstly ethnicity was ascertained by the 
‘observed’ race of the patient by the clinicians that saw them when they 
were treated in either inpatient or outpatients. As Singh (1997) notes 
‘Measures of ethnicity based simply on physical appearance highlight the 
racial foundation of the ethnic façade’ and can lead to observer bias 
(Singh, 1997, p. 306). Singh (1997) argues that adding measure such as 
place of birth or place of parental birth can help narrow definitions of 
ethnic groups, but even this may not necessarily produce homogeneous 
samples. Self-assigned ethnicity has become a popular measure in 
psychiatric epidemiology since it appears to eliminate observer bias 
(Singh, 1997).  
 
Secondly the Copeland et al. (2003) study combined the ‘Hispanic 
Black’ and Hispanic White’ group into one ethnic category (because of 
small numbers) to compare to White and African American patients. 
While this may capture the differences in the shared culture of Native 
Americans, versus African Americans versus Hispanics it fails to recognise 
the potential socio-economic differences that Black skinned Hispanics 
may have from White skinned Hispanics. 
 
Although there are notable selection biases in the McLean et al. 
(2012) study, measurement of ethnicity was determined through genetic 
analyses. These findings may be better understood in terms of race 
rather than ethnicity and as genetics does not determine cultural 







3.4.3 Conceptualising and measuring comorbidity 
It is important that studies exploring comorbidity of psychosis and 
substance use disorders are homogeneous in their conceptualisation. 
Studies need to distinguish between co-occurring substance use and the 
dual diagnosis of misuse, abuse or dependence (see Table 3). 
Differentiating between the negative effects of co-occurring substance 
‘use’ as opposed to a diagnosable substance use disorder is an important 
consideration for studies looking at the outcomes of dually diagnosed 
patients. Studies that have looked at the dose-response effect of 
cannabis use in psychotic populations have found that heavier cannabis 
use is more strongly associated with psychotic relapse (Linszen et al., 
1994).  
 
The majority of studies defined comorbidity as diagnosable 
substance abuse or dependence (the main differences between the two 
are dependence is additionally characterised by symptoms of withdrawal 
and increased tolerance). However definitions ranged between studies. 
Even when diagnostic criteria were employed it is difficult to compare 
findings which look at differing degrees of severity of comorbid substance 
use.  
 
Miles et al. (2003) argued that their low threshold for self-reported 
(as opposed to case manager rated which made up a significant 
proportion of the eligible sample) drug ‘abuse’ was based on the 
observation that persons with severe mental illness may be vulnerable to 
adverse effects from even low levels of drug use (Drake, Essock & 
Shaner, 2001). Studies using differing concepts of comorbidity make 
comparison difficult. In some studies there were inconsistencies within 
the study.  Although many studies may be fairly consistent in their 
measurement of comorbidity the Copeland et al. (2003) paper highlights 
the problems in interpreting findings when terms with different clinical 
meaning are used interchangeably. 
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Most studies used ICD or DSM criteria to define comorbidity. The 
difficulty is that not all studies used the same information sources to 
determine diagnoses. For example, some studies used case notes while 
other used structured clinical/research instruments to collect information 
on psychopathology to which they applied the diagnostic criteria.  One of 
the studies used self-reported (Warfa et al., 2009) substance use 
disorder as the only measure, which may or may not have pertained to a 
clinical diagnosis and may not be comparable to studies which used both 
validated/structured diagnostic schedules and formal diagnostic criteria.  
 
Rosenthal et al. (1992) note in their paper that data for the three 
studies were collected differently. They argue that the data in study I 
which was collected using case note review (albeit from routine clinical 
diagnoses), were likely to be ‘methodologically under sensitive in 
documenting and diagnosing multiple substance abuse disorders’ 
(Rosenthal et al., 1992, p. 18). Data for Study III derived from 
standardised structured clinical interviews. When they compared the rate 
of poly-substance use in Study II (where data was collected using routine 
clinical assessment) with that of Study III they found a five times 
increase in study III. They propose that this is mostly likely because 
standardised assessment provides a much more comprehensive 
assessment of multiple substance use routine clinical assessments, ‘When 
routine clinical procedures take account of substance abuse, they may 
focus only upon the one or two addictive disorders with the most obvious 
implications for treatment’ (Rosenthal et al., 1992, p. 18). 
 
The discussion section of the paper by McLean et al. (2012) 
highlights a methodological issue that cuts across issues of ethnicity 
measurement as well as psychopathology measurement.  They note that 
caution should be made when using standardised/structured 
psychopathology instruments across different cultures, as converting 
thoughts and feelings across languages can be difficult (Barrett, 2004). 
McLean et al. (2012) employed rigorous translation methods on their 
instruments (DIGS) and used local interviewers who interviewed in the 
country’s native tongue. Additionally they tested the inter-rater reliability 
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(within and between sites) of the DIGS. However they do admit that this 
method was not performed for other measures used in the study and 
inter-rater reliability tests were not performed for diagnosis between 
India and Sarawak. 
 
The problem of reliability and validity of data collection tools is not 
the only issue for concern when measuring comorbidity or more 
specifically substance use disorders. The employment of diagnostic 
criteria (ICD and DSM) adds an important layer of accuracy in 
measurement and comparability of substance use disorders within and 
between epidemiological studies. However the validity and reliability of 
these diagnostic criteria has been challenged (Rounsaville, 2002). 
Ratings can span across several domains. Similar to the Cantwell et al.’s 
(1999) study, Veen et al. (2002) used the SCAN and PPHS study 
instruments as well as consensus ICD-10 diagnostic criteria, despite this 
‘use’ and ‘misuse’ were defined by frequency and duration of substance 
use alone and did not seem to include some of the criteria’s based on 
psychological, social or legal consequences of substance use. 
 
Misuse, abuse and dependence can be measured on various 
dimensions such as symptoms of withdrawal; effect use has on social 
relationships or interactions; or whether the patient has had any 





















*Substance use disorder; dependence with institutionalisation; drug psychosis
Authors Use Misuse Abuse Dependence Other* 
U.K 
Cantwell et al. (1999) √ √    
Miles et al. (2003) and  Afuwape et al. (2006)   √ √ √ 
Warfa et al. (2006)     √ 
USA 
Strakowski et al. (1992)   √   
Rosenthal et al. (1992)   √ √ √ 
Jerrell and Wilson (1996 & 1997)   √ √  
Mueser et al. (2001)      
Copeland et al. (2003) √   √  
Ahuja et al. (2007)    √ √ √ 
Other 
Cantor-Graae et al. (2001) (Sweden)   √   
Veen et al. (2002) (Netherlands) √ √    




In addition, the time-line of the diagnosis in which substance 
misuse and mental health problems are ‘actively comorbid’ is an issue. As 
noted by Todd et al., (2004) comorbidity can occur with substance 
misuse as the primary disorder or as an underlying disorder. The lack of 
explicitly defining the dual diagnosis time-frame or comparing studies 
with different time frames could help to explain disparities in prevalence 
figures across studies (Todd et al., 2004). 
 
Many, but not all of the studies excluded patients with substance 
induced psychosis. It has been shown that this particular group are 
distinct in terms of demographic and clinical outcomes to patients who 
have a primary psychotic disorders and co-occurring substance misuse 
(Caton et al., 2005). As Schuckit (2006) notes, the methods of 
operationalising diagnostic criteria and definitions of comorbidity or dual 





The evidence presented so far pertaining to an interaction between 
ethnicity and comorbid diagnosis is a ‘mixed bag’ to say the least, and 
seems anecdotal in comparison to the corpus of epidemiological literature 
around ethnicity and psychosis or ethnicity and substance 
abuse/dependence. It is unclear whether ethnicity can be considered a 
risk factor for comorbid substance use or not, and if it is whether Black 
Caribbean (or other ethnic groups) would be at greater risk. 
 
Several studies have found ethnic differences in the prevalence of 
comorbidity. However, issues with sample size, measurement and 
operationalisation of concepts need to be weighed against these findings. 
There does seem to be some evidence that Black groups tend to have 
higher prevalence of comorbid substance abuse/dependence in 
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psychiatric populations. We are yet to see if this trend however holds up 
in drug abusing populations. When comparing prevalence rates between 
these two treatment settings in the US the evidence does suggest that 
there is a bias towards White clients in the mental health setting and 
Black clients in the drug abuse treatment setting. It is still to be 
determined if this is the same in UK.  
Findings from the British Crime Survey 2001/2002 (BCS) have 
shown that people from Black Caribbean groups are more likely to use 
cannabis than White or Black African groups (Aust & Smith, 2003). 
Evidence from the studies outlined here seem to refute this showing 
cannabis use is equivalent between these groups and that it is cocaine 
use which tends to be higher in Black comorbid populations.  
In line with evidence of higher levels of compulsory admission within 
Black patients in the psychotic population (Morgan et al., 2004), the 
evidence presented here points towards a similar pattern in comorbid 
populations (Afuwape et al., 2006).  
 
Half of the studies reviewed here were conducted in the US. Only 
four studies were conducted in the UK highlighting the need for more 
research in this area here at home. Research into possible interactions 
between comorbidity, ethnicity and other socio-demographic 
characteristics (such as gender and class), not to mention ethnic 
differences in treatment outcome will also be necessary. 
  
More qualitative research similar to the Warfa et al. (2006) study 
will help illuminate important issues such as immigration, differences in 
drug choice between first and second generation Black and Asian ethnic 
groups and engagement with services that are missing from population 






Chapter Summary 3.   
Chapter Summary 
 
Aims of the Chapter: 
 
To present findings from a systematic review of current literature on ethnicity 
and comorbidity with particular attention given to ethnic differences in 





 Evidence relating to the relationship between ethnicity and prevalence or 
risk for comorbidity is disparate 
 There is evidence that minority groups with comorbidity may be at higher 
risk for certain negative outcomes 




CHAPTER 4:  MEANING IN EXPERIENCE: HELP 
SEEKING AND CONSTRUCTIONS OF MENTAL 
ILLNESS, SUBSTANCE USE AND SERVICE USE 
EXPERIENCES IN PSYCHOTIC AND SUBSTANCE 





An overview of evidence detailing the relationship between comorbid 
psychosis and substance use disorders and poor clinical and social 
outcome, as well as the relationship between Black Caribbean ethnicity 
and negative outcomes in psychotic populations and substance abusing 
populations, has been discussed in Chapter 2. Ethnic differences in the 
prevalence of comorbidity, service utilisation and clinical and social 
outcomes of patients with comorbidity has also been discussed in the 
previous section.  
 
Much of this research is epidemiological, and although this helps to 
highlight patterns in clinical and social characteristics and service 
utilisation of those with comorbidity it does not claim to explain why 
those patterns may be present.  Furthermore, research in this area has 
been conducted almost exclusively within psychiatric and psychological 
research communities with the arguably understandable aims of 
enumerating rates and patterns of referral, admission and clinical and 
social outcome.  
 
In line with realist approaches to scientific enquiry (a notion that I 
will discuss in more detail in Chapter 5), epidemiological data from this 
type of research has been used to test hypotheses relating to, and 
correlations between, the outcomes of interest as well as socio-
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demographic and clinical characteristics (Morgan et al., 2004). Skrabanek 
(1994) has argued that historically much of epidemiological research has 
been subject to the ‘black box’ strategy, whereby the causal mechanism 
behind an observed relationship remains hidden and unknown, despite 
the assumption of a causal link by virtue of a statistically significant 
association. Black Caribbean ethnicity may well be associated with poor 
clinical or social outcome in people with psychosis or increased likelihood 
of certain types of substance use in the general population, yet the 
mechanism or causal link that lies behind these associations remains a 
mystery.  
 
Using statistical analyses to uncover associations between disease 
and exposure may tell us if there are ethnic differences in the risk of 
having comorbidity.  However, they may not help explain the reason for 
this association. For example, people from Black Caribbean ethnic groups 
may find heavy cannabis use more socially acceptable which, in 
conjunction with socio-economic pressures,  puts them at greater risk of 
having a psychotic disorder. Alternatively, conceptualisations of mental 
illness in Black Caribbean populations may lead to a delay in seeking help 
for psychosis and an increased need to self-medicate with illicit drugs 
and/or alcohol.    
 
 
4.2 EXPLAINING ETHNIC DIFFERENCES IN PSYCHOTIC AND 
SUBSTANCE ABUSING POPULATIONS 
 
If we are going to understand associations between ethnicity and 
prevalence and correlates of comorbidity we need to understand why 
psychotic patients from different ethnic groups use drugs and alcohol. We 
also need to examine whether ethnic differences in substance use 
behaviours after initial episodes of illness may impact on illness outcome 
and patterns of service utilisation.  
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Several questions need to be considered when looking at 
epidemiological research in this area: What is the direction of the causal 
link between substance use disorder and psychosis?; Are there 
differences in the conceptualisation of mental illness, substance use and 
help-seeking between Black and White ethnic groups and are these 
differences likely to explain ethnic differences in prevalence of 
comorbidity or relapse and compulsory admission rate?   
 
For example research highlighting the relationship between 
ethnicity and compulsory admission in psychotic populations has also 
looked at the role of poor insight suggesting that poor insight may be an 
indicator of a worse clinical presentation. Moodley and Perkins, (1991) 
found in a small study of pathways to care in London, found that 32% of 
Black Caribbeans did not believe they had a problem compared to none 
of the Whites. Moreover other work has shown that Black patients tended 
to deny mental illness (Pipe et al., 1991; Commander et al., 1999). 
Morgan et al. (2004) argued that it is difficult to determine whether 
denial of mental illness is a function of the underlying illness or a 
reflection of different explanatory models of health or illness belief used 
by minority ethnic groups. 
 
In addition higher rates of compulsory admission in Black 
Caribbean patients could be explained by differences in how Caribbean 
and White families respond to mental illness. Speculating on the work of 
Harrison et al. (1989), Morgan et al. (2004) suggest that more severe 
stigmatisation of mental illness in the Black Caribbean community may 
hinder voluntary help-seeking.   
 
Suggestions for working with drug abusers published by the 
National Treatment Agency for Substance Misuse suggest that drug use 
among black and minority ethnic users should be located within a wider 
context of social exclusion, deprivation and discrimination (Models of 
Care, 2003). There is some research evidence that black and minority 
ethnic drug users find treatment services less accessible than do the rest 
of the population and are under-represented in treatment services 
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(Advisory Council on the Misuse of Drugs 1998; Mirza et al., 1991; Patel 
1993; Sangster et al., 2002).  
 
Institutional racism has also been suggested as an argument for 
higher incidence of schizophrenic illness (Fearon et al., 2006), more 
compulsory admission (Morgan et al., 2005) and negative experiences of 
mental health and drug treatment services (Perera et al., 1993; Khan, 
1999). 
 
To understand why certain ethnic groups may be more likely to 
have certain experiences we need to draw on academic realms (in 
addition to Psychiatry and Psychology) within the Social Sciences: 
Sociology and Anthropology. Research in these areas, which has tended 
to be qualitative in nature, may help uncover the meaning behind the 
behaviours of those with psychosis (Salmon, 2000) and comorbid 
psychosis and substance use disorders.  
 
Constructions and beliefs about health are key to understanding 
these relationships: the way in which people construct illness, but also 
the way they construct substance use and help seeking, may help 
uncover the relationships between ethnicity, psychosis, substance use, 
poor illness outcomes and negative service use experiences. Moreover, 
beliefs about causes of illness and drug use initiation are likely to be at 
the heart of constructions of comorbidity.  
 
It is beyond the scope of this thesis to discuss all the literature 
around models of health belief and help-seeking, however this chapter 
does aim to give an overview of the key literature in relation to illness, 
substance use and treatment experiences of patients with psychotic 
disorders and substance use disorders.  
 
A discussion of the limitations of applying these models and 
frameworks to comorbid populations, discussion of lay belief frameworks 
in Black ethnic cultures, theoretical hypotheses of the relationship 
between psychosis and substance use disorders, as well as a discussion 
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of other qualitative research that has helped uncover beliefs and 
experiences of patients with comorbidity both generally and within 
specific cultures is also attempted. 
 
 
4.3 MODELS OF HELP SEEKING AND HEALTH BELIEF 
 
Theoretical models of beliefs about illness that are shared by the 
same ethnic and cultural groups which may help us interpret why, when 
and how people seek help have received much attention in the last ten 
years (Morgan et al., 2004).  Rüdell, Bhui & Priebe, (2009) have argued 
that two types of theory around illness perception research have 
dominated: (a) Explanatory Models; and (b) Illness Representations as a 
part of the self-regulatory theory. These theories will be briefly outlined 
and discussed in relation to ethnicity and help-seeking. 
 
4.3.1 Illness behaviour and help-seeking 
 
In order to understand constructions of illness experience we must 
first draw a distinction between a disease or illness itself and the 
behaviours associated with that illness. For Kleinman (1986), illness 
behaviour is simply the way researchers within sociology have 
conceptualised illness.  What underlies the distinction between these two 
concepts is that disease (a biological or psychological process) is 
transformed into illness (a psychosocial process) or illness behaviour 
through a socio-cultural process that shapes how an individual and 
significant others perceive, and respond to, symptoms of the disease 
(Morgan et al., 2004).   
 
Early research by Mechanic (1968) identified ten factors known to 
influence illness behaviour. These factors relate to the symptoms of a 




Figure 4: Ten factors known to influence illness behaviour. 
Factors influencing illness behaviour 
1. Visibility, recognisability, and perceptual salience of deviant signs and 
symptoms 
2. The extent to which the symptoms are perceived as serious 
3. The extent to which symptoms disrupt family, work and other activities 
4. The frequency of appearance of the deviant signs or symptoms, their 
persistence, or their frequency of recurrence 
5. The tolerance threshold of those who are exposed to and evaluate the 
deviant signs and symptoms 
6. Available information, knowledge and cultural assumptions and 
understandings of the evaluator 
7. Basic needs which lead to autistic psychological processes 
8. Needs competing with illness responses 
9. Competing possible interpretations that can be assigned to the symptoms 
once they are recognised 
10. Availability of treatment resources 
Adapted from Mechanic, 1968, pp. 142-155. 
 
Although, as Mechanic (1968) acknowledged, this list is not 
exhaustive, we can see how these factors all relate to the experience and 
effect of symptomatology for the person as well as his/her surrounding 
support network, the cultural beliefs about illness that are held, the 
response that the individual and their support networks have to the 
symptoms and the type of available treatment options.  
 
In other words, as Morgan et al. (2004) noted, these factors 
highlight how responses to illness or illness behaviours are a combination 
of ‘self’ and significant ‘other’ -orientated illness conceptualisations and 
roles. In addition, Morgan et al. (2004) highlight how Mechanic (1968) 
stressed the need for research to distinguish between self-defined and 
other-defined illness, a distinction particularly relevant to psychotic 




The influence of culture on patterns of help-seeking and 
subsequently service utilisation has received much attention in the social 
sciences. Aligning symptoms with an illness may not always result in 
seeking help however.  In a sociological study modelling help-seeking by 
Zola (1973) it was found that people’s responses to symptoms were 
contingent upon their cultural values and beliefs concerning health.  In 
other words their perception of what is 'normal' plays a significant part. 
Subsequently, the decision to seek professional help is either promoted 
or delayed by social factors.  
 
Zola (1973) outlined five triggers that he suggested are indicative of 
whether a person seeks help or not. These include experiences of 
interpersonal crisis, perceived interference of illness on physical and 
psychosocial activities and temporalising symptomatology. These triggers 





















Figure 5: Zola’s model of help seeking 




For Zola (1973), resolving the physical or psychological aspects of 
health problems was only one of several reasons for seeking help. Other 
factors (such as going to work) may in fact be more salient to the person 
and influence their decision making process.  
 
According to Zola (1973), people draw upon what is termed a 'lay 
referral' system which may include family, friends or they may engage in 
'self-medication' or alternative therapies. Despite the additional element 
of social or cultural factors, these triggers are in line with several of the 
factors Mechanic (1968) indicates as influencing help-seeking (in 
particular needs competing with illness responses).  
 
One of the interesting features of this model is that the decision to 
seek help does not necessarily lead to the utilisation of medical 
Perception of symptoms
(i.e. Physical, Personal, Social)
Accommodation to symptoms
Breakdown of accommodation due to:
1. Inter-personal crisis
2. Perceived interference with work activities
3. Perceived interference with social/leisure activities
4. Sanctioning by others who insist help be sought
5. Symptoms persists beyond arbitrary time limit set by individual
Decision to seek help
Lay referral Visit G.P Self-medication
Alternative therapies
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professional services.  What models of help-seeking and illness behaviour 
highlight is the social and culture fluidity of responses to illness and 
disease. Culturally-shaped beliefs about illness in individuals as well as 
the conceptualisation of illness by significant others both play a part in 
the ultimate responses to illness and decisions to seek help (Morgan et 
al., 2004).  
 
 
4.3.2 Explanatory health belief models and help seeking and their 
application to psychotic illness  
According to Rüdell, Bhui & Priebe (2009), two theories have 
dominated illness perception research: Explanatory Models and Illness 
Representations. 
 
Becker and Maimon’s (1983) Health Belief Model (HBM) has been a 
central explanatory model of disease and illness in determining how 
people respond to illness episodes and interact with the local Healthcare 
Systems. The HBM has been widely researched within the fields of social 
anthropology, medical sociology and cross-cultural psychiatry.  
 
The corpus of evidence around health beliefs demonstrates a close 
relationship between cultural beliefs and help-seeking behaviour and a 
range of authors have documented how responses to illness tend to 
mirror the cultural framework within which individuals make sense of 
their experiences (for example, Campion & Bhugra, 1998; Patel, Simunyu 
& Gwanzura, 1997; Patel, Musara, Butua, Maramba & Fuyane, 1995; 
Helman, 1994; Leff, 1988; Marsella & White, 1982; Kleinman, 1980).  
 
The HBM was originally based on four constructs representing 
perceived susceptibility, perceived severity, perceived benefits, and 
perceived barriers to seeking help for an illness. These concepts relate to 
people's "readiness to act." The concepts cues to action, (which would 
activate that readiness), and more recently self-efficacy, (or one's 
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confidence in the ability to successfully perform an action), have been 
added to the HBM (Rosenbock et al., 1988), to help the HBM better fit 
the challenges of changing habitual unhealthy behaviours, such as being 
sedentary, smoking, or overeating. 
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Table 4: Components of the Health Belief Model 
Concept  Definition  Application 
Perceived 
Susceptibility 
One's opinion of chances 
of getting a condition 
Define population(s) at 
risk, risk levels; 
personalize risk based on 
a person's features or 
behaviour; heighten 
perceived susceptibility if 
too low. 
Perceived Severity 
One's opinion of how 
serious a condition and 
its consequences are 
Specify consequences of 
the risk and the condition 
Perceived Benefits 
One's belief in the 
efficacy of the advised 
action to reduce risk or 
seriousness of impact 
Define action to take; 
how, where, when; 
clarify the positive effects 
to be expected. 
Perceived Barriers 
One's opinion of the 
tangible and 
psychological costs of the 
advised action 




Cues to Action 






Confidence in one's 
ability to take action 
Provide training, 
guidance in performing 
action. 
Adapted from Glanz, K., Marcus Lewis, F. & Rimer, B.K. (1997). Theory at a Glance: A 
Guide for Health Promotion Practice.  National Institute of Health. 
 
The premise of the HBM is that people will take action to undergo a 
health prevention behaviour when they are ready; they see it as 
beneficial; and the difficulty is not greater than what is to be gained. 
Readiness is determined by the consequences a health risk may impose. 
When perceived susceptibility is seen as likely and perceived severity of 
an illness is high, motivation increases. What is interesting in this model 
is that individuals may demonstrate behaviour to both take action and 
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avoid illness. The model however privileges the individual decision 
making process over the socio-cultural models of help seeking. 
 
Mechanic and Zola’s models of help seeking both highlight the role 
that available treatment resources play in illness behaviour. Based on a 
similar framework Kleinman (1980) proposed a model of Health Care 
Systems (HCS) which was built on the premise that the health-related 
components of all societies are more or less interconnected and form a 
cultural ‘system’.  For Kleinman (1980) the infrastructure of all health 
care systems are roughly the same across cultural boundaries, while the 
content varies with the social, historical, cultural and environmental 
circumstances of each system.  The structure of health care systems, 
according to this framework, comprises three sectors - the popular, folk 
and professional - which overlap with each other to some degree (see 
Figure 6).  
 
The professional sector consists of organized, legally sanctioned 
healing professions often based within the discipline of modern medicine 
(e.g. physicians, nurses, therapists). The term “professional” can include 
anyone acknowledged (through credentials), or perceived, in a culture as 
belonging to a professional group. In the folk sector, healers are non-
professional and they have received little or no training in professional 
medicine.  
 
According to Kleinman, healers in this sector are frequently 
classified as sacred or secular and are considered important because they 
have a special healing powers and take a holistic approach (often 
involving natural and supernatural (for example homeopathy). The 
popular sector includes non-professional and non-specialist healers. It is 
at this level where medical problems are first recognized and defined and 
includes all the healing options that people use that do not fall into folk or 
professional sectors. Kleinman argues that illnesses are often self-
diagnosed, and methods for treating them are based on this self-
assessment or on the advice of family or friends. Healing and treatment 




Figure 6: Venn diagram of Kleinman’s Health Care Systems 
 
             
 
Essentially the HCS model places emphasis on available health 
care resources as well as the socially and culturally constructed illness 
beliefs and behaviours, which combine to shape help seeking practices in 
populations and sub-populations. What the above models assume is that 
individuals possess a complete, self-orientated and consistent set of 
health or illness beliefs overtime which can be measured against 
universals models.  
 
Pesocsolido and colleagues (Pesocsolido & Boyer, 1999; 
Pescosolido, 1991), sought to overcome what was termed ‘contingency 
approaches’ to models of health belief and help seeking (a 
sociodemographic and clinical profile of service users at a particularl time 
point is used to explore the correlations between these and other 
variables), from ‘‘process orientated’’ approaches (dynamic social 
process, involving the sufferer and significant others within the sufferer’s 
social network, and influenced by the illness career of the sufferer), by 
proposing a model of Network Episodes (Morgan et al., 2004). 
Pesosolido’s Network Episode Model (Pesocsolido & Boyer, 1999), argues 
that responses to health problems involve social processes that are 
managed through various contacts (or networks) within the individuals’ 
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community, as well as the treatment systems and agencies available. 
Pesocsolido, based on the work of Clausen and colleagues (Clausen & 
Yarrow, 1955), mapped sequences of help seeking during the course of 
an individuals’ illness.  Responses to illness then, are a process of 
negotiating the meaning of symptoms within a social network over the 
course of the sufferer’s illness (Morgan et al., 2004). 
 
Illness representation research is based on the self-regulatory 
theory (SRT) (Leventhal, 1970) and originates from a psychological 
theory that explains individuals’ behavioural response to physical threats. 
These threats or ‘illness dangers’ are assessed using two partially parallel 
processing systems (Rüdell et al, 2009); cognitive and emotional 
(Diefenbach & Leventhal, 1996; Leventhal, 1971).  
 
Leventhal argued that individuals have cognitive and emotional 
representations of illness and that these representations and responses 
are continuously appraised leading to change and a self-regulated coping 
response (Rüdell et al, 2009). Cognitive representation of illness shares 
some of the theoretical underpinnings as explanatory models however it 
allows for learning and changes in the individuals emotional states.  
 
SRT consists of several stages (Kanfer, 1970; Kanfer & Karoly 1972): 
 The patient deliberately monitors their own behavior, and 
evaluates how this behavior affects their health.  
 If the desired effect does not take place, the patient changes their 
behavior.  
 Again if the desired effect is not realised, the patient reinforces the 
effect by continuing the behavior.  
 
A further approach is for the patient to acknowledge and 
understand the factors involved in a health issue, and then decide upon 
an action plan for resolving the health issue. In this process the patient 
must monitor the results of their subsequent actions in order to evaluate 
whether there is a desired effect and whether changes to the action plan 
are needed (Leventhal & Nerenz, 1984). 
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         Semi structured interviews for clinical settings have been devised 
for measuring illness perception and health belief based on Health Belief 
Models and SRT, as I will discuss in the next section. 
 
4.3.2.1 Measurement of psychotic illness beliefs using 
explanatory models 
 
  ‘…rarely does clinical practice systematically apply the process 
rules to elicit explanatory models and to maximise collaboration 
and communication between patient and professional.’ (Bhui & 
Bhugra, 2002, p. 181).  
 
When explanatory models are investigated, the anthropological 
methodologies of participant observation and narrative research 
encourage authentic patient world view. However as Bhui and Bhugra 
(2002) explain there is a difficulty of uncovering explanatory models of 
mental illness during clinical interactions (due to the focus on making a 
diagnosis and introducing a treatment) and that when explanatory 
models of mental illness are uncovered they may include a variety of 
explanations that are either held simultaneously or taken up and 
dismissed rapidly (Williams & Healy, 2001).  
 
Three instruments for measuring illness beliefs in patients with 
mental health have been traditionally used. The Explanatory Model 
Interview Catalogue (EMIC) and the Short Explanatory Model Interview 
(SEMI) have been suggested as tools for bridging the gap between 
qualitative and quantitative methods of gathering health belief data 
(Weiss, 1997; Lloyd et al., 1998). The SEMI in particular can be used in a 
semi-structured way to identify causal and other health beliefs and allows 
for discussion of the patient’s problems, as well as exploring the different 
ways in which distress can be explained by using vignette material (Bhui 
& Bhugra, 2002). 
 
Leventhal’s SRT has also inspired the development of a 
standardised assessment for clinical settings: The Illness Perception 
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Questionnaire IPQ. The Illness Perception Questionnaire (IPQ) is another 
instrument typically used in research exploring models of illness belief. It 
includes a range of fixed causal explanations from which patients can 
identify the one closest to their own views (Weinman et al., 1996) but 
has been critiqued for not being in keeping with the aims of ‘explanatory 
models’ (Bhui & Bhugra, 2002). 
 
A concern with methods for collecting data on health belief in 
mental illness, (and indeed of extrapolating models of physical illness to 
uncover mental illness beliefs), is that in psychological research in 
physical health, it is generally assumed that the sufferer’s beliefs about 
an illness are internally consistent and relatively stable, or that coherent 
belief models are strived for.   
 
Psychiatric patients, in contrast, may not have coherent beliefs 
about their ill health (Holzinger, Kilian, Lindenbach, Petscheleit & 
Angermeyer, 2003; Williams & Healy, 2001). For example, people 
suffering from schizophrenia frequently experience severe conceptual 
disorganisation  (Docherty, 2005), meaning that constructions of illness 
may be confused, inconsistent, contradictory, or may even change during 
periods of mental stability and over the course of their illness. As 
Kinderman et al. (2006), noted conventional approaches to illness beliefs 
in physical health may suppose that the entity called an ‘illness’ can be 
appraised by or distinguished  between an entity called the ‘self’ 
(Helman, 1994).  
 
 
4.3.2.2 Ethnicity, explanatory models of psychotic illness and 
help-seeking 
 
As we have explored in the previous section, illness behaviour and 
help-seeking are influenced by the immediate culture of the individual. 
Culture also plays a part in the interaction between conceptualisation of 
illness and utilisation of available health care services.  
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It would be true to say that all societies have an eclectic range of 
health care services, be it nationally-operated systems with regulated 
services, a collection of traditional or spiritually-based folk healers or 
black market organisations. Despite the success of Western medicine in 
treating numerous diseases, traditional, alternative and complementary 
approaches have continued to be utilised by numerous individuals as well 
as various groups in modern societies (Campion & Bhugra, 1998; Patel et 
al., 1997 & 1995; Leff, 1980).  
 
As we have discussed in the previous section, decisions to seek 
help for an illness are dependent on the cultural and social beliefs and 
values of the individual with the ailment as well as their immediate socio-
cultural network. They are also based on available treatment resources 
within that society or cultural sub-group. 
 
An example of this would be popular beliefs in the Caribbean 
attributing ‘madness’ to the intrusion of spirits or the workings of black 
magic (‘Obeah’) which have been shown to influence interactions with 
local Health Care Services (such as traditional healers, obeah doctors and 
professional medical treatment facilities (Littlewood, 1988; Laguerre, 
1987; Fisher, 1985).  
 
The assumption that a social group share the same cultural 
understandings has been challenged by research investigating the 
relationship between ethnicity and health beliefs. In the UK an early 
study by Helman (1978) has shown how popular lay constructions of 
illness among White residents in north London predicted responses to 
illnesses and expectations of medical services. In addition, from the 
limited research examining mental health beliefs and explanatory models 
in minority groups in the UK there is a suggestion that traditional spiritual 
views and subsequent utilisation of culture-specific faith healers remain 




In a US study of mental health beliefs in the general population, 
Schnittker, Freese and Powell (2000), explored racial differences in the 
perception of the aetiology and treatment of mental illness. Using data 
from the 1996 General Social Survey they found that lay causal models 
fell into several distinct categories including Biological; Environmental; 
Social; and Spiritual. They found that African Americans were less likely 
than Whites to endorse a genetic or unhealthy family upbringing model of 
causation, although other forms of biological and environmental models 
of causation were used. They proposed that people from Black ethnic 
groups may be more sceptical of these causation models because of their 
alignment with racial stereotyping (e.g. arguments that position Blacks in 
a socio-economic disadvantage). They also found that racial differences 
in aetiological beliefs played a substantial part in explaining increased 
negative attitudes towards mental health professionals and treatment in 
Black groups compared to Whites. 
 
In a more recent study in East London McCabe and Priebe (2004) 
used the SEMI to investigate and compare explanatory models of illness 
in White, West African, African Caribbean and Bangladeshi patients with 
schizophrenia. Focusing on measures of insight, treatment compliance, 
health locus of control, quality of life, treatment satisfaction, therapeutic 
relationships and symptomatology, biological, social and supernatural 
causes of illness were compared.  
 
Whites were more likely to report biological causes than the three 
non-White groups, who reported supernatural causes more frequently. 
Whites also reported biological causes more frequently than African-
Caribbeans and Bangladeshis; who reported social causes more 
frequently. McCabe and Priebe (2004) concluded that a biological 
explanatory model was related to enhanced treatment satisfaction and 
therapeutic relationships but not treatment compliance. 
 
Studies investigating the views and conceptualisations of illness by 
family members of patients from minority groups have also highlighted 
possible differences in how Black Caribbean and White families respond 
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to mental illness, suggesting that more severe stigmatisation of mental 
illness in the Caribbean community may hinder voluntary help-seeking 
(Harrison et al., 1989). 
 
Further studies looking at the relationship between doctor and 
patient have highlighted the role that ethnicity and culture can play in 
patient engagement and satisfaction with services, particularly when the 
patient and doctor do not share the same illness belief structures. For 
example, the tendency of some ethnic minorities to somatise emotional 
distress was found to result in difficulties in communication between the 
patient and a White doctor (Kleinman & Good, 1985; Racy, 1980). 
 
 
4.3.3 Explanatory health belief models and help seeking and their 
application and measurement in substance use disorder 
populations 
Literature addressing models of health belief which inform help 
seeking for substance abuse problems is limited. In a study by Bardsley 
and Beckman, (1988) the Health Belief Model (HBM) was used to study 
the utilisation of alcoholism treatment programmes in the US. Comparing 
a sample of 407 patients in treatment across all treatment centres in Los 
Angeles County and 203 patients not currently receiving treatment, 
patients were interviewed on each of the HBM components. Only two of 
the five HBM components (perceived severity and cues to action)-showed 
strong, consistent relationships with the decision to enter treatment. 
Women and men in treatment had higher perceived illness severity than 
those not in treatment. In addition, the in-treatment group reported a 
greater number of unusual events (cues to action) during the previous 
month than the not in treatment group (Bardsley & Beckman, 1988). 
 
In another study the HBM was used to examine whether perceived 
susceptibility to and severity of two injection-related health conditions 
(non-fatal overdose and bacterial infections), as well as perceived 
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benefits of, barriers to, self-efficacy to, social acceptance of, and recent 
use of two harm-reduction behaviours (i.e., injecting test shots and pre-
injection skin cleaning), predicted injecting drug users' near-term 
intentions to engage in these two harm reduction strategies.  
 
Bonar and Rosenberg (2011) found that recent use of these two 
harm reduction strategies consistently and positively predicted near-term 
intentions in each of four drug-use situations (i.e. in withdrawal, not in 
withdrawal, alone, and with others). Perceived susceptibility to non-fatal 
overdose predicted intentions to do test shots, but only when participants 
imagined not being in withdrawal or injecting when alone. Perceived self-
efficacy to clean one's skin predicted intentions to engage in this 
behaviour, but only when participants imagined injecting while not in 
withdrawal. Participants' ratings of how often other injectors in their 
social network engage in pre-injection skin cleaning was also a significant 
positive predictor of intentions to clean one's skin, but only when they 
imagined being in withdrawal. 
 
Although there is a small corpus of literature relating to youth 
attitudes and health beliefs in substance abusers with comorbid HIV, to 
date there is little or no conclusive literature on ethnic differences in 
health beliefs of people with substance use disorders.   
 
 
4.4 LIMITATIONS OF APPLYING THESE MODELS TO 
COMORBID POPULATIONS 
 
It has been argued that significant modifications to models of help-
seeking and health beliefs are necessary if they are to apply to mental 
disorders. As noted by Kinderman et al. (2006), it is probable that some 
of the assumptions underlying the models (particularly different 
dimensions of understanding which may be present in mental illness but 
not in physical illness) will be inappropriate. The same caution will no 
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doubt need to be applied to models of beliefs in populations with 
comorbid psychosis and substance use disorders. The additional belief 
structures surrounding substance use will need to be considered, added 
to which the likely inconsistency  between cultural models of drug taking 
and mental illness which may lay blame in one construction and find 
victim in the other. 
 
 
4.4.1 Models substance use disorders in psychotic populations 
Lay models of causation are related to overall constructions of 
illness, and illness behaviours including help seeking. However there has 
been limited research into models of the aetiology of comorbidity. Much 
of the literature looking at aetiological theory of dual diagnosis has 
originated in traditional epidemiological research. There have been three 
broad hypotheses for the relationship between psychosis and substance 
use: Substance use as a risk factor for psychosis; Psychosis as a risk 
factor for substance use; and shared underlying risk for both disorders. 
There have been several theories proposed to help uncover this 
relationship, most of which have been generated within traditional 
epidemiological research.  
 
Essentially the underlying question in terms of the relationship 
between substance use disorders and psychosis is which came first? 
 
 
4.4.2 Substance use disorder causes psychosis 
 
There is a body of evidence that suggests that stimulant abuse 
may be a risk factor for developing psychotic symptoms (Brady et al., 
1991; Cohen, 1952; Curran et al., 2004).  However this evidence does 
not show that this relationship may lead to a long and enduring psychotic 
illness (Gregg et al., 2007). 
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There has been much research over the past 20 years regarding 
the relationship between sustained cannabis use and schizophrenic 
disorders. Indeed, there is evidence to suggest that the main 
psychoactive component of cannabis, Δ-9-Tetrahydrocannabinal (THC), 
can induce psychotic symptoms in healthy members of the general 
population (DeSouza et al., 2004; Morrison et al., 2009) and increase the 
sensitivity of the negative effects of cannabis in persons at risk of a 
psychotic disorder (Barkus et al., 2006; Verdoux et al., 2003).  
 
In addition, recent studies have shown an association between 
cannabis use and chronic schizophrenic disorders (Moore et al., 2007) 
although evidence for direct causation is in its infancy. There is an 
increasing public awareness of the relationship between cannabis and 
schizophrenia, however little is known as to whether models of mental 
illness causation which include substance abuse differ by ethnicity and if 
these differences are reflected in illness behaviours and help-seeking. 
 
 
4.4.3 Psychosis causes substance use disorder 
 
The basis of this aetiological hypothesis is the self-medication 
hypothesis (SMH). This hypothesis suggests that individuals abuse 
substances to relieve psychotic and affective states that they find 
undesirable (Khantzian, 1985 & 1997).   
 
The SMH has been applied to substance abuse and dependence in 
persons with psychotic disorders such as schizophrenia and it has been 
proposed that substances may be used to alleviate positive and negative 
symptoms of psychosis (e.g. Henquet et al., 2010; Chakroun, Johnson & 
Swendsen, 2010). It has also been proposed that substances may be 
used to alleviate the extrapyramidal side effects of antipsychotic 
medications (Schneider & Siris, 1987)  
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A criticism of this hypothetical model is that we would expect 
certain drugs that are abused in psychotic populations to be related to 
specific mental disorders depending on the weight of the psychotic and 
affective components of the illness. However, there is evidence that 
individuals with a severe mental illness abuse the same substances as 
the general population, just at an inflated rate (Addington & Addington, 
2007). SMH has made its way into lay explanatory models of substance 
use in psychotic populations and no doubt plays a part in decisions to 
seek help for either disorder as I discuss in the following sections. 
 
 
4.4.4 Psychosis and substance misuse are derived from the same 
cause 
 
Genetic twin studies have provided the basis for evidence of the 
heritable nature of psychosis (Shih et al., 2004) and substance use 
disorders (Van den Bree et al., 1998; Cadoret et al., 1996). There has 
been limited research into a common genetic predisposition for both 
disorders with studies finding contradictory evidence (Gershon, 1988; 
Byrne et al., 2002).  
 
Moreover, socio-economic factors that put individuals at risk for 
psychosis and substance abuse have been proposed as the common 
denominator in increased rates of substance use disorder in psychotic 
populations (Faris & Dunham, 1939) and little research has been 
conducted to ascertain whether this model is mirrored in lay 







4.5 UNCOVERING CONSTRUCTIONS OF THE EXPERIENCE OF 
PSYCHOSIS AND COMORBID SUBSTANCE USE  
 
‘Beliefs about health and illness shape emotional responses to 
illness, health-related behaviour and relationships with health care 
providers in physical illness’. (Kinderman et al., 2006, p. 1900).  
 
It would be fair to say that the truth of this statement for psychotic 
illness has been evidenced in the previous sections. Very few studies 
however, have looked qualitatively at constructions and 
conceptualisations of psychotic illness and comorbid SUDs or health 
beliefs in this population. Research into health beliefs has tended to focus 
broadly on severe mental illness or schizophrenic populations or 
substance abusing populations separately.  
 
There has been limited qualitative research in areas where these 
populations overlap (as we saw in Chapter 3) and even less that looks at 
the role ethnicity may play in constructions of illness and substance use.  
 
As Bhui and Bhugra (2002) note, Kleinman’s original work involved 
asking questions through an exploratory process of qualitative enquiry. 
Bhui and Bhugra (2002) argue that this leads to complex and multi-
layered responses which provide information about social rituals, symbols 
in communication, types of knowledge and illness narratives. It is these 
illness narratives that help build a more detailed picture of 
conceptualisation of illness and provide the basis for generating new 
theory and models of health belief. 
 
The aim of this section is to exemplar qualitative investigation in 
psychiatry, psychology and the social sciences which have used 
qualitative approaches. We have seen how qualitative methodology in the 
form of structured and semi-structured questionnaires (EMIC, SEMI and 
IPQ) can elicit models of mental illness belief in patients with psychosis. 
It is also useful however to draw on research which doesn’t use pre-
existing models of health belief as a framework.  
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These studies may challenge health belief models of illness or use 
entirely different frameworks of understanding to uncover constructions 
of illness and substance use. Not surprisingly this type of research is 
scarce in the area of comorbidity. 
 
 
4.5.1 Constructions of mental illness in psychotic populations 
In a study by Kinderman et al. (2006) the beliefs about illness 
experiences of 20 patients diagnosed with schizophrenia (10 currently 
psychotic inpatients and 10 outpatients in remission) were examined 
using qualitative interviews and thematic analysis. The study sought to 
clarify and extend possible conceptual differences between illness belief 
structures in physical health, based on explanatory models such as HBM 
and SLT and on doubts about both the existing methodological 
approaches, and the conceptual frameworks which underpin them. The 
study recruited patients purposively from local inpatient and outpatient’s 
mental health services in the Liverpool area who were over 18 years of 
age with a diagnosis of schizophrenia. Twenty patients (10 inpatients and 
10 outpatients) were interviewed.  
 
The interviews were conducted using a semi-structured interview 
guide, which listed key areas to be explored, including patients’ beliefs 
about: the reasons that they entered psychiatric care; associated 
experiences; any illness labels, such as ‘illness’, ‘schizophrenia’ or 
‘depression’, that they or others had applied to their problems; the 
effects and mode of action of treatments they had been offered. 
Questioning was responsive to the participants’ own comments and 
situation, so the ordering and amount of time spent on each of these 
areas varied between interviews. 
 
All inpatients at the time of interviewing were experiencing 
psychotic symptomatology (hallucinations, delusions or formal thought 
disorder) as assessed by the clinical team in charge of the patients’ care. 
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Conversely, all outpatients were confirmed by the clinical team in charge 
of them to currently be in a period of relative remission. 
 
The analyses of interview transcripts used elements of grounded 
theory (Dey, 1993) and were conducted in parallel with data-collection so 
that aspects of the developing analysis could be tested and developed in 
subsequent interviews. Thematic analysis was performed by all authors.  
 
80% of the sample was male and all but two participants described 
themselves as White British. The study found different conceptualisations 
of illness between inpatients and outpatients as highlighted in Tables 5 
and 6. 
 
Table 5: Properties of the beliefs of the inpatient sample 
Properties of the beliefs  
 
The inseparability of illness from patients’ identities: 
 psychotic problems inseparable from the patients’ wider lives, sense of 
self and spiritual and moral issues 
 psychosis not appraised as a ‘thing’ apart from the appraiser 
 
The flexibility and uncertainty of beliefs: 
 absence of consolidated ‘models’ of illness in acute psychosis 
 inconsistent and fluid beliefs about psychotic problems 
 puzzlement and confusion 
 
The social dimensions of illness labels: 
 patients have a strong tendency to own the use of labels such as 
‘psychotic’ and ‘schizophrenia’ 
 such labels experienced as statements about the individual and with 
moral as well as descriptive significance 
 models and labels concerning psychotic problems are commonly 
experienced as pejorative 
 
 
Adapted from Kinderman, P., Setzu, E., Lobban, F. and Salmon, P. (2006).  Illness beliefs in 




Table 6: Properties of the beliefs of the outpatient sample 
Properties of the beliefs  
 
Patients’ separation of current self from past experiences: 
 ‘illness models’ discernible during periods of relative remission 
 periods of psychosis viewed as autobiographical episodes 
 psychosis described as a state of detachment from reality 
 
Illness labels: 
 labels such as ‘psychotic’ and ‘schizophrenia’ remain perceived as 
statements about the individual 
 models and labels concerning psychotic problems are commonly 
pejorative 
 
The social and psychological elements of illness labels: 
 discussion of ‘illness’, but also psychosocial stress, morality and 
spirituality 
 accounts of past psychotic experiences enmeshed in other aspects of the 
patients’ lives and part of the sense of self 
 integration of physical, social and other approaches implied and 
idiosyncratic 
 
Hopelessness and resignation: 
 unremitting hopelessness 
 resignation and a lack of personal agency 
 
 
Adapted from Kinderman, P., Setzu, E., Lobban, F. and Salmon, P. (2006).  Illness beliefs in 
schizophrenia. p. 1906. 
 
The themes identified in the two samples show that patients 
currently experiencing psychosis did not identify their experiences as 
separable ‘illnesses’ and did not have coherent and consistent models of 
illness belief. Patients currently in a period of remission evaluated their 
experiences as distinct from their own normal behaviour, but used 
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conceptual frameworks of understanding that were not in line with 
conventional ‘health belief’ models.  
 
What is evident from the constructions in both samples is that ‘self’ 
is a salient feature of understanding illness whereas the appraisal of 
symptomology in patients’ immediate social networks such as family and 
friends (an important aspect in both Mechanic’s (1968) factors influencing 
illness behaviour and Zola’s (1973) model of help-seeking) does not 
feature as expected.  
 
What should be noted is that this study does not look at constructions 
of substance use or substance use disorders in either sample. It is likely 
that there would be differences in the conceptualisation of illness and its 
relationship to self in a sample of patients with co-occurring problems 
with drugs or alcohol.  Nevertheless, what this study does highlight is 
that patients’ ways of understanding mental illness do not necessarily 
parallel those described in physical illnesses.  
 
Boydell et al. (2010) conducted a review of qualitative studies 
examining constructions of psychotic experience. They found 31 papers 
summarising 27 studies conducted in FEP populations across the world. 
Findings were organised according to interpretive philosophies of general 
social processes (GSP) (Prus, 1996 & 1997) such as: achieving identity; 
acquiring perspectives; doing activity; and developing relationships. 
Six of the studies focused on the subjective experience of psychosis 
under the GSP ‘achieving identity’. Boydell et al., (2010) found that 
young people who have experienced their first episode of psychosis seek 
to find meaning for their psychotic experiences and adopt multiple 
explanations over time (Hirschfeld et al., 2005; Kilkku, Manukka & 
Lehtinen, 2003; Larsen, 2004; Perry, Taylor & Shaw, 2007; Werbart & 
Levander, 2005; Sin, Moone & Wellman, 2005).  
One study (Larsen, 2004) found that knowledge gained from psycho-
educational interventions allowed respondents to better understand 
symptoms and these understandings were found to help them control 
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reoccurrence of those symptoms. Another study (Kilkku, Manukka & 
Lehtinen, 2003) found that respondents identified the role of receiving 
information about their experiences early on in their treatment journey 
and how this created a sense of relief as well as providing a tool for 
future symptom management. 
Boydell et al. (2010) found that several of the studies (Fisher & Savin-
Baden, 2001; Larsen, 2007; McCann & Baker, 2001; Newton et al., 2007; 
O’Toole et al., 2004; Sin, Moone & Wellman, 2005) reviewed focused on 
the respondents’ views of early interventions services and these themes 
collectively were related to ‘acquiring perspectives’ as part of GSP. 
Respondents talked about the importance of the relationships they had 
with services. Additionally the personal qualities that providers brought to 
that relationship were considered just as important as the therapeutic 
frameworks they used. 
Findings relating to ‘doing activity’ included the subjective experience 
of help-seeking. Three studies identified barriers to help-seeking which 
included: the time it took to receive a diagnosis; unreturned phone calls; 
and the lack of communication between various service providers 
(Bergner et al., 2008; Corcoran, 2007; Czuchta & McCay, 2001). Four of 
the studies examined the recurring features of the help seeking pathway 
and demonstrated that when symptoms persist, significant others begin 
to search for answers through a wide range of professional sources. The 
role of social networks was also found to be significant in many studies. 
In addition many of the studies reported findings on ‘experiencing 
relationships’. Themes within these studies revealed the importance of 
peer relationships to young people with FEP as well as descriptions of the 
experiences of multiple difficulties feelings of isolation and stigmatisation. 
Although this review was thorough and included studies from a range 
of geographical populations, all the papers have been reviewed within 
one philosophical leaning and may not have been re-analysed or grouped 
according to the original authors’ theoretical framework. 
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4.5.2 Constructions of substance use in comorbid populations 
In one of the few qualitative studies that has looked at the lived 
experience of patients with psychosis and substance use disorders, 
Bradizza and Stasiewicz (2003) in the US found that in a group of 
patients with severe mental illness (SMI) (psychotic and severe affective 
disorders) and substance use disorders (SUD) several interpersonal and 
intrapersonal factors influenced the situational risk for using substances.   
 
Using a focus group methodology, which included ten audio-taped 
focus group discussions with patients that were currently in treatment at 
a centre for dual diagnosis, participants were asked questions regarding 
general social situations they found difficult to manage as well as the 
perceived benefits and problems resulting from alcohol and drug use.  
 
Participants were also asked about high-risk situations or 
‘‘triggers’’ for substance use. The qualitative data were analysed using a 
multi-level process that focused on the classification of responses related 
to high-risk drug and alcohol use situations.  Two raters independently 
identified all instances in which a participant mentioned a high-risk 
situation and coded the situation into a classification system developed 
independently of the other rater.  
 
Qualitative data analysis uncovered ten themes that encompassed 
33 high-risk situations for substance use. These included: 
 Psychological symptoms (avoiding or coping with symptoms such 
as paranoia, auditory hallucinations and feelings of anxiety or 
nervousness). 
 Positive and negative affect (positive and negative emotions 
triggered drug and alcohol use including: feeling good, bad, 
sad/depressed, angry, bored, frustrated, lonely, 
stressed/overwhelmed and guilty). 
 Reminders of substance use (being around certain people, 
environments or objects that had been highly associated with 
substance use often led to drug and alcohol use).  
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 Being around people who use drugs and alcohol (encountering 
people with whom they have previously used drugs, being around 
friends who use, friends who pressure use, seeing one’s partner 
drunk or high and being around family members who use 
substances).  
 Interpersonal conflict (negative interpersonal interactions such as 
arguments with family members, criticism about their alcohol or 
drug use and having people criticise or try to control them). 
 Offers of drugs or alcohol (difficulties in avoiding drug use, 
particularly since they were frequently offered drugs by others).  
 Experiencing loss (not getting anywhere in life, death of a family 
member and having their children removed by Social Services).  
 Receiving money (government assistance, borrowed money from 
family or friends or money they obtained from strangers as a 
trigger for use).  
 Loss of appetite (for women only: knowledge that they have not 
been eating due to an absence of hunger can be a trigger to smoke 
marijuana, which increased their hunger).  
 Being abstinent (having been abstinent for a while can generate 
strong urges to use a substance). 
 
The study findings were compared to literature on risk for 
substance use in SUD populations without SMI and suggested that 
individuals with an SMI and SUD experience a number of unique high-risk 
situations that differ from those reported by non-SMI substance abusers. 
 
Patients with SMI and comorbid SUD experience several categories 
of high-risk situations that are commonly found among SUD patients 
without SMI, including the experience of unpleasant emotions, urges or 
temptations to use substances, conflict with others, social pressure to use 
substances, enjoying pleasant times with others and pleasant emotions.  
 
However, Bradizza and Stasiewicz (2003) found that there were 
significant differences between the two groups. Unlike patients with SUD 
only, patients in this study did not report physical discomfort or testing 
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personal control as high-risk situations. They did however highlight high-
risk situations unique to this comorbid population including psychological 
symptoms, experiencing loss, receiving money, loss of appetite and being 
abstinent. 
 
As well as having important implications for the measurement of 
the prevalence of substance use in populations with psychotic disorders 
(or vice versa as it was intended) this study also provides a basis for the 
development of relapse assessment instruments and treatment strategies 
appropriate for dual diagnosis populations.  
 
In relation to understanding why patients with comorbidity (despite 
having poorer outcomes than patients with just psychosis) are likely to 
continue using substances this study highlights two things.  Firstly, 
despite the obvious negative effects of substances (such as symptom 
worsening) substance use in psychotic populations can be just as 
enjoyable as it is in the general population.  Secondly, self-management 
and mastery of psychosocial stresses through self-medication is likely to 
be key.   
 
In addition, this study highlights how patients with comorbidity 
have cumulative stresses and life difficulties to contend with (such as 
dealing with the physically and socially addictive elements of substance 
use and difficulties with family members because of substance use), 
compared to patients with only a psychotic disorder, that would have an 
undeniable impact on substance use and psychotic relapse.  
 
Moreover the added pressure of family monitoring of both 
substance use and signs of recurring mental illness remains a double 
edged sword.  It may provide additional support within a larger coping 
framework. but is also provides additional pressure (including feelings of 
disappointment) and increased likelihood of contact with drug treatment 
and mental health services which may account for the elevated rate of 
hospital admissions in this group.  
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In an early nineties study by Noordsy et al. (1991) subjective 
experience of alcohol use in a sample of schizophrenic patients in an 
outpatient community mental health treatment centre in New Hampshire 
uncovered several positive effects of prolonged alcohol use. Using a 
structured interview schedule and reporting responses of ‘sometimes’ or 
‘often’ to having a particular experience, 75 patients were interviewed 
about their psychotic symptoms and alcohol use.  
 
Over half of the sample reported that alcohol use improved social 
anxiety, tension, dysphoria, apathy, ahedonia and sleep difficulties. 
Although only 15% of respondents reported that alcohol was used to 
relieve psychotic symptoms, self-medication for psychotic symptoms was 
associated with lifetime alcohol use disorders. Positive effects on non-
psychotic experiences were also associated with lifetime alcohol use 
disorders 
 
Archie et al. (2013) conducted a study that sought to identify 
factors that contribute to the initiation of alcohol and illicit drug use in 
young patients with FEP. Forty-five participants were recruited from five 
early intervention programmes located across Ontario. Eight focus groups 
were conducted which involved four to six participants per group. 
Thematic analysis was used to systematically code transcripts from the 
focus groups for concepts, patterns and themes that related to initiation 
of alcohol and illicit drug use. The participants were not asked explicitly 
about substance use, but they discussed their experiences with alcohol 
and drug use spontaneously during every focus group.  
 
Three main themes relating to the initiation of substance use were 
identified. 
1) facilitating social interaction: illicit drugs appealed to 
respondents because substances provided a social context and a 
means for interacting with other young people. The social 
experience of substance use was seen as shaping respondents 
personality, values and interests. 
2) self-medicating: some individuals used substances to help 
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reduce unwanted symptoms. Respondents used substances to 
reduce stress, but this reason was often fleeting. 
3) altering perceptions: substances altered experiences, were 
considered pleasurable and created a more interesting world 
helping them to develop a new sense of being 
 
Archie et al. (2013) note that their study has several limitations 
including failing to categorise substances into classes even though 
different types of substances may have had different effects and 





Despite a large corpus of epidemiological literature detailing the 
association between comorbid psychosis and substance use disorders the 
underling mechanism of this relationship is still up for debate. The 
negative outcomes (such as more frequent relapse and more 
hospitalisations) of dual diagnosis may be better explained by models of 
health belief and help-seeking that place the health behaviours including 
decision making processes of the suffer within a wider socio-cultural 
context. Furthermore, ethnic differences in prevalence and correlates of 
comorbidity may also be better understood through exploration of the 
differences in individual’s models of mental health belief (including 
models of illness aetiology) as well as constructions of psychotic 
experience and substance use within the context of their mental illness. 
As discussed in earlier chapters there is a need for robust longitudinal 
population-based studies, which can explore the various interactions 
ethnicity may have with comorbid diagnosis.  
 
This PhD study aims, through a mixed method study design, to 
estimate the prevalence of comorbid psychosis and substance use 
disorders in different ethnic groups, giving special attention to Black 
African and Black Caribbean populations. It also aims to explore in detail 
 130 
the relationship between comorbid diagnosis and various clinical and 
psychosocial outcomes as well as uncover patient perceptions of 
psychotic illness, substance use and service responses within different 
ethnic populations. Chapter 6 summarises the method used in this study. 
However, the following chapter first provides a summary of the 
philosophical stance within which the study is framed. It also provides 
detailed discussion of the necessary theoretical and methodological 
considerations of using a mixed method design for investigating this 
phenomena. 
 
Chapter Summary 4.  
Chapter Summary 
 
Aims of the Chapter: 
 
To highlight the limitations of epidemiological research in understanding the 
experience in patients with comorbid psychosis and substance use. To provide an 
overview of models of help seeking, health beliefs and lay constructions of 
experience of psychosis and substance use and how they may relate to lay 





 Ethnic differences in prevalence and correlates of comorbidity may be 
better understood through exploration of the differences in individual’s 
models of mental health belief 
 Negative outcomes may be better explained by models of health belief 
and help-seeking that place the health behaviours, including the decision 
making processes of the suffer within a wider socio-cultural context. 
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CHAPTER 5:  THEORETICAL CONSIDERATIONS 
 
5.1 SUMMARY OF SCIENTIFIC JUSTIFICATION 
 
The aims of this chapter are to situate and give reason to the 
methodological design of the PhD study. To do this we need to first 
understand the origins of research methodology and methods used in 
social enquiry. I will outline and discuss the ontological/epistemological 
assumptions in and compliments and contentions between quantitative 
and qualitative methodology. This will lead onto a discussion of the 
common belief of the incompatibility of quantitative and qualitative 
methods; an overview of the epistemological flexibility of some methods 
and methodologies; and how quantitative and qualitative methodologies 
are not necessarily incompatible as well as why the methodological 
approach of combining these two methodologies is increasingly being 
used in health service research.  I will also discuss a ‘middle ground’ 
position of subtle realism and its ontological and epistemological 
appropriateness for mixed methods research and this study. 
  
 
5.2 SHAPING THE DISCIPLINE 
 
To understand research in mental health (or more specifically 
mental health services research) one must look at the disciplines that 
guide it and more importantly the underlying philosophical assumptions 
and scientific axioms that underpin it. Much of the research discussed in 
the previous chapters spans a range of disciplines; psychology, social 
psychiatry and anthropology, as well as various areas of research 
interest: health research, mental health and addictions. It is necessary 
then to acknowledge these areas of influence and the philosophical 




5.2.1 Ontological and epistemological debates in the ‘soft 
sciences’  
Traditionally much of research conducted within the realm of social 
science (namely psychology, social psychiatry, sociology and 
anthropology) has used quantitative methodology (Murphy et al., 1998) 
and those wishing to uncover events, characteristics and patterns in 
health (epidemiology) have tended to use quantitative methods to do so.  
 
Quantitative enquiry is often situated within a realist ontological 
perspective (Murphy et al., 1998). Pure realists assume that it is possible 
to state objective truths about the material world (Murphy et al., 1998). 
Qualitative enquiry sits at the other end of the theoretical spectrum. In 
contrast to quantitative enquiry it has been argued by leading writers on 
social research epistemology and methodology that the appropriate or 
‘legitimate’ epistemological paradigm for qualitative research is 
constructivism (Guba and Lincoln, 1989; Denzin & Lincoln, 1994a; 
1994b; Guba, 1990; Lincoln & Guba, 1985). Constructivism (in 
Psychology) or constructionism (in Sociology) have an idealist ontology. 
 
Indeed much of qualitative enquiry is framed within idealist ontology 
and constructionist epistemology (Smith, 1983a; 1983b; 1985; 1989). 
Scientific idealism holds that the external world consists merely of 
representations and is a creation of the mind (May & Williams, 2002). 
Constructivism adopts a similar position (Guba & Lincoln, 1989). It 
rejects the idea that the world is made up of facts to be uncovered 
(Palmer, 1928); instead any objective knowledge or truth can be reduced 
to a perspective (Scwandt, 1997). Constructivism has been termed a 
‘relativist’ or ‘subjectivist’ position which could be held in opposition to 
the traditional   ‘objectivist/empiricist’ approaches that have dominated 
scientific enquiry (Lincoln & Guba, 2000).  
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With the increased use of qualitative methodologies a scientific 
‘paradigm war’ began in the 1980s. Because quantitative and qualitative 
enquiries were seen as being situated in different and opposing scientific 
paradigms (Smith, 1995; Murphy et al. 1998, p. 4) and thus each were  
inseparably bound to a set of specific and incompatible ontological and 
epistemological (i.e. realist and constructivist) assumptions they could 
not be combined (Greene, 2007). 
 
This notion has been contested. For example, Hacking (1999) 
argues that a social constructionist (or constructivist) approach to 
researching a phenomena can be employed at both global and local levels 
(i.e. that everything we know about a phenomena is socially constructed 
or that elements of it are). The idea that an individual phenomena in its 
creation is subject to socio-historic and political influences and that in, for 
example an alternate reality, it might well be different (i.e. a ‘social 
construction’) is not incompatible with realist stances (i.e. that it is 
knowable).  Similarly Shadish, Cook and Campbell (2002) argued that 
"all scientists are epistemological constructivists and relativists" in the 
sense that they believe that both the ontological world and the worlds of 
ideology, values, etc. play a role in the construction of scientific 
knowledge” (p. 29). In other words it is possible to approach research 
with a realist ontology but a constructivist epistemology (Maxwell, 2011), 
a notion that is discussed more fully in the next section.  
 
 
5.2.2  Finding a common ground: a Subtle Realist perspective 
Qualitative work is often identified with idealism while quantitative 
work is identified with realism. Hammersley has argued that neither 
realist nor idealist (or constructivist) approaches offer a sound 
philosophical basis for social research (Hammersley, 1992).  Instead, an 
approach that sits between naïve realism and relativism/idealism would 
be a more appropriate research stance; subtle realism.  Murphy et al. 
(1998) summarises subtle realism in the following way: 
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“If we adopt a subtle realist position we are able to hold on to 
truth as a regulative ideal, while, at the same time, accepting 
that it will always be impossible to be absolutely certain that 
truth has been attained in any particular instance. This allows 
us to assess both qualitative and quantitative research in terms 
of two fundamental criteria – those of validity and relevance” 
(Murphy et al., 1998, p. 11). 
 
I argue however that subtle realism is not simply ‘sitting on a 
paradigmatic fence’ or a ‘middle ground’ along an ontological or 
epistemological spectrum. Instead it is a combination of both seemingly 
opposing stances, and according to Murphy et al.  (1998) can be 
considered as an ideal epistemology for a mixed method study as both 
quantitative and qualitative methodologies can be assessed under the 
same two criterion (relevance and validity) (Murphy et al. , 1998).  
 
Subtle realist perspective is based on the belief that ‘truth’ is a 
regulative ideal, that phenomena exist independently of the knower’s 
claims about it yet it is impossible to be certain about claims of 
knowledge of ‘truth’. Any given reality can be represented from a range 
of different perspectives and each of these representations may be 
treated as true. The objective of research should be to search for 
knowledge about which we can be ‘reasonably confident’. Such 
confidence in our representation of reality will be based upon judgements 
about the credibility and plausibility of knowledge claims (Hammersley & 
Atkinson, 1995).  
 
Similarly, Hamilton’s (2002) definition of knowledge as beliefs in 
which one can have reasonable confidence in their validity or truth, falls 
in line with what Hammersley (1992) considers a ‘common sense’ 
understanding and consensual notion of what constitutes social 
knowledge. Andrews (2012) considers this to be a ‘pragmatic view of 
knowledge’: a knowledge which involves judging truth in relation to what 
is already known, not by appeal to philosophy. 
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Murphy et al. (1998) set out the three key elements of subtle 
realism according to Hammersley (1992): 
1. Absolute truth in knowledge which the knower can be certain 
of is not possible. This is because claims to valid knowledge 
are based on assumptions that are presupposed an often 
axiomatic. Truth should be reinterpreted as “beliefs about 
whose validity we are reasonably confident” (Hammersley, 
1992, p. 50). 
 
2. It is essentially possible to claim to have knowledge of a 
phenomena that is independent of the phenomena itself (i.e. 
the claim or belief does not change reality in order to make 
the phenomena true or false), and that this knowledge will be 
more or less representative of the phenomena. 
 
3. The aim of social research is to represent rather than 
reproduce reality and that phenomena can be ‘represented’ 
from multiple perspectives. 
(Murphy et al., 1998, p. 174) 
 
We can extend the understanding of subtle realism by looking at 
Philips’ (1990) argument that just because observations or claims to 
knowledge are based upon perspectives or theory it doesn’t mean that we 
cannot judge between them. Phillips (1990) also argued that it is possible 
to combine a commitment to the social construction of reality with an aim 
for ‘truth’, through studying the different constructions of reality people 
make without accepting that only particular beliefs are true. 
 
As Murphy et al. (1998) states about subtle realism: ‘This middle-
way allows us to accommodate some elements of social constructivism, 
without abandoning a commitment to independent truth as a regulative 
ideal [idealism].’ (Murphy et al., 1998, p. 69) 
 
Similarly, much like the view held by Shadish et al. (2002) and 
Maxwell (2011), Banfield (2004) observed that the underpinnings of 
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subtle realism is this medley of realist ontology and constructivist or 
idealist epistemology. In his critique of Hammersley, Banfield (2004) 
asserted that the ontological claim within subtle realism is a realist one: 
phenomena exist independent of human knowledge of them. However he 
believes that this is then ‘set against constructivist accounts of social 
reality, the social world contains objects whose existence does not 
depend upon what we think about them’ (Banfield, 2004, p. 54). This 
realist ontological position aligned with a constructivist or relativist 
epistemology is not too dissimilar to a critical realist approach (whereby 
phenomena are knowable but there is an emphasis on the ‘fallibility of 
human knowledge’) (Banfield, 2004, p. 54). 
 
Maxwell (2011) in Soini et al.’s (2011) Epistemologies for Qualitative 
Research argues that realism ‘can do useful work’ for qualitative 
methodology. He proposes four main areas where a realist perspective 
can make contributions: (1) causality: the legitimacy of this concept in 
qualitative research, and the contributions that qualitative research can 
make to causal explanation. (2) The understanding of mind and mental 
phenomena: the value of a realist understanding of these, one that does 
not reduce them to brain states or behaviour. (3) diversity: seeing 
diversity as a real phenomenon, rather than as "noise" or "error" that 
obscures the essential commonalities in different individuals, events, or 
situations. (4) validity: how we can assess the value, credibility, and 
quality of qualitative research. 
 
As Murphy et al. states: “Subtle realists accept that material reality 
can itself be a constraint on the possibility of definition. We can only 
perceive the world in ways which are in some sense consistent with the 
immanent organisation of that world. (Murphy et al., 1998, p. 4). As I 
have discussed above the marriage of a realist ontology and a 
constructionist or Idealist epistemology is not only compatible with both 
quantitative and qualitative enquiry it facilitates the use of both these 
research methods within one single study (a notion that is discussed in 




5.2.3 Theory in research process 
The design of a research study and the research process used within 
it are closely linked to the ontological and epistemological assumptions it 
holds to.  Quantitative research process as well as mostly being aligned 
to realist research philosophy finds its origins with Popper (1959). 
Popper, as summarised by Chalmers believed that science starts with a 
problem which then leads to falsifiable hypotheses which can be tested 
(Chalmers, 1982). This deductive (hypothetico-deductive theory) and 
falsification process were not concerned with the source of the 
hypothesis. Many who follow the research theories of Glaser and Strauss 
(1967) see qualitative research as an inductive process. Glaser and 
Strauss opposed the imposition of a priori theory upon data and asserted 
that the researcher should seek to generate ‘Grounded Theory’ (Murphy 
et al., 1998). 
 
Interestingly,  Murphy et al. (1998) states that “much contemporary 
qualitative work stresses its inductive character, while quantitative work 
tends to stress its deductive character. In fact, it is clear that good 
science involves both for different purposes at different times.” (p. 2).  
 
These methodological ‘research process’ perspectives (founded in 
either realist truth seeking or Idealist perspective seeking frameworks) 
relate to the underlying logic, or ways of thinking about the data and 
should be  connected to but distinguished from other parts of research 
process (Johnston, 2004). For example Johnston outlines the thoughts of 
Erlandson et al. (1993) (an advocate for naturalistic rather than 
laboratory research settings) in which he distinguishes, the method, 
which refers to types of data (i.e., quantitative or qualitative), from the 
tools used in data collection (i.e. quantitative survey instruments or 
qualitative interviews), and the techniques for analysing the data (i.e. 
statistical methods or thematic analysis) from the logical process of 
conducting research (Johnston, 2004). 
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In the same way seemingly opposing ontology’s and epistemologies 
can be combined so too can opposing research processes. Johnston 
(2004) describes the practical process of triangulation in a mixed method 
doctoral study (similar to that of less fundamental applications of 
Grounded Theory), involving both deductive and inductive process. For 
her, the quantitative data was analysed deductively yet, “…the overall 
iterative process of data interpretation involving between-methods data 
triangulation was inductive” (p. 267).  
 
Similarly to many of the authors referred to in the previous section, 
Patton (1988), argued for a “paradigm of choices”. In other words 
paradigms should not be considered to be rigid or fixed, and researchers 
should not have to choose between two opposing paradigmatic camps. 
Patton proposed that “different methods are appropriate for different 
situations” (p. 119) and that “wherever possible, multiple methods 
should be used” (p. 136). Johnston (2004) infers that implicit in this 
statement is a support for mixed method research even within one study: 
“…indeed, that both inductive and deductive reasoning can be 
complementary, rather than mutually exclusive, data analysis tools” 
(Johnston, 2004, p. 262). I shall discuss this in more detail in the 
proceeding sections.   
 
As Wallace (1978) posits, scientific process involves both induction 
and deduction in a circular, rather than linear process. In other words 
qualitative research being inductive and quantitative research being 
deductive is another assumed dichotomy which doesn’t hold in practice. 
 
 
5.3 MIXED METHODOLOGY IN SOCIAL SCIENCE RESEARCH 
 
Mixed methods research has been used throughout the 20th and 21st 
century. Since the 1930 and 40’s quantitative and qualitative methods in 
sociology and social psychology have been used side by side in social 
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enquiry (Hammersley & Atkinson, 2007) and that it was after the rise of 
‘logical positivism’ when qualitative research began to be seen as 
belonging to an alternate scientific paradigm (Murphy et al. 98). There is 
a large corpus of literature around the philosophical and practical 
possibilities, benefits and constraints of mixing quantitative and 
qualitative research within one study. As I have discussed earlier it is 
possibly theoretically at least to combine opposing research paradigms 
and processes but what are the practical implications of that? 
 
 
5.3.1 Mixed methodology in Health Services Research 
Maxwell’s (2011) exposition of Epistemological Heuristics in Soini, 
Knronqvist and Huber’s ‘Epistemologies for qualitative research’ (2011) 
argues that it ‘is not simply that qualitative research can be conducted 
from a number of different ontological and epistemological perspectives. 
In addition there are significant advantages to incorporating diverse, 
even "contradictory," epistemologies in one's conceptualization and 
practice of qualitative research’ (p. 11).  
 
A notion cultivated by Green (Green, 2007 & 2008; Greene & 
Caracelli, 1997) who refers to mixed methodology (either quantitative 
and qualitative or several different types of qualitative research) as not 
only a ‘dialectic stance’ (a paradigmatic ‘conversation’ within a single 
study where it is important to value each in their own right) toward 
mixing paradigms (Greene & Caracelli, 1997; Greene, 2007) but also as a 
distinctive methodology in its own right (Green, 2008). The specific ways 
in which quantitative and qualitative research methodologies and 
methods can be combined is discussed in the next section (5.3.2) but 
essentially the premise behind their combined use is that the disparate 




Historically, health services researchers in the UK have tended to 
use quantitative methods to investigate issues in health care provision 
(O’Cathain, Murphy & Nicoll, 2007).  As Murphy et al. (1998) note we 
may establish by the methods of social epidemiology that certain kinds of 
health risks are unequally distributed within a population (Murphy et al., 
1998). In the last decade or so health services research has welcomed 
the use of qualitative approaches (Pope & Mays, 1995). Mixed methods 
research is relatively common in Health Services Research in the UK now 
and pragmatic rather than ideological reasons have often been given for 
using mixed methodology in one study. Other reasons have included the 
perceived deficit of quantitative methods alone (O’Cathain, Murphy & 
Nicholl, 2007). 
 
Qualitative methods are often employed in addition to quantitative 
methods when little is known about the topic area (Morse & Field, 1995), 
and there has been a renewed interest in mixed methods research in the 
health services research field in general (Barbour, 1999). 
 
 
5.3.2 Mixed methodology models 
Mixing quantitative and qualitative methods can be done in several 
ways. Murphy et al. (1998) outlines three ways in which quantitative and 
qualitative methodologies can be combined within one study; qualitative 
research as a junior partner; ‘horses for courses’ (the choice and 
combination of types of research methods should fit the research aims); 
and qualitative research as a senior partner. These models are concerned 
with the weighting of quantitative and qualitative research within one 
study.  
 
The first and the last types of mixed method design speak for 
themselves. Qualitative research being used as a junior partner was born 
out of the attitudes many social scientist had towards qualitative 
research. Murphy et al. (1998) refers to the works of Dean, Eichhorn and 
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Dean (1969) who advocated the use of ‘unstructured’ methods when 
quantitative methods could not be used for example in hard to reach 
groups or as an exploratory exercise in new areas of research interest to 
help generate research hypothesis. For Murphy et al. (1998) the 
axiomatic assumptions of this mixed methodology are clear: there is a 
hierarchy to the methods used for knowledge creation with the traditional 
‘objectivistic’ or idealist, statistical methods being at the top.  
 
In contrast, research as a senior partner has an opposing 
assumptive basis; qualitative research methods in a ‘battle for the best’ 
win out. Murphy at al. (1998) discusses the position of Becker and Geer 
(1969a and 1969b) to illustrate this. They proposed that participant 
observation provided the most ‘complete’ accounts in sociological 
enquiry. ‘Completeness’ however, was only one side of a multifaceted 
evaluation criterion that can be used to measure appropriateness of a 
research method; along with other philosophical and practical criteria, 
relevance, accuracy and reproducibility should also be considered.  
 
The ‘horses for courses’ mixed methodology has a more complicated 
philosophical process. The question that needs to be asked when using 
this type of methodology is ‘what is the best combination of methods?’. 
To answer that question you must first ask the question ‘what do you 
want to know?’ (Silverman, 1997). This approach to mixed method 
design traditionally is based on the premise that your choice in methods 
is related to what you are trying to find out. Similarly to the other two 
approaches where qualitative methods have either a junior or senior role 
in the research design the issue is one of determining the best way of 
either measuring or understanding the thing we need to know. Here 
there is no hierarchy to either quantitative or qualitative methods 
(Murphy et al., 1998). 
 
As I have suggested in the previous sections it is also a question of 
your ontological and epistemological approach. Should researchers 
choose a method from a methodological ‘tool-kit’ that is ‘best for the job’ 
or should the epistemological or more importantly the ontological 
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underpinnings of a method or methodological approach be the decider in 
its use? Turning briefly then to the above question, I consider there to 
have been two ways of thinking about approaches to mixed methodology 
design and quantitative/qualitative weighting (see Figure 7).  
 
Approach A bears close resemblance to Murphy et al.’s (1998) 
research as a junior or senior partner. The ontological and 
epistemological standpoints are fixed and considered together. From 
these standpoints decisions about methodology and method are made. 
For example, when a constructivist perspective is employed then the idea 
of representing the ‘truth’ becomes irrelevant and the choice of method 
becomes a question of whether it assumes the same ontological and/or 
epistemological stance that the researcher aligns them self to.  
 
It is not surprising then that constructivist researchers use 
qualitative methodologies and methods such as case studies to examine, 
describe, de-align concepts and phenomena and may have quantitative 
methods as a junior partner. Conversely realist researchers tend to use 
data collection methods that enumerate so data can be tested against a 





















However in approach B the initial steps (consideration of ontological 
and epistemological position) are considered together but they are 
assumed and left out of the conscious research design decision making 
process. This clear lack of attention paid to philosophical standpoints is 
often how psychiatric and psychological research is conducted with 
obvious realist axioms (i.e. that there is a knowable and measurable 
truth and it is the type of question you ask that determines the method 
you use to answer it).  
 
Coming back then to what Murphy et al. (1998) term a ‘horses for 
courses’ perspective on mixed method design, this approach I propose 
has an assumed (most likely realist) philosophical basis (i.e. Approach B). 
It is this position that enthuses some of the earlier writings on a ‘horses 
for course’ type perspective on mixed methodology (e.g. Trow, 1970; 
Vidich & Shapiro, 1969). 
 144 
 
What is needed then is an approach (see Figure 8) which combines 
the approach of Murphy et al. (1998) and Maxwell (2011). That not only 
allows for flexible methodological considerations but also flexible 
philosophical considerations as well.  
 
 
Figure 8: Approaches to mixed method design 
 
 
In this approach to mixing methodologies, ontology and 
epistemology can be separated out (e.g. a subtle realist approach that 
combines a realist ontology with a constructionist epistemology). Realism 
and idealism (or constructivism) can be considered tools which can be 
taken from an epistemological tool-kit (Abbott, 2004; Maxwell, 2011), 
and quantitative survey questionnaires and qualitative semi-structured 
in-depth interviews can be considered tools from a methodological or 
method tool-kit (Murphy et al., 1998). In other words this approach 
allows for a deeper more varied ‘tool-kit’ from which to choose the 
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appropriate methods for measuring phenomena and making knowledge 
claims. 
 
Although these models or approaches are useful, there are other 
considerations when thinking about mixed method design. There still 
needs to be an emphasis on the quantitative-qualitative weighting of a 
design. Models which tackle issues such as timing and theoretical mixing 
(particularly at the analytical and interpretation phases), as well as how 
quantitative and qualitative data are going to be integrated, have been 
developed (Creswell & Plano Clark, 2007; Creswell & Plano Clark, 2011; 
Kettles, Creswell & Zhang, 2011).  
 
Designs have been split into two main types; sequential and 
concurrent. This refers to the timing of each phase of the research. 
Sequential designs have the quantitative and qualitative phases running 
one after the other whereas concurrent designs run the phases at the 
same time. For each of these there are 6 variants; convergent 
(triangulation); embedded; explanatory; exploratory; transformative; 
and multiphase (see Table 7) 
 
The idea of convergent designs is to produce different but 
complementary data on the same topic (Morse, 1991). Embedded 
designs are used when one set of data is not considered enough to 
answer a research question. One phase (often the qualitative) is 
embedded with in a larger phase of the research project as a supporting 
role so to speak (Kettles, Creswell & Zhang, 2011). Explanatory mixed 
method designs are two phase designs. One type of data (usually 
quantitative) is collected but then followed up with a further qualitative 
phase to gain in-depth meaning of the first phase. The exploratory design 
is similar to the explanatory design in that the two types of data are 
collected in two separate phases however weighting is usually given to 
the qualitative phase (Kettles, Creswell & Zhang, 2011). 
 
Creswell and Plano Clark (2011) added two additional mixed method 
research designs in their second edition of Designing and Conducting 
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Mixed Methods Research. The transformative design is a design that the 
researcher shapes within a transformative theoretical framework. A 
transformative theoretical framework is a framework used for advancing 
the needs of underrepresented or marginalized populations and it 
involves the researcher being sensitive to the needs of the population of 
interest, and using research to inform recommendations for 
strategic/political change to improve social justice for that population 
(Creswell & Plano Clark, 2011). 
 
As Greene (2007) argues, the purpose for mixing methods in the 
transformative design is for value-based and ideological reasons more 
than for methodological or practical reasons relating to data collection 
procedures. In other words the aim is to use the methods that are best 
suited for advancing the transformative or ideological goals of the study. 
 
Lastly the multiphase design the multiphase design combines both 
sequential and concurrent designs, usually within a time-limited program 
of study with an overall program objective. Quantitative and qualitative 
approaches are used to support the development, adaptation, and 
evaluation of specific programs. It provides an overarching 
methodological framework, and is particularly useful in developing 
multiphase, complex mental health nursing research projects (Creswell & 
Plano Clark, 2011).  
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Table 7: A summary of the major mixed methods research designs 
 




2. Data transformation 
3. Validating quantitative data 
4. Multilevel 
Concurrent: quantitative 




Merge during the interpretation or 
analysis 
Embedded 
1. Embedded experimental 
2. Embedded correlational 
Concurrent or sequential Unequal 
Embed one type of data within a larger 
design using the other type of data 
(transformation) 
Explanatory 
1. Follow-up explanations 
2. Participant selection 
Sequential: quantitative 
followed by qualitative 
Usually 
quantitative 
Connect the data between the two 
phases 
Exploratory 
1. Instrument development 
2. Taxonomy development 
Sequential: qualitative 
followed by quantitative 
Usually 
qualitative 
Connect the data between the two 
phases 
Transformative 
Advocacy lens (e.g., feminist 
perspectives, critical theory), 
Concurrent or sequential Unequal 
Connect or transform the data between 
the two phases 
Multiphase 
Overarching methodological 
framework for large scale 
projects 




Embed data from phase in the next 
phase (merge, connect or transform 
data) 
 
Adapted from Creswell J.W. and Plano Clark V.L. (2007) Designing and Conducting Mixed Methods Research and Creswell J.W. and Plano 
Clark V.L. (2011) Designing and Conducting Mixed Methods Research (2nd edition). 
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Quantitative and qualitative designs produce different type of data. 
One of the challenges of mixed method designs is how to treat these 
data. Creswell and Plano Clark (2007) propose three strategies for mixing 
or integrating data; merging, embedding, connecting. The assumption of 
mixing data is to maximise the strengths and minimizes the weaknesses 
of each type of data.  
 
Merging data involves combining the qualitative data (e.g. texts or 
images) with the quantitative data (e.g. numeric information) by 
reporting results together in a discussion section of a study. For example, 
a person could first report the quantitative statistical results followed by 
qualitative quotes or themes that support or refute the quantitative 
results. Another method for merging data is to transform the qualitative 
dataset by counting occurrences of themes so that it can be compared 
with the quantitative data (Sandelowski, Voils & Knafl, 2009).  
 
An alternative to merging data is to connect the two types of data. 
This involves analysing one dataset and then using that information to 
inform subsequent data collection for another dataset. In other words, 
the integration occurs by connecting the analysis of results from the 
initial phase (e.g. quantitative data collection) with the data collection 
from the second phase of research (e.g. qualitative data collection).  
 
The last method for merging data is embedding data. With this type 
of data integration, a dataset of secondary priority is embedded within a 
larger, primary design (e.g. qualitative research as a junior or senior 
partner). While no type of data mixing is privileged we need to consider 
the overall mixed method design we are utilising when deciding how best 





5.4 QUALITATIVE METHODS 
 
Having considered the philosophical and methodological aspects of 
mixing quantitative and qualitative research I now turn to the question of 
what qualitative methods are best used in mixed methodology? Having a 
‘tool-kit’ of methods is useful but which methods will get the ‘job done’ in 
epidemiological and health services research? 
 
Although there are several methods used in qualitative research 
including questionnaires, interviews, participant observation and 
secondary research techniques such as document analyses or 
conversational analyses, the most common forms of qualitative methods 
used in social science research are interviewing methods or participant 
observation (Murphy et al., 1998). 
 
Silverman (1985) has argued that the advantage of observational 
research is that it is able to produce representations of the way in which 
people actually behave. Conversely questionnaire and interview data only 
produce idealised accounts of attitudes and behaviours which bear 
uncertain relation to actual real situations. In a similar vein Strong 
(1979a) argued that what people say in an interview situation depends 
upon what questions have been asked and that interview responses may 
not take into account difficulties of immediate recall.  
 
Some of the difficulties of using participant observation in mixed 
method research however are obvious, such as time and money 
(particularly if qualitative research is being done alongside a large 
survey). Murphy et al., (1998) outlines several areas where interviews 
are useful including; accessing the respondent’s definitions and 
interpretations; penetrating respondents’ public accounts; and flexibility 
in exploratory research. In health services research they are particularly 
useful for uncovering what beliefs and attitudes underlie particular kinds 
of health behaviour and what might encourage change in health-related 
behaviours an as Murphy et al., (1998) states “If you want to understand 
what people do, believe and think, ask them” (p. 112). 
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Denzin (1970) identified three types of interview:  
• The standard schedule interview (question working and order are 
standardised for every respondent)  
• The non-schedule standardised interview (a topic list is of 
information required from each respondent is devised but the 
wording and order of questions is flexible)  
• The non-standardised interview, (no specific set of questions is 
employed. Interviews are primarily conversational) 
 
Denzin (1970) has argued that standardised non-schedule and 
non-standardised interviews offer the advantage of allowing for detailed 
constructions of their view of the world as well as allowing respondents to 
raise salient topics. These types of interview are also known as semi-
structured and depth interviews (Britten, 1995).  
 
Standardised or structured interviews have been used in help-
seeking research for example Sheikh and Furnham (2000), used the 
Mental Distress Explanatory Model Questionnaire (MDEMQ), (Eisenbruch, 
1990) to examine the relationship between cultural beliefs and causes of 
mental distress and the desire to seek professional help for mental health 
problems. This questionnaire is a 45-item questionnaire, developed with 
items derived from the Murdock et al. (1978a & 1978b) categories, with 
additional items covering western notions of physiological causation and 
stress.  
 
Structured qualitative interviews have been critiqued for arising 
from the positivist assumption and eliciting a ‘body of facts’ from 
respondents (Silverman, 1985; Murphy et al., 1998). In addition Cicourel 
(1964) has argued that while it may be possible to standardise question 
wording and order, it is impossible to standardise behaviour exhibited in 
the interview (interviewer and interviewee). 
 
As I discussed in the previous chapter giving an overview of 
models of illness belief and help seeking, three instruments for 
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measuring illness beliefs have been traditionally used. These instruments 
have tended to be of semi-structured nature and the Explanatory Model 
Interview Catalogue (EMIC) and the Short Explanatory Model Interview 
(SEMI) have been suggested as tools for bridging the gap between 
qualitative and quantitative methods of gathering health belief data 
(Weiss, 1997; Lloyd et al., 1998). The SEMI has been used in a semi-
structured way to identify causal and other health beliefs and allows for 
discussion of the patient’s problems, as well as exploring the different 
ways in which distress can be explained by using vignette material (Bhui 
& Bhugra, 2002). 
 
Unstructured interview techniques have also been used in 
psychiatric health services and addictions research. Stenhouse (2011) 
used unstructured interviews to gather narrative data on patient 
experiences of acute psychiatric inpatient care. Holistic analysis of the 
narratives produced several themes of experience including help, safety 
and power.  Although unstructured interview methods may elicit detailed 
narratives they are difficult to perform with large sample sizes and may 
generate data from which empirical generalisation is difficult to make 
(Martin & Stenner, 2004; Neale, Allen & Coombes, 2005). 
 
Bhui and Bhugra (2002) have argued that illness narratives may 
help build a more detailed picture of conceptualisation of illness and 
provide the basis for generating new theory and models of health belief. 
It would be true to say then that methods which allow for deep 
exploration of respondents constructions in a fairly systematic way while 
simultaneously providing room for respondents to divulge salient 









Murphy et al. (1998) has discussed a number of different 
approaches to qualitative study sample selection. Four broad types are 
identified: 
• probability sampling 
• opportunistic sampling 
• non-random sampling for representativeness 
• theoretical sampling. 
 
Two considerations should be given when sampling for qualitative 
research: Whether the intention is to make empirical generalisations or 
theoretical generalisation. The first and third approaches described by 
Murphy et al. (1998) are concerned with what empirical generalisation, 
whereas the fourth is concerned with theoretical generalisation 
(Hammersley, 1992). The second approach however, is typically not 
considered generalisation. The second, third and fourth approaches are 
all considered forms of purposive sampling (Kuzel, 1986). 
 
A prerequisite in empirical generalisation as Hammersley (1992) 
emphasised, is that the population to which generalisation is to be made 
is adequately defined. For example non-probabilistic sampling methods 
can be used to demonstrate the typicality of a setting being studies. 
Alternatively theoretical sampling may be used to test a theoretical issue. 
For example, theoretical sampling may be used in an on-going way over 
the course of a research study to help develop and refine theoretical 
propositions which emerge from the research (Murphy et al., 1998). For 
Murphy et al. (1998), sampling decisions in qualitative research should 
be pragmatic and systematic: opportunistic sampling should be avoided if 
possible.  
 
Ritchie and Lewis (2003) propose a third type of generalisation. 
They argue that empirical generalisation can be separated into two areas; 
generalising to the population within which the study sample is taken; 
and generalising to wider contexts. They therefore suggest three 
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concepts for generalisation: representational generalisation 
(generalisations from study sample to its parent population); inferential 
generalisations (generalisations from study sample to wider/other 
contexts; and theoretical generalisation (theoretical propositions drawn 
from the study findings). Differences in these types of generalisations 
should be considered not only when sampling but also when interpreting 
qualitative research findings. 
 
 
5.6 THE PHD STUDY 
 
The starting point for the PhD study was its ontological and 
epistemological positions. This which has been discussed in detail in 
section 5.2 was that of subtle realism. Given the flexibility of this 
philosophical standpoint a mixed method design was proposed for the 
investigation of ethnic differences in prevalence, correlates and 
illness/substance use constructions of patients with comorbid psychosis 
and substance use disorders. The study used a mixed method approach, 
in part because of complexity and sensitivity of the subject matter to the 
study population. In addition there is also an increasing demand for 
research to inform policy and practice, which for Health Services 
Research is now leaning towards the use of both quantitative and 
qualitative methods simultaneously (O'Cathain, Murphy & Nicholl, 2007).  
 
The PhD study utilised a sequential design, that was part 
explanatory part exploratory. The findings from the qualitative study 
attempted to explain in part, the findings of the quantitative study. 
However much like the works of Dean, Eichhorn and Dean (1969) the 
qualitative study was used to explore the impact comorbidity might have 
on perceptions of the usefulness of treatment services by unveiling 
constructions. It also aimed to help generate future research hypothesis.   
 
Choosing this type of mixed method design (as I have touched on in 
the preceding sections), requires consideration of various methodological 
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issues. These issues include  the priority or weight given to the 
quantitative and qualitative data collection and analysis in the study, the 
sequence of the data collection and analysis, and the stage/stages in the 
research process at which the quantitative and qualitative phases are 
connected and the results are integrated (Creswell et al., 2003).  
 
Much of the nature of the design of the PhD study was determined 
by the AESOP-10 follow-up study (discussed below) which formed the 
basis of the first quantitative phase of the PhD study. This study began 
data collection in 2007 after extensive tracing of patients who took part 
on the AESOP baseline study. Data from both studies was connected 
(data from the AESOP-10 study and first quantitative phase was used to 
inform participant selection in the second phase). Since partial analysis of 
the AESOP-10 data was needed to identify eligible participants for the 
second phase, data collection for the qualitative study did not begin until 
2008. 
 
As mentioned above, in sequential designs the quantitative data are 
usually collected and analysed first and then followed by the qualitative 
data collection and analysis. The weighting of these studies are usually in 
favour of the quantitative phase and data analysis is often connected 
(Creswell et al., 2003; Hanson, Creswell, Plano Clark, Petska & Creswell, 
2005). However the quantitative and qualitative arms of the PhD study 
can be considered to have equal weighting. 
 
The next chapter outlines the method utilised in the PhD in more 
detail, including sampling and recruitment for both phases. 
 
 
5.7 THE REFLEXIVE PROCESS AND REFLEXIVITY 
 
Insider perspective is paramount to qualitative research (Fetterman, 
1989). However it is always difficult to disentangle the etic perspective of 
the researcher from the emic perspective of the respondent (Pike, 1990).  
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An emic perspective, or insider standpoint, represents the viewpoint of 
the members of a culture or group being studied or observed; while an 
etic viewpoint reflects more the perspective or values of the researcher, 
that is, an outsider stance (Pike, 1990). Reflexivity plays a part in 
illuminating etic perspective. The term reflexivity refers to being sensitive 
to the researcher’s presence in the research process and how it has 
contributed to the data collected and how their own priori assumptions 
have shaped the data analysis (Murphy et al., 1998). 
 
Essentially conscious self-reflection should play a part in all 
qualitative research and attention to the fact that the findings of research 
are inevitably shaped by the research process itself should be considered. 
Interview data reflect the social relationships within which they are 
embedded and Altheide and Johnson (1994) believe that when drawing 
conclusions from data, the researcher should reflect upon his or her own 
impact upon the setting. The credibility of research findings can also be 
enhanced when reflexive practices are used (Marshall, 1985). 
 
Murphy et al. (1998) outlines several ways an assessment of the 
impact of the researcher can be made. These include comparing the 
interviewee statements from interview data and normal everyday talk 
with others (Silverman, 1989) and monitoring changes in the data 
obtained over time (Guba & Lincoln, 1989). A number of authors have 
recommended that the self-conscious monitoring of the researcher’s 
impact upon the setting should be carried out alongside the data 
collection.  
 
For example prompts, probes and encouragement are features of 
semi-structured interviewing. Prompts are typically considered cues that 
an interviewer may use to remind the respondent about an event. Probes 
involve getting the respondent to say more about a particular topic and 
encouragement is also used in verbal and non-verbal form to get a 
respondent to continue speaking about an event or topic. Emerson and 
Pollner (1988) have talked about the concept of the Transactional context 
in interviewing, whereby the way the researcher frames his questions and 
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probes interviewees may tacitly direct or pre-structure the responses 
received. Paying attention to this type of interviewer affect during data 
collection as well as analysis is one way of being reflexive. 
 
LeCompte and Goetz (1982) suggest that taking time out away 
from the interview to reflect) and possibly taking notes about the 
research process are also useful reflexive processes. However whatever 
process is employed a researchers’ claim to credible knowledge (an 
important concept in all realist research) will be strengthened by a 
demonstration on reflexivity in data collection, analyses and conclusions 




I have discussed the origins of quantitative and qualitative research, 
where quantitative enquiry has traditionally been situated within a realist 
ontological perspective, while much of qualitative enquiry has been 
framed within idealist ontology and constructionist epistemology.  
 
Because quantitative and qualitative enquiries have been viewed as 
being situated in different and opposing scientific paradigms the 
combination of them within one study has not historically been 
considered. However, through the marriage of a realist ontology and a 
constructionist or idealist epistemology (Subtle Realism) I have argued 
that is possible to combine a quantitative epidemiological study with a 
qualitative investigation within a single study design. This is the 
perspective which frames the PhD study. 
 
Several models of mixed method study design have been proposed, 
each with different emphasis on the qualitative component, however the 
model most appropriate for answering the research hypotheses and 
questions should be utilised. Various qualitative methods for exploring 
patient constructions have been discussed. However methods that allow 
for deep exploration of respondents conceptualisations (such as 
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interviewing techniques) in a fairly systematic are considered the most 
appropriate. 
 
When using qualitative research methods, consideration of the 
sample and sampling method or techniques should be given. Specifically, 
the issue of generalisability should be considered. Differences in the 
types of generalisation that can be made from qualitative or mixed 
method research should be considered not only when sampling but also 
when interpreting qualitative research findings. Furthermore emic 
perspective is paramount in qualitative research. Subsequently reflexive 
techniques should be used where possible. 
 
Chapter Summary 5.    
Chapter Summary 
 
Aims of the Chapter: 
 
To situate and give reason to the methodological design of the PhD study. To 
critically discuss theoretical and methodical approaches to mixed method design 





 Quantitative and qualitative enquiry should not be considered 
incompatible within a single study 
 A Subtle Realist perspective may be considered as an appropriate 
theoretical stance within which to frame mixed method study design 
 It is useful to consider individual methods as being part of a larger  
methodological ‘tool-kit’  where decision for utilisation is based on what is  
‘best for the job’ (i.e. answering the study hypotheses or research 
questions)  
 Issues of generalisability should be considered when sampling for 
qualitative studies 
 Respondent (emic) perspective is important in qualitative research and 
Reflexivity can play a part in illuminating researcher (etic) perspective 
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CHAPTER 6:  METHODOLOGICAL STRUCTURE 
AND DESIGN OF THE STUDY 
 
 
6.1 OVERVIEW OF THE EPISTEMOLOGICAL AND 
METHODOLOGICAL FRAMEWORK FOR THE STUDY 
 
The PhD study is situated within a subtle realist position which holds 
that knowledge is socially constructed, but that these constructions are 
constrained by the world existing ‘out there’. This perspective is situated 
between a constructionist or idealist perspective that sees truth as a 
matter of personal belief and a realist perspective which maintains that 
the external world exists independently of or representations of it 
(Murphy et al., 1998). 
 
The study combines, (using a sequential design, part explanatory 
part exploratory with both a deductive and inductive research process) a 
quantitative epidemiological study (Phase One) with a qualitative study 
(Phase Two).   
 
 
6.2 STUDY DESIGN AND HYPOTHESES 
 
 The PhD study was nested within the larger MRC funded AESOP-10 
(Aetiology and Ethnicity in Schizophrenia and Other Psychoses) follow-up 
study which looked at the course and outcome of psychosis in an 
ethnically diverse cohort of psychiatric patients (N = 557) being followed-
up 8-12 years after their first presentation to services (see figure 9). As 
we have discussed in the previous chapter the study adopted a part 
exploratory, part explanatory sequential design whereby the qualitative 
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study was conducted after the data collection for the AESOP-10 study 
and first phase of the PhD study had been completed.  
 
Figure 9: Venn Diagram of PhD Study Design 
 
 
P1 – PhD Study Phase 1; P2 = PhD Study Phase 2 
 
6.2.1 Study population 
As I will discuss in more detail in the following sections, the study 
sample was drawn from the larger AESOP-10 sample. The AESOP-10 
study followed up patients who made contact with psychiatric services 
between 1997 and 2000 in two distinct geographical areas; South London 
and Nottingham.  
 
In the London centre patients presenting to psychiatric services in the 
South London and Maudsley (SLAM) mental health trust were included. 
The SLAM NHS Trust is divided into four boroughs: Southwark; Lambeth; 
Lewisham; and Croydon. The trust also provides specialist services in 
Bromley, Bexley and Greenwich. These areas have been found to have 
high levels of mental health need (Hatch et al., 2012). They also have 
high proportions of ethnic minorities and migration. 
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 Lambeth for example, has the second highest proportion of Black 
Caribbean people in the country. It also has the second highest 
proportion of Black Caribbeans born in the Caribbean, behind Lewisham 
(Lambeth Census Headlines, 2011). Lambeth ranks 5th for Black African 
people and it has the highest proportion of mixed race White / Black 
African and multiple / mixed ethnic group in the country. Southwark and 
Lewisham equally have high proportions of Black African, Caribbean and 
Mixed race residents. 
 
 In the Nottingham centre patients presenting to psychiatric 
services in the Nottingham City area were included. There is a long 
history of migration in Jamaican, Indian and Pakistani groups to 
Nottingham, however according to the 2001 census around 81% of the 
population were from a White British ethnic group (2011 Census  
Nottingham City Key Statistics, 2012). 
 
 
6.2.2 Aims and objectives 
 The overall study objectives of the PhD study were to: 
1) To make a theoretical and methodological contribution to 
the understanding of the relationship between comorbidity 
of psychosis and substance use disorder and ethnicity. 
2) To estimate the prevalence and correlates of comorbidity 
of psychosis and substance use disorder in different ethnic 
groups.  
3) To describe service responses to and explore perceived 
quality of care of patients with comorbid diagnoses from 
different ethnic populations, with special attention to Black 





6.2.3 Hypotheses and research questions 
The two primary hypotheses tested in the first quantitative arm of 
the study were: 
1) The prevalence of comorbid substance use disorders in 
individuals with an 8-12 year history of psychosis will differ 
according to ethnic group.  More specifically, rates of 
comorbidity will be higher in Black Caribbean, and lower in 
Black African, patients than White patients.  
2) In all ethnic groups, comorbid substance use disorder will be 
associated with:  
   a) more frequent relapses,  
   b) more compulsory admissions and   
independent of potential confounders, including age, gender, 
diagnosis and study centre. 
 
 In other words, the study hypotheses propose that a greater 
prevalence of comorbid psychosis and substance use disorders in the 
Black Caribbean group will contribute to poorer outcomes over the 8-12 
year follow-up period.  Similar patterns would not be evident for Black 
Africans or other ethnic groups. 
 
 The second, qualitative phase of the study, which purposefully 
selected a sub-sample of patients from the AESOP-10 cohort, 
investigated the following research questions: 
 
1) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
‘psychosis’ and drug and alcohol use 8-12 years after their 
first-episode?  
2) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
mental health and substance abuse treatment services? 
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3) What is the perceived role (if any) of family, friends and 
other social support networks in the treatment process for 
‘psychosis’ and substance use disorder? 
 
In other words the second arm of the study aimed to both describe if 
and how the problem of comorbidity differs for ethnic minorities in 
psychotic populations and to identify conceptualisations illness and 
substance use. The study also aimed to explore the impact comorbidity 
might have on attitudes towards the perceived usefulness of treatment 
approaches (namely hospitalisation, community treatment) and the role 




6.3 PHASE ONE: QUANTITATIVE INVESTIGATION 
6.3.1 Sample 
 The sample for the quantitative arm included patients that were 
eligible for inclusion in the AESOP-10 follow-up study which I discuss in 
the next section. The findings from the 2001/2002 British Crime and 
Drug Survey have estimated drug use in Black African groups to be 
significantly lower than in Black Caribbean or White ethnic groups (Aust & 
Smith, 2003). Equally high rates of psychosis have been found in Black 
Caribbean and Black African groups (Sharpley et al., 2001), with 
numerous studies showing these groups are at greater risk of compulsory 
admission to hospital (Bhui et al., 2003; Morgan et al., 2004; Morgan et 
al., 2005) and more likely to be treated in secure and forensic settings 
(Bhui et al., 2003; Morgan et al., 2004). The first arm of the PhD study 







Study Inclusion and Exclusion Criteria 
 Phase One of the PhD study used similar inclusion and exclusion 
criteria as the AESOP studies. The AESOP baseline study inclusion criteria 
for cases were:  
a) age between 16 and 65 years;  
b) resident within tightly defined catchment area of South-East 
London;  
c) presence of a first-episode of psychosis (F10-F29 and F30-
F33 in ICD-10 (WHO 1992)) within the time frame of the 
study; and  
d) No previous contact with health services for psychosis. 
 
 The additional inclusion criteria for cases in the PhD Phase One study 
were: 
e) White British, Black Caribbean or Black African ethnicity 
f)  
  
 The exclusion criteria for cases were:  
a) evidence of psychotic symptoms precipitated by an 
organic cause;  
b) transient psychotic symptoms resulting from acute 
intoxication as defined by ICD-10; 
c) IQ less than 50; and 
d) previous treatment for psychosis 
  
  Figure 10 summaries the final sample for the first phase of the PhD 
study. The total AESOP sample was 557.  Phase One of the PhD study 
was only concerned with patients from White, Black Caribbean and Black 
African ethnic groups, so patients not belonging to those groups were not 
included (N=99) leaving an eligible sample of 458. Due to information 
being limited for patients with a follow-up of less than eight years and 
because of patients who had died or moved abroad, resulting in a final 








6.3.2 Study power 
The study’s primary hypothesis in the first phase focused on the 
prevalence of comorbid diagnoses in different ethnic groups.  In one of 
the very few studies to provide any data on this, Afuwape et al. (2006) 
found a prevalence of comorbid cannabis use and psychosis of 40% in 
their Black British group, compared with 6% in their White group.  This 
study had high statistical power to detect such differences.  A power 
analysis calculation was performed before data collection had been 
completed to estimate the study power assuming a conservative 
difference in prevalence of comorbidity of 20% between White patients 
and either Black Caribbean or Black African patients. A two group test 
Eligible for PhD 
Study Phase One 
N=171 
Ineligible for PhD 
Study Phase One 
N=34 











Eligible for PhD 
Study Phase One 
N=287 
Ineligible for PhD 
Study Phase One 
N=65 
 Adequate data 
available 
N=133 













with a 0.05 two-sided significance level was estimated to have 80% 
power to detect the difference between a White patients with 30% 
prevalence of comorbidity and Black Caribbean patients with 50% 
prevalence of comorbidity (odds ratio of 2.333) when the sample size in 
each group is 103.  
 
 The study aimed to estimate risk for comorbidity while controlling for 
potential confounders. The more variables you have in a model, the more 
power is reduced.  In general, a recognised rule of thumb is that 20 
subjects per predictor variable in regression analysis is acceptable. 
However, researchers might have better power to detect a small effect 
with approximately 30 participants per variable. Wilson VanVoorhis & 
Morgan (2007) have outlined Cohen and Cohen’s (1975) guidelines for 
multivariate analysis: for regression analysis with five predictors and a 
population correlation of .30, 187 participants would be needed to 
achieve 80% power. Assuming a sample size with 103 patients in each 
group using multivariate analysis the PhD study was expected to have 
high statistical power to detect ethnic differences in prevalence of 
comorbidity. 
 
6.3.3 The AESOP-10 Study 
 The PhD study was nested within a larger AESOP-10 study. This 
study had two aims: 
1) To identify the factors that predict the course and outcome 
of psychosis following a first-episode, focusing specifically 
on the role of biological and social risk indicators, cannabis 
use, and duration of untreated psychosis (DUP). 
2) To study and explain the differences in the course and 
outcome of psychosis in Black and White patients in the 
decade following a first-episode. 
 
 The longitudinal follow-up study addressed these aims through a re-
examination at eight to 12 years of an ethnically heterogeneous 
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epidemiologically-based cohort of 557 individuals who initially presented 
with their first-episode of psychosis between 1997 and 2000 in defined 
populations in South London and Nottingham and who took part in the 
baseline AESOP study. The sample comprised of all incident cases who 
presented to specialist mental health services within tightly defined 
catchment areas in the two centres (N = 532) and additional cases 
identified on an ad-hoc basis to supplement the MRI component of the 
baseline study in the London centre (N = 25). 
 
6.3.3.1 Tracing and re-contact procedures 
 
The procedures for tracing cases were in line with those used in 
previous long term follow-up studies of individuals with psychosis (e.g., 
Harrison et al., 2001; White et al., 2009). Patients recruited into the 
AESOP study at baseline provided the study team with their contact 
information including their current GP and relatives addresses. They also 
gave consent to be contacted at follow-up. The process for re-contacting 
current and past patients who took part in the baseline study happened 
in several stages:  
1) contact with cases were currently in contact with mental 
health services was initially established.   
 
For those who were, we sought to make contact and invite them to 
participate via their consultant psychiatrist and clinical teams.  For those 
who were not,  
2) letters were sent to their last known address with details 
about the study and inviting them to participate, enclosing a 
reply slip and stamped addressed envelope 
3) Non-responders were sent a further letter two weeks later 
and, if necessary 
4) researchers made a maximum of three visits to the address 
(morning, afternoon and evening) to make initial contact. 
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For those who had moved address (and for whom we had GP contact 
details),  
5) Contact was sought via their GP and they were invited by 
letter to participate in the study. Letters were followed up 
where ever possible by a telephone call until initial contact 
was established.  Non responders were sent 2 further 
invitations at one month intervals. Cases who had moved 
residence since baseline were traced through their original 
GP or consultant psychiatrist. 
  
 Towards the end of the study, a final check was conducted to 
determine whether any cases who at that point had not been traced had 
been re-referred to mental health services and, for any that had, we then 
sought to make contact via their clinical team, as above.  Additionally, all 
deaths and emigrations were identified by a case-tracing procedure with 
the Office for National Statistics (ONS) for England and Wales and the 
General Register Office (GRO) for Scotland using name, sex, date of 
birth, and last known address of each case.  
 
6.3.3.2 AESOP Baseline Study 
 
During the AESOP baseline study, detailed information was collated 
from clinical records and interviews with cases and their relatives on 
clinical presentation (including mode of onset, duration of untreated 
psychosis, lifetime substance use, symptomatology, and diagnosis). Basic 
sociodemographic characteristics and detailed assessments were 
completed with cases on a range of biological, psychological and social 
risk factors (see Morgan et al., 2006).  Baseline ICD-10 diagnoses were 
determined using data collected with the Schedules for Clinical 
Assessment in Neuropsychiatry (World Health Organisation, 1993 & 
1994) (either from interview or from case records using the Item Group 
Checklist (IGC) part of the SCAN) on the basis of consensus meetings 




6.3.3.3 AESOP-10 Follow-up data collection and study measures 
 
 Case Interviews 
 Patients who were re-contacted (see above) were invited to take 
part in a face-to-face interview with the author or one of the AESOP-10 
research team. The interviews involved several AESOP-10 assessments 
(see following sections) including the WHO Life Chart which most of the 
first phase of the PhD data was based on.  Interviews were done over 
one, two or three visits depending on the availability of each individual 
case, the length of the WHO Life Chart Interview, and the number of 
additional AESOP-10 assessments the patient was willing to complete. 
 
Case Note Review 
 Clinical records for all cases were also collected and data from 
these were used in addition to the interview data. 
 
 WHO Life Chart 
  Extensive information was collated across three course and 
outcome domains (clinical, social, and service use), first from clinical 
records and then, where possible, from corroborative follow-up interviews 
with cases and treating clinicians using an extended version of the WHO 
Life Chart.   
 
  The Life Chart has been used successfully in previous long term 
follow-up studies, including those with follow-up periods in excess of 10 
years, and is designed to collate information from multiple sources.  In 
the extended version the original Life Chart was adapted to include more 
items on substance use and service contacts and to include a timeline to 
document, month by month where possible, presence of psychotic 
symptoms and contacts with mental health services.  
 
Following the approach adopted in other long term follow-up studies, in 
interviews with cases we used significant anchor dates (birthdays, births, 
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deaths, publicly significant events, etc.) to orientate subjects and assist 
recall and, as appropriate, interviews were structured around key events, 
such as hospital admissions. Using all available information, researchers 
reconstructed case histories over the follow-up period to complete all 
sections of the Life Chart. It has been shown that it is possible to obtain 
reliable ratings using the Life Chart (Susser et al., 2000), nevertheless, 
all clinical ratings in the Life Chart were made by consensus at weekly 
meetings (see below).  
 
Clinical Course, Outcome and Diagnosis 
 Detailed information on clinical course and outcome was collected 
using the WHO Life Chart.  In addition, information on current symptoms 
at follow-up (i.e. preceding month) was collected using the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN) Version 2, the Scale for 
the Assessment of Negative Symptoms (SANS), and the Global 
Assessment of Function (symptom score). Information from the Life 
Chart and SCAN were used to make a life time diagnosis for cases.  
 
Consensus Ratings and Diagnosis 
 In line with the approach to diagnosis at AESOP baseline, a consensus 
approach to Life Chart clinical ratings and lifetime diagnosis was adopted.  
At weekly meetings involving at least one of the principal investigators 
involved at baseline and senior clinicians, researchers presented detailed 
summaries of the clinical symptomatology, course and outcome for each 
case based on information collated from clinical records and interviews 
with cases and other informants.   
 
 During these meetings consensus ratings of: a) variables relating to 
the occurrence and nature of psychotic episodes and substance use 
during the follow-up period, including month by month ratings of 
presence or absence of psychotic symptoms using the Life Chart timeline; 
and b) lifetime ICD-10 and DSM-IV diagnoses, were made.  A 
conservative approach was adopted. The presence or absence of 
psychotic symptoms was only made if there was definite evidence. All 




Primary Outcome of PhD study: Comorbid Substance Use disorder 
 The data for quantitative PhD investigation relating to life time ever 
drug and/or alcohol use was collected using the WHO Life Chart.  On the 
basis of information obtained, the presence or absence of a diagnosis of 
substance abuse or dependence (according to DSM-IV) was determined 
at consensus rating meetings. Patients were scored as having either  
 No drug or alcohol use 
 Sporadic drug taking (no evidence of regular use) or occasional 
social drinking 
 Sporadic drug taking (suspected regular use) or moderate alcohol 
use 
 Frequent or regular drug use or excessive alcohol use  
 Drug or alcohol abuse 
 Drug or alcohol dependence 
 
 The primary study outcome measure for the PhD study was a 
diagnosis of substance (drug and/or alcohol) use disorder. Substance use 
disorder was defined as having a diagnosis of drug or alcohol abuse 
and/or drug or alcohol dependence. 
 
 Ethnicity  
 Ethnicity was assigned to patients during the AESOP baseline study. A 
number of data sources were used. The primary source was self-ascribed 
ethnicity (according to 2001 census categories), collected as part of the 
socio-demographic interview schedule. If this was not available other 
sources were used, including other informants and case notes. Where 
there was ambiguity, a consensus rating was made by members of the 
research team; this always included those with long-standing expertise in 
the study of ethnicity and mental health (Morgan et al., 2005).  
 
 Social Measures 
 Information on sociodemographic markers of social function were 
collected (i.e. housing, employment, relationships, education and social 
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networks) during and at follow-up using the Life Chart.  In addition other 
social function measures including the WHO Disability Assessment 
Schedule (DAS) and the GAF (disability score) were used. These 
measures were not used in the PhD study. 
 
Mental Health Service Use 
  Detailed information on the nature and types of contacts with 
specialist mental health services as well as the prescription of and 
compliance with anti-psychotic medication throughout the follow-up was 
collected using the Life Chart. A timeline was used to document, month 
by month, contacts with services and to include detailed data on each 
hospital admission and community contact (i.e. dates of admission or 
contact, mode of contact, source of referral, reason for referral, and 
family and police involvement in pathway to contact).  
 
Other Assessments 
 Additional assessments were conducted for those who agreed to be 
re-assessed at follow-up, including medication side effects, neurological 
soft signs, insight, neuropsychology were completed, and a proportion 




6.4 PHASE TWO: QUALITATIVE INVESTIGATION 
6.4.1 Sample 
6.4.1.1 Theoretical and methodological issues around qualitative 
sample size 
 
 Sample size is a contentious issue in qualitative research. 
Qualitative studies are not designed to be representative in terms of 
statistical generalisability (Pope et al., 2000), instead sample size should 
be determined by number of participants it takes to reach thematic 
saturation (Morse, 1995; Sandelowski, 1995). This however is 
problematic in itself when trying to set a target sample size during the 
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design phase of a study (Guest, Bunce & Johnson 2006).  The sample 
size should also be influenced by the research question and analytical 
requirements (Pope et al., 2000).  
 
 The sample for Phase Two was taken from the AESOP-10 follow-up 
study sample. AESOP-10 started recruitment for the follow-up study in 
2007 and data collection for the qualitative study began in the second 
half of 2008. The second qualitative arm of the PhD study used 
convenience sampling..  
 
  As we discussed in the previous section convenience sampling was 
used. Hammersley (1992) suggested that the combination of smaller 
sample qualitative research alongside survey research in the same 
investigation may be useful in increasing the generalisability of 
qualitative research. For Hammersley (1992) when the quantitative 
investigation comes first (as with this study) it may be used to inform 
participant selection decisions in the later qualitative phase. This was the 
case for the PhD study, where participants who took part in the first 
quantitative phase who were diagnosed with a diagnosis of comorbid 
substance use disorder were identified as eligible to take part in the 
second qualitative investigation.   
 
  In addition, (as suggested by Murphy et al., (1998) for multi-site 
research) quota sampling or stratified sampling (Patton, 1990) was used 
to increase the likelihood that the sample covers the range of variation 
which was found in the aggregate from which generalisation was sought 
(namely the AESOP-10 study). Participants were selected based on their 
ethnicity and gender to allow for differences between the four ethnic 
groups (Black Caribbean, Black African, White and Other), and genders to 
be explored. The key element of this type of sampling is selecting 
information-rich cases to study in detail (Patton, 1990). 
 
  After discussion with the AESOP-10 study co-ordinator who was 
experienced in qualitative research a target sample of thirty-two 
participants was set for the qualitative study. This would include eight 
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6.4.1.2 Inclusion and exclusion criteria 
 
Differences in outcomes between current and past psychiatric 
patients without any substance use, with non-problematic substance use 
or diagnosable substance use disorders were explored in Phase One of 
the study.  The second phase sampled cases with diagnosable substance 
abuse or dependence only to allow for detailed exploration of perceptions 
of illness, substance use, treatment and recovery in this group. For 
practical reasons only current and past patients that took part in the 
London study centre were sampled. 
 
As part of the AESOP-10 study and first phase of the PhD study, 
data was collected from all cases relating to their clinical presentation, 
sociodemographic characteristics, and pathways into care. The patients 
sampled into the qualitative PhD study were included if: 
a) They took part in the London study centre of the AESOP 
baseline and AESOP 10 studies. 
b) They had a diagnosis (according to DSM-IV) of comorbid 
psychosis and substance abuse / dependence (F20-F29 and 
F30-F33 and co-occurring F10-19 in ICD-10 (WHO 1992).  
 
In other words, they had to have scored at least a four on the 
WHO Life Chart in the AESOP-10 study. 
 
Patients were excluded if: 
 
a) They refused consent to the AESOP or Quality of Care Study 
b) They were unable to be interviewed (e.g floridly psychotic 
and/or too unwell to consent to the study) 
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At the time of recruiting for the second phase of the PhD study 
only 170 patients had been followed up for the AESOP study. Of these 
cases 56 received a diagnosis of comorbid substance use disorder.  
Patients with a comorbid diagnosis were then assessed against the 
inclusion and exclusion criteria. 
 
All eligible patients were grouped by their gender  and self-
ascribed ethnicity (Black Caribbean, Black African, White and Other) as 
recorded in the Culture and Identity Schedule I (CANDID I) (Mallet & 
Bhugra, 1996) for the AESOP study  (see section 6.3.3.3). The aim was 
to obtain roughly equal numbers of male and female participants within 
each ethnic group. Once an ethnic quota had been fulfilled attention was 
paid to recruiting in other ethnic groups. This meant seven eligible 
patients in the White ethnic group were not approached to take part in 
the study and efforts to recruit respondents in the other ethnic groups 




Table 8: Summary of study sample exclusions 
Reasons for exclusion/attrition N 
Exclusions 
Refused consent to AESOP/QOC 
 
15 
Too unwell to interview 
Deceased 
 
Unable to interview 
6 
2 
Untraceable / Uncontactable 
Declined Phase Two PhD Study 
6 
1 




This process resulted in a final sample (N=19) smaller than the 
target sample for this phase of the PhD. Figure 11 summarises the 
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process of obtaining the final sample. Section 8.2 compares the 
sociodemographic and clinical characteristics of  patients that were 












































Did not meet 





The quantitative arm of the PhD study hypothesised that the 
prevalence of comorbid substance abuse / dependence in White and 
Black Caribbean ethnic groups will be higher than in Black African ethnic 
groups. The qualitative arm of the study however was interested in 
whether there were any differences in constructs of experiences between 
White, Black Caribbean and Black African and other ethnic groups of 
individuals with comorbid substance abuse or dependence.  I have 
discussed in the previous chapters the way different ethnic groups 
perceive mental illness and why Black Caribbean, Black African and White 
groups were of particular interest in the study of psychosis aetiology and 
comorbidity epidemiology and perceptions of service use. Phase Two in 
addition to investigating perceptions of illness, substance use and 
treatment also sought to explore the complexity of participant’s 
conceptions of their ethnicity and culture and thus critique the apparently 
neat boundaries of ethnicity as defined by the U.K Census.  
 
 
6.4.2 Methods and process for data collection 
6.4.2.1 Recruitment 
 
In keeping with many sequential mixed method research studies, 
the second qualitative phase of this study was started after the AESOP-
10 follow-up study and first phase of PhD study had begun. As the follow-
up study had begun four years prior to the qualitative study, all cases 
who had been followed-up to the start date of the qualitative study had 
their Life Chart screened for eligibility. This produced an initial sampling 
frame of Fifty-six cases current and past psychiatric patients. This 
sampling frame was then subjected to further screening to exclude 
patients who didn’t meet the inclusion criteria (see section 6.4.1.2).  
 
  Eligible patients who had completed all AESOP-10 assessments 
were contacted and an information sheet was sent to them. Those who 
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had not completed all their AESOP-10 assessments were given an 
information sheet or sent an invitation to participate in the Qualitative 
Study after completion of the AESOP-10 interviews. Invitations to 
participate were then followed up by a phone call from the PhD 
researcher whereby the study aims and objectives were explained in 
detail and the each person was given an opportunity to ask questions 
about the project. Patients were asked informally whether they would be 
happy to participate and a date was set to take consent and conduct the 
interviews.  Separate informed consent was obtained for everyone 
participating in Phase Two interviews. All interviews were tape recorded 
and then transcribed for analysis.   
 
6.4.2.2 Interview setting 
  
  The settings of the interviews were determined by each individual 
participant. Participants that were in contact with services were generally 
seen at the mental health team base or in hospital. For those that 
weren’t in contact in services interviews were conducted either at the 
Institute of Psychiatry or in the person’s home. Safety procedures were 
put in place for interviews conducted in the home. This included 
informing a member of the AESOP-10 research team of the interview 




6.4.2.3 Phase Two topic guide for semi-structured interviews 
 
 As current and past psychiatric patients participating in Phase Two 
will have participated in Phase One, data relating to psychiatric diagnosis, 
ethnicity, and the participants illness and service use timeline was 
available. This information was expanded on in the qualitative interviews, 
and detailed accounts of the participants’ experiences of mental illness 
and drug/alcohol addiction as well as experiences of treatment services 
(both mental health and substance use disorder) was explored through 
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the use of a topic guide designed specifically for this study (see appendix 
1). Broadly the areas that were investigated were:  
 experiences leading up to and around first (and subsequent) 
contact with services for mental health problems;  
 decisions to and/or processes of seeking help for substance use 
disorder problems;   
 perceptions of and satisfaction with care received by treatment 
services (including treatment services ability to deal with comorbid 
problems);  
 perceptions of usefulness of treatment in recovery/stabilisation of 
mental health and addiction;  
 the role or perceived importance of family, friends or community 
support systems in engagement in treatment and recovery;  
 the role or perceived importance of cultural awareness in mental 
health and substance treatment services; perceived areas in need 
of improvement in mental health and substance abuse treatment 
services.   
 
The topic guide was piloted on the first two respondents to make  
sure that appropriate topics were covered and to refine the types of 
questions asked if needed. These first two interviews highlighted the 
need for more detailed exploration of ethnicity and its relationship with 
constructions of illness, substance use and treatment. With the first and 
second supervisors (who have expertise in qualitative research and 
constructions of ethnicity) of the PhD researcher the topic guide was then 




6.4.2.4 Research diary 
 
 As discussed in the last chapter there is a need for a reflexive 
approach to qualitative or mixed methods research. As part of this 
reflexive process a research diary was kept which included notes on 
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thoughts and feelings around the interview experience for each 
participant but also the PhD data collection process as a whole. The diary 
was not intended to be a primary source of data for the qualitative study, 
however it was used to jot down initial ideas for codes and categories as 
well as connected themes that might be uncovered during analyses. 
 
 
6.4.3 Ethical considerations 
 The AESOP-10 study obtained ethical approval from local ethics 
committees for the two study centres and all participants gave written 
informed consent to be interviewed. In addition separate ethical approval 
was sought from a local ethics committee for the qualitative study (see 
appendix 1 for ethical approval confirmation letter). As with the AESOP-
10 interviews, informed consent was given by all respondents in the 
qualitative study.  
 
 Due to the sensitive nature of the topic great care was taken to 
emphasise to participants the confidentiality of the data collected during 
the course of AESOP-10 and qualitative interviews. Patients were 
reminded throughout the course of the interview that they did not have 
to respond to any questions they felt uncomfortable with or did not wish 
to answer.  If patients became uncomfortable or distressed during the 
course of the interview the interviewer asked the participant if they 
wanted to take a break or stop the interview altogether.  
 
 A procedure was set so that if more problematic issues arose during 
the course of the interview possibly requiring action (e.g. participants 
disclosure of intent to harm oneself or others), then the interviewer 
would inform the PhD supervisors and/or consult one of the Consultant 
Psychiatrists who formed part of the AESOP research study team. All data 





The PhD study is situated within a subtle realist position and 
combines, (using a sequential design, part explanatory part exploratory 
with both a deductive and inductive research process) a quantitative 
epidemiological study (Phase One) with a qualitative study (Phase Two).  
The study was nested within the larger MRC funded AESOP-10 (Aetiology 
and Ethnicity in Schizophrenia and Other Psychoses) follow-up study 
which looked at the course and outcome of psychosis in an ethnically 
diverse cohort of psychiatric patients. This study followed up patients 
who made contact with psychiatric services between 1997 and 2000 in 
two distinct geographical areas; South London and Nottingham. 
 
 The aims and objectives of the PhD study were to make a theoretical 
and methodological contribution to the understanding of the relationship 
between comorbidity of psychosis and substance use disorder and 
ethnicity. It also aimed to uncover patient perceptions of psychotic 
illness, substance use and service responses within different ethnic 
populations. 
 
 Several tracing processes previously used in other long term follow-up 
studies of individuals with psychosis were used in this study. In Phase 
One of the PhD study patients who were re-contacted were invited to 
take part in a face-to-face interview with the author or one of the AESOP-
10 research team. The interviews involved several AESOP-10 
assessments, including the WHO Life Chart which most of the first phase 
of the PhD data was based on.   
 
 The sample for Phase Two was also taken from the AESOP-10 follow-
up study sample and used convenience sampling. Participants were 
selected based on their ethnicity and gender to allow for differences 
between the four ethnic groups (Black Caribbean, Black African, White 
and Other), and genders to be explored. Participants were invited to take 
part in an interview which used a semi structured interview topic guide. 
The setting within which the interviews took place varied from 
respondent to respondent. 
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As with all research involving NHS patients ethical approval for both 
phases of the study was obtained. 
 
Chapter Summary 6.   
Chapter Summary 
 
Aims of the Chapter: 
 
To provide a summary of the methodological structure and design of Phase One 
and Phase Two of the PhD study, including description of the sample population, 
study hypotheses and research questions, inclusion and exclusion criteria, 




 The PhD study is situated within a subtle realist philosophical stance 
 The study is mixed method design including a quantitative 
epidemiological study (Phase One) and a qualitative study (Phase Two 
 A sequential, part explanatory part exploratory design is used with both a 
deductive and inductive research process  
 Both phases of the study sample and use data from the AESOP-10 follow-
up study 
 To PhD study aimed to make a theoretical and methodological 
contribution to the understanding of the relationship between comorbidity 
of psychosis and substance use disorder and ethnicity. 
 The study aimed to estimate the prevalence and correlates of comorbidity 
of psychosis and substance use disorder in different ethnic groups.  
 The study also aimed to describe service responses to and explore 
perceived quality of care of patients with comorbid diagnoses from 
different ethnic populations, with special attention to Black Caribbean and 
Black African groups. 
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 The aim of this chapter is to both outline the analytic strategy for 
the PhD study for both the quantitative and qualitative stages and to link 
this to the epistemological stance of the PhD study. As discussed in the 
previous two chapters the design of the study was sequential mixed 
method. Data in these types of studies are often connected (connecting 
the analysis of results from the initial quantitative data collection with the 
data collection from the second qualitative phase of research). 
Preliminary analysis of the primary outcome in the first phase was used 
to inform the qualitative sample. Data from each study was then 
analysed separately (Chapters 8 and 9) but linked together in the 
discussion chapter (Chapter 10). 
 
 
7.1 PHASE ONE – QUANTITATIVE INVESTIGATION 
7.1.1 Summary of statistical analysis 
 To address the first hypothesis chi-square (2) tests were used to 
compare those with a comorbid substance use disorder, those who were 
users of substances and those without a history of substance use by 
ethnicity. Logistic regression analysis was used to estimate odds ratios 
for having a comorbid substance use disorder by ethnic group, while 
adjusting for potential confounders. 
 
 To address the second hypothesis, associations between 
sociodemographic, clinical and service use variables were investigated 
using chi square (categorical variables) or Kruskal Wallis (non-normally 
distributed count variables) tests as well as binary logistic regression, 
multinomial logistic, poisson regression and negative binomial.  
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Regression analyses allowed for main and interaction effects to be 
estimated, while adjusting for potential confounders.   
 
 Ethnic differences in the prevalence of psychosis were found between 
the two study centres in the baseline study (Morgan et al., 2006). In 
addition (as I discussed in Chapter 3) Mueser et al. (1992) found 
differences in the diagnosis of patients with comorbidity similar to those 
in normal psychotic pops where Black Caribbeans were more likely to 
have a diagnosis of schizophrenia. Accordingly psychiatric diagnosis and 
study centre were set as a priori confounders (alongside age and gender) 
and adjusted for in the phase one data analyses. Analysis was also 
stratified by study centre. All analyses were conducted using SPSS 
version 20.0 for windows (SPSS Inc., Chicago, IL, USA). 
 
 
7.1.2 Study outcome variables 
 The primary study outcome in the quantitative phase of this study was 
the prevalence of comorbid psychosis and substance use disorder. Data 
collected for this study outcome was used in part, to inform the sampling 
frame for the qualitative study.  Comorbid drug and/or alcohol use 
disorder was defined by a score of 4 (abuse) or 5 (dependence) on the 
relevant sections of the WHO Life Chart.  
 
 Two (one for drug use and one for alcohol use) three level categorical 
variables were created and used as outcome variables to address the first 
hypothesis. A three-level variable separating drug users from non-users 
and those with use disorders was used for two reasons: drug users and 
non-users are likely to be characteristically different; and studies have 
shown mild and heavy substance use to have differing strengths of 
association with poor outcome (e.g. Linszen et al., 1994).  
 
 The second hypothesis aimed to investigate with the association 
between ethnicity, comorbidity and frequency of relapses over the follow-
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up period and frequency of compulsory admissions over the follow-up 
period. Two count variables (number of psychotic episodes and number 
of compulsory admissions) created from data from the clinical and service 
use sections of the WHO Life Chart were used.  
 
 
7.2 PHASE TWO – QUALITATIVE INVESTIGATION 
 
The second phase of the PhD study sampled patients with diagnosable 
substance abuse or dependence only to allow for detailed exploration of 
perceptions of illness, substance use, treatment and recovery in this 
group. This sample was generated from preliminary analysis of patient 
data (drug and alcohol use scores on the Life Chart and 
sociodemographic data including gender and ethnicity) from the London 
arm of the AESOP-10 study. Of the 56 patients eligible to take part in the 
qualitative study, 19 were interviewed. Below is a detailed summary of 
analytical process for Phase Two. 
 
 
7.2.1 Analytical process 
Field notes and Memos 
Grounded theorists have argued that a ‘grounded theory’ does not 
just rely on the interview transcript as a source of data (Corbin & 
Strauss, 1990).  Strauss and Corbin (1990) also advocate the use of 
‘memos’. These are ‘written forms of our abstract thinking about the 
data’ (Strauss & Corbin, 1990, p. 198). Memos include notes about the 
data collection as well as notes on emerging theory. The importance of 
reflexivity in research particularly qualitative research has already been 
discussed. Field notes and memos are one way of being reflexive during 
the stages of data collection and analysis. Because participants were 
sampled from the AESOP study there was a possibility that they had 
already been interviewed before by the PhD researcher.   
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For some of the participants, prior knowledge about their 
psychiatric diagnosis at first contact with mental health services had 
already been obtained, including detailed knowledge of their 
symptomatology as well as any related personal experiences. This 
information was both a help and a hindrance to the interview. This 
knowledge could be used to ask salient questions or steer interviews in a 
particular direction because of preconceived ideas. For each interview 
field notes were made which included thoughts, impressions and 
information obtained from previous meetings with the respondents. This 
was to help make the data collection and analysis process transparent. 
Memos were used during all of the analysis stages but most frequently at 
the beginning of analysis. Memos are thoughts and ideas about the 
interview data and the researchers’ own behaviour and thinking, and can 
be a good source of data in their own right (Dey, 1993). Memos were 
used to note inferences about what was being said in an interview 
transcript but also were re-read again to help form categories for the 
initial coding framework. They gave context to the data segments that 
were identified for categorisation. 
 
 
Codes, Categories and Themes: Developing the Initial Coding framework 
Reading is the foundation of qualitative data analysis. Dey (1993) 
has summarised various techniques for critical reading of data to help us 
categorise and subsequently form theory. How well we read (and 
annotate) our data can determine how well we analyse it (Dey, 1993, p. 
83). In other words, to know what our data is telling us is in part 
dependent on how well (or how critically) we read it.  
 
Secondly, it is useful to apply a varied approach to the reading. For 
example, attending to each word within each line of the interviews as 
well as the interviews as a whole. Dey (1993) outlines several methods 
for reading qualitative data, including free association (writing down all 
the images that come to mind when we read the data), shifting focus  
(e.g. looking at a transcript as a whole then looking at the detail of each 
line) and shifting sequence (i.e. reading the data in non-linear sequence). 
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In order to develop good familiarity with the interview transcripts as well 
as aid categorisation of the data several methods of reading were utilised 
in the analysis process. 
  
Creating codes and categories are the next fundamental steps in 
the thematic analysis of interview transcripts (or any form of document 
analysis). Codes (words or phrases used to describe manifest content) 
are the starting point for creating categories and help us compare and 
contrast segments of data. A set of categories can then be built up and 
used as framework to help us analyse and make sense of large amounts 
of qualitative data, find links and connections between themes within and 
between respondent accounts and generate theory. 
 
A ‘category’ is the collection of similar data sorted into the same 
place (Morse, 2008), or a group of content that shares a commonality 
(Krippendorff, 1980). Often the description of the characteristics (and 
consequently how the parameters of inclusion and exclusion are set) of a 
category happens alongside the identification of data segments that, at 
the start of analysis, loosely fit within it. Characterisation of the category 
then enables it to be compared and contrasted with other categories 
(Morse, 2008).  
 
Often categories start broad and are ‘split’ (divided into sub-
categories) or start narrow and are then ‘spliced’ with other categories 
(combined to become larger categories) (Dey, 1993). This type of 
categorisation formed the starting point for an initial coding framework 
for the analysis of the qualitative data. In-vivo coding (Crisp, 2000) was 
also used to identify terms used by respondents which evolved into more 
general categories or sub-categories at the later stages.  Formal 
connections between categories (i.e. those that are characterised 
according to similarities and differences) as well as what Dey (1993) 
refers to as ‘substantive’ connections (e.g. connections that form the 




As discussed in the preceding chapters the research process in reality 
is often deductive as well as inductive (Murphy et al., 1998) and this 
included the analytical process. Categories in qualitative analysis can be 
generated during the analysis process (i.e. inductive, theory generating 
and grounded in the data), as well as developed from a priori knowledge 
and influenced by literature in the area of investigation (deductive and 
theory testing). The approach to creating categories then becomes a 
circular one (see Figure 12).  
 
It is true to say that in the development of the interview topic guide 
used to collect the data for this study, a priori themes (based on the 
researchers philosophical leanings and understanding of the study area, 
as well as key epidemiological and anthropological research) were 
considered, and these have influenced in part the categorisation of the 
data during the analysis stages. However, as much as possible the 
categories were developed from the data. The process of categorisation 
involves abstracting data segments from whole accounts and 
subsequently some meaning is lost. Qualitative analysis computer 
software is a useful tool for keeping records of information about the case 
and the original context each data segment comes from. Such 
information is vital to the interpretation of the data. 
   
Figure 12: Qualitative analysis as a circular process  
 
Adapted from Dey, 1993, p. 32. 
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Further along the analysis process categorisation leads to 
identifying themes within the data. As Bazeley (2009) has highlighted, 
the terms code, category and theme are often used interchangeably in 
qualitative data analysis literature. For clarity it is important then to 
distinguish between these terms as defined in this thesis. Codes have 
been described above. Categories here were considered to be collections 
of manifest data segments that share the same characteristics. Themes 
however were considered to be the latent meaning or ‘essence’ that runs 
through the data (Morse, 2008; Krippendorff, 1980; Downe-Wamboldt, 
1992). Themes have multiple meanings; they answer the question ‘How?’ 
and are a way to link the underlying meanings of codes and categories 
(Graneheim & Lundman, 2003).   
 
Baxter (1991) defines themes as threads of meaning that recur in 
domain after domain. It is useful in the analysis process and notably in 
theory generation to uncover categories as well as themes. Van Manen 
(1990, p. 87) has argued that the function of a theme is to ‘describe an 
aspect of the structure of experience’, and because themes tends to have 
multiple meanings they do not have to be mutually exclusive as we would 
often want categories to be. Once a set of categories (and their 
connections) had been identified they were sorted thematically into a list 
which formed an initial coding framework. 
 
In Chapter 5 I discussed what the appropriate criteria for assessing 
qualitative and indeed mixed methodology were. The epistemological 
stance of subtle realism was identified as a means of framing mixed 
methodology designs as well as enabling the evaluation of conclusions 
made from mixed methodology research findings in terms of validity and 
relevance. However in order for this to be possible it is imperative that 
the process of data collection (as outlined in Chapter 6) as well as the 
process of analysis (as outlined here), be made transparent.  
 
Several of the phases of qualitative analysis have been outlined 
above.  However with the last point in mind, the step-by-step process of 
developing an initial coding framework for analysing the whole data set is 
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succinctly outlined below. These stages have been adapted from the 
steps for analysis of semi-structured interviews suggested by Smith 
(1995, pp. 19-22) and phases of thematic analysis in psychological 
qualitative research suggested by Braun and Clarke (2006, p. 87) and 
were used by the author and co-coders (discussed below): 
 
1. Read in detail and several times, 3 interview transcripts picked at 
random 
2. Generate annotations (i.e. memos of initial ideas about the data) 
on each transcript and note these in a margin to the side of the 
transcript (or using a computer based analysis package). 
3. In another margin down the other side of the transcript (or using a 
computer based analysis package) note down emerging codes and 
categories. 
4. Collate categories looking for connections between them, sort 
them into potential themes, give each theme a code/categorical 
name and order them in a coherent list. 
5. Revisit the transcripts gather all data relevant to each potential 
category and theme.  
6. Collate, compare and contrast category and theme lists from all 
coders 
7. Check if the themes work in relation to the coded extracts and 
sub-sample of transcripts as a whole, producing new categories 
and themes that emerge and re-arrange the thematic list where 
necessary.  
8. Keep refining the specifics of each theme and category, and the 
overall story the analysis tells, generating clearer definitions and 
names for each theme/category using the raw data. 
9. Produce a final coding framework 
 
Below is an illustration of the process of assigning codes, 
categories and themes. It also shows how memos were used to remind 
the author to think critically about the data and to navigate them to other 
categories and themes. 
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In this illustration it is possible to see how data segments are 
extracted and put into categories according to their manifest meaning. 
The category ‘psychiatric terms’ is self explanatory and forms part of a 
larger category called ‘Terminology & Signs’ which is a collection of terms 
used by the respondents to describe their experiences as well as larger 
data segments which point to signs or views of what ‘mental illness’ is. 
This category could be kept as it is or turned into a categorical variable to 
show differences between respondents that tended to use psychiatric 
terms and those who tended to use lay terms to describe their 
experiences.  
 
Initially three other categories were found; ‘previous knowledge’ 
(previous knowledge about mental illness in general or their own mental 
illness); ‘Not given enough info’ (examples of when the respondent felt 
they weren’t given any or enough information about their 
experiences/mental illness by hospital or community staff); and ‘Finding 
out info yourself’ (examples where respondents have researched their 
own experiences/mental illness). When these categories were looked at 
together a relationship between them was found. They all relate to how 












When the rest of the account was scrutinised in this way it was 
found that ‘Understanding illness’ formed part of a theme running 
through the whole account which related to the amount of control and 
command a person felt they had over their experiences including the 
amount of involvement they had in their treatment experiences. 
 
This theme was based on more latent content in the data. The 
memo that was made for this data segment asked the author to be 
mindful of the inconsistency in this data segment (and thus its reliability). 
It also sent the author back to look at other categories that were made 
around recall (‘remembering’) which formed part of a larger theme called 
‘account devices’ (ways of giving an account or creating shared meaning, 
possibility related to social desirability). This in turn may lead to this data 
segment being used in another category or just highlight more what is 
going on in the data segment. 
  
 
Enumerating responses, identifying typologies and the importance of A-
typical cases 
Part of qualitative analysis is uncovering patterns in the data. Dey 
(1993) advocates the use of quasi-statistical methods in qualitative 
analysis to help with this. Qualitative computer analysis packages are 
really useful for this. They allow crude categorical variables to be created 
from codes used to describe categories and themes.  
 
These variables can then be analysed statistically and used to 
generate frequencies and even to cross-tabulate categorical variables 
with sample characteristics. This enables the identification of variations or 
confirmation of regularities, as well helping to explore connections within 
the data (Dey, 1993).  It is this process that allowed comparisons to be 
made in the qualitative study between genders and the different ethnic 
groups, but also those with different types of addiction and between 
respondents who constructed different relationships between their mental 
health and drug use. This formed the basis of identifying typologies 
within the data. 
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One way to increase the reliability and validity of interpretation 
and theorising in the analysis process is by using atypical or negative 
cases (Miles & Huberman, 1994). These are essentially exceptions to the 
rules or characteristics used to set the boundaries of a category or 
theme. Searching for these exceptions helps the researcher avoid the 
temptation to only look for evidence that confirms their views or theories 
(Dey, 1993). They can also help redefine the boundaries of categories 
and themes as well as explain what is going on in larger samples 
(Bazeley, 2009). As part of the analysis process for the qualitative study 




Thematic analysis: Generating theory 
In grounded theory research generating theory is the ultimate 
goal. Although this thesis does not fall within the definition of grounded 
theory research, generating theory was a primary aim. I have outlined 
above the process of creating an initial coding framework for analysing 
the whole sample of accounts, as well as the role enumeration, creating 
typologies and examining negative cases played in the analysis process.  
The last stage of the analysis process as outlined by Braun and Clarke 
(2006) is the selection and analysis of compelling extracts which are then 
related back to the research question and background literature. However 
we need to see whether we have created a coherent and ‘sound’ model or 
theory from the data.  
 
Enumeration, typologies and examination of negative cases all 
form part of this process, but it is useful to outline some of the steps or 
better ‘criteria’ which signify theory generation and were used to guide 
the more detailed and final stages of data analysis in this study. These 
three steps are adapted from suggestions by Pat Bazeley (2009) and 
referred to as ‘moving from garden path analyses’. Some of the 
processes described can be found in the earlier analysis steps described 
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above while others were reserved for the reporting of the results. Each 
step (repeated for each theme) is outlined below: 
 
 Describe. 
Outline the context for the study and provide details about sources of 
data (demographics and characteristics of the sample). Describe the 
interrelationships between these characteristics which give background to 
the data and form the basis of comparative analysis. Move on to the first 
major category or ‘theme’, describing its characteristics and 
boundaries. Ask questions like; how did people talk about this aspect, 
and how many talked about it? What’s not included? 
 
 Compare  
Look at differences in the characteristics and boundaries for each 
category or theme, contrasting between demographic groups or across 
variations in context. Ask questions like: Do themes occur more or less 
frequently for different groups? Are they expressed differently by 
different groups? Report meaningful associations as well as the absence 
of associations. 
 
 Relate  
Relate each category or theme to others already written about. 
Ask more questions like: Under what conditions does this category or 
theme arise? What actions/interactions/strategies are involved? What are 
the consequences and do these vary depending on the particular 
circumstances or the form in which it is expressed?  
 
As Bazeley highlights: ‘As you describe, compare and relate for 
each element with an enquiring mind and an eye for evidence, your 
picture will become increasingly complex and your theory or thesis will 
develop, building on the foundation you have laid. Your analysis, then, 
will come together around an integrating idea, with arguments to support 






7.2.2 Reliability, validity and multiple coders  
Although issues around reliability and validity of data analysis 
imply one single truth (in philosophical terms), there is still a need to 
increase the likelihood that interpretation of data is representative of the 
account giver, study sample and if possible population of interest. The 
interviewer has influence over both the data generation (the instruments 
used and the interview itself) and data analyses.  
 
Various considerations were given during data analysis and 
interpretation including the possible indirect influence interviewer 
characteristics may have had on accounts elicited as well as the context 
in which interviews were conducted (for example treatment or clinical 
settings vs. community or home settings).   
 
It would be true to say that commissioners of research look at 
processes and procedures that constitute ‘good’ qualitative research 
(Barbour, 2001). Having two (or more) primary coders has been 
considered one way of producing ‘good’ qualitative research (Berends & 
Johnston, 2005).  Barbour (2001) has argued that the benefits of 
multiple coders can be found in the content of agreement and 
disagreement in codings and that discussions between coders about their 
‘choices’ of data segments can provide insights and help to refine coding 
frameworks.  
 
Three coders were used to produce the initial coding framework. 
The primary coder was the author and the two other coders were PhD 
students in the authors department. Each coder coded between 1 and 3 
transcripts (using the process for creating the initial framework above) 
and once an initial list of categories and themes had been generated 




  Although evaluative criteria such as inter-rater reliability (which 
assumes one single truth) are not appropriate for qualitative research, it 
is useful to detail some of the agreements and disagreements between 




Table 9: Summary of the process of agreeing a final coding framework for the Qualitative Study 
 
Theme/Category/Code Coder 1 Coder 2 Coder 3 Coding Agreement 
Treatment and Recovery 
 
 The benefits of 
hospitalisation 
 Change in thinking  
 Change in mood 
 Involvement vs. being done to – 
passivity vs. agency, 
contradictions and consistencies 
 Perceived reasons for admittance 
 Frustration 
 Impact of treatment vs. impact 
of hospitalisation  
 Staff as friends/allies/enemies 
 Dissociation from other patients 
– patients as ‘other’, special 
 Playing the game, acting out 
 Inside vs. outside 
 Leaving/re-entering community 
 Post-discharge care and 
continuity 
 Treatment and Recovery 
 What (what type of treatment is 
useful)  




 positive experience / negative 
experiences 
 Definition (what was treatment 
defined as i.e. the provider) 
 Treatment services 
 Family support (recognising the 
person is ill, taking them to the 
hospital, having someone to talk 
to / care for you 
 Responsibility 
 Active / passive participation 
 Emotional / psychological 
experiences 
 Personality change 
 Mood change 
 
Yes (separation of 
hospitalisation, treatment 




*Hospitalisation theme to 
include: usefulness of being in 
hospital; transition of care to 
community services or 
discharge home; experiences 
inside hospital compared to 
outside hospital; behaviour on 
ward; frustration; view of 
other patients;  
 
*Active and passive 
involvement in treatment 
theme. 
 
*Treatment and Recovery 
theme to include: what type 
of treatment; where should 
treatment take place; who 
should treat. 
Symptoms and illness 
experiences 
 Recognising symptoms 
 The benefits of 
hospitalisation 
 Change in mood 
 
 External vs. internal origin – ‘it 
was happening to me’ 
 Description of symptoms as 
psychosis, mentally ill? Proper 
psychosis? 
 Attribution of cause – external 
vs. internal 
 Defining the experiences 
 Terms (psychiatric vs. lay) 
 Definitions / conceptualisations 
(physical vs. behavioural) 
 Acting out (on purpose as 
opposed to not being able to help 
the way you behave) 
 Emotional / psychological 
experiences  
 Personality change 





symptomatology as a theme 
to include: understanding and 
recognising your own illness 
symptoms; defining 
symptoms;  type of symptom; 
attribution of cause of 
symptoms; changes in 
symptoms 
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Theme/Category/Code Coder 1 Coder 2 Coder 3 Coding Agreement 
Drug use and mental 
health relationship 
 Is drug use separate 
from mental health? 
 
 Effects of drug use on self 
(mental/physical/practical) 
 Perceived link to episode/MH 
 





*Drug use related to my 
experiences theme. Use this 
theme as a categorical 
variable. 
Risk Factors 
 Living context theme  






Risk factors were not directly 
elicited in accounts. This 
relates to psychiatric models 
not lay models. Is not clearly 
constructed. 
Coping  Coping  Coping and drug use N/A 
Yes 
 
*Coping theme to include: 
general coping; constructions 
of drug use as a coping 
mechanism. 
Locus of Control/ 
Responsibility/Cause: 
(internal vs. external) 
N/A 
 Symptoms 
 External vs. internal origin – 
‘it was happening to me’ 
 Attribution of cause – 
external vs. internal 
 
 Causes of the experiences 
 Located in wider society 
(responsibility with other) 
 Located in immediate social 
setting (responsibility with other) 
 Located in individual 




Confusion of concepts (LOC 
and responsibility). LOC 
constructs not clearly elicited 
in accounts. This theme needs 
further development. 
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 The above Table (Table 9) summarises an example of the process 
in which several themes and categories were agreed between the three 
co-coders for the final coding framework. Many themes identified in the 
individual coder’s preliminary coding frameworks were similar and 
featured in the combined framework (e.g. the relationship between drug 
use and mental illness experiences). Other themes were either only 
present in one or two of the preliminary coding frameworks or differences 
in the description or categorisation of the theme were apparent. A theme 
was included in the combined coding framework if at least two coders 
had highlighted it. For example, the theme relating to ‘coping’ was 
highlighted in only coder 1 and coder 2’s frameworks.  
 
However some themes required splitting or splicing even when 
there was agreement. For example all three coders highlighted 
constructions of treatment and recovery in the accounts they coded. 
Coder 1 focused primarily on the individual patient’s cognition and 
emotional states, coder 2 uncovered constructions of patients perceptions 
of treatment, interactions with other patients, involvement in treatment 
and experiences when not in treatment, while coder 3 focused on the 
details of treatment agencies, the patients and significant others 
involvement and the patients emotional states. However all three coders 
highlighted the distinct relevance of the experience of hospitalisation. 
Subsequently the theme ‘treatment and recovery’ was split into three 
different categories: 
 Hospitalisation 
 Active and passive involvement in treatment and 
 Treatment and Recovery. 
 
Some themes identified by the three coders were not included in  
the combined coding framework. For example, two of the coders 
highlighted themes of control and responsibility. On further discussion 
these concepts where considered separate. Clear constructions falling 
within Rotters (1954) concept of ‘locus of control’ (internalisation and 
externalisation), were not clearly elicited in the transcripts. Constructions 
of causes were elicited, however these constructions were more closely 
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framed within understanding rather than control. Instead, themes of 
power and control in the treatment process rather than external and 
internal attribution of causes were more clearly prominent in accounts. 
This theme was omitted in its initial form from the combined framework 
however after further analysis it was revisited, redeveloped and included 
as the account giving mechanism ‘apportioning responsibility’. 
 
As highlighted in the chapter sub section detailing the process of 
developing the initial coding frameworks, each coder analysed the data 
using a nine-step process. However, as is often the case with qualitative 
data analysis the process of checking if the themes in the coding 
framework worked in relation to a sub-sample of transcripts resulted in 
producing new categories and themes, as well as refinement of initial 
categories (steps 7 through to 9).  
 
This meant that the combined coding framework generated from 
the consensus meetings with the three co-coders was subject to 
additional changes when the PhD author tested it against other interview 
transcripts. For example the theme concerning symptomatology was 
adapted further after additional analysis of the interview transcripts to 
include sub themes which reflected the different ways in which a 
symptom could be experienced (i.e through feelings, thoughts or 
behaviours). 
 
Although the author was responsible for creating a final coding 
framework (see appendix 4 for summary of the three initial coding 
frameworks of individual coders, as well as the final coding framework), 
which was the applied to the rest of the sample, these considerations 







7.3 THEORETICAL CONSIDERATIONS 
 
It is important to discuss the philosophical assumptions 
underpinning the analysis of the PhD study data. I have discussed the 
framework within which the PhD study is situated and it is this ‘middle 
ground’ theoretical stance that also frames the analytical approach to the 
study.. In other words, the analytical structure of the study is also bound 
by the same ontological and epistemological understandings as its 
method. Approaches to data analyses need to either share the same 
theoretical understandings of the overall design of the study or use 
analytical methods that allow for the studies philosophical standpoint to 
be embraced. It should be noted that Subtle Realism is not a 
methodological or analytical approach in its own right like the commonly 
used Grounded Theory. 
 
Similar to  the ‘grounded theory’ approach of Glaser and Strauss 
(1967) and Strauss and Corbin (1990) howver, the analytical structure 
for the qualitative phase of the PhD study is based upon on a variety of 
different strategies for ‘coding’ or ‘categorising’ data and generating 
theory that is grounded. It would be true to say that thematic analysis 
has been considered the corner stone of GT research (Ryan & Bernard, 
2000). Some of the reasons as to why the research here despite 
assuming many of the methodological techniques used in Grounded 
Theory (GT) (creating codes and categories, using memoing techniques 
during data collection and analysis, constant comparison in the analysis 
process and going beyond description and generating theory which is 
grounded in the data) cannot be classed as a piece of grounded theory 
research have been outlined by Becker (1993) in Common Pitfalls in 
Published Grounded Theory Research. 
 
 Here Becker describes several obstacles which researchers claiming 
to use GT find themselves having to overcome including using narrative 
rather than theoretical approaches to data collection and analysis, using 
selective as opposed to theoretical sampling as well as making sure they 
use a true constant comparative method. She also points as Milliken and 
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Schreiber (2012) have, to the importance of seeing the research project 
through the correct ‘theoretical lens’ namely Social Interactionism. It can 
be argued however that these elements of GT which are essential in 
creating a true piece of GT research, are arguably the backbone of how 
to do ‘good’ GT and possibly represent the ‘rigor’ part of the GT research 
process.  
 
In addition the question as to whether it is theoretically appropriate 
to use elements of GT in the research process (and by virtue using 
techniques which are informed by social interaction) while aligning the 
study to a completely different epistemological stance should also be 
considered?  Milliken and Shreiber (2012) refute in the possibility of 
conducting a piece of a grounded theory research without social or 
symbolic interactionism.  They argue that ‘the ontology, epistemology, 
method, and techniques of grounded theory are all steeped in symbolic 
interactionism, such that the two cannot be divorced’ (Milken & 
Schreiber, 2012). They also argue that grounded theory is more than a 
sum of techniques. 
 
However it is also arguable that there are individual techniques 
associated with GT which could be used more freely (i.e. they have more 
philosophical flexibility). So can methods be epistemologically naïve and 
subsequently aligned to virtually any methodological or epistemological 
positions? Although there are data collection and analytical methods 
which do have clear philosophical leanings, some qualitative researchers 
have argued (including Milken & Shreiber themselves) that many 
methods and techniques are more closely linked with practical concerns 
(Silverman, 2013). 
 
Similarly, Bryman (1988, p. 124) has argued that research methods 
are probably much more autonomous and adaptable than some 
epistemologists would like to believe, and Braun and Clarke consider 
thematic analysis (the foundation of GT analysis) to be flexible enough to 




Many of the qualitative analytical techniques described in this 
chapter have been advocated by Ian Dey.  Indeed Dey (1993) argues 
that ‘practical problems of conceptualizing meanings are common to a 
range of different perspectives’.  In his book Qualitative data analysis: A 
user-friendly guide for social scientist he describes how interpretive 
approaches (e.g. Patton, 1980) have emphasised the role of creating 
patterns, categories and using basic description. He also outlines how the 
Network approach used by Bliss et al. (1983) equally focuses on 
categorisation, and  Miles and Huberman (1984) have advocated the use 
of quasi-statistical approaches in qualitative analysis (‘pattern coding’) 
(Dey, 1993).  
 
From a similar standpoint as above I would argue that the 
qualitative analytical techniques used in the PhD study (those that could 
be considered elements of grounded theory) are methods that could be 
considered ‘good’ practice in producing reliable and valid qualitative 
research and are flexible enough to be used within a non-Social 
Interactionist framework. In other words, thequalitative phase of this 
study is not simply using elements of GT but using methodological and 
analytical techniques that have formed part of GT research but also have 
flexibility to be used in research subsumed by subtle realist philosophy.  
 
The assumptions underpinning the epistemological stance and 
methodological approach to the PhD study are firstly that, data collection 
and analytical methods can be seen as tools in a tool-kit (as described in 
Chapter 5) and secondly, that the analytical techniques (as with the 
methodological techniques) used in both phases of the PhD study make 
sense within and can be framed by the studies ontology.  
 
The ontology and epistemology of Subtle Realism acknowledges the 
existence of an independent reality (i.e. that comorbid psychosis and 
substance use disorders exist as a health condition), and a world that has 
an existence independent of our perception of it, but it also assumes that 
there cannot be direct access to that reality (through quantitative or 
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qualitative methods). The emphasise instead, is on representation not 
reproduction of social phenomena. This representation can be achieved 
through enumeration and statistical testing as well as through account 
giving and thematic constructions.  
 
As noted by Andrews (2012), representation of reality implies that it 
will be from the perspective of the researcher, thereby implicitly 
acknowledging reflexivity, which is acknowledgement that researchers 
influence the research process. This could, for example, be the choices 
made when creating variables, choosing confounders and statistical test 
in quantitative research as well as the question choices made when 
conducting semi-structured interviews as well as the codes and 
categories created in thematic analysis). 
 
The question as I have argued in the previous chapters is do these 
techniques ‘get the job done’? It is in this very process of trying to 
answer the above question that mixed methodology has been made 
possible. It is not a case of ignoring epistemology altogether rather 
embracing conflicting epistemology or as in the case of subtle and 








To address the study hypothesis in Phase One of the PhD study various 
statistical methods were used including chi-square (2) tests; Kruskal 
Wallis tests; and regression analyses.  The primary study outcome and 
variable of interest in the quantitative phase of this study was the 
prevalence of comorbid psychosis and substance use disorder (drug or 
alcohol). Data collected for this study outcome was used in part, to 
inform the sampling frame for the qualitative study.   
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 Along with the interview transcripts themselves, field notes and 
memos were used to help construct codes, categories and themes within 
the qualitative data.  A varied approach to ‘reading the data’ formed the 
preliminary stages of data analyses. The categories and themes 
generated from analysis of respondent’s interviews formed the basis for 
identifying typologies within the data. Thematic analysis techniques were 
used for analysing the qualitative data. This analytical method was 
chosen for its philosophical naivety and subsequent compatibility with a 
subtle realist perspective. 
 
 Three qualitative coders were used to create a coding framework from 
which the whole data would be analysed. Enumeration, creating 
typologies and examination of negative cases all form part of this process 
of theory generation. 
 
 The assumptions underpinning the epistemological stance and 
methodological approach to the PhD study were that, data collection and 
analytical methods can be viewed as tools in a tool-kit. 
   
Chapter Summary 7.   
Chapter Summary 
 
Aims of the Chapter: 
 
To outline the analytic strategy the PhD study used to address its aims and 




 Approaches to data analyses need to either share the same theoretical 
understandings of the overall design of the study or use analytical 
methods that allow for the studies philosophical standpoint to be 
embraced. 
 Various statistical analysis methods were used to address the study 
hypotheses in the first phase of the PhD study. 
 Thematic analysis is considered a technique, and was chosen as the 
method for analysing the qualitative study data because of its 
compatibility with a subtle realist perspective. 
 Co-coders were used in the qualitative analyses process 
 Theory generation was attempted through enumeration, creation of 
typologies and examination of negative cases 
 Data from each phase of the study was analysed separately but linked 
together in the discussion chapter (Chapter 10). 
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CHAPTER 8: PHASE ONE RESULTS 
 
The quantitative study design, including details of the study 
assessments, has been discussed in Chapter 6 and the analytical 
framework for the quantitative arm of the PhD study, including the 
overall method of statistical analyses, has been discussed in Chapter 7.   
 
This chapter aims to summarise the findings from the quantitative 
arm of the PhD study. In line with the study hypotheses it will examine 
firstly the ethnic differences in the prevalence of comorbid drug (DUD) 
and alcohol (AUD) use disorders in a sub-sample of the larger Aetiological 
study AESOP; with particular attention to whether comorbid substance 
use disorders (SUD) are more likely in Black Caribbean groups and less 
likely in Black African groups compared to Whites. The chapter will then 
examine whether regardless of ethnic group comorbidity was associated 
with the frequency of psychotic relapse and compulsory hospital 
admissions over the follow-up period. 
 
 
8.1 SOCIODEMOGRAPHIC AND CLINICAL VARIABLES 
 
The main study outcome was comorbid substance use disorders 
which included drug use disorders and alcohol use disorders. These two 
types of substance use disorder were analysed separately.  
 
As discussed in section 6.3.3.3 substance use over the follow-up 
was measured using the WHO Life Chart. Drug use was categorised in six 
ways (no drug use; sporadic drug taking, no regular use; sporadic drug 
taking, possible frequent or regular use; frequent or regular use definitely 
present; drug abuse; drug dependence). Comorbid drug use disorder was 
defined as having either drug abuse or drug dependence. Alcohol use was 
also categorised in six ways (no alcohol use; only occasional social 
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drinking; moderate alcohol use; excessive alcohol use; alcohol abuse; 
alcohol dependence). Comorbid alcohol use disorder was defined as 
having either alcohol abuse or alcohol dependence. Any type of non-
abusive or non-dependent drug use was grouped together and a three-
level categorical comorbid drug use disorder variable was created (no 
drug use; drug use; comorbid drug use disorder). The same was done for 
alcohol use. 
 
Other sociodemographic and clinical data from the AESOP follow-up 
study (see Chapter 6 for the method for data collection) were used in the 
PhD study analysis and the following variables were created: 
 
• Ethnicity: this was a three-level categorical variable (White 
  British, Black Caribbean and Black African).  
• Gender: Males and females. 
• Age at first contact with mental health services: this variable 
was dichotomised (16-29 years and 30+ years) in accordance 
with the BCS. 
 Diagnosis: ICD-10 and DSM-IV diagnosis were generated for 
each patient (see section 6.3), however for the purposes of 
these analyses the variable for diagnosis was split into a three-
level categorical variable: non-affective psychosis (including 
schizophrenia, schizoaffective, substance related psychosis, 
delusional disorder, acute psychotic disorder and other non-
affective psychosis), manic and depressive psychosis. 
• Study centre: Nottingham and South East London. 
 Course type: The type of illness course each patient 
experiences was categorised into five groups (Episodic -  
Continuous, primarily positive symptoms; Continuous, primarily 
negative symptoms; Continuous, primarily symptoms positive 
and negative symptoms; Neither episodic nor continuous). For 
the purpose of data analysis in this investigation the 
‘Continuous’ groups were collapsed into one category and a new 
three-level variable was created (Episodic, Continuous and 
Neither). 
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 Compulsory admission; a new binary variable for whether a 
patient had experienced a compulsory admission or not was 
created for all patients that had had at least one hospital 
admission over the follow-up.  
 
 
8.2 SAMPLE CHARACTERISTICS 
 
 The total AESOP sample was 557.  Data was collected for all ethnic 
groups but, as mentioned above, the PhD study was only concerned with 
patients from White, Black Caribbean and Black African ethnic groups, so 
all patients not belonging to those groups were also excluded (N=99) 
leaving an eligible sample of 458. As mentioned in section 6.3.1 
information was limited for patients with a follow-up of less than eight 
years and because of patients who had died or moved abroad, the 
following analyses for this study involved only patients who had at least 
eight years of follow-up, meaning there was a final sample of 325.  
 
A subsequent power analysis calculation was performed to 
estimate the study power after data collection. Looking at prevalence of 
comorbid alcohol use disorders (AUD), tests with a 0.05 two-sided 
significance level were found to have 98% power to detect the difference 
between White patients (Group 1) with 64% prevalence of comorbid AUD 
and Black African patients (Group 2) with 14% prevalence of comorbid 
AUD (unadjusted odds ratio of 0.093) when the sample sizes were 42 and 
21, respectively (a total sample size of 63, which included those with no 
alcohol use and those with comorbid AUD). 
 
Table 10 compares the sample characteristics of eligible patients 
included (those with at least eight years of follow-up data) and excluded 
(those with less than eight years of follow-up data) from the analysis for 
the three ethnic groups of interest.  Chi square analyses were used to 
explore differences on primary sociodemographic and clinical variables at 
baseline for the two groups for each study centre. Numbers in the Black 
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Caribbean and Black African groups for Nottingham were too small to 
make comparisons between those included and excluded.  
 
 There were significant differences in the gender of those with at 
least eight years of follow-up and those without, with slightly more 
females in the included sample for the London centre (2 =7.979, d.f.=1, 
p=0.05). There were also significant differences in ethnicity between the 
two groups in the London centre, with slightly more Black Caribbeans in 
the included sample (2 =6.337, d.f.=2, p=0.042). This difference was  
only just significant however.
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Table 10: Comparison of included and excluded cases by study centre 







































Agea                
16-29 
30 yrs and over 
104 (54.2) 
88 (45.8) 


































2   (5.6) 
1   (2.8) 
 -  - 
a













8.3 EXPLORATION OF DIFFERENCES BY ETHNICITY AND 
SUBSTANCE USE 
 
Tables 11 and 12 show the social and clinical characteristics of the 
final sample (N=325) by drug use and alcohol use. There were 
significantly more males than females with comorbid drug use disorders 
(2=33.412, d.f.=2, p=0.000), and significantly more patients with 
comorbid drug use disorders in the younger 16-29 age group than the 
older age group (2=39.360, d.f.=2, p=0.000). There were also 
significantly more Black Africans in the non-drug user group (2=13.122, 
d.f.=4, p=0.011). Patients with drug use or comorbid drug use disorder 
were less likely to have a diagnosis of depression (2=13.815, d.f.=4, 
p=0.008). 
 
 When we look at the characteristic of the sample by alcohol use we 
see that there was a higher proportion of patients with no alcohol use 
over their lifetime before in the London (81%) centre than in the 
Nottingham (19%) centre (2=11.048, d.f.=2, p=0.004).  There were 
also significantly more Black African than White or Black Caribbean 
patients with no alcohol use (2=25.330, d.f.=4, p=0.000), which may 
have explained the higher proportion of no alcohol users in the London 
sample.  
 
 Patients with comorbid alcohol use disorders tended to be male 
(72%, 2=16.277, d.f.=2, p=0.000) and tended to have a diagnosis of 
Schizophrenia (85%, 2=8.836, d.f.=4, p=0.065) although this didn’t 
quite reach statistical significance.  
 
 When we look at the characteristics of the sample by ethnic group 
we can see from Table 13 that apart from a higher percentage of no drug 
use in the Black African group and a higher percentage of alcohol use in 
the White group the only other significant differences were with the 
ethnic distribution by study centre. London had significantly more Black 
Caribbean (London, n=94 vs. Nottingham, n=14) and Black African 
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(London, n=46 vs. Nottingham, n=1) patients than Nottingham 
(2=121.253, d.f.=2, p=0.000). 
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Table 11: Social and clinical characteristics by drug use 















Study Centrea            
     London 
     Nottingham 
78 (60.0) 
52 (40.0) 







2  0.436 
Sociala            
Gendera  
     Male 





















     16-29 













2  0.000 
Ethnicitya  
     White 
     Black Caribbean 























Clinicalb            
Diagnosisb      
     Schizophrenia 
     Mania 
























45 missing cases. 
b
46 missing cases. 
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Table 12: Social and clinical characteristics by alcohol use 
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Clinicalb            
Diagnosisb      
     Schizophrenia 
     Mania 

























44 missing cases. 
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2  0.000 
Social            
Gender 
     Male 
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Clinicala            
Diagnosis 
     Schizophrenia 
     Mania 



























     No drug use 
     Drug use 


























     No alcohol use 
     Alcohol use 
























72 missing cases. 
b
45 missing cases. 
c




As we can see from exploration of the differences in the study 
sample there were significant differences in the age, gender, ethnicity 
and diagnosis of patients with comorbid DUD and significant differences 
in the gender, ethnicity and study centre of patients with comorbid AUD. 
There were also differences by ethnicity. The main differences were: 
 There was significantly less drug and alcohol use as well as drug 
and alcohol use disorders in Black Africans. 
 Patients with comorbidity were more likely to be male, young and 
have a diagnosis of schizophrenia. 
 Patients with comorbid alcohol use disorders were more likely to be 
male, have a diagnosis of Schizophrenia and to have been 
recruited from the London study site. 
 There were significantly less Black Caribbean and Black African 
patients in the Nottingham sample. 
 
Although these findings point towards ethnic differences in the 
prevalence of drug and alcohol use as well as differences in social and 
clinical characteristics between those with and without substance use 
disorders, further exploration was needed to answer the two research 
questions. The subsequent sections looked at ethnicity as a risk factor for 
comorbid drug or alcohol use disorder and then comorbidity as a risk 
factor for psychotic relapse and hospital admission.  
 
To recap, the study hypotheses were as follows: 
1) The prevalence of comorbid substance use disorders in 
individuals with an 8-12 year history of psychosis will differ 
according to ethnic group.   
More specifically, rates of comorbidity will be higher in Black 
Caribbean and lower in Black African patients than White patients. 
  2) In all ethnic groups comorbid substance use disorder 
will be associated with:  
a)  More frequent relapses 
b) More compulsory admissions and independent of potential 
confounders, including age, gender, diagnosis and study centre. 
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To answer the first hypotheses the odds or the likelihood of having 
either substance use or a comorbid substance use disorder by ethnic 
group were calculated.  To address both parts of the second hypotheses 
odds and rate (risk) ratios were calculated for the whole sample and then 
(where possible) for each ethnic group separately so that comparisons 
could be made. As highlighted in the chapter covering the analytical 
structure of the PhD study (Chapter 7), regression analyses allow for the 
effect of ethnicity and comorbidity to be uncovered as well as for 
interaction effects to be estimated, while adjusting for potential 
confounders. Unadjusted odds and rate ratios were calculated first and 
where possible analyses were stratified by study centre. Following that, 
adjusted odds and rate ratios were calculated using a priori confounder’s 
age, gender and diagnosis as well as study centre. 
 
 
8.4 ETHNIC DIFFERENCES IN THE LIKELIHOOD OF HAVING 
SUBSTANCE USE DISORDERS 
 
As discussed in Chapter 7, multinomial regression analyses were 
used to test the first research hypotheses. The three-level comorbid drug 
use disorder variable used compared non-drug users (N=130) (patients 
who had never used drugs in their lifetime before their follow-up) with 
patients who had used drugs at least once in their lifetime before follow-
up but didn’t score for a drug use disorder (N=85), while simultaneously 
comparing non-drug users with patients who had a diagnosed drug use 
disorder (drug abuse or drug dependence) (N=65) in their lifetime before 
follow-up. 
 
Using ‘no drug use’ as the reference group for all analyses, the odds 
ratios (OR) for having drug use over the follow-up period were compared 
by ethnic group. Table 14 shows that Black Caribbean patients had 
roughly equivalent odds of having drug use compared with White patients 
(OR 0.918, CI 0.501-1.682, p=0.783), however Black Africans were 0.2 
less likely than Whites to have drug use (OR 0.245, CI 0.094-0.636, 
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p=0.004). A similar pattern was observed for the ORs for having a 
comorbid drug use disorder (DUD). Black Caribbeans had similar odds of 
having a comorbid DUD (OR 1.182, CI 0.616-2.267, p=0.615) while 
Black Africans were significantly less likely to have a comorbid DUD 
compared with Whites (OR 0.364, CI 0.137-0.963, p=0.042). 
 
A priori confounders were set for this study. As well as age, gender 
and diagnosis, study centre was set as a confounder. Although there 
were significant ethnic differences between the London and Nottingham 
sites (see Table 10) the number of patients in the Black African group 
was too small to report stratified analyses for drug or alcohol use. After 
adjusting for the a priori confounders, Black Caribbeans were half as 
likely to have used drugs compared with Whites (OR 0.501, CI 0.224-
1.119, p=0.092). As with the unadjusted odds, Black Africans were much 
less likely to have used drugs over the follow-up (OR 0.073, CI 0.022-
0.241, p=0.000).  
 
Similar odds were observed when ethnic differences in likelihood of 
comorbid DUD were examined, with Black Africans being significantly less 
likely to have a comorbid DUD (BC vs. W: OR 0.689, CI 0.280-1.697, 
p=0.419; BA vs. W: OR 0.090, CI 0.025-0.327, p=0.000).   
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Table 14: Ethnicity and prevalence of drug use and drug use disorders 
 























































































































Table 15: Ethnicity and prevalence of alcohol use and alcohol use disorders 
 























































































































Table 16: Ethnicity and prevalence of drug use and drug use disorders 
 
CI, confidence interval. 
























































































































Table 17: Ethnicity and prevalence of alcohol use and alcohol use disorders 
 
CI, confidence interval. 
aAdjusted for age, gender, diagnosis and study centre. 
  












































































































Next the likelihood of using alcohol and having an AUD was 
examined (see Table 15). Again a three-level variable was used. The 
variable compared patients who had never used alcohol in their lifetime 
before study follow-up (N=57) with patients who had used alcohol at 
least once in their lifetime but didn’t score for an alcohol use disorder 
(N=177) as well as patients who had a diagnosed alcohol use disorder 
(alcohol abuse or alcohol dependence) (N=47) in their lifetime before 
follow-up. 
 
Black Caribbeans with under 0.4 the odds of Whites were 
significantly less likely to have used alcohol or have had an alcohol use 
disorder (Alcohol use: OR 0.353, CI 0.171-0.726, p= 0.005; Comorbid 
AUD: OR 0.394, CI 0.162-0.954, p=0.039). The same pattern was 
observed in Black Africans who had roughly 0.1 the odds of Whites 
(Alcohol use: OR 0.157, CI 0.068-0.364, p=0.000; Comorbid AUD: OR 
0.093, CI 0.023-0.366, p=0.001). This preliminarily suggests that alcohol 
use and alcohol use disorders are much less likely in both Black ethnic 
groups. 
 
After adjusting for a priori confounders the odds for both alcohol 
use and comorbid AUD in the Black Caribbean group remained equivalent 
(Alcohol use: OR 0.376, CI 0.149-0.949, p=0.038; Comorbid AUD: OR 
0.290, CI 0.095-0.885, p=0.030) as did the odds for patients in the Black 
African group (Alcohol use: OR 0.174, CI 0.059-0.511, p=0.001; 
Comorbid AUD: OR 0.066, CI 0.013-0.322, p=0.001). Table 17 shows the 
likelihood for having alcohol use and alcohol use disorders in a patient’s 
lifetime before with these adjustments. 
 
Several conclusions can be drawn from the findings in the previous 
section and this section:  
 Black Caribbean and White patients have equivalent lifetime before 
prevalence of drug use as well as equivalent lifetime before 
prevalence and likelihood of having comorbid drug use disorders. 
When key social and clinical variables are held constant Black 
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Caribbeans are half as less likely to have drug use and slightly less 
likely to have comorbidity. 
 Black Africans on the other hand have significantly lower lifetime 
before prevalence and likelihood of having both lifetime before 
drug use and drug use disorders compared with Whites. When key 
social and clinical variables are held constant these findings hold. 
 Black Caribbean and Black African patients have lower lifetime 
before prevalence and less likelihood of having lifetime before 
alcohol use and comorbid alcohol use disorders. When key social 
and clinical variables are held constant these patterns are even 
more apparent. 
 
Given that the first hypotheses predicted higher prevalence of 
comorbid SUDs in the Black Caribbeans compared to Whites we cannot 
accept the primary experimental hypothesis for the study. Moreover a 
reverse pattern of use was found for alcohol use and alcohol use 
disorders in this ethnic group.  
 
However, as we have seen, lower prevalence and likelihood of both 
drug and alcohol use as well as comorbid drug and alcohol use disorders 




8.5 RELATIONSHIP BETWEEN COMORBIDITY AND 
FREQUENCY OF RELAPSE 
 
The second hypothesis to be tested was whether, regardless of 
ethnic group, comorbidity was negatively associated with psychotic 
relapse. In other words, did having comorbid substance use disorder 
increase the likelihood of someone having more frequent episodes of 
psychotic illness? To measure frequency of relapse the variable ‘number 
of psychotic episodes over follow-up’ was used. The variable ‘number of 
psychotic episodes’ estimated the frequency of psychotic episodes 
patients had not including their baseline episode. Many of the patients 
only experienced their episode of inclusion into the AESOP baseline study.  
 
Additionally, some of the patients were still in their episode of 
inclusion at follow-up or had episodes of illness with short periods of 
remission in between (a continuous illness), while others experienced, for 
example, several short episodes that were separated by longer periods of 
remission (an episodic illness).  
 
The hypothesis was concerned with patients that had the latter 
presentation. It was hypothesised that patients with comorbid substance 
use disorders would have more relapses (in other words more psychotic 
episodes) and so, by association, would have an episodic or neither 
episodic nor continuous illness course. It was useful however to first see 
if there were any differences between those who had continuous, episodic 
or neither type of illness course and whether the likelihood of having a 
particular course type was related to comorbid substance use.  
 
 
8.5.1 Relationship between comorbidity and illness course type 
Multinomial logistics regression was used to compare patients who 
had an episodic course type (i.e. their illness course included episodes 
that did not last longer than six months with at least six months of 
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remission between) (N=92) with those that had either a continuous 
course type (i.e. their illness course had no remission that lasted longer 
than six months) (N=67) and patients that had neither an episodic nor 
continuous course type (i.e. at least one episode and one remission 
lasted over six months) (N=131).  
 
A three-level variable was used, with patients categorised as 
having an episodic illness course coded as ‘1’,  those with a continuous 
illness course coded as ‘2’ and those with neither type of course type 
coded as ‘3’.  
 
Table 18 shows how the analysis was split: firstly the risk of having 
an episodic or neither course was calculated for the whole sample (all 
three ethnic groups), then the risk for having an episodic or neither 
course type was calculated for each of the three ethnic groups 
separately. As with the analyses above two three-level variables for 
comorbid substance use were used (one for drugs and one for alcohol) to 
predict course type. The unadjusted odds for the whole sample and for 
each ethnic group for having an episodic course type compared to a 
continuous course type were mixed in the drug using group.  
 
In the whole sample drug users had similar odds to non-drug users 
for having an episodic course type while patients with comorbid DUD 
were slightly less likely (OR 0.598, CI 0.247-1.449, p=0.255). The 
opposite pattern was observed for the likelihood of having a neither 
episodic nor continuous course type, with drug users being less likely and 
patients with comorbid DUD having an equivalent odds to non-drug users 
(Drug use: OR 0.459, CI 0.222-0.948, p=0.035; Comorbid DUD: OR 
0.904, CI 0.418-1.955, p=0.797).  
 
When the three ethnic groups were looked at separately very 
different patterns were observed. White patients with drug use were 0.3 
less likely to have an episodic course type compared to non-drug users 
while Black Caribbeans with drug use were over twice as likely to have an 
episodic course type compared to non-drug users (W: OR 0.326, CI 
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0.097-1.096, p=0.070; BC: OR 2.333, CI 0.638-8.538, p=0.201). Black 
African drug users had equivalent odds to non-drug users for having an 
episodic over a continuous illness course.  
 
When comorbidity was examined, White patients with comorbid 
DUD were also significantly less likely than non-drug users to have an 
episodic course type, whereas Black Caribbean patients with comorbidity 
were 1.3 more likely to have an episodic course type (W: OR 0.290, CI 
0.069-1.216, p=0.090; BC: OR 1.333, CI 0.281-6.325, p=0.717). Black 
Africans with comorbidity had 0.6 the odds of having an episodic course 
type compared with Black African non-drug users (OR 0.600, CI 0.066-
5.447, p=0.650).  However the confidence intervals for odds of the Black 
African and Black Caribbeans with comorbid DUD were very large and 
numbers for Black Africans in both the episodic and continuous groups 
were very small. 
 
It should be noted that numbers in the White and Black African 
groups (specifically for patients with a continuous illness course) were 
very small.  In the drug use adjusted analyses numbers in the depression 
group for diagnoses were very small for White patients and in the alcohol 
analyses several expected counts for White and Black African patients 
were fewer than 52 making it impossible to calculate likelihoods for these 
two groups. Subsequently a summary for the whole sample and for Black 
Caribbeans is given for adjusted analyses for drug use and both 
unadjusted and adjusted analyses for alcohol use. 
 
When the odds for having an episodic course type (see Table 20) 
for the whole sample were adjusted for a priori confounders, patients 
with drug use had equivalent odds to those with no drug use for having 
                                                 
2 There are assumptions and restrictions in the statistical analysis of contingency tables 
which logistic regression analysis is based on. "No more than 20% of the expected counts 
are less than 5 and all individual expected counts are 1 or greater" (Yates, Moore & 
McCabe, 1999, p. 734). In addition Yates, Moore and McCabe suggest that it is acceptable 
to have some expected counts less than 5, provided none are less than 1, and at least 
80% of the expected counts are equal to or greater than 5. 
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an episodic vs. a continuous illness course (OR 0.936, CI 0.390-2.245, 
p=0.881).  
 
Patients with a comorbid DUD disorder had slightly higher odds of 
having an episodic course type although these findings had large 
confidence intervals and did not reach significance (OR 1.226, CI 0.429-
3.506, p=0.704).   
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Table 18: Relationship between course type and drug use 
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CI, confidence interval  
a By study centre:   
London    Episodic  Drug use versus No drug use   Unadjusted OR 1.599 (0.650-3.931) 
     Comorbid DUD versus No drug use  Unadjusted OR 0.926 (0.316-2.715) 
   Neither  Drug use versus No drug use   Unadjusted OR 0.565 (0.236-1.349) 
     Comorbid DUD versus No drug use  Unadjusted OR 1.100 (0.453-2.672) 
Nottingham  Episodic  Drug use versus No drug use   Unadjusted OR 0.234* (0.055-0.999) 
Comorbid DUD versus No drug use  Unadjusted OR 0.303 (0.051-1.805) 
Neither  Drug use versus No drug use   Unadjusted OR 0.238* (0.057-0.998) 




Table 19: Relationship between course type and alcohol use 
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Table 20: Relationship between course type and drug use 
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Table 21: Relationship between course type and alcohol use 
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CI, confidence interval. 
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When Black Caribbeans were examined separately drug users and 
patients with comorbidity had nearly double the likelihood of having an 
episodic course type (Drug use: OR 2.443, CI 0.584-10.226, p=0.221; 
Comorbid DUD: OR 1.737, CI 0.309-9.759, p=0.531), although, as with 
the unadjusted odds, these findings should be treated with caution as the 
confidence intervals for both groups were very wide.  
 
Next the relationship between course type and alcohol use was 
analysed (see Table 19). In the whole sample alcohol users had an only-
slightly-elevated likelihood of having an episodic course type over a 
continuous one compared with non-alcohol users (OR 1.136, CI 0.444-
2.904, p=0.790) while those with comorbidity had considerably less odds 
compared with non-alcohol users of having that type of illness course (OR 
0.462, CI 0.144-1.483, p=0.194). This pattern was almost identical when 
Black Caribbeans were examined separately.   
 
All patients with alcohol use had half the odds of having a neither 
illness course compared with patients that hadn’t used alcohol and 
patients with comorbid AUD were 0.3 less likely to have a neither 
episodic or continuous course type (Alcohol use: OR 0.514, CI 0.222-
1.189, p=0.120; Comorbid AUD: OR 0.368, CI 0.135-1.004, p=0.051).   
 
When Black Caribbeans were looked at separately a similar pattern 
for patients with comorbidity was found,  However, patients with alcohol 
use had an even lower likelihood than the whole sample of having a  
neither illness course compared with patients with no alcohol use (OR 
0.293, CI 0.082-1.051, p=0.060). 
 
When odds ratios for alcohol use were adjusted (Table 21) for then 
those patients with alcohol use retained their slightly higher odds for 
having an episodic course type (OR 1.227, CI 0.432-3.483, p=0.701) 
while those with comorbid AUD were 0.7 less likely to have an episodic 
course type (OR 0.758, CI 0.207-2.772, p=0.676).  
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The adjusted odds of patients with alcohol use and comorbid AUD 
for having a neither episodic nor continuous illness course were similar to 
the unadjusted odds, with patients in both groups having approximately 
half the likelihood of those with no alcohol use (Alcohol use: OR 0.502, CI 
0.206-1.221, p=0.129; Comorbid AUD: OR 0.407, CI 0.141-1.178, 




8.5.2 Relationship between comorbidity and psychotic episodes 
For patients that had an episodic or neither episodic nor continuous 
illness course type rates of psychotic relapse were calculated. As we can 
see from Figure 14 the frequency of psychotic episodes for the whole 
sample was over-dispersed with patients that had no additional episode 
of illness, meaning that non-parametric tests for samples without normal 
distribution were used to explore differences between ethnic groups and 
risk factors for having high frequency of relapses.  
 
The number of relapses patients had ranged from 0-12, with the 
majority having fewer than 3 episodes of illness. A Kruskal-Wallis ANOVA 
was conducted to compare the average number of psychotic episodes in 
each ethnic group. As we can see from Table 22 no significant differences 
in the frequency of psychotic relapse was found between the three ethnic 
















As we can see from Figure 14 the data for patients with an episodic 
or neither course type had an over dispersion of zeros and was not 
normally distributed. This type of data would normally require a negative 
binomial regression (Cameron, 2009)3. In addition to over dispersion of 
zeros, inequality between the conditional means and conditional 
variances are another reason for using negative binomial regression.  
 
When conditional means and variances were explored (see 
appendix 3) the differences were found to be minimal. Added to which, 
because the sample size was slightly smaller than it was in the other 
regression analyses4 (due to the exclusion of patients with a continuous 
course type) risk for psychotic relapse was calculated using poisson 
regression.  
 
                                                 
3 Zero inflated regression analyses are also advised for when dealing with over-dispersion 
of zeros; however this is reserved for data which generate more than one type of ‘zero’. 
4 The UCLA Statistical Consulting Group does not recommend using Negative Binomial 
Regression analyses for small sample sizes. 
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Despite finding no difference in the average number of relapses 
between the three ethnic groups, there were several differences in the 
rates of psychotic relapse by ethnic group.  When the sample was looked 
at as a whole the risk factor for having more psychotic relapses were 
equivalent in patients with drug use and comorbid DUD compared to 
patients that didn’t have drug use. However, when each ethnic group was 
looked at separately different patterns of risk emerged despite numbers 
in the Black African group being too small to explore.  
 
Table 23 shows rates of relapse for drug users compared to non-
users where slightly higher in the White group and slightly lower in the 
Black Caribbean group although these findings didn’t reach statistical 
significance. Moreover, White patients had much lower rates of relapses if 
they had a comorbid DUD (RR 0.389, CI 0.169-0.897, p=0.027), whereas 
Black Caribbeans with comorbid DUD had nearly twice the rate of relapse 
compared to those with no drug use (RR 1.901, CI 1.052-3.434, 
p=0.033).  
 
After adjustment (Table 23), these patterns were retained with 
only a slight reduction in rate ratios for those in the Black Caribbean 
group (White: RR 0.367, CI 0.153-0.879, p=0.024; Black Caribbean: RR 
1.654, CI 0.610-4.488, p=0.323).When rates of relapses were looked at 
for alcohol use a completely different pattern was observed.  
 
In the whole sample patients with alcohol use and comorbid 
alcohol use (Table 24) had slightly lower rates of relapse compared to 
non-alcohol users (Alcohol use: RR 0.656, CI 0.437-0.986, p=0.043; 
Comorbid AUD: RR 0.754, CI 0.422-1.345, p=0.339). White patients had 
slightly higher rates of relapse if they had comorbid AUD.  However, both 
Black Caribbean and Black African patients had half the rate of risk for 
psychotic episodes if they had either alcohol use (BC: RR 0.545, CI 
0.292-1.020, p=0.058; BA: RR 0.655, CI 0.334-1.283, p=0.217) or 
comorbid AUD (in just the Black Caribbean group) (RR 0.593 CI 0.228-
1.542, p=0.284). 
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When rate ratios were adjusted for a priori confounders these 
patterns were roughly retained (Table 24).  However, rates in the White 
group for both drug use and comorbid DUD were slightly more elevated 
and rates in Black Caribbean drug users and Black Africans with 
comorbidity were even lower, while also reaching statistical significance 
(BC drug use: RR 0.361, CI 0.196-0.668, p=0.001; BA Comorbid DUD: 
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CI, confidence interval.  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre:   
London   Drug use versus No drug use   Unadjusted RR 0.939 (0.599-1.473) 
   Comorbid DUD versus No drug use  Unadjusted RR 0.974 (0.521-1.822 ) 
 Nottingham Drug use versus No drug use   Unadjusted RR 1.134 (0.604-2.128) 
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CI, confidence interval.  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre:  
London   Alcohol use versus No alcohol use   Unadjusted RR 0.513* (0.322-0.815) 
    Comorbid AUD versus No alcohol use  Unadjusted RR 0.612 (0.297-1.260) 
  Nottingham Alcohol use versus No alcohol use   Unadjusted RR 1.268 (0.604-2.665) 







When we take the findings from both sections 8.4.1 and 8.4.2 
together and look at them in relation to the second hypothesis (whether, 
regardless of ethnic group, comorbidity was negatively associated with 
psychotic relapse), we find that comorbidity is associated negatively with 
psychotic relapse but that the relationship differs in strength by ethnic 
group. Contrary to what was expected, these findings show that: 
 The likelihoods of having either an episodic course or a neither 
episodic nor continuous course type are lower for the whole 
sample, White and Black African patients with drug use and 
comorbid drug use disorders, yet higher in Black Caribbean 
patients with drug use and comorbid drug use disorders. 
 Although adjusted findings for White and Black African patients 
were not possible we can see that findings for the whole sample 
are drastically changed (increased likelihood of an either or neither 
course type in the comorbid group) when other sociodemographic 
and clinical variables are held constant. Black Caribbeans retain 
their increased likelihood. 
 When the full samples of patients and Black Caribbean patients 
only were looked at those with a comorbid alcohol use disorder are 
around half as likely to have an episodic or neither course and 
these likelihoods are roughly retained when a priori confounders 
are adjusted for. 
 For patients that have a non-continuous type illness course, the 
average number of psychotic episodes was similar in all three 
ethnic groups.  However, Black Caribbeans with comorbid drug use 
disorders have higher risk of more frequent relapses, while Whites 
with comorbid drug use disorders have lower risk. 
 The opposite is observed for Black Caribbean and White patients 
with alcohol use disorders. 
 Black Africans with comorbid alcohol use disorder have an even 




8.6 RELATIONSHIP BETWEEN COMORBIDITY AND 
HOSPITALISATION 
 
The second hypothesis for the quantitative investigation was 
concerned with the relationship between comorbidity and hospitalisation. 
It was hypothesised that comorbidity, irrespective of ethnic group, would 
be associated with more compulsory admissions. To give this 
investigation context, differences in the number of hospital admissions 
was examined first.  
  
 
8.6.1 Relationship between comorbidity and frequency of hospital 
admissions 
The median number of hospital admissions over the follow-up 
period was 2 (Range 0–14) for White British patients, 3 (Range 0–20) for 
Black Caribbean patients and 2 (Range 0–15) for Black African patients 
(see Figure 15 and Table 25). As with the analyses above, two three-level 
variables (one for drugs and one for alcohol) were used as the predictor 
for frequency of hospital admission, using ‘no use’ as the reference group 
for all analyses.  
 
Exploratory analyses were conducted to make sure the data met 
the criteria for poisson regression analyses. The data had an over-
dispersion of zeros and was not normally. When the conditional means 
and conditional variances were examined (see Appendix 3) it was found 
that they differed considerably from each other. Given that there was a 
sample size of nearly 300 cases, negative binomial regression analyses 
was used to estimate rate ratios for frequency of hospital admissions in 
people with drug and alcohol use. This regression analyses uses the same 
statistical structure as poisson regression, but allows for over-dispersion 
of zeros in the data. 
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Table 26 shows the rate ratios (RR) for having a high frequency of 
hospital admissions over the follow-up period if you have a comorbid 
drug use disorder. When the sample was looked at as a whole patients 
with drug use had roughly equivalent rates of hospital admissions to 
those who hadn’t used drugs in their lifetime before, although the rates 
were slightly lower after adjustment for confounders (RR 0.896, CI 
0.680-1.181, p=0.437). Patients with a comorbid drug use disorder, at 
just over 1.3 times the rate of non-drug users, were significantly more 
likely to have more hospital admissions (RR 1.365, CI 1.038-1.795, 
p=0.026).  
 
A similar pattern was uncovered after adjustment of confounders 
(RR 1.288, CI 0.952-1.742, p=0.100). Stratified unadjusted analyses 
were performed for rates of hospital admissions by study centre. Rates 
for hospital admissions for the London and Nottingham centres were 
examined separately. Patients in the London sample with comorbidity had 
similar rates to non-drug users however in the Nottingham sample 
patients with comorbidity had nearly twice the risk for high frequency of 
admissions (London: RR 1.164, CI 0.834-1.624, p=0.371; Nottingham: 
















Figure 15: Total number of hospital admissions at follow up by 
ethnic group                           
 
 
Next, the likelihood for having more hospital admissions over the 
follow-up was estimated for each ethnic group (see Table 26). In the 
White British group, those with drug use and those with a comorbid DUD 
(when compared to those with no use) were significantly more likely to 
have more hospital admissions (Drug use: RR 1.518, CI 1.074-2.145, 
p=0.018; Comorbid DUD: RR 1.387 CI 0.939-2.051, p=0.101).  
 
When rate ratios were adjusted for only the patients with drug use 
retained higher rates of hospital admissions (Drug: RR 1.268, CI 0.862-
1.864, p=0.228; Comorbid DUD: RR 1.079, CI 0.692-1.685, p=0.736). 
Black Caribbeans with drug use had 0.6 the risk for frequent hospital 
admissions while patients with comorbidity had around 1.6 the risk 
compared with non-drug users. These rate ratios held when a priori 
confounders were controlled for (Drug use: RR 0.670, CI 0.415-1.081, 
p=0.101; Comorbid DUD: RR 1.636, CI 0.983-2.722, p=0.058).  
 
Black Africans also had a different pattern of rate ratios from the 
whole sample. The unadjusted rates for both drug users and those with 
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comorbidity were lower than for patients that didn’t use drugs (Drug use: 
RR 0.680, CI 0.290-1.590, p=0.373; Comorbid DUD: RR 0.566, CI 
0.236-1.358, p=0.203). When other confounders were adjusted for these 
rate ratios increased making them similar to patients who didn’t use 
drugs (Drug use: RR 0.790, CI 0.326-1.916, p=0.602: Comorbid DUD: 
RR 0.755, CI 0.314-1.818, p=0.531).   
  
The rates for high frequency of hospital admission when a patient 
had an alcohol use disorder were also mixed (see Table 27). When 
analyses focused on the whole sample both patients with alcohol use and 
alcohol use disorders had a lower risk for having lots of hospital 
admissions than patients who had never used alcohol in their lifetime 
before follow-up and after adjustment for confounders these rates were 
maintained (Alcohol use: RR 0.699, CI 0.524-0.933, p=0.015; Comorbid 
AUD: RR 0.757, CI 0.520-1.100, p=0.144).  
 
Stratified analyses were again performed for unadjusted rate 
ratios. Patients with comorbid AUD (as with alcohol use) from the London 
study centre had lower rates of hospital admissions compared to non-
drug users, while patients recruited from the Nottingham centre had 
higher rates of risk (London Comorbid AUD: RR 0.740 CI 0.491-1.116, 
p=0.151; Nottingham Comorbid AUD: RR 1.432, CI 0.661-3.103, 
p=0.363).  
 
Rates varied by ethnic group. White patients who used alcohol or 
who had an alcohol use disorder had significantly higher rates (compared 
to patients who had never used alcohol) for having had frequent 
admissions over the follow-up (Alcohol use: RR 1.614, CI 0.928-2.807, 
p=0.090; Comorbid AUD: RR 1.938, CI 1.037-3.625, p=0.038). Although 
rates remained higher for these two groups after adjustment the 
difference in rate ratios compared to non-alcohol users did not reach 
significance (Alcohol use: RR 1.498, CI 0.850-2.640, p=0.163; Comorbid 
AUD: RR 1.623, CI 0.839-3.140, p=0.150).  
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Black Caribbean and Black African alcohol users both had around 
0.6 the risk of non-users for having more hospital admissions which 
remained the same after adjustment. Black Caribbeans with comorbid 
alcohol use had around 0.7 the risk for high frequency of hospital 
admissions compared to non-users after adjustment (RR 0.680, CI 
0.391-1.183, p=0.172), however, with a rate ratio of just 0.1, an even 
lower rate was observed in Black Africans with comorbidity after  
adjustment (RR 0.147, CI 0.029-0.748, p=0.021).
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CI, confidence interval.  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre: 
London   Drug use versus No drug use   Unadjusted RR 0.842 (0.610-1.163) 
   Comorbid DUD versus No drug use  Unadjusted RR 1.164 (0.834-1.624)  
 Nottingham Drug use versus No drug use   Unadjusted RR 1.138 (0.740-1.751) 
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CI, confidence interval  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre:  
London   Alcohol use versus No alcohol use   Unadjusted RR 0.617* (0.450-0.844) 
   Comorbid AUD versus No alcohol use  Unadjusted RR 0.740 (0.491-1.116)  
 Nottingham Alcohol use versus No alcohol use  Unadjusted RR 1.461 (0.766-2.786) 











8.6.2 Relationship between comorbidity and compulsory 
admission 
This section is concerned with unveiling the patterns of compulsory 
admission and therefore relates to the focus of the second hypothesis. As 
we saw in the previous section rates of hospital admission varied by 
ethnicity with rates in most groups actually being lower for patients with 
comorbidity; with the exception of Black Caribbean patients with 
comorbid drug use disorder and White patients with comorbid alcohol use 
disorder, where risk was higher than non-users. 
 
For patients who had had at least one admission the number of 
those admissions that were under section on admission was calculated. A 
binary variable was created with patients who had no compulsory 
admissions scored as ‘0’ and patients who had at least one compulsory 
admission scored as ‘1’. Binary logistic regression was used to explore 
the relationship between patients that had at least one compulsory 
admission and substance use. 
 
All patients with drug use were 1.5 times more likely and patients 
with comorbid drug use disorders were over 2.5 times more likely to have 
had a compulsory admission over the follow-up compared to patients 
with no drug use (Table 28). After adjustment for a priori confounders 
these likelihoods were only slightly decreased (Drug use: OR 1.457, CI 
0.739-2.872, p=0.277; Comorbid DUD: OR 2.270, CI 1.003-5.135, 
p=0.049).  
 
As above, stratified analyses were conducted. With odds of roughly 
1.5 of those of non-drug users, patients with drug use in both the London 
and Nottingham sample and comorbid drug use disorder in the London 
sample were more likely to have had a compulsory admission. However, 
patients with comorbidity in the Nottingham only sample were over four 
times more likely to have had a compulsory admission (OR 4.875, CI 
1.400-16.973, p=0.013). This was statistically significant, although 
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caution should be taken with this interpretation as the confidence 
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CI, confidence interval.  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre: 
London   Drug use versus No drug use   Unadjusted OR 1.442 (0.614-3.391) 
       Comorbid DUD versus No drug use  Unadjusted OR 1.607 (0.650-3.973)  
 Nottingham Drug use versus No drug use   Unadjusted OR 1.517 (0.577-3.987) 
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CI, confidence interval.  
aAdjusted for age, gender, diagnosis and study centre. 
bBy study centre:  
London   Alcohol use versus No alcohol use   Unadjusted OR 0.552 (0.224-1.358) 
   Comorbid AUD versus No alcohol use  Unadjusted OR 2.023 (0.480-8.521)  
 Nottingham Alcohol use versus No alcohol use   Unadjusted OR 1.734 (0.449-6.695) 
Comorbid AUD versus No alcohol use  Unadjusted OR 2.000 (0.384-10.409) 
*p<0.05   
 254 
When likelihood of compulsory hospital admission was examined 
by ethnic group even more elevated likelihoods for compulsory admission 
were found.  White patients with drug use were more than two times 
more likely and White patients with comorbid drug use disorders were 
more than four times more likely than non-drug users to have had a 
compulsory admission. These likelihoods held after confounders were 
adjusted for (Drug use: OR 2.381, CI 0.931-6.092, p=0.070; Comorbid 
DUD: OR 4.435, CI 1.398-14.062, p=0.011), however the confidence 
levels for both findings were very wide. 
 
Similarly, Black Caribbeans with drug use were roughly 2.6 times 
as likely and Black Caribbeans with Comorbid DUD were 3.4 times as 
likely to have had a compulsory admission compared to non-drug users. 
After adjustment the likelihood for drug users was around three fold and 
the likelihood for patients with comorbidity was four and a half times the 
odds of non-drug users (Drug use: OR 3.103, CI 0.699-13.773, p=0.136; 
Comorbid DUD: OR 4.564, CI 0.747-27.886, p=0.100). 
 
For Black Africans the likelihoods for compulsory admission were 
very different. Drug users were 0.34 times less likely to have had a 
compulsory admission over the follow-up (OR 0.348, CI 0.047-2.576, p= 
0.301) and after adjusting for a priori confounders this decreased to 0.24 
(OR 0.247, CI 0.023-2.664, p=0.249). For Black African patients with a 
comorbid DUD the likelihoods of having a compulsory admission were 
even less at 0.26 the odds of non-drug users (OR 0.261, CI 0.033-2.089, 
p=0.206) and after adjustment this reduced to 0.1 the odds of non-drug 
users (OR 0.117, CI 0.009-1.602, p=0.108).  
 
Patients who had alcohol use disorders were then investigated 
(Table 29). Firstly the whole sample was looked at.  Patients with drug 
use were 0.6 less likely to have had at least one compulsory admission 
whereas patients with comorbid AUD were 1.4 times more likely (OR 
1.414, CI 0.535-3.740, p=0.485) than those who had never used alcohol.  
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After adjusting for a priori confounders the likelihood for drug 
users remained (OR 0.649, CI 0.303-1.388, p=0.265), however the 
likelihood for patients with comorbidity was reduced to being almost 
equivalent to that of non-alcohol users (OR 1.129, CI 0.394-3.238, 
p=0.821).  
 
When stratified analyses were conducted the odds for having a 
compulsory admission in patients with comorbidity in both the London 
and Nottingham samples were twice that of patients that hadn’t used 
alcohol.  However, the odds for alcohol users in the London sample were 
0.5 of non-alcohol users (OR 0.552, CI 0.224-1.358, p=0.196) and 1.7 in 
the Nottingham sample (OR 1.734, CI 0.449-6.695, p=0.424). 
 
Numbers in the Black African group were too small to perform 
analyses and analyses for White patients and Black Caribbean patients 
were conducted separately. White patients with alcohol use were more 
than twice as likely to have had a compulsory hospital admission 
compared with non-alcohol users, while those with comorbidity were 4.5 
times as likely. After adjustment alcohol users had similar odds but 
patients with comorbidity had slightly reduced odds (Alcohol use: OR 
1.925, CI 0.527-7.031, p=0.322; Comorbid AUD: OR 3.340, CI 0.673-
16.581, p=0.140).  
 
Conversely, Black Caribbean drug users had a lower likelihood for 
compulsory admission (OR 0.617, CI 0.152-2.501, p= 0.499) and this 
decreased after confounders where adjusted for (OR 0.399, CI 0.091-
1.755, p=0.224). Black Caribbean patients with comorbidity were 1.4 
times more likely to have had a compulsory admission compared to Black 
Caribbean patients that never used alcohol. However this was reduced to 
equal odds with non-alcohol users after adjustment (OR 0.998, CI 0.134-
7.419, p=0.998) although the result was not statistically significant and 
had wide confidence intervals. 
 
In summary, the findings above show that the average number of 
hospital admissions differed between White, Black Caribbean and Black 
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African patients. With the exception of Black Africans, who had lower 
rates, patients with comorbidity had higher rates of hospital admissions 
than patients with no drug use. Although only Black Caribbean patients 
with comorbidity had higher rates after other sociodemographic and 
clinical variables were held constant. When looking at alcohol use 
disorders only White patients have higher rates of hospital admission 
compared to patients that had never used alcohol and Black African 
patients with comorbidity had significantly lower rates of hospital 
admissions.  
 
In terms of the PhD research question, which hypothesised that 
regardless of ethnicity patients with comorbidity would have more 
compulsory admissions, it is clear from the above evidence that having a 
compulsory admission was significantly more likely in drug users as well 
as patients with comorbidity. However, as with other evidence, this was 






As the findings above confirm, the hypothesis that the prevalence of 
comorbid substance use disorder in individuals with an eight year history 
of psychosis will differ according to ethnic group and that the prevalence 
of comorbidity will be higher in Black Caribbean, and lower in Black 
African, patients compared to White patients was only partially accepted 
when drug use disorders and alcohol use disorders were examined.  
 
There was significantly less drug and alcohol use, as well as drug 
and alcohol use disorders in Black African patients compared to Whites 
and Black Caribbeans. Black Caribbeans did not have an increased 
prevalence of drug or alcohol use disorders.  
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Slightly lower rates of drug use and drug use disorders were found 
in Black Caribbean patients compared to White patients. This finding is 
similar to that of Cantwell et al., (1999), however prevalence was rates 
were only marginally lower and these did not reach statistical 
significance. These findings may be explained by changing patterns in 
types of drugs used or alternatively by an increase in overall drug use 
disorders in psychiatric patients from a Black Caribbean ethnicity, which 
was estimated in UK studies in the late nineties and early 2000s at six to 
seven percent (Cantwell et al., 1999; Miles et al., 2003) but was found to 
be forty percent in this study. Moreover, it is interesting to note the 
differences in the prevalence of drug use disorders and alcohol use 
disorders in each ethnic group. Similarly to the early Cantwell et al. 
(1999) study, alcohol use was more prevalent in White patients and the 
likelihood for using alcohol and having an alcohol use disorder was 
considerably higher in White patients. 
 
Although this study sought to test ‘true’ comorbidity (i.e. the 
presence of a diagnosable substance use disorder in addition to a 
diagnosis of a psychotic disorder), it was useful to separate out substance 
users from those that had substance abuse or dependence.  
 
In relation to the second hypothesis (whether, regardless of ethnic 
group, comorbidity was negatively associated with psychotic relapse), we 
see that the findings do not support this hypothesis. Despite the finding 
that there wasn’t a higher prevalence of comorbid substance use 
disorders in Black Caribbeans the study did observe increased likelihoods 
for having either an episodic course or a neither episodic nor continuous 
course type in Black Caribbean patients with drug use and comorbid drug 
use disorders although these findings were not statistically significant.  
This finding was not found in patients with alcohol use disorders however.  
 
In addition, Black Caribbeans with comorbid drug use disorders 
were found to have higher rates of psychotic relapses, while Whites with 
comorbid drug use disorders had lower rates of risk. While the opposite is 
observed for Black Caribbean and White patients with alcohol use 
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disorders which may well be explained by increased the likelihood of  
alcohol use and alcohol use disorders in White patients.  
 
Not surprisingly, Black Africans who had a low prevalence of both 
drug and alcohol use disorders had lower rates of psychotic relapse. 
 
The last hypothesis was concerned with service utilisation. The 
average number of hospital admissions that patients had over the follow-
up period differed by ethnic group. Additionally, after key 
sociodemographic and clinical variables were controlled for only Black 
Caribbean patients with comorbid drug use disorders had higher rates of 
hospital admissions than patients with no drug use and this did not reach 
statistical significance.  
 
In line with the other findings in this study it was the White patients 
with comorbid alcohol use disorders that had higher rates of hospital 
admission compared to patients that had never used alcohol and Black 
African patients with comorbidity that had significantly lower rates of 
hospital admissions. This finding is in complete contrast to the 
preliminary findings by, Afuwape et al. (2006) as part of the UK COMO 
study which found higher levels of admissions in Black African patients 
with comorbidity.   
 
With regard to the PhD research question, which hypothesised that 
regardless of ethnicity patients with comorbidity would have more 
compulsory admissions, it was clear from the evidence that having a 
compulsory admission was significantly more likely in drug users as well 
as patients with either type of comorbidity. However, as with other 
evidence, this was not the case for Black African patients who were less 
likely to have had a compulsory admission.  
 
 
The next section of this thesis examines the findings from the 
qualitative arm of the study. I will revisit the findings from this phase of 
the study very briefly in next section. However, a full discussion of the 
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findings in both arms as well as the study limitations will be discussed in 
Chapter 10. 
 
Chapter Summary 8.   
Chapter Summary 
 
Aims of the Chapter: 
 
To summarise and evaluate the findings from Phase One of the study (including 
prevalence , estimates of risk for comorbidity and the relationship between 





 The hypothesis that the prevalence of comorbid substance use disorders 
(SUD) in individuals with an 8-12 year history of psychosis differs 
according to ethnic group and that the prevalence of comorbid substance 
use disorders is lower in Black Africans compared to Whites was 
supported.  
 Findings did not support the hypothesis that the prevalence of 
comorbidity is higher in Black Caribbeans compared to Whites. 
 The second hypothesis that comorbidity is negatively associated with 




CHAPTER 9: PHASE TWO RESULTS 
 
The analytical framework for Phase Two is summarised in more detail 
in Chapter 7. Briefly, themes relating to key areas of interest were 
identified through a process of detailed reading, annotating and 
categorising of interview transcripts and formed the basis of an initial 
coding framework.  The analysis explored relationships between 
categories both within and between transcripts, which allowed differences 
and similarities between respondents from the three ethnic groups to be 
explored, thereby addressing the study research questions.  Analysis was 
aided by use of the computer software package MaxQDA.  The following 
chapter summarises the findings of the qualitative study. Where 
appropriate, brief summaries of each section of findings are given, 
including preliminary discussion of these findings in relation to the 
quantitative study findings. 
 
 
9.1 ADDRESSING THE RESEARCH QUESTIONS 
 
  This phase of the study, aimed to both describe if/how the problem 
of comorbidity differs for ethnic minorities in psychotic populations and to 
identify conceptualisations of illness and substance use. The following 
research questions were investigated: 
 
1) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
‘psychosis’ and drug and alcohol use 8-12 years after their 
first episode?  
2) How do individuals with comorbidity of psychosis and 
substance use disorders construct their experiences of 
mental health and substance abuse treatment services? 
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3) What is the perceived role (if any) of family, friends and 
other social support networks in the treatment process for 
‘psychosis’ and substance use disorder? 
 
Before themes identified in accounts are described and interpreted 
it is important to detail here how the research questions were addressed 
through detailed analyses of the data. It is also important to detail as 
part of addressing the three research questions how patterns and 
typologies were uncovered in the data and in particular how these 
patterns are representative of this small sample of respondents only and 
generalisations beyond that should be made with caution.  
 
 
9.1.1 Describing the sample and interpreting the data 
This chapter is split into three main parts: Describing the 
characteristics of the qualitative sample; describing the devices and 
mechanisms (what the respondents were doing in their accounts) that 
the respondents used to construct their experiences; and describing the 
themes (what the respondents were saying in their accounts) that 
respondents used to construct their experiences. 
 
Describing the sample and its characteristics is the first sub-section 
in the main body of the findings of the qualitative study. Here a summary 
of the sociodemographic and clinical characteristics of AESOP patients 
who were identified as eligible for the qualitative study is given as well as 
the number and type of subsequent exclusions that were made. Next, the 
chapter moves onto a description of the devices and mechanism that the 
respondents in the final qualitative sample used to describe their 
experiences and ultimately show us ‘how’ they gave their account and 
constructions. The final part of the chapter summarises the themes that 
became apparent after detailed analyses of the content of the accounts, 
as well as a discussion of the relationships (typologies) between the 
account themes and the respondents sociodemographic and clinical 
 262 
characteristics (and other categorical descriptors used to create 
typologies).  Finally interpretation of the account devices, themes and 
typologies are discussed in relation to the research questions and findings 
from phase one of the PhD study. 
 
 
9.1.2 Answering the ‘how’. 
‘How’ respondents constructed their experiences has been 
addressed in two ways; the first part of addressing the ‘how’ was to 
describe the more latent (see section 7.2) aspects of how people with a 
long history of psychosis and substance use disorders construct their 
experiences. The ‘how’ is described in terms of the mechanisms and 
devices which respondents use to describe their experiences. They are an 
analysis of what people are doing in an account rather than just what 
they are saying (Silverman et al., 1993).  In other words uncovering the 
frameworks which they use to create their account not only lends toward 
a better understanding of how accounts are created but also serves as 
foundational elements in attempt understand the content of the accounts 
(what they are saying).  
 
The second part of addressing the ‘how’ in how individuals 
construct their experiences involve looking at the content of the 
accounts; finding similarities in categories and themes themselves and 
then by  the characteristics of the respondents. This is uncovering what 
people are saying in their account, (what their constructions are rather 
than how they do it) and comprises both the latent and manifest aspects 
of talk.  
 
 
9.1.3 Interpreting talk: Creating themes 
The topic guide was semi-structured;  a list of questions was used 
to guide the interview, but there was room for  follow-up or probing 
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questions when respondents appeared unable (through lack of recall) or 
unhappy (through lack of rapport or embarrassment) to give detailed 
answers, as well as to  encourage elaboration of interesting comments.  
 
Broadly, these questions were asked of all respondents: 
 How respondents defined their ethnicity 
 What had lead them to make contact with mental health services 
the first time 
 Whether they had experienced any difficulties around that time 
 Whether their family or friends were involved in their contact with 
mental health services 
 How they felt when they experienced those difficulties 
 Did they think they needed help 
 When did they first start using drugs or alcohol 
 Have they ever used substances more or less frequently and why  
 What were their experiences of mental health services or drug 
treatment services 
 Did the respondent find mental health services/drug treatment 
services involvement useful 
 
Additional follow-up questions were asked to gauge more detail of 
events and perceptions. Below is an example of how an initial question 
(asking whether the respondent was put on a section during his first 
admission to a mental health hospital) lead to further questioning (using 
probes, prompts and encouragement) on the details of that admission: 
 
QS3 Lines 222-241 (Male, White) 






Resp: It was just standard stuff of you know first week or what have you in the 
… and stuff like that so. 
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Resp: It was it was it was quite full on. 
 
Int: How do you mean? 
 
Resp: Well it was going into, into, into a you know an admissions ward where 
there were people there that were ill and stuff and they’ve got different 
issues and so it was quite a quite a and living there for three months you 
know it was quite a quite a unusual experience at first but you get used 
to it and I and I started getting back to being myself again you know and 
gradually little bits were coming out and I was like you know everyone 




Resp: Got on well with most people and stuff. 
 
Int: Did your mum come and visit you regularly? 
 




Resp: Yeah you know and I remember the first day going out you know well the 
first the first step was the step of leaving the ward on my own was just to 




Resp: And get a drink and then come back and stuff that was the first sort of 
step and. 
 





The topic guide also allowed the researcher flexibility to adopt the 
respondents’ language to clarify questions as well the flexibility to use 
other forms of questioning to illicit accounts about events that were 
sensitive (e.g. asking questions about criminal activity).   
 
The above extract is an example of how it was not always 
appropriate to map categories and themes onto the interview questions 
(for example mapping this extract to a theme called ‘experience of first 
contact with services’).  This extract of data as well as other contextual 
data relating to the experiences of this respondent’s first admission 
(either located immediately around this extract or elsewhere in the 
account) can be used to create several themes.  These include: 
experiences of hospitalisation; involvement of family members during the 
treatment process; perceptions of similarities and differences between 
the respondent and other patients; and mastery in the treatment 
process.  
 
As with normal organic talk people tend to elaborate or shut down 
to questions and often construct answers in a way that makes sense to 
them and not necessarily in the same way that the questioner has 
conceptualised or asked the questions. In addition, as we discussed in 
Chapter 7 salient themes can be disentangled from the latent aspects of 
talk, giving us hints and signs about how people frame their experiences 
and the world in general.  
 
With that in mind, the categories and themes created from each 
stage of the analyses bear more relationship to the content of the 
interviews (the data) than the interview topic guide (the instrument used 
to collect the data). In this way categories and themes correlate more 
closely with the interviewees conceptualisations of the world and not the 
interviewer’s pre-conceptions of illness experience which will no doubt be 




9.1.4 Prompts, probes and encouragement 
Prompts, probes and encouragement are features of semi-
structured interviewing as was touched on in section 5.7. They are 
considered common processes in conducting interviews and the 
significance of them is arguably overlooked in the analysis of interview 
accounts. It was evident from the interview data for this study that not 
only were prompts and probes used but they were needed to open up 
discussion points and elicit more detail. However, they went toward 
creating and reinforcing many of the account mechanisms used in the 
interviews and themes elicited from the accounts. In other words, they 
example how ‘an account’ is a co-creation between interviewer and 
respondent.  
 
While the account mechanisms and themes described below are 
those often created by respondents who were trying to construct 
experiences of illness, drug use and treatment (or more accurately this 
group of respondents) and on many occasions came in the form of 
detailed and coherent talk (i.e. there was no or limited need for prompts 
and probes), they were also an illustration of account giving which was 
more heavily directed by the interviewer (i.e. prompts and probes were 
required to expand talk). Unprompted responses can be considered to be 
more accurate constructions of events than those given in response to an 
interviewers questioning (National Institute of Justice, 2013).  
 
In addition, distinguishing between prompted and unprompted 
responses can be a useful way of determining what is ‘most’ salient to 
the interviewee as was demonstrated in a New Zealand Ministry of Health 
commissioned study investigating youth knowledge and attitudes towards 
mental illness where they categorised ‘top of mind’ responses from 
prompted responses (Fearne et al., 2006). 
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The discussion of the account themes that form the body of the 
results section for this arm of the study includes examples in both these 
two instances and so can, albeit crudely, grouped into ‘prompted’ and 
‘unprompted’ themes. Prompted responses were considered to be 
responses to direct questioning about a topic. Unprompted responses on 
the other hand were responses that occurred when the respondent was 
giving descriptions of events or perceptions that did not directly relate to 
the preceding question or could be considered additional information. 
When estimations of prompted and unprompted forms of themes have 
been given these are based on the primary (the first instance the 
thematic response was elicited in the account) responses of the 
respondent (respondents often gave prompted and unprompted 
responses on the same topic within their account). In this way we can 




9.1.5 Creating typologies: Uncovering the different roles of the 
social actor 
As discussed in Chapter 7 part of qualitative analysis is uncovering 
patterns in the data. This can be done using quasi-statistical methods 
Dey (1993). The qualitative computer analysis package MaxQDA was 
helpful for this very purpose. Along with the typical a priori variables of 
interest (for example gender and ethnicity) other categorical variables 
were created from codes that were used to describe categories and 
themes. These variables were then used to generate frequencies and 
even to cross-tabulate categorical variables with sample characteristics. 
The categorical variables where then used to explore connections within 
the data (Dey, 1993).  This formed the basis of identifying typologies 
within the data.  
 
It should be noted that the numbers in the final sample were far too 
small to perform formal statistical tests such as chi square, however 
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summarising the frequency in which a theme was used by respondents 
with particular characteristics can give us a picture of how certain types 
of respondents construct illness and drug use experiences in certain 
ways. As well as gender and ethnicity, variables used in the first arm of 




 Type of substance use disorder 
 Whether the patient was in remission from their first episode 
 Whether the patient had had a compulsory admission to hospital 
 
The variable ‘family history’ (whether a respondent described in their 
account having a family member who had experiences and/or been 
treated for a mental health problem) was also noted and used as a 
variable for comparison.  In addition to the above sample characteristics 
there were several themes that emerged within accounts during the 
analyses that subsequently became categorical variables. These 
categorical variables related to the roles within which the respondents 
put themselves during the interview and provided additional 
characteristics with which comparisons could be made.  
 
 
9.1.5.1 I have a mental illness 
 
The first theme that was used to create typologies of constructions 
of illness, substance use and experiences of treatment services was 
related to whether respondents (despite having a psychiatric diagnosis) 
felt they had a mental illness.  One of the primary aims of the qualitative 
study and the first research question was how people with comorbidity 
construct their experiences of psychosis. This question, in part, relates to 
whether people with comorbidity categorise their experiences as a mental 
disturbance or if they use another framework of understanding. The term 
‘experiences’ which was used during the interview, was considered more 
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neutral than ‘mental illness’ and allowed respondents to identify their 
experiences using a broader framework than that of psychiatry.  
 
Further unpacking of what respondents believed constituted ‘a 
mental illness’ is looked at in the main body of the results, but here this 
theme around whether a respondent saw themselves as having a mental 
illness or not was used to crudely categorise respondents. The category ‘I 
have a mental illness’ (along with the categories described below) was 
useful for looking at patterns of constructions between different types of 
respondents (for example whether respondents who constructed their 
experiences as a mental illness were more prominent in a particular 
ethnic group or whether drug use as a cause of experiences was found 
more frequently in respondents who did not see their experiences as a 
mental illness). 
 
Respondents were directly asked during the interview if they felt their 
experiences constituted a mental illness. A number of respondents also 
gave unprompted indications of whether they constructed their 
experiences in that way. Both types of responses where coded as either 
viewing themselves as having a mental illness or not.  
 
Additionally, using the lexical search function in MaxQDA, instances 
where terms such as ‘mental illness’, ‘depression’, ‘breakdown’ and all 
other terms used by respondents to describe their experiences (see 
section 9.4.1.1) were found and coded (including the relevant talk around 
the term) into one of these two categories if appropriate.  Because 
counting instances of the appearance of a code is a crude way to 
measure subjective construction, and for additional accuracy, each coded 
segment (both prompted and unprompted responses as well as coded 
segments from the lexical search) was reviewed a second time and then 
each respondent was categorised as falling primarily into one of three 
category levels (I did not have/do not have a mental illness; I have/had a 
mental illness; or undefined) using two criteria:  
1) the number of instances each category level appeared in an 
account (using the ‘transform code into categorical variable’ 
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function in MaxQDA which transforms sub themes under a larger 
theme into levels of a categorical variable and then counts 
instances each level appears in the whole document) and which 
category level had majority and;  
2) the overall impression of ‘self’, ‘mental illness’ and construction of 
experiences given by the respondent in the account as a whole. 
Thirty-seven percent of respondents gave an overall construction 
of their experiences as having had a mental illness or that they 
currently had a mental illness.  
 
QS19 Lines 601-605 (Male, Other) 
Int: Well the question was do you think it is an illness?  So do you think 




Int: You do? 
 
Resp: Yeah because I don’t know what dementia is but I think it could be like 
similar to dementia.   
 
The respondents that were categorised as ‘undefined’ gave mixed 
or incoherent conceptualisations of their experiences in relation to mental 
health. Or as is evident in the following extract a response of not having 
a perception. 
 
QS12 Lines 273-277 (Male, Black African) 
Int: Did you, at the time when you went into hospital, did you feel that you 
had a mental illness?  Or what did you feel was wrong? 
 




Resp: No.  Never made any sense when I was thinking about it.  I never really 
thought about it as such. 
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Table 30: Perceptions of mental illness experiences 
  
 n % 
Perception of experiences (n=19)   
I did not have/do not have a mental illness 










A number of respondents (n=3) who did not believe they had a 
mental illness did however believe that they had been suffering from 
depression (which was not considered to be a mental illness). 
  
 
9.1.5.2 I have a problem with substances 
 
The second theme that was used as a categorical variable was 
whether a respondent felt they had a problem with substances. This 
theme was not as clear cut as the above theme as ‘problem’ could be 
defined in many ways including: 
 the frequency with which a substance was used,  
 the amount that was used when using,  
 any withdrawal problems encountered when not using the 
substance 
 any problems with the law or social relationships as a 
consequence of using a substance 
 simple ‘addiction’ which may have included some or all of the 
above (the concept of addiction is unpacked in more detail in later 
sections) 
 
One of the other primary aims of the qualitative study was to 
uncover how people with comorbidity construct their experiences of 
substance use. This question, in part, relates to whether people with 
comorbidity categorise their use as acceptable or as a cause for concern 
for either themselves or others around them. This theme, turned 
categorical variable, was used as a respondent characteristic to highlight 
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patterns and relationships between types of respondents and themes 
used in accounts. 
 
Respondents were directly asked during the interview if they felt 
they had a problem with each of the substances they talked about during 
the course of the interview or if they had ever sought help for their 
substance use.  In addition a number of respondents gave unprompted 
indications of whether they constructed their substance use as having 
been or currently being problematic. Both types of responses where 
coded as either viewing themselves as having a problem with at least one 
substance or not. The same process that was detailed above (for mental 
illness) was used to code relevant data into one of these two categories 




Table 31: Perceptions of substance use experiences 
  
 n % 
Perception of substance use (n=19)   
I do have a problem with substance use 










Nearly sixty per cent of the sample of respondents considered 
themselves to have had or have a problem with at least one of the 
substances they had mentioned using. Interestingly, as we can see from 
the following extract problematic use or addiction in all but one of the 
respondents that believed they had a problem with substances was 
explicitly stated. 
 
QS16 Lines 517-519 (Female, Black Caribbean) 
Int: Have you ever wanted to stop completely? 
 
Resp: I’m definitely addicted to it but I could never just put it down and say  
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“Right I’m never going to smoke again”.  I think personally I think to 
myself “I want to die.  I’m going to be really ill”.  People say “It’s not 
heroin you know.  Come on it’s just weed” and I’m like “No you don’t 
know what it’s like.  I’ve been smoking for years.  You don’t know what 
it’s like”.   
 
  
9.1.5.3 The relationship between substance use and experiences 
 
This arm of the study only included current or past psychiatric 
patients who had suffered from psychosis as well as a substance use 
disorder. Subsequently detailing the relationship between the mental 
illness experiences and substance use was of utmost concern. With that 
in mind a theme around this relationship was coded for in accounts and 
transformed into a categorical variable. Questions concerning the 
relationship between experiences (whether they defined them as a 
mental illness or not) and substance use were directly asked in the 
interview and prompted and unprompted responses relating to views on 
this relationship were identified and coded within accounts. Both 
problematic use and use not considered problematic were examined.  
 
Using the process described above respondents overall 
constructions of the relationship between their mental illness experiences 
and substance use (drug and alcohol) were grouped into one of three 
categories; Substance use is not related to my mental health; Substance 
use is related to my mental health and; undefined. 
 
Table 32: Constructions of the relationship between experiences and 
substance use 
  
 n % 
Perception of substance use (n=19)   
Substance use is not related to my mental health 











Nearly eighty per cent of the respondents (n=15) expressed that  
they saw a relationship between the substances that they used and/or 
had a problem with and the experiences that  lead them to into contact 
with mental health services. The majority of these respondents’ 




QS6 Lines 385-386 (Male, Black Caribbean) 
Int: And when you’ve had periods where you’ve wanted to stop smoking, 
could you tell me why, what has been your main reasons for wanting to 
stop? 
 
Resp: Paranoia was the main reason.  Because I’m on medication as well, and 
I’ve been prescribed as mentally ill.  Suffering from schizophrenia.  So I 
thought to myself  “It could make it worse than what it already is.”  And 
because I was going through the depression at the time they were saying 
to me “Oh if you smoke, the medication’s not going to work.”   
 
 
9.1.5.4 Other patients and otherness 
 
Whether a respondent considered themselves to be the same (i.e. 
suffering from the same or similar mental illness or experiencing the 
same type of things that other patients had) or different (i.e. not 
experiencing the same things or having the same diagnosis) from other 
patients they came across in hospital and community services was an 
important construction in most accounts.  
 
Questions relating to  these similarities and differences were asked 
of respondents during the interviews; however there were many 
instances where this self-categorisation was offered unprompted in 
accounts.  Severity of illness was one way in which respondents created 
distance between their own experiences and the experiences of other 
patients; by creating a 'me' and 'them' dichotomy. Negative terms or 
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extreme forms of terms used to describe others in the following extract is 
an example of how one respondent created this dichotomy.  
 
QS7, Lines 312-315 (Male, White) 
Int: What did you before you went into hospital and you have talked about 
this a little bit, what did you think about mental illness?  What did you 
know about it already? 
 
Resp: I didn't, I don't know, I suppose I was probably like a lot of other people.  
Like people were literally like lunatics; proper mad people, they need to 
be locked away because they're dangerous people.  I don't know I sort of 
like everybody that's, I've got a mate who's probably a severe 
schizophrenic I think that was the only kind of definition back then.  
People didn't even really talk about depression.  There wasn't so much 
associated with being in the mental hospital.  It was just like you're a 
paranoid or a delusional schizophrenic and those sort of people will mash 
you up if they see you.  Do you know what I mean?  It just totally was 
but I do remember being in the car and there was sort of like, "What am I 
going to be going into?" 
 
  
How respondents situated themselves in relation to other patients 
was coded and categorised using a similar process for creating 
categorical variables detailed above. Respondents were grouped into one 
four category levels: I am different from other patients; I am the same 
as other patients; no opinion expressed; undefined.  
 
This self-categorisation was used to compare other themes and 
constructions within accounts along with the other categorical variables 
discussed above. Only 2 of the 19 respondents conceptualised 
themselves as being the same or similar to the other patients they saw in 
hospital or in community services. Whether a respondent felt that they 
were the same or different from other patients can be seen as related to 




Table 33: Perceptions of self 
  
 n % 
Perception of self (n=19)   
I am different from other patients 
I am the same as other patients 












Interestingly there was an equal spread of perceptions self among 
men, however all of the female respondents saw themselves as different 
from other patients. 
 
 
9.2 PHASE TWO SAMPLE CHARACTERISTICS 
 
Having discussed the ways in which the qualitative data was used 
to address the research questions and how categories of sample 
characteristics were generated from account theme to help create 
typologies of experience in the above sections we now move on to the 
first part of the main body of the results section. This section describes 
the respondents. Here patients that were included and excluded from the 
final sample are discussed and compared by sociodemographic and 
clinical, characteristics.  
 
 
9.2.1 Final sample characteristics and comparisons with AESOP 
data 
Nineteen patients were interviewed for the second phase of the 
PhD study. As discussed in Chapter 6 these patients were sampled from 




Table 34 compares the sociodemographic and clinical 
characteristics of AESOP patients with a diagnosis of comorbid substance 
use disorder (either drug/alcohol abuse or dependence) that were either 
excluded or defined as subject to attrition from the qualitative study to 
those that were included in the final sample and interviewed.  As is often 
the case in comorbid psychosis and substance misuse populations 
(Addington & Addington, 2007; Donoghue et al., 2011; Larsen et al., 
2006; Sevy et al., 2009) there were more men than there were women 
in the eligible sample and subsequently the final sample included more 
males. Similarly patients recruited to the qualitative study tended to be 
of younger age at their first episode of illness which is often the case for 
comorbid substance abusers in psychotic populations (McCleery, 
Addington & Addington, 2008). There were no significant differences 
between AESOP cases that were included and excluded from the 
qualitative study.  
 
Table 35 summarises the sociodemographic and clinical 
characteristics of the final qualitative sample. There were small numbers 
of Black African and Other ethnicity cases in the eligible sample and so it 
was difficult to recruit adequate numbers of respondents in these ethnic 
groups to the final qualitative sample. There were no female respondents 
or respondents in the older age category for Black African or respondents 
from other ethnic groups. Equally Black African respondents all had an 
AESOP diagnosis of a schizophrenic disorder and comorbid drug use 
disorder. 
 
In addition to the above there were a number of other differences 
within the final qualitative sample. Eight participants were interviewed in 
a home or social setting, five were interviewed in a psychiatric hospital or 
community health team, five were interviewed at the Institute of 
Psychiatry and one was interviewed in prison.
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Follow Up            
 n M 
(SD) 
 n M 
(SD) 
 df  2  p 
AVERAGE LENGTH OF FU (YRS) a 18 9.73  37 8.79  1  0.837  0.360 
Sociodemographic Variables 
 n %  n %  df  2  p 
GENDER 
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AGE GROUP AT BASELINE 
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1 missing case 
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 n %  n %  n %  n % 
Sociodemographic variables 
GENDER 
     Male 
     Female  
AGE GROUP AT BASELINE 
     16-29 

















































Clinical variables            
DIAGNOSIS 
     Schizophrenia 
     Mania  
     Depression 
REMISSION 
    Remission from 1st episode 
    Subsequent episodes of illness 
COURSE TYPEa 
    Episodic 
    Continuous 
    Neither 
DRUG ABUSE/DEPENDENCE 
     Drug use disorder  


















































































































1 missing case 
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9.2.2 Constructions of ethnicity 
As discussed in Chapters 1 and 3 constructions of ethnicity are 
contentious and often based upon the salience of  complex socio-cultural 
and religious beliefs (Singh, 1997).   
 
Although detailing constructions of ethnicity was not a primary 
research question of the qualitative study, it became clear that 
illuminating participant’s constructions of their ethnicity might play a part 
in understanding their constructions of their illness. It was found in the 
quantitative study that there were differences in the prevalence of 
comorbid drug use disorder between Black African and White patients, 
but not between Black Caribbean and White patients. Differences in 
negative outcomes (for example, frequency of relapse and number of 
psychotic episodes) were found between Black Caribbean and White 
patients with comorbid substance use in the quantitative arm of the PhD 
study.  
 
However differences in prevalence of drug and alcohol use 
disorders between Black Caribbean and White patients were not found. It 
would have been useful to examine whether differences in AESOP ethnic 
categorisation (which grouped mixed parentage patients in Black ethnic 
groups and did not account for place of birth) and the qualitative 
interview self-categorisation of ethnicity might go some way to explaining 
the lack of differences in prevalence.  As we saw in section 3.3.1 a UK 
study looking at ethnic differences in comorbid psychosis and substance 
use disorder (Afuwape et al., 2006) found that the Black Caribbean and 
White patients had similar prevalence of cannabis and stimulant abuse; 
however, British Black patients had significantly higher prevalence’s in 
both substances than Caribbean’s and White patients.  
 
Table 36 compares categorised self-ascribed ethnicity used in the 
AESOP study (used for sample selection) with the in-depth self-ascribed 
ethnicity documented during the course of the qualitative interviews. This 
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table highlights differences between the crude categorical groupings of 
ethnic minorities used in the analysis in first quantitative arm of this 
study and how they perceive themselves in relation to their ethnicity, 
nationality, colour and religion.  
 
As we can see, one of the Black African respondents and over half 
of the Black Caribbean respondents considered themselves to be Black 
British or Mixed Black and White parentage. The majority of the Black 
respondents were British born but the differences described here are 
based on their own conceptualisation of ethnicity rather than just their 
place of birth.  
 
Most respondent’s constructions fell into the same categories as 
their AESOP ethnic groupings. The main differences were where 
respondents considered themselves to be ‘mixed-race’ and where 
geography or nationality played a part in their constructions (e.g. Black 
British). 
 
Unfortunately because of low numbers in each ethnic group in the 
qualitative study it was difficult to uncover possible reasons for this lower 
than anticipated prevalence of substance use disorders in the first arm of 
the study.  However, it was useful to look at respondents’ constructions 




Table 36: Final Phase Two sample by qualitative interview self-ascribed ethnicity and AESOP ethnicity 





















Black African  
Black Caribbean/Afro-Caribbean 





























































































9.3 ACCOUNT DEVICES 
 
Ethnomethodologists such as Dingwall (1997) have argued that all 
social interaction (including interviews) can be seen as a ‘dance of 
expectations’. Citing Goffman (1959 & 1983), Dingwall proposed that 
social interactions can be viewed as opportunities to manage others’ 
impressions of them and each party will strive to present themselves as 
competent and sane to the other (Goffman, 1959 & 1983 cited in 
Dingwall, 1997). It is not surprising then that when interviewing people 
who have had, in psychiatric terms at least, a ‘mental illness’ examples of 
what Baker calls membership categorisation is produced during the 
account giving (Baker, 1997).  
 
Membership categorisation relates to the roles we as social actors 
ascribe ourselves to. For example ‘the mother’ or the ‘teacher’ or most 
commonly in medicine ‘the patient’ and ‘the doctor’. The membership 
categorisations used in the linguistic exchanges of the researcher and the 
mental health patient, are that of the ‘sane’ person or indeed the unwell 
or recovered person, with both parties subscribing to the membership of 
the sane person category or role during different points of the interview. 
Interestingly in this way roles are not only linguistically fulfilled but 
created within the interview experience by both the interviewee and the 
interviewer.   
 
Additionally, respondents may feel obliged to display competence in 
the role of the ‘interview respondent’ (Murphy et al., 1998). For Dingwall 
this desire to demonstrate competence as a interview respondent or 
whatever role the interviewer has cast them in, is one of the reasons why 
interviews must be treated as an ‘account’; a representation of the 
respondent’s attempt to present themselves as a competent member of a 
particular community, rather than a literal description of the respondent’s 
reality (Dingwall, 1997). 
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Although categorisation of how accounts are given or what social 
roles are ascribed to during the interview (Baker, 1997), was not a 
primary objective (i.e. was not a research question for this arm of the 
PhD study) it was clear when analysing the interview transcripts that 
‘how’ a respondent constructed their experience could be answered in 
part by identifying the way they framed or presented their constructions 
(i.e. what the respondents were doing in their accounts). Moreover, 
during the analyses of the accounts certain types of mechanism or 
account devices seemed to be used by all the respondents in their 
accounts whereas some account devices were used by only some of the 
respondents.  
 
Analyses of these frameworks can be viewed as one way of 
uncovering the moral and cultural assumptions that a respondent holds, 
what the most salient aspects of an event are as well as an illustration of 
the simple ways in which the respondent could increase researcher 
understanding of a concept or direct the interview to or away from a 
particular event. They are also useful in understanding how people with 
comorbid psychosis and substance use give accounts and create 
understanding of their experiences. 
 
Figure 16 shows a schematic of the mechanisms uncovered during 
analysis. These mechanisms were categorised and can be grouped into 
three distinct areas: ‘When’ in time is the respondent locating their 
account; ‘What’ feature of the event is it that the respondent is 
describing and focusing on in their account; and ‘How’ (i.e. using what 
device or through what lens?) are they creating or giving the account of 
that event? Each of these areas was then subdivided again into themes 
that ran through the whole interview and categories located within  
specific sections of interviews.
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The account mechanism ‘When’ was split into two sub-thematic 
mechanisms: ‘Then’, which focused on whether a respondent specifically 
highlighted remembering (or not) an event; and Hindsight which was 
defined as the respondent constructing an understanding of an event (or 
specific features of an event), with knowledge acquired after the event 
had happened. 
 
The sub-thematic account mechanism ‘then’ was based around the 
concept of remembering. The structure of the topic guide, as is the way 
with semi-structured interviewing, meant that respondents were asked 
initially to describe an event (for example and illness episode) and then 
as discussed above, probing questions were used to illicit more detail 
about how the respondent felt about that event or what other things had 
happened around that event. Sometimes this included asking the 
respondent what they remembered about an event.  
 
However, there were many occasions in the accounts where 
respondents spontaneously directed (i.e. unprompted) the researcher to 
a memory. The sub-thematic mechanism ‘then’ is defined by its 
appearance only in unprompted responses; for example, in interview QS2 
the respondent talked about the information she was given by the staff 
on the causes of her manic symptoms while in hospital. She was not 
asked directly by the interviewer if she could remember the event. 
However much of her description of the event was framed around the 
fact that she did not remember much except one exchange between her 
and a psychiatrist. This she detailed remembering ‘perfectly’.  
 
One of the male respondents used this mechanism in a similar way 
to describe him seeking help for his experiences. 
 
QS4: Line 64-71 (Male, White) 
Int:  So did you go she took you to a GP to begin with? 
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Resp:  Went to the GP in Streatham Hill I’d again at that point didn’t really 
even know couldn’t didn’t have the conception of or the idea that it was 
the drug I was just fucked. 
 
Int:  Yeah. 
 
Resp:  I was you know and he sat me down he said have you been taking any 
drugs and I said yeah loads and it was then. 
 
Int:  Yeah. 
 




Resp:  And … that because I, I remembered very clearly going in and the 
receptionist saying what do you want to see a doctor for. 
 
Six respondents used this mechanism at least once in their 
accounts and two used it on more than three occasions.  Account giving 
is framed in the past, where past events and experiences are described. 
However respondents can signpost us both intentionally and 
unintentionally to details about the event that are salient to them. It 
became apparent from further analysis that ‘remembering’ was a useful 
tool. Firstly the respondent could highlight an event (for example feeling 
a particular way or doing a particular thing) by stressing the fact that 
they recalled it.  
 
While many respondents seemed to aim to create clarity and 
coherence in their accounts, some respondents used recall, or more 
specifically the lack of recall as way of justifying gaps, lack of detail and 
coherence. In addition lack of recall which would most commonly be 
viewed as an impediment in their cognition because of the time in 
between the event occurring and the attempt to recall it, could also be 
because of mental disturbance at the time of the event, confusion due to 
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sedative medication at the time of the event or simply discomfort with 
the interview question. 
 
Related to but separate from the mechanism around remembering 
was the mechanism ‘hindsight’. This mechanism was considered to have 
been used when the respondent had framed their account of an 
experience or event within their current understanding of that event 
compared with their retrospective understanding of that event.  
 
For example those who spoke about whether they needed to be in 
hospital may have described believing (what they thought or how they 
felt about the event) at the time of hospitalisation that they were not 
‘unwell’, but they may also retrospectively believe the opposite to be 
true. Similarly a respondent may have described a particular reason (or 
lack of) for their drug taking at the time of using (for example taking 
drugs because they were available to them), but may retrospectively 
describe the reasons or causes of that experience in a different way (for 
example looking back at their drug use they see it was a coping 
mechanism).  
 
This mechanism was represented in the accounts by two distinct 
types of responses. The first was ‘I did not agree then but I do now’. This 
theme was evident in 12 of the 19 interviews and included instances 
where, for example, a respondent felt that they did not agree with their 
diagnosis or treatment or did not know they needed treatment at the 
time but they do (now on retrospect) agree with it or understand it now. 
The respondents talked about their treatment experiences and they 
framed these experiences as what they thought then in comparison to 
what they think now. For example, in seven interviews, going into 
hospital was seen as something that was done to them (which was 
related to themes around power and control in treatment), and the 
benefits were nearly always seen retrospectively. 
 
QS7: Lines 316-317 (Male, White) 
Int: Did you feel like you needed to go into hospital that first time? 
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Resp: I probably didn't know I needed to.  Now I know I did need to yeah but 
I don't think I thought.  Well I don't think I would have probably, I don't 
know what would have happened if I didn't because I was going down a 
pretty destructive path.  But I wasn't happy about being in there when I 
first got there.  And then like I say, I don't know what is was like I was 
given but once I'd sort of come to and stuff I did feel pretty relaxed 
being in there.  And I'd got used to it.   
 
The other thematic representation of the hindsight mechanism was 
‘I did not know at the time anything was wrong’. This theme was 
categorised by instances when respondents thought at the time of their 
experiences that they were fine or nothing was wrong with them (either 
in terms of their mental health or drug use). Although this theme 
incorporates elements of ‘I did not agree then but I do now’ it represents 
a slightly different linguistic way of expressing hindsight. 
 
QS2: Lines 155-157 (Female, White) 
Resp:  But I wasn’t aware at the time at all that this was happening no not at  
all. 
 
Int:  Right that you didn’t think that there was anything wrong. 
 
Resp:  No absolutely not no. 
 
Account giving relies on accurate or at least perceived accuracy in 
the recollection of an event. For the respondents interviewed in this 
study, these events may have covered over ten years of their life.  
Hindsight was one of the strongest thematic mechanisms observed in the 
accounts, however some respondents offered restricted responses 
requiring more direction and clarification from the interviewer (i.e. 







As mentioned before the structure of the topic guide meant that 
respondents were asked initially to describe an event and then probing 
questions were used to illicit more detail. As discussed in Chapter 7, often 
the language used by the interviewer (how did you feel?; tell me what 
was happening around that time?), was mirrored in the respondents 
responses. Despite this there were many occasions in the accounts where 
respondents spontaneously offered descriptions of how they were feeling 
or what they did in addition to one-dimensional or chronological accounts 
of events.  
 
Respondents described their experiences in terms of how they felt 
about an event, what happened or what they did. For example, 
respondents may have described how they felt about the experience of 
being hospitalised (such as evoking feelings of anger or loss of control). 
Alternatively they may have described the experience of hospitalisation 
by time-lining and describing the process they experienced (e.g. a parent 
called the GP, then an ambulance arrived).  All respondents used a 
combination of these descriptive methods and often interchangeably 
however they weighted them differently. This weighting gives us insight 
into the salient features of an experience for that respondent.  
 
For some respondents, there were differences in the amount of 
‘feeling’ based constructions used in accounts. All respondents talked 
about how they felt during their experiences but for six respondents their 
emotional responses (e.g. feelings of sadness, frustration or anger) were 
clearly more salient in their constructions compared to what happened or 
what they did. In relation to constructions of illness, substance use or 
treatment experiences it was evident that for this handful of respondents 
the emotional aspects of their experiences were key.  
 
QS15: Lines 87-89 (Male, Black African) 
Int: And did you - what happened when you were at [Name of Psychiatric 
Hospital]? Do you remember? 
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Resp: I just felt very, very angry and fed up with the world, and having a lot of 
fights with people and they had to restrain me all the time, because I was 
yelling at them – I wasn’t used to a place like that. 
I was probably the youngest person in there. I was scared and frightened 
so all I was doing by defending myself was fighting.  
 
This was evident particularly when respondents were talking about 
their mental illness type symptoms, a notion we will explore in more 




Part of the respondents' accounts were related to their desire to 
present their account within what they consider to be acceptable social 
models of causation of their experiences and events. Lay models of 
causation of mental illness experiences and substance use were one of 
the most prominent features of the all of the respondents’ accounts. I will 
discuss themes on causation in the following sections but it is useful here 
to highlight ‘how’ the respondents created their models of causation.  
 
Intellectualisation was the strongest way in which respondents 
explained the things they had experienced. Intellectualisation comprised 
several types of responses and can be categorised in four different ways; 
excuses; justifications; apportioning responsibility; and association. This 
mechanism as mentioned above can be seen as linked to social 
desirability (Holden, 2001)5 and is similar in nature to Scott and Lymans 
(1968) account classifications of either ‘excuses’ or ‘justifications’. Scott 
and Lyman (1968), who have defined an account as “a linguistic device 
employed whenever an action is subjected to linguistic inquiry”, explained 
that excuses and justifications arise when the possibility that an 
individual has acted in some ‘untoward’ manner is raised.  
                                                 
5




Excuses  and justifications are defined in similar terms to those of 
Scott and Lynman but form only part of a larger account mechanism; 
Intellectualisation. Although behaviours when unwell or having mental 
health experiences and drug taking may have negative implications for 
the respondents (for example the police being called) no moral 
judgement is made.  
 
Scott and Lynman (1968) believe accounts represent attempts to 
refute challenges either by denying responsibility (excuses; I did it and it 
was wrong but it wasn’t my fault) or by arguing that the behaviour in 
question was understandable, given the situation (justifications; I did it 
but it wasn’t wrong). These two themes were used in most accounts 
when respondents were describing the events leading up to a 
hospitalisation. They were also used when respondents were describing 
criminal behaviour (n=4) or when talking about not taking medication 
(n=2). The following are examples of excuses (QS5, highlighted in red) 
and justifications (QS8, highlighted in blue). 
 
QS5: Lines 455-459 (Male, Black African) 
Int:  Ok and between say like 95 and 99 did you spend time with friends either 
from school or around your area? 
 
Resp:  We were just were just they were just leading me astray really 
you know doing all bad stuff. 
 
Int:  What type of bad stuff? 
 
Resp:  I don’t want to say this because. 
 
Int:  Ok. 
 
Resp:  But it was all kind of bad stuff you know that I like doing  
trouble get into trouble you know getting into fight but I wasn’t in the 
fights because there was one time I saw my friends get into a fight they 
wanted to bully somebody and instead I saw them beating up the person 
and they wanted me to join in but somehow I kicked the boy once and I 
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realised it wasn’t right so then I stop and I told my friends I said no it’s 
not worth it let let’s leave him you know and but as well as I’ve got into 
trouble where it was always me getting beaten. 
 
 
QS8: Lines 466-469 (Male, White) 
Int: What about after that?  Have you had another… 
 
Resp:  I've been stopped for being drunk and disorderly and they found a so-
called offensive weapon in my pocket, a butterfly knife.  Which I maintain 
was a defensive weapon, not that I would have ever used it, because it 
wasn't a very good one anyway.  But anyway, that was the way it was 
and I was done for an offensive weapon and I was fined £250.  And that 
was a long time ago, so that was a lot of money. 
 
Int: Was there a particular reason why you were carrying it? 
 
Resp:  I owned it, and it wasn't illegal to own butterfly knives in those days, and 
I was carrying it for defensive purposes.  If anyone wanted to have a go 
at me for whatever reason, that I'd have something to fend them off with 
basically. 
 
The frequency that these two mechanisms were used can be 
related to several factors including the respondent’s overall level of 
comfort with the interviewer.  In one interview (QS8) the respondent who 
was a White male, used justifications as the backbone of his account 
giving, this mechanism arguable helped to frame what may be 
considered (in psychiatric terms) delusional and disorganised 
experiences.   
 
Another aspect of intellectualisation was associations. During 
analysis data for this category included instances where respondents had 
used characters or plots in films as either a metaphor for their 
experiences or as a simile or comparison to their experiences. This could 
be either as part of their narrative or description of the experience or as 
a clarifying remark to the researcher. Five respondents in particular drew 
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comparisons between their experiences and films/TV programmes. Films 
were used as a way of helping the researcher understand what they were 
experiencing, what the experience meant to them, how they understand 
it themselves, and how they explained it to others. Interestingly two 
respondents picked the same film; the zeitgeist. When we look at the 
characteristics of these respondents we see that all five of these 
respondents are British born but from different ethnic groups.  
 
QS16: Line 402 (Female, Black Caribbean) 
 
Resp: If anyone would have told me they seen things before I would’ve said 
they’re mad and that’s impossible.  How can you see something that’s 
really not there?  But it does happen.  That’s why I’m watching 
Eastenders at the moment.  I’m watching Stacey and I feel really sorry 
for her.  And I said I just…and everyone goes “Why do you, it’s not real.  
Why do you feel so sorry?” and I said “Well that’s how I used to feel”. 
 
This is arguably a form of normalising experiences and while 
psychiatric frameworks may be used as a way of making sense of 
experiences by aligning them with that of an ill person rather than the 
deviant person, association is similarly a way whereby many of the 
respondents in this study made sense of their experiences and 
behaviours. It also illustrates that although people who have mental 
health problems may not understand their illness in psychiatric terms (for 
example having insight) they still attempt to make sense of their 
experiences nonetheless. 
 
The last aspect of intellectualisation was apportioning responsibility 
for the experiences. We discuss what respondents felt were the causes of 
their experience in detail in section 9.4.2. Apportioning responsibility 
formed part of respondents models of causation. The majority of 
respondents gave constructions of what part they felt they had played in 
their experiences. Whether they conceptualised themselves as mentally ill 
or not all respondents gave constructions of them having little 
responsibility for their symptoms or behaviours when they were ‘unwell’. 
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When drug use was given as the cause of experiences excuses and 
justifications were used to explain substance use and again no 
respondents conceptualised themselves as having caused their 
experiences by virtue of taking the substance that led to the experiences. 
The following extract is an example of a respondent apportioning the 
responsibility of being violent before and on admission to hospital as 
being related to life stresses. 
 
QS15 Lines 109-111 (Male, Black African) 
Int: What did you think was causing you to be angry and – 
 
Resp: I just felt – I just went through a rough time, was a bit fed up, lost my 
temper because when I do lose my temper, I got a temper.  
 
And that’s all I thought of it.  And they classed me as a – what do you call 
it – a schizophrenic and all that. I was labelled and that, and I didn’t like 
all of that. 
 
Two of the nineteen respondents gave clear constructions of other 
peoples actions being the direct cause of their experiences 
 
QS8 Line 78 (Male, White) 
Resp: My mum told lies in front of the psychiatrists and I used to think to 
myself “I'm sure part of the reason why I'm here is because of the lies 
my mum is telling him.”  But obviously I was exhibiting, but that's what 
I'm saying, is that the way people were treating me, was making me feel 
ill. 
 
What the accounts in this study show is that similar to finding of 
Martinez (2010) patients with severe mental illness are more likely to 






9.4 ‘I DON'T THINK I WAS PSYCHOLOGICALLY ILL.  I STILL 
MAINTAIN THAT I WAS EMOTIONALLY ILL’: 
CONSTRUCTIONS OF ‘EXPERIENCES’ 
 
This sub-section is the first of four sections that summarise the 
themes that were uncovered in the respondents' accounts. They can be 
considered the ‘what they are saying’ part of how respondents 




9.4.1 Describing experiences 
A good starting point for uncovering the different constructions 
respondents gave of their illness experiences is to first look at how the 
respondents described their experiences. All respondents over the course 
of the interviews gave indications or signs as to how they saw mental 
illness either in themselves or in others.  Respondents were asked what 
their perception of mental illness or psychiatric hospitals had been before 
they came in to contact with mental health services. Many respondents 
gave descriptions of what they thought mental illness was and ten 
respondents gave clear description of how they see or saw the mentally 
ill. Respondents were also asked for terms they used to describe these 
experiences and all 19 respondents gave at least one term or description 
of what they felt they had experienced. The terms used for their 




9.4.1.1 Terms and signs 
 
Table 37 shows a list of the most commonly-used terms employed by 
respondents to describe their experiences. Each respondent was asked 
how they would categorise their experiences or why they thought they 
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had experienced the things they had and some were asked whether they 
felt their experiences constituted a mental illness. As has been found in 
other studies (Kinderman et al., 2006), the terms that respondents used 
were sometimes ones adopted by the respondent themselves and 
sometimes ones applied by other people. The terms that respondents 
adopted themselves are summarised below. 
 
 
Table 37: Terms for experiences used in accounts 
  
 n % 
Terms (n=19)   
Psychiatric (n=3) 
     Psychosis 
 
Lay (n=15) 
     Breakdown 
     High 
     Bonkers 
     Funny 
     Low 
     Vexed 
     Mad 
     Crazy 
 
Combined (n=17) 
     Paranoia/paranoid 
     Paranoid schizophrenia 
     Depressed 
     Ill 








































The terms used can be categorised into three distinct groups: 
Psychiatric; Lay; and Combined. Respondents on the whole tended to 
use a mixture of these types of terms to describe their experiences at 
different times within their accounts. Only three respondents used the 
word psychosis and all of them were from a White ethnic background.  
 
All but one respondent used more than one type of term. 
Respondents could however for the most part be grouped as mainly 
subscribing to lay terminology or mainly subscribing to combined 
terminology. For a few this division could not be made as they used a 
mixture of psychiatric, lay and combined terms (n=6).
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Table 38: Type of terminology used by perception of experiences 
 I have a 
mental illness 
(n = 7) 
 
 I do not have a 
mental illness 
(n = 6) 
 
 Undefined 
(n = 6) 
 
























Table 38 shows that the majority of respondents that felt their 
experiences equated to a mental illness used the combined terms to 
describe their experiences. 
 
Only three respondents used the term ‘mental illness’ and 
interestingly two of those respondents gave an overall construction of not 
having had a mental illness. This illustrates how constructions within 
accounts can be contradictory or how people with a ‘mental illness’ can 
see certain symptoms as being indicative of mental illness but may also 
believe that they do not  meet a criteria for having a mental illness.  
 
Many of the respondents talked about their experiences in terms of 
individual symptoms, paranoia being the most common. The term 
paranoia was the most complex because it drew on both constructions of 
mental health experiences as well as drug use experiences. Table 37 
shows the number of respondents that referred to their mental health 
experiences as paranoia (either directly or indirectly through drug use).   
Many of them also used this term to describe the effect cannabis or 
specific types of cannabis had on them separate from mental health 
experiences. I discuss the relationship between paranoia, mental health 
and cannabis use further in section 9.6.1. 
 
The most commonly used terms (paranoia/paranoid, n=12; 
depression/depressed, n=12; and ill/illness, n=12) were those that can 
be found in both psychiatric and lay language used to describe mental 
illness. These terms would have originated in psychiatric discourse, but 
with increasing public awareness of mental illness they have found their 
way into lay descriptions. The terms that can be found in both domains 
have been labelled combined because even though they originated in 
psychiatric language they have taken on a slightly different form because 
of lay understandings of them.  
 
It should be noted that respondents were using terms that 
describe a level of 'unwellness' without directly subscribing to the 
psychiatric framework of mental illness. All three of these terms enable 
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this to some degree and detailed constructions around these terms were 
prominent in nearly all accounts as we will see in the following sections. 
 
In addition, two respondents used terms in personal and an 
idiosyncratic way as seen in a study by Kinderman et al. (2006). 
Respondents slightly changed the meaning of psychiatric terms to 
encompass their own understandings of mental illness or experiences. 
 
QS10, Lines 257-258 (Female, White) 
Int: Can I ask you when you were in hospital did anybody talk to you about 
what’s called like a diagnosis of why you were there?  The reason why 
you were there – your illness? 
 
Resp: I can’t remember.  I think so.  They said that it could be depression.  It 
would be psychological depression or something like that.  
 
QS5 Lines 1130-1131 
Int:  Yeah have you spoken to anybody about what, a diagnose if you have a  
diagnosis or something. When you’ve been in hospital a couple of times 
and with a community mental health team for a while has anybody ever 
talked to you about a mental illness or if you have a diagnosis. 
 
Resp: Yeah the doctor told me that I’ve been diagnosed with schizophrenic  
epilepsy or so yeah. 
 
The largest proportion of terms used were made up of a mixture of 
lay and combined terms. As we can see from Table 38 these were used 
regardless of how the respondents defined themselves in terms of having 
a mental illness.  This mix of terminology  can further be explained by 
the fact that a number of respondents subscribed to psychiatric or 
combined frameworks of mental illness in a general sense but used lay or 
colloquial terms to describe their experiences or illness in a comical or 
self-deprecating way (n=4). The terms ‘mad’ or ‘crazy’ for example tend 
to be traditionally aligned with negative associations of mental illness. 
Even when a respondent used psychiatric or combined terms to describe 
their illness, they sometimes used these negative lay terms in a comical 
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way to describe the bizarre or deviant behaviour they had been 
exhibiting.  
 
Interestingly, the respondents who used lay terms in this way 
tended to have manic presentations according to both their Aesop study 
psychiatric diagnoses as well as their own self-diagnosis (n=3). 
 
QS17 Lines 134-138 (Female, Black Caribbean) 
Resp: …But when I'm ill, I just, don't know. It's crazy, the way I think when 
 I'm ill. 
 
Int: What other things happened when you were ill? 
 
Resp: Just crazy thing like, I don't know like when, what was it? I'm just  
 trying to think. About four years ago, I snuck into.. where was it? I  
 don't know how I did it but I did it. I snuck into 'This Morning.' 
 
Int: Did you? (Laughter) 
 
Thirteen respondents needed to be prompted to give precise terms 
to describe their experiences. These respondents when asked initial 
questions about what had been happening around the time of their first 
hospitalisation responded with descriptions of feelings or thoughts or 
behaviour rather than a concrete term or concept as this example 
illustrates. 
 
QS12 Lines 141-142 (Male, Black Caribbean) 
Int: Okay.  And so you said the doctor had asked you what had brought you 
into hospital and what did you think had brought you into hospital? 
 
Resp: I just started to think about my mum again and it just went straight to 
my head, I couldn't cope.  So I started to collapse and said "That's it, I 
want to die."  I just had a fixation on trying to kill myself.  I couldn't do it, 
everything I tried I failed at.  So I just had to give up on that notion, 
nothing was working. 
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When we look at typologies in the data we can see that the 
majority of White respondents tended to use predominantly psychiatric 
terminology.  In contrast, the Black Caribbean respondents tended to use 
predominantly lay or colloquial terminology. This gives us insight into 
how the three ethnicities may frame their understanding of mental 
illness, its causes and possibly the relevant treatments available to them 
as modelled by Kleinman (1980). 
 
 
9.4.1.2 What are people with mental health like? 
 
Part of constructions of mental illness came in the form of 
describing other people’s illness and experiences. Constructions of ‘the 
mentally ill’ were found throughout most accounts. The constructions 
came in prompted and unprompted form (mostly unprompted). Ten 
respondents gave clear descriptions of what they thought the mentally ill 
were like. Lay terms with negative connotations tended to be used to 
describe people with psychiatric problems. Table 39 gives an overview of 
the terms, behaviours and physical attributes that the respondents felt 
were associated with people with mental illness. 
 
Table 39: Descriptions of people with mental illness 
 prompted unprompted 
 N % n % 
Mental illness (n=10)    
Term (n=4) 
     Crazy 
     Lunatic 
     Nutter 
     Mad  
Behaviour (n=7) 
     People talking to themselves  
     Exploding  
     Keeping self to self  
     Chaotic/unpredictable  
     Doing bad things  
Physical appearance (n=3) 
     Looking dishevelled 






























































QS10 Lines 374-375 (Female, White) 
Int: ...I wanted to also ask you what you think mental illness is?  Like what in 
your mind, what does it mean? 
 
Resp: Mental illness to me is someone.  You know like sometimes you would be 
walking down the street and you get that nutter, which is absolutely off 
his head.  Talking to himself.  All that.  I think that is mental illness.  I 
think people like that being locked up.  Like this whole thing of like when 
I came to [Mental Hospital] I thought it was like a Victorian Asylum.  
That’s what I think.  But it’s not like that but you know… 
 
Respondents often used stereotypical constructions of the mentally ill 
even if they had been hospitalised themselves. Part of the respondents’ 
constructions of what they thought mentally ill people were like related to 
whether they perceived themselves as the same or different from people 
with mental illness. 
 
 




 No Family 
History 
(n=13) 
 n %  N % 
Perception of self (n=19) 
I am different from other patients 
I am the same as other patients 




















Table 40 shows that 6 of the 19 respondents had family members 
who had a mental illness. Most respondents with a family history of 
mental illness saw themselves as different from other patients that they 
encountered.  Nearly all of those respondents believed that their illness 
was qualitatively different from their relatives.  Moreover, their own 
illness was described as less severe (despite the added difficulties of 
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substance use disorders) as is exemplified in the second half of 
respondent QS14’s construction of ‘the mentally ill’. 
 
QS14 Lines 359-360 (Female, Black Caribbean) 
Int: Do you know if your Mum had – or your Step-Dad had - that kind of 
perception about your illness because of what your brothers had been 
through? 
 
Resp: No.  Because mine was completely different.  My brothers used to hear 
voices and hallucinate and shit like that.  Mine was – my attitude would 
just get different.  Higher.  My personality would change.  My mum didn’t 
have a clue what was going on with me.  She just thought that I was 
angry and vexed or….I think it really does stem back from when my Dad 
– my Dad got murdered in Jamaica.  And from that my whole personality 
changed.  I got depressed and low.  I think it just stems back from that – 
because she just used to put it down to my Dad. 
 
 
9.4.2 Causation and explanation 
According to Pill and Stott (1982) broadly speaking, aetiology or 
causation of illness can be divided into two main groups, those which 
place the cause within themselves or the individual and those which place 
it outside themselves or the individual. Where respondents located the 
origins of their experiences or the aetiology of their ‘disease’ is roughly 
related to the account mechanism apportioning responsibly. 
 
As discussed in Chapter 4, causation forms part of explanatory 
models of illness which encompass a person’s beliefs about the nature of 
their problems, its severity, prognosis and treatment preferences 
(Kleinman, 1980). The theme around causes of the respondents’ 
experiences can also be seen, if not directly then at least indirectly, as 
part of the justification or excuse process used in account giving. Every 
respondent had constructed a model of causation with differing emphases 
based on the level of responsibility (apportioning responsibility) they had 
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for their experiences. These models were of differing levels of coherence 
and consistency.  
 
Accounts of causation and explanation fell into three broad 
categories; Psycho-social; Biological and Spiritual. This broadly mirrors 
the explanatory models uncovered by McCabe and Priebe (2004) in a 
study of patients with schizophrenia (Social, Biological, Supernatural and 
Non-specific). In addition the majority of respondents saw multiple 
reasons or triggers for their experiences and they did not necessarily 
subscribe to one aetiological framework. Table 41 shows the specific 
causes elicited in accounts under each of the frameworks 
 




Causes were often elicited at the very beginning of interviews and 
were unprompted. Respondents often qualified or added to their model of 
causation when specific questioning around causes was asked later 
during the interview 
 
Causation and explanation were elicited in accounts in two ways; 
as part of the construction of the respondents’ first episode of illness and 
as part of the construction of subsequent episodes of illness. ‘Episodes of 
illness’ is part of psychiatric schema and it was difficult to unpack what 
was considered an ‘episode’ in the respondent’s accounts. Often what 
 prompted unprompted 
 N % n % 
Causes (n=19)    
Psycho-social (n=15) 
     Stress/Life event  
          Bereavement 
          Relationship breakdown 
          Other person being deceptive  
     Personality 
Biological (n=18) 
     Genetics 
     Allergic reaction 
     Drug use 



















































was described was a worsening of symptoms. Moreover it became 
apparent during analysis that many respondents described subsequent 
experiences that were similar to yet distinct from the experiences that 
brought them into contact with mental health services in the first place. 
However these were sometimes constructed in a different way.  
 
Eight respondents only had one episode of illness and 11 
respondents had more than one episode.  However 12 respondents spoke 
of ways of managing recurring symptoms. In the majority of these 
accounts drug use was the reason for ‘relapse’ or worsening of symptoms 
(n=4) as was not taking medication (n=5).  
 
Psychosocial causes (which were characterised by stress and life 
events) and biological causes were the most common themes in 
accounts. Stress, or life events, warrants attention and so is discussed in 
the next section along with substance use.  
 
Personality was the second category under psychosocial causes. 
Six of the respondents described their personality as being related to 
reasons for their experiences. This may have been a pre-existing 
personality trait that made them susceptible to mental illness or that 
would exacerbate symptoms (such as being someone who ruminates or 
being an aggressive person).  
 
Two respondents normalised manic or aggressive behaviour as 
being part of a normal response to stressors (see example below). In 
three accounts the respondents’ personality made them susceptible to 
the effects of drugs (which in turn led to mental illness). In all accounts 
that described the relationship between personality and their experience, 
personality traits were not described as a direct cause; illness 
experiences were a combination of personality traits and other things 
(e.g. a personality of thinking too much + skunk = paranoid 
experiences).   
 
QS1 Lines 103-105 (Male, Black Caribbean) 
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Resp: I think that's part of why I was paranoid and why I needed to get a lot of  
shit out of my system because my brain, not that I find it hard to go to 
sleep but sometimes if something’s not bothering me but if I'm thinking 
about something I think quite intently on it, 
 
Int:  yeah 
 
Res:  I'm quite a what's the word thorough, I like to open things a little bit and 
combine that with skunk it makes it worse, some people it just  mongs 
them out where they can't do anything, other people it just kept me 
awake, I can remember weeks before going into hospital sleeping maybe 
one or two hours a night proper narcoleptic 
 
Drug use (not including alcohol) and not taking medication were 
two of the causes related only to experiences that happened subsequent 
to their first experience of psychosis or episode.  By the nature of the 
respondents’ illness pathways, the theme ‘not taking medication’ was 
reserved only for explaining episodes of illness or mental health 
experiences after their initial episode.  Pescosolido (Pescosolido & Boyer, 
1999; Pescosolido, 1991) constructed the Network Episode Model based 
on the work of Clausen & Yarrow, (1955), and proposed that models of 
belief would be influenced by the ‘illness career’ of the sufferer. This was 
apparent in accounts in this study and gives some indication that many of 
the initial aetiological frameworks are seen as (retrospectively) fluid and 
renegotiable.  
 
Personality as a cause is the only aetiology that could be 
considered fixed.  However additional theories of causation could be 
retrospectively added as participants had more illness episodes or 
experiences.  
 
The final category, spiritual causes was endorsed by two 
respondents from Black ethnic groups (Black Caribbean and Black 
African). As we discussed in Chapter 4 Caribbean’s can hold traditional 
beliefs that attribute madness to the intrusion of spirits, ‘obeah’ (black 
magic) (Littlewood, 1988; Laguerre, 1987; Fisher, 1985; Morgan et al., 
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2004) or ‘worries’ caused by external pressures. This was evident in one 
female Black British born Caribbean respondent. The other respondent 
who subscribed to a spiritual framework was a Black British African male 
and he gave slightly less clear constructions of the causes of his 
experiences, but saw them as being outside of his control and as a 
possible punishment from God for things he had done. 
 
 
QS5 Lines 544-551 (Male, Black African) 
Int:  And so what happened after that? 
 
Resp:  I brush it again and again until, until I start think I was feeling better  
but then I was getting paranoid say it would happen again I weren’t able 
to breathe and I pray that it won’t happen again and somehow yeah and 
it happen for that it stopped for that day and then the next day it happen. 
 
Int:  It happened again? 
 
Resp: Yes you know and you know it was it was if yeah I felt as if there was  
some kind of like evil spirits against me and yeah and, and maybe it was 
because of the friends and the, the way of life I was living that’s all led 




Resp:  Yeah. 
 
Int:  So that it was like a kind of I don’t know how to put it like a punishment 
is that what you mean? 
 
Resp:  I don’t know maybe yeah it could have been a punishment you know 
































































Table 42 shows the primary framework of causation employed in 
each respondent’s account by ethnic group. The majority of respondents 
used a mixed framework (n=10); many respondents had different 
frameworks for their initial episode and subsequent episodes. Black 
Caribbean respondents had emotional or biological frameworks, whereas 
White respondents tended to have combined frameworks.  
 
There is a lot of literature around mental illness and racism in 
psychiatry (Bhui, 1999; Patel & Heginbotham, 2007). Interesting none of 
the respondents gave institutional racism as a cause of their experiences 
or although one respondent gave constructions of institutional racism in 
the criminal justice system (this related to the causation of his family 
member’s illness rather than his own). 
 
 
9.4.2.1 Stress and life events 
 
Stress was one of the most prominent causes elicited in accounts 
and was constructed from mostly unprompted responses. Respondents 
constructed stress as a cause of their experiences in two ways: 1) as a 
cause in its own right; and 2) as a way the effect of negative psycho-
social (Life events) or spiritual experiences were manifested, which in 
turn caused their mental health experiences. 
 
Stress was conceptualised in several ways. In some accounts, the 
respondent assumed it was an agreed concept between them and the 
researcher and they did not give any specific examples or definitions of 
what was stressful for them. In other accounts, examples were clearly 
given.  As we can see from Table 41, 13 respondents believed stress to 
be a cause of their experiences. For all of these respondents, stress was 
considered a cause in conjunction with other factors.  The majority of 
respondents gave major life events as the cause of their stress, such as 
relationship problems or breakdown (n=9) or bereavement (n=7), 
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however everyday stresses were also considered causes or triggers and 
in 3 respondents the stress of not sleeping were mentioned. 
 
Stress as a cause in its own right was conceptualised as ‘stressing 
out’, worry or anxiety. This type of stress was elicited in four accounts  
and constructions were often unclear which is illustrated in the example 
below.  
 
QS14 , lines 466-467 (Female, Black Caribbean) 
Int: How would you kind of summarise it?  Would you say it was a mental 
health issue, would you say it was something else…? 
 
Resp: No, I got stressed out.  I didn’t know how to cope with it.  I wasn’t used 
to stress and everything on top of me.  And that was my outlet.  Just 
getting mad, angry, going out, staying out.  That was it.   I don’t think I 
have got a mental illness, or I am mad or anything.  I just get stressed 
sometimes.  And my way of dealing with stress is different to people – 
other people.  Simple. 
 
This type of stress was mediated by two factors: 1) the ability to 
cope with stress and; 2) the individual’s personality (for a minority of 
respondents). The focus in some accounts, on the ability to cope (as 
illustrated above) was typically seen in the latter parts of a number of 
accounts whereby the respondents talked about learning to cope as a 
strategy for managing symptoms or triggers/causes of their experiences.  
 
 
9.4.2.2 Models of multiple causes and mediators 
 
Ten of the respondents believed there to be more than one cause 






QS17 Lines 377-378 (Female, Black Caribbean) 
Int: Do you ever feel that any of the drugs is related, or has contributed, or 
has made better, any of the experiences you've had? 
 
Resp: Yeah I think probably it has contributed. I'm probably in denial  saying 
weed don't do anything. But I think, with the mixture of charlie and coke, 
I mean, charlie which is coke, weed, and the madness at [Person’s house 
where she believes a spiritual ritual was performed], it all infused 
together. So it did affect me.  
 
The most common combinations of aetiological frameworks were 
life events or stress in addition to drug use. Figure 17 shows a typical 
model of causation. In this model a life event or stressor combined with 
substance use leads to low mood or depression. The experience of 
depression is mediated by their ability to cope with the stressor. This in 
turn leads onto other experiences (psychotic) that put them into contact 
with services. Depression is seen as the beginning of their experiences 
and in many respondents their experiences are categorised as solely 
depression, a notion I will discuss in section 9.4.3.  
 
As I discussed in the previous section, the respondents that had 
more than one episode of illness often changed their causation model to 
accommodate either their continuation or discontinuation of cannabis use 
or the effects of not taking their medication. Stressors were still seen as 
triggers for illness episodes or recurring symptoms, however in five 





















Figure 18 shows the most common (n=8) model of causation for 
subsequent episodes of illness or relapses. This second model is based on 
a construction of illness experiences, that for some respondents,  had 
changed the respondent in some permanent way, such that it may 
require abstinence or reduction of substance use (often cannabis) and/or 
medication as is illustrated in the following account. 
 
QS18 Lines 141-142 (Male, Other) 
Int: So did you put down those experiences to smoking the cannabis? Or did 
you think there was another reason? 
 
Resp: My reasoning was that there was some kind of gate that stops normal 
brain, I guess neurology to perceive the world in that kind of way. Then 
LSD kind of opened those gates towards that perception if you like. 
(Laughter) And because that door had been swung open it became 
accessible with lesser potent drugs like cannabis. And because I was 
smoking quite heavily I started feeling that kind of effect or perception; 
however you might want to put it. 
 
In this model, respondents give different weight to on-going 
substance use, life stressors and medication non-compliance. These 
weights are dependent on several factors including how they construct 
the aetiology of their illness experiences (their first model of illness 
causation), whether they believe they have a mental illness or not, 
whether they want to continue using substances (or a substance) or not, 
whether they consider there to be a relationship between substance use 
and mental illness and whether they believe psychotropic medication is 
benefiting them.  
 
 
9.4.3 Depression is not a mental illness 
 
‘I wouldn’t say it was a mental illness.  But it was more depression’. 
QS10 Line 272 (Female, White) 
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While 12 of the respondents used the term depression to describe 
some or all of their illness experiences, four of the respondents felt that 
depression solely explained their experiences. In these cases their 
psychotic type experiences were constructed as the additive combination 
of depression and drug use (or in the case of one of the respondents an 
allergic reaction to prescription drugs) rather than a psychotic illness. 
 
QS15 Lines 242-250 (Male, Black African) 
 
Int: And you said at the time, that the first time you were in hospital, you 
didn’t feel that – they were saying you had a mental illness, and you 
didn’t feel you did. What do you think now? 
 
Resp: I still think I didn’t have a mental illness, I was just depressed. I didn’t 
think I was mentally ill, something like I hurt someone or do something 
to someone. I just think I had an allergic reaction with the pills 
[prescription drugs that family gave him], lost my temper and that was it 
basically.  
Then they section me, and from then I been under the mental health 
treatment. 
 
Int: Since then. Now, what you do think now? Do you think you have a mental 
illness now? 
 
Resp: Kind of like, the stuff I’ve been through, I do need to take medication to 
stabilise my mind so I kind agree. Then I was young and I was confused, 
I didn’t know what’s going on.  
 
Int: Do you have your own name for what you think you’re going through or 
you’ve experienced? 
 
Resp: I just think it’s depression. 
 






In this extract the respondent sees that it was his aggressive 
behaviour caused by a reaction to the medication his family had given 
him that led to his sectioning. He does not see that he has a mental 
disturbance. Moreover he does categorise his experiences as having 
suffered from a depression, but this is differentiated from a ‘mental 
illness’. 
 
Although there were not enough respondents that conceptualised 
experiences in this way to look at patterns of constructions by gender or 
ethnicity it provides us with a first look at how drug use and psychotic 
experience are interwoven in the constructions of comorbid experience. 
 
 
9.4.4 Feelings, thoughts and behaviours: symptom experiences 
Data under the theme ‘symptom experiences’ included instances 
where respondents constructed aspects of their experiences in terms of 
the feelings they had (e.g. emotional feelings like 'being low' or 
sensations like visual or auditory hallucinations or odd sensations), the 
behaviours they exhibited (e.g. criminal behaviour) or the thoughts they 
had (e.g. paranoia). This theme builds upon the account device ‘Feelings, 
thoughts and behaviour’ by examining how the respondents  felt or what 
they did. Descriptions under this theme relate solely to ‘‘how’ a symptom 
(defined explicitly or implicitly) was constructed and what symptom-like 
and related experiences were salient to people with comorbidity. This 
theme is illustrated in Figure 19.  
 
One of the symptoms that ten of the nineteen respondents 
described was sleep deprivation. This experience tended to be described 
as the noticeable onset of problems. 
 
QS3 Lines 420-423 (Male, White) 
Int: So is that something that you identify now rather than at the time did you 









Resp: And before that a couple of days before it happened and I started to lose 
sleep and develop insomnia it was all it was quite a short build up but 
quite a big explosion. 
 
As we saw in section 9.4.1.1 12 of the respondents used the term 
‘depressed’ to describe the whole or part of their mental illness 
experiences. Section 9.4.3 also discussed the relationship between 
depression and constructions of illness, however it is noteworthy to 
mention here that depression or low mood was also seen in a more 
symptom like manner (normally as a response to a life stressor and as a 
precursor to other experiences) in two respondents rather than a disorder 
in its own right. 
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Figure 19: Constructions of symptoms and related feelings using account device ‘What’ 
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Five of the nineteen respondents described seeing or hearing 
strange things as part of their experiences. These descriptions bear 
similar resemblance to what would be considered hallucinations, but only 
two of the five respondents used that term. Two of the respondents saw 
these experiences as being solely related to their drug use. 
 
Twelve of the respondents described having paranoid experiences. 
As we will discuss it is difficult to unpack these experiences because they 
can be considered a symptom of mental illness as well as drug use 
(specifically cannabis). Nevertheless, five respondents talked about 
paranoia as being separate from drug use. 
 
QS9 Lines 212-217 (Male, White) 
Int: That's good.  So you've said you haven't had any experiences up until 
recently?  You came to hospital in December, is that right? 
 
Resp: That's right, yes. 
 
Int: So what had been happening? 
 
Resp: I was having paranoid thoughts and hearing voices and hallucinations 
again.  I found it a little bit strange because that's the sort of thing I 
experienced when I was using drugs, but I hadn't been using anything.  
But I just out of the blue had these feelings come back. 
 
Apart from paranoia, bizarre beliefs which are of delusional quality 
are also a characteristic of schizophrenia. Two respondents spoke about 
beliefs that were ‘out of the ordinary’ and only one of them used the term 
delusion to describe these experiences. 
 
QS4 Lines 533-535 (Male, White) 
Resp:  I’m prescribed three five mgs tablets a day of Diazepam and that’s what  
I keep to. 
 
Int:  That’s what you take? 
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Resp:  And I take them sporadically, I don’t take them, they were given to me 
for delusions, is what they called it? When I thought people could read 
my mind looking back I know exactly what it was it was kind of flashback 
things of the telepathy that I felt was real at the time of taking drugs 
looking back it was me getting anxious which then led to the racing the 
endorphins in my brain an active transmission whatever you want to call 
it would bring hallucinations and they were horrific you know and I was 
prescribed Diazepam because it would tranquilise. 
 
The last aspect of symptom like experiences was found in the 
description of behaviours exhibited prior to or on admission to hospital. 
These behaviours can be categorised into two types: criminal behaviours 
and suicide attempts. Criminal behaviours were described in six accounts 
and in two of these they were related to behaviour when the respondent 
believed they were ‘high’ (what might be termed in the psychiatric field 
as a manic episode) or having a manic episode. Four respondents 
described criminal behaviour associated with their illness: 
 
QS13 Lines 227-235 (Male, Black Caribbean) 
Int: Was that the only time you've had any contact with the criminal justice 
system? 
 
Resp: No, I've got common assaults, that's it really. 
 
Int: And when did that happen?  How old were you when that happened? 
 
Resp: I can't remember how old I was, but back in hospital, having a fight with 
the nurses. 
 




Int: How did you feel about that? 
 
Resp: What can I say in it.  I was ill wasn't I?  I still don't like to hit somebody. 
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Others (n=2) described criminal behaviour associated with substance 
use. 
 
QS11 Line 31 (Male, Black African) 
Resp:  The crack became everything because the issues were there and the 
crack was dealing with the issues. It became my friend, really. And 
unfortunately, when my money ran out at the bank. I wasn’t working at 
this time because my self-esteem and everything had gone. When the 
money ran out of the bank, I began associating with this girl and the 
company that she kept. And this company wasn’t very decent company. 
Went into shops and started nicking bottles of whiskey and things like 
that. 
 
One of the difficult experiences that was elicited in accounts was 
that of attempting suicide. Five respondents spoke about trying to end 
their life and in all of these cases those feelings were precipitated by a 
difficult life event or stressor and formed a significant aspect of their 
whole mental illness experience. 
 
 
9.5 CONSTRUCTIONS OF DRUG AND ALCOHOL USE 
 
Constructions of drug and alcohol use fell into three main areas:  
reasons for the initiation of drug or alcohol use; substance use after their 
initial episode of illness or mental health experiences (whether they 
continued using or not); and construction of what constituted a problem 
with substances (i.e. an addiction). Each of these themes is discussed in 
detail in this section and then the relationship between substance use 







9.5.1 The type of substances used 
During the course of the interview all respondents were asked 
questions about their substance use. Many gave unprompted descriptions 
of their drug use as a cause of their experiences (see section 9.4.2). All 
respondents described having used cannabis in their lifetime. All 
respondents had also used alcohol at some point during their lifetime 
with 18 of the 19 reporting regular use (n=18). However, only six 
respondents thought that their alcohol use had ever become problematic. 
In addition to cannabis and alcohol use, there were a number of other 
drugs that respondents described using.  
 
Table 43: Types of Substances used in the lifetime 
  
 n % 
Types of substances used 
Tried but not used regularly 
    Coke 
    Crack 
    Heroin 
    Ecstasy 
    Alcohol 
Used regularly and/or considered problematic 
    Coke 
    Crack 
    Heroin 
    Ecstasy 
    Speed / Amphetamines 
    LSD / Hallucinogens 
    Cannabis 
































Respondents were asked what their perception of their substance use 
was and whether they felt they had a problem with the substances they 
used. As we can see from Table 43, only five of the respondents had an 
AESOP diagnosis of both drug and alcohol use disorder (DUD and AUD). 
Respondents who had been given a diagnosis of comorbid DUD only in 
the AESOP study elicited mixed perceptions as to whether they felt they 
had a problem with drug use. However all of the respondents that had an 




Table 44: Perception of substance use by comorbid diagnosis 












 n %  n %  n % 
 
AESOP diagnosis of comorbid DUD 
















It is not surprising that there was a disagreement in the perception 
of problematic substance use between mental health 
practitioners/researchers and the respondents themselves. This theme is 
strongly elicited using the account mechanisms excuses and 
justifications. Many of the respondents used social setting and normal 
behaviour for their peer group as either a justification for drug use while 




9.5.2 Initiation of substance use 
One of the less prominent themes was how substance use was 
initiated. Because of the obvious cultural and legal differences in the use 
of alcohol and drugs, questions around substance use and unprompted 
responses tended to be focused on illicit drug use. Probing questions 
were asked about the initiation of drug use, and only a few respondents 
spontaneously talked about why they started using drugs. Instead, they 
focused on why they take drugs in general. Nevertheless 
conceptualisation of the respondents first experience of drugs (and 
alcohol) as well as how drug taking progressed and changed over their 
life were elicited in all account.  
 
Reasons of initiation of substance use can be categorised into three 
main areas: psycho-social reasons; physical reasons; and situational 
reasons.  Initiation of substances was defined as initial use of an illicit 
drug  or excessive use of a prescribed drug . Initiation of alcohol use was 
defined as the respondent using alcohol regularly or frequently.  Only 
three respondents spoke about how they first used alcohol differently and 
all three conceptualised the initiation of their regular use as the beginning 




Table 45: Constructions of reasons of initiating substance use 
 
 
Table 45 gives a summary of respondent conceptualisations of 
their substance use initiation. As with the theme around causes of mental 
health experiences, respondents often gave more than one reason. 
Eleven of the respondents only gave one reason for the initiation of 
substance use.   
 
Situational reasons 
In all of these instances, when the reason given was situational it 
often included the initiation of multiple substances. Respondents 
attributed the reason for first using the substance as being related to 
their immediate social situation. In those cases, the respondents did not 
attribute any emotional, personality, physical or economic reason to drug 
taking. It was considered an incidental part of growing up and socialising. 
Respondents reported seeing family members or friends using drugs (in 
particular cannabis and LSD) and they were merely ‘experimenting’ with 
that person when the opportunity was presented in social situations. . 
This reason for initiation was normalised for both drug and alcohol use 
and in keeping with the respondents immediate sub-culture. 
 
QS4, Lines 216-229, (Male, White) 
Int:  So did this start in your what year were you in when this started when 
you started going out? 
 
Resp:  Well I mean the, the it kind of like it started I think smoking weed started 
at school. 
 
 prompted unprompted 
 N % n % 




     Depression / Grief 
     Bad relationships with friends or family 


























Int:  How old were you? 
 
Resp:  That would have been 16 17 the classic way mates got a joint do you 
want to try I remember the first time I smoked it, it had no effect nothing 
didn’t puffed away nothing what’s all this about. 
 
Int:  What’s this? 
 
Resp:  Everyone else was giggling I’m sitting there eating it I think and like I 
just don’t feel anything what’s going on but I think that’s because my 
mind was so ready. 
 
Int:  Yeah. 
 
Resp:  Kind of wow you know. That it didn’t and then every so often you know  
have a drag and it was all very fun very giggly very munches very and in 
hindsight I can see the development almost to the, the specific nights. 
 
Then you get involved in knowing someone who you can buy it off. Then 
you get involved in buying it for other people then you get involved in the 
classic they call it a step way drug I don’t believe that but the possibility 
is there because you are buying it from someone that does also have 
that. 
 
Int:  That they’ll be selling something else. 
 
Resp:  But yet again at art school everyone that I know smoked dope and not  
you know a minority did what we did. 
 
Int:  Yeah. 
 
Resp:  You know everyone puffed but you know 20% maybe which was little at  
that point. Took it the whole way. 
 
This extract also illustrates the respondent’s construction of how 
drug use developed. In the accounts of three respondents, this step-wise 
development of drug use is spoken about in a clichéd way but is also 




Five respondents talked about the physical reasons they started 
using a substance. In all but one of these accounts, respondents who had 
already been using drugs and were initiating the use of another 
substance for the first time did so as a form of substitution.  Substitution 
was considered to include examples where respondents had used a 
substance (drug or alcohol) as a way of coming off another drug (usually 
a drug other than cannabis) or alleviating the physical or psychological 
withdrawal from another drug. The following extract was typical for 
respondents that constructed initiation of substance use for physical 
reasons: 
 
QS2, Lines 445-449, (Female, White) 
Int:  What about cocaine when did you first do that? 
 
Resp:  Cocaine well obviously when the heroin was going on I did both which  
was not the best … but I did both I got really hooked on that and then 
obviously because I was treated with this anti… well I did a detox and I 
was given my dad used to give me one of those anti… pills every day so I 
couldn’t feel the heroin I wouldn’t touch the heroin but I needed the coke 
really badly and I kept on fixing and doing things like that and that went, 
went for a while kept on going but again with the cocaine it was different 
I just you know if I didn’t have it I didn’t have it you could stop it, it was 
a different thing it didn’t have the same. 
 
Int:  What made you start using it more though when, when you, you said that 
when you were detoxing. 
 
Resp:  Well because well I had to use something pretty much was you know I 
deal with I definitely dealt with the physical side of the addiction but 
probably not with the psychological side of the addiction you know. 
 
Int:  Ok you wanted to carry on taking something? 
 





Psycho-social reasons fell into three groups. The first of these 
reasons elicited in two accounts was depression because of life difficulties 
or grief following the loss of someone special. Four respondents talked 
about negative relationships with their family members which led them to 
try drugs. Stress as a reason was given in only one account. Psycho-
social reasons were also interrelated to themes around coping.  
 
Psycho-social reasons were also elicited in accounts in the form of 
self-medication. Respondents used substances to help them numb pain or 
get through the difficult time they were having as the following extract 
shows: 
 
QS10, Lines 20-22 (Female, White) 
Int: Okay.  And what type of things were you kind of experiencing when you 
were taking the drugs.  Like what? 
 
Resp: At the time I was experiencing, you know, a high.  I didn’t really think 
about the problems that I had at home.  I was more concerned about 
going out and going clubbing and going into clubs and getting the drugs 
really.  Do you know what I mean?  And just staying up.   
 
Because when you’re high on stuff like that you don’t really think things 
that you’re depressed about don’t really matter.  Because you’re all about 
the moment.  But the comedown is horrible.  But that is the feeling I got 
when I did the stuff.  I wasn’t really concerned about… it’s like you lose 
your problems.  If you get what I mean. 
 
 
As with many of the themes, there were no obvious patterns in the 
reasons for initiation of substance use by the characteristics of the 
respondents. This is important in that it seems from this small sample of 
respondents that regardless of your gender or ethnicity, or whether you 
see yourself as having a problem with substances, the reasons for your 




9.5.3 Cessation and continuation of substance use 
Questions around changes in drug use behaviours were explicitly 
asked during the interview. Respondents themselves did not necessarily 
see their drug use in terms of on-going ‘changes’, instead they often 
gave constructions of whether they were still taking drugs (which often 
involved normalisation through intellectualisation of their substance use) 
or whether they had decided to stop (where pride was often evoked 
during their account giving).  
 
Respondents constructed their substance use after the initial 
episode of experiences that brought them into contact with services in 
three main ways, regardless of whether they had continued using 
substances, changed their use or stopped their use altogether. The three 
thematic constructions were: Psychological; economic/Legal; and social. 
These are summarised in the table below. The majority of respondents 
gave multiple constructions of cessation and continuation of substance 
use (n=17). Economic and social reasons tended to be elicited in 
prompted form whereas psychological reasons were elicited in prompted 
and unprompted form. 
 
 
Table 46: Reasons Cessation or continuation of substance use 
 
 prompted unprompted 
 N % n % 
Reasons (n=19)    
Psychological (n=16) 
     Addictive Personality 
     Choice or Willpower 
Economic/legal (n=10) 
     Legal implications 
     Work schedule 
     Money 
Social (n=18) 
     The music scene 













































The psychological reasons for why substances were used after the 
initial episode of illness or mental health experience came in two forms. 
The majority of respondents (n=16) believed that continuing or stopping 
substance use came down to individual choice and/or willpower. This 
construction can be closely linked with themes around mastery and 
involvement in the treatment and recovery process discussed in the next 
sections. Choice was constructed as not being influenced by other 
internal (addictive personality) or external (legal sanctions) processes. It 
was also concerned with the benefits that could be gained from stopping 
or continuing.  
 
In five accounts choice was constructed as having a tiredness of  
drug-related lifestyles; this gave respondents a boost of determination 
and a genuine desire to stop. Respondent QS2 talks about stopping drugs 
when she started her Hepatitis C treatment because she was tired of 
putting her family through it.  For QS11, it was the effects of being in 
prison and how that affected his family that led him to choose to stop. 
For QS3, it was the possibly being ill again.   
 
Moreover, having a ‘turning point’ or reaching ‘rock bottom’ 
seemed to be a concept that ran through constructions of choice. For 
those that continued using substances, justifications were often used in 
descriptions of continuation. In QS1’s account, he talks about being able 
to recognise the different sensations of certain types of cannabis which 
has allowed him to continue using weed but stop using skunk. 
 
QS1, Lines 309 (Male, Black Caribbean) 
Resp:  I smoked differently.  When I came out for the first year I never really 
smoked any weed and after that when I started working again I smoked 
maybe one or two spliffs a week and that was usually. 
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Actually I did smoke skunk after I came out of hospital after about a year 
or so and as I smoked a joint or half a joint, you know when you can feel 
not familiar feelings but familiar sort of sensations that sort of make you 
sit and draw back on the drug and think well that didn't really agree with 
me, let me put that down and now if we're at a party or something and I 
picked up a joint that had skunk in it even if it was a joint that you 
couldn't really taste it after two or three drags in five or ten minutes I'd 
know whether or not I could smoke the joint so yes I haven't smoked any 
skunk now for about a month after I came out of hospital would have 
been 2001, since 2001 so it’s since 2002 
 
Only two respondents felt substance use was related to having 
certain personality traits such as an addictive personality. 
 
QS4, Line 331, (White, Male) 
Resp:  …I think and your partly a product of your environment but your  
partly you know the genes in you, you know its nature that nature 
nurture thing and I think somewhere along the line I would have got I 
would whatever have got completely fucked up on a substance but in my 
life at this time it was ecstasy and raving it could have been alcohol at a 
different and in a different place it could have been heroin, it could have 
been benzos, it could have been anything but that’s what happened to 
me at that time. 
 
Economic and/or legal reasons 
Economic and/or legal reasons for how substances were used after 
respondent initial episodes were not as common as psychological or 
social. Nevertheless ten of the nineteen respondents spoke about how 
economic or legal considerations played their part. As the term suggests 
legal implications related to whether a respondent (n=4) felt their 
substance use would have implications for their legal status (i.e. whether 
they would get arrested to go to prison or have some other legal 
problem). Constructions around legal implications only related to whether 
a respondent should cut down substance use or stop altogether. Only one 
respondent talked about their job as a consideration for how they used 
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drugs. This was specifically in relation to them not being able to use as 
much because of the hours they would be working.  
 
Nine of the nineteen respondents elicited financial reasons for how 
they had or would use substances. Not having enough money was 
frequently given as a reason for not using substances but only related to 
changes in use and not cessation (n=8) and being able to use substances 
when they wanted because of extra money obtained through benefits was 
spoken about in two accounts.  In one account the respondent mentioned 
being able to make money from discontinuing drug use because of a drug 
treatment programme that used a form of contingency management. 
 
Social reasons 
The most common explanations for how substances were used 
after the respondents ‘first episode of psychosis’ were social, with 18 of 
the 19 respondents using social reasons as part of their explanation . The 
first thematic construction under this explanation is the relationship that 
respondents drew between their drug use (namely party drugs such as 
ecstasy, LSD and cocaine) and the music scene in their local area. 
Enhancement of the enjoyment of music was a way of justifying drug use 
and formed a firm part of six of the respondents’ cultural identity when 
they were using heavily. The relationship was seen as both positive and 
negative.  
 
QS4, Line 207, (Male, White) 
Resp:  Yeah but I, I remember puking up three pills and just going through the  
puke and taking them again, again it started off going out at a well it 
didn’t start it started off from [Place name] where I did my foundation in 
art and we used to go into the city go to different clubs it was when 
jungle it was just starting and we used to go to a club called the paradise 
club in Islington and it was like a proper hardcore sort of rude boy yardi 
kind of place how it ever kept its licence I don’t know but it was kind of 
like funny because our group of people we called or we became known as 
the clueless possy because it was really a group of white middle class 
upper middle class art students taking loads of drugs not really knowing 
what was going on. 
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Social relationships (with friend and family), was another reason 
for changes to substance use. Constructions included reaffirming positive 
relationships as we see in the following extract where the respondent is 
talking about why he drinks alcohol. 
 
QS8 Lines 233-235  (Male, White) 
Int: And is that to help? 
 
Resp: Probably yes.  It's to get away from everything really.  No it's not to get 
away from everything at all.  It's to make friends.  Although I will be 
chatting away to the cabbies and all that, maybe I'm changing.  Maybe 
I'm actually changing and I'm not as introverted as I used to be.  I'm 
definitely more lonely than I used to be. 
 
So therefore I can't afford to be on my own.  So therefore I'm making 
more of an effort to reach out to people.  But if I want to make a real 
friendship and I want to start talking to someone, I will have to be a little 
bit drunk. 
 
Constructions also included repairing broken relationships as we 
see in the following extract; the respondent (who joined a drug treatment 
programme to become abstinent from all drugs) describes what 
happened to his family relationships when he was using. 
 
QS11 Lines 173-175 (Male, Black African) 
Int: No, I understand what you mean. Can I ask you, how was your 
relationship with your siblings when you left hospital in 97? What was it 
like? 
 
Resp: I went back on the drugs so there was no relationship. That thing is an 
evil thing. It takes away everything. It takes away your children, it takes 
away your ambitions, it takes away your family, it takes away your good 
friends. Friends that care, friends that don’t use drugs, you don’t want to 
know them because they don’t use drugs. It takes away your quality of 
life, it takes away everything. That’s number one, it comes before 
everybody. Without that, if I didn’t have that then the emotions are going 
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to come back; I want to see my kids and I’m going to cry and why can’t I 
see my kids?  
 
And then you think, I don’t want to see my kids in this state that I’m in. 
I’m embarrassed, it’s not how I used to be. Meeting my partner, she’s 
going to faint. This is not the man that I married. So the shame and 
embarrassment makes you avoid that. But now I can say, I want to see 
my kids.   
 
 
9.5.4 Constructing addiction 
A smaller but no less important theme was that of addiction. 
Eleven of the respondents described aspects of what they felt constituted 
an addiction. These mostly fell into three groups: Physical, Social and 
Psychological (see Table 47). 
 
Table 47: Constructions of addiction 
 
 
Physical aspects of addiction related to whether respondents 
experienced the need for certain sensations associated with that 
substance (e.g., needing the buzz or relief when the buzz comes or 
suffering from withdrawal symptoms). Social ‘addiction’ however was 
defined not by the respondents’ ability or inability to retain normal social 
function. These constructions included examples where the respondent 
felt their social and economic function (i.e. going to work every day, 
dressing well or socialising) had not been impaired by drug or alcohol use 
and consequently they did not have an addiction.  Examples also included 
instances where respondent felt that their addiction had not been noticed 
because they maintained normal functioning. 
 prompted unprompted 
 n % n % 


















QS2, Line 389, (Female, White) 
Resp:  Experimenting yeah absolutely, you would do anything that would come 
up in your hands after, because it was a new thing [talking about heroin 
use] a new opening in the country and, and then you know and then I got 
addicted to it and I needed more just to keep me going basically and but 
still you know I worked as a PA for seven or eight years absolutely fine 
nobody ever noticed family didn’t notice you know I had money enough 
to deal with it so it was only when the money came short that things 
started getting….. 
 
Psychological addiction was mentioned by 9 of the 11 respondents. 
Two forms of psychological addiction stood out in these constructions; 
coping and control. Examples within this theme were where substance 
use became a necessity for coping with either mental illness symptoms, 
life stresses or just to help cope with daily life. In the following extract, 
respondent QS4, who later in his account gave clear constructions of 
having an addictive personality, talked about how alcohol became one of 
those addictions. 
 
QS4 Lines 323-325 (Male, White) 
Resp: When they’d come back and I’d I mean I was using alcohol then just to  
numb the pain I know it’s like a bit of a but to numb it to numb the 
paranoia. To because it was just I was living it 24 seven. I can’t impose 
enough. 
 
Int:  So you had. 
 
Resp:  I was living in hell. 
 
Also within this category is control. This concept was considered to 
be  a way of determining whether or not the substance use (even with 
addiction) was problematic or not.  Respondents defined having a 




It should be noted that not all constructions of addiction were 
clear. In three accounts, a general construction of addiction was given. 
For some of the respondents their constructions did not fall into the 
categories above. Instead, frequency, amount or length of use, as well as 
constructions of over indulging formed part of their understanding of as 
addiction. 
 
QS19 Line 141, (Male, Other) 
Resp: But I did have an addiction on Speed for a while but then that’s because 
someone gave me it in a large quantity.  A very, very large quantity, 
yeah and I was out of it for a while.  And we was just addicted on it – we 
were just all addicted it.  And so we all got a bit smashed on the Speed 
for a while for I don’t for a month. 
 
What is interesting is that only one of the five female respondents 
did not give a construction of addiction, which might highlight gender 
differences in the need to make sense of or intellectualise their 
experiences of problematic use. 
 
 
9.6 THE RELATIONSHIP BETWEEN SUBSTANCE USE AND 
EXPERIENCES 
 
In the previous two sections we have looked at how respondents 
constructed their experiences of psychosis and how they constructed 
their experiences of substance use. A central aim of this study is to  
examine the relationship between mental health experiences and 
substance use in this comorbid group of respondents. The first example 
of the relationship between psychosis experiences and substance use was 
found in section 9.4.2 where we saw that drug use was considered to be 
one of the identified causes of experiences in 13 respondents. 
Additionally, substance use was seen as contributing to worsening of 
symptoms or illness relapse in many respondents and was firmly built 
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into models of causation for the initial episode as well as subsequent 
episodes. 
 
In this section, we look more closely at the models of causation for 
psychotic experiences and unpack the role that substance use plays in 
symptom management, treatment and recovery. Table 48 presents four 
main areas where respondents felt they could see how their mental 
health experiences overlapped with their substance experiences. 
 
Table 48: How substance use was related to mental health 
 
 
Nearly half of the respondent (n=9) spoke about their drug use 
and experiences of paranoia. Most responses were prompted. This will be 
discussed in more detail in the next section, but first it is useful to 
highlight the other three ways respondents combined constructions of 
substance use and their mental illness experiences.  
 
Using substances to self-medicate was a theme that related closely 
to constructions of coping. Self-medication was defined as instances 
where respondents detailed using substances to numb the pain of 
depression or difficulties of psychotic phenomena and mostly arose in 
unprompted form. Over half of the respondents (n=12) detailed using 
drugs or alcohol in this way at some point since their first episode. 
 
QS14 Lines 267-274 (Female, Black Caribbean) 
Int: Did anyone talk to you about smoking weed?  Any of the psychiatrists?  
Or any of the nurses? 
 
 prompted unprompted 
 n % n % 
Relationship (n=19)    
Self-medication with substances 
Paranoia 
No relationship: non-problematic cannabis use 


















Resp: I think so, yes.  Especially when they found me smoking it in the hospital 
and told me I shouldn’t be doing it there and encouraging other patients 
and this, that and the other.  “It’s not good for your health”, and “it’ll 
make you worse”, and, yes…. 
 
Int: What did you think? 
 
Resp:  I thought it was making me better. 
 
Int: What was it doing that you needed?  What kind of a buzz did you get out 
of it? 
 
Resp: I thought that it was because…when I am high I get racing thoughts as 
well and I think it used to calm them down, you know, so I wouldn’t have 
to think so hard, or I could understand my thoughts, instead of them 
racing into one. 
 
Int: You could slow down. 
 
Resp: I could slow them down, yes. I didn’t want to eat.  I didn’t want to cook  
or do anything.  I was just very chaotic. 
 
Five of the respondents gave prompted constructions of health 
professionals having highlighted the negative effects of substance use on 
mental health. For these respondents the relationship between substance 
use and their experiences was only made on the advice of health 
professionals and not because the respondents saw a link themselves.  
 
The perception of cannabis use as not being problematic is an 
important theme to highlight as well. Seven respondents described 
having changed their cannabis use (decreased) since their first contact 
with services. Of these seven, six of them gave constructions of them 
having viewed their cannabis use as not being problematic at some point 
since their index episode.  Equally, of the ten respondents that 
subsequently stopped using cannabis altogether, three gave 
constructions of them not seeing their cannabis use as problematic at 




9.6.1 Paranoia and cannabis 
Many respondents saw a clear relationship between their paranoia 
and their drug use. For some respondents the paranoia was seen as an 
effect of drug use (mostly cannabis use) rather than a symptom of a 
mental illness. For example respondent QS15 in this extract sees his 
paranoid experiences as associated with cannabis use. He had spoken 
earlier in the account about the types of difficult experiences he had had 
(depression and irritability) but these were seen as separate from the 
paranoia.  
 
QS15 Lines 124-127 (Male, Black African) 
Int: Was there anything else you were experiencing apart from the depression 
and the irritability and anger – was there anything else? Did you ever get 
worried about people wanting to harm you or see things you hadn’t seen 
before? 
 
Resp: No. All I, them days – all it was, I just used to smoke a lot of cannabis. I 
think I suffered from a bit of paranoia. 
 
Int: Do you think that was to do with the cannabis? 
 
Resp: Yeah, I do think that was to do with the cannabis.. 
 
 
A typical model of illness causation was apparent in the 
respondents that saw drug use as a cause of their paranoia:  drug use    
paranoia + life events = nervous breakdown. It was not always apparent 
in accounts however where the drug use based paranoia ended and the 
mental illness paranoia began (or indeed vice versa). Furthermore as we 
see in the following extract from this one account, it was not always clear 
whether or not paranoia as a product of cannabis use was considered the 
same as paranoia as a product of abnormal psychological processes.  
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QS1 Lines 62-66 (Male, Black Caribbean) 
Resp:  I'd been moving around again I'd been moving around a lot and I was  
living away from home quite a way away from home and not that it's 
attributed to my problems  but I was having trouble with my bird, I was 
having trouble with drugs, major trouble with drugs as well and it was 
affecting my head with paranoia and stuff like that 
 
Int:  yeah 
 
Resp:  and my Mum basically admitted me voluntarily to the Bethlem hospital  
and where I was so paranoid for the first, for the first week I thought that 
I was being set up to be sent to prison I was that paranoid  
 
Int:  yeah 
 
Resp:  and the first month after that it took at least a month for the paranoia to  
work itself out of my system, television talking to me, people saying 
things and meaning other things and me reading too much into things as 
well.  I kind of think too much anyway 
 
An important factor in the relationship between cannabis and 
paranoia in respondents’ accounts was their decisions to reduce cannabis 
use. Ten respondents choose to stop their cannabis use after their initial 
episode of psychosis. In all of these accounts respondents gave paranoia 
or fear of paranoid experiences returning as one of the reasons for 
cessation. 
 
QS18 Lines 390-397 (Male, Other) 
Int: (Laughter) Okay. Can I just ask you actually about, just going back to 
smoking cannabis, after you - did you smoke cannabis when you were in 
hospital? Do you remember?  
 
Resp: No I don’t think I did.  
 
Int: And after you left hospital did you continue to smoke as much as you had 
before? No. Smoked more? Smoked less? 
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Resp: Smoked less.  
 
Int: Smoked less, any particular reason? 
 
Resp: Paranoia.  
 
Int: Okay so you linked - so you saw a link between the cannabis and the 
paranoia? 
 
Resp: I did see a link; yeah there was definitely a link between smoking 
cannabis and getting paranoid.  
 
Respondents in this study often gave mixed, incomplete and 




Table 49: Perception of experiences by drug use as a cause 
  














 n %  n %  n % 

















All the respondents in this study had been given a diagnosis of 
comorbid substance use disorder a part of the AESOP study yet not all of 
the respondents believed they had either a mental illness or a substance 
use disorder. Of those that felt they had or had had a mental illness, the 
majority saw drug use as ‘the’ or one of the causes of that illness. 
Interestingly, among those that did not see their experiences as a mental 
illness, the majority saw drug use as a cause of their experiences as well. 
Constructions of the relationship between cannabis and paranoia may 
help explain this.  
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Furthermore, not all respondents who saw a link between their 
substance use and their experiences thought that they had a problem 
with substances. For many respondents this is explained by cannabis use 





Table 50: Perception of substance use by perception of relationship 
between substance use and mental health 
  
 
















 n %  n %  n % 
Perception of relationship (n=19) 
Substance use related to my experiences 






















9.6.2 Illness causation, illness exacerbation and cannabis 
cessation 
When we unpack the relationship between substance use and 
mental illness further we see (as mentioned above) that if a respondent 
believed that they had a problem with substances that those substances 
were often not cannabis. Cannabis could still be related to paranoia and 
mental health but it was not always seen as problematic at least initially 
after the respondents' first illness episode. When drug use was 
considered a cause of experiences not all respondents considered 
cannabis to the problematic drug. Five (n=5/13) respondents saw other 
substances as the cause of their illness. However three of these 
respondents associated cannabis with their mental health and 




Cannabis use in some cases wasn’t seen as something that the 
respondents wanted to give up altogether either. All of the respondents 
used cannabis at some point since their initial episode that had brought 
them into contact with mental health services. Nine of the nineteen 
respondents saw their cannabis use as not problematic. Not surprisingly 
the majority of these respondents had continued (or simply changed) 
their cannabis use (n=6).  
 
QS12, Lines 338-339 (Male, Black Caribbean) 
Int: Did you ever feel at any point during your life that you had a problem 
with cannabis use? 
 
Resp: I still don't see that I've got a problem now.  It's an alright drug to have 
at the end of the day.  It's better than the other things that are out there 
anyway.  That has naturally come straight out of the ground, everything 
else is man-made isn't it? 
 
Ten respondents, however, stated they had given up using 
cannabis altogether. Three respondents reported coming on and off 
cannabis. Two respondents reported that their drug use had changed, but 
it was only that they financially and practically had problems getting it. 
 


















(n = 2) 
 n %  N %  n % 
Cannabis use (n=19) 
Stopped cannabis use 
Changed cannabis use 




























The majority of respondents saw a relationship between cannabis 
use and mental illness or illness experiences, however this relationship 
was not always seen as a causal one. One respondent who throughout his 
account often had contradictory notions of the relationship between drug 
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use and his experiences, described, (at least tentatively), an overall 
construction of a relationship between the two but it was a complex one. 
In this extract he is talking about the paranoia that he had been 




QS18: Lines 136-141 (Male, Other) 
Int: Did you have any idea of what was happening? Why it was happening? 
Did you think there was a reason why it was happening? 
Resp: My understanding at the time was that these things can and do happen 
but not very often otherwise it would be well known. The reason was, 
prior to that time I'd taken some amount of, I think it was LSD where it 
kind of had... 
Int: Similar effect.  
Resp: Similar effect yeah and almost seemed as if that was happening when I 
was smoking cannabis.  
Int: So did you put down those experiences to smoking the cannabis? Or did 
you think there was another reason? 
Resp: My reasoning was that there was some kind of gate that stops normal 
brain, I guess neurology to perceive the world in that kind of way. Then 
LSD kind of opened those gates towards that perception if you like. 
(Laughter) And because that door had been swung open it became 
accessible with lesser potent drugs like cannabis. And because I was 
smoking quite heavily I started feeling that kind of effect or perception; 
however you might want to put it.  
 
In this example the respondent constructs drug use as a mediator 
of his experiences. His experiences are seen as being able to perceive the 
world in a way in which ‘normal’ people cannot because of some 
biological inhibitor. His inhibitor was broken by the drug use which did 
two things, it allowed him access to an alternate view of the world and 
secondly made him oversensitive to the effects of cannabis smoking; 
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namely paranoia. Paranoia then is constructed as seeing the world in a 
particular way. LSD is seen as an enabler.  
 
Fifteen respondents believed substance use (drug or alcohol) to be 
related to their mental health whilst two did not see the relationship. If 
we look at those who stopped using cannabis over the course of their 
illness (n=10),  we see that all of them believed that substance use was 
related to their experiences or mental health but only seven believed 
cannabis use was problematic.  
 
Beneath the complex surface of the relationship between drug use 
(or cannabis use) and illness experiences is the sometimes contradictory 
nature of beliefs about whether a drug is a cause of mental illness, an 
exacerbater of illness experiences and whether respondents felt they had 
a problem with drugs. A respondent may believe drug use to have been a 
cause of illness experiences or to be related to it, but it does not follow 
that the same respondent sees their drug use as problematic or that they 
stopped using drugs as is illustrated in Table 51 above and Table 52 
below. 
 
Table 52: Relationship between cannabis use and perceived cannabis 
use problem 
 Cannabis use 
possibly 
problematic 
(n = 9) 
 Cannabis use 
not 
problematic 
(n = 9) 
 n %  n % 
Cannabis use (n=18) 
Stopped cannabis use 
Changed cannabis use 















9.7 SUPPORT, COPING AND EXPERIENCES OF SERVICES 
 
The second aim of this study was concerned with how respondents 
with comorbidity constructed their experiences of treatment services. The 
interview topic guide asked specific questions about when respondents 
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came into contact with services, as well as what their expectations of 
services were before their first contact.  
 
All of the respondents had contact with mental health services. 
However, only 9 respondents had contact with drug or alcohol services 
and only six of those respondents had received any consistent help. 
Because of the small numbers it was impossible to see if there were any 
patterns by gender or ethnicity. Three of the respondents had been 
referred to services or referred themselves to a substance abuse service, 
but had found after one contact that it was either unhelpful or 
inappropriate for them. Two of these respondents had been referred by 
mental health services. Of the six respondents that had notable input 
from drug treatment services four of them sought help themselves, and 
again most were organised through mental health services.  
 
When describing the help given to them by services two main points 
became apparent; firstly nearly all respondents were focusing on the help 
mental health services provided and only talked about substance abuse 
treatment services when directly prompted to; secondly ‘help’ and 
‘recovery’ were very difficult to disentangle. Respondents spoke mostly 
about hospital and medication when referring to the formal treatment 
they had received but help, support and recovery had blurred boundaries.  
 
Themes around treatment incorporated aspects of the support 
needed (from friends and family as well as mental health services) and 
processes, goals or mechanism for how recovery was achieved. The 
mechanism hindsight was often evoked in accounts of treatment and 
recovery. Respondents described not thinking that they needed help or 
treatment at the time of their psychotic experiences.  It was either   
during their hospital stay or as their illness progressed that they realised 
they had been helped and that it was necessary at the time it occurred. 
 
This section below looks at constructions of hospitalisation, which 
were distinct from other aspect of treatment and recovery, who 
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respondents felt were responsible for providing treatment and support, 





Constructions of hospitalisation where elicited in two ways: 
respondents drawing a parallel between hospital and prison; and 
respondents describing the role or benefits of having been in hospital. 
 
 
9.7.1.1 Inside vs. Outside: The prison parallel 
 
The theme ‘inside vs. outside’ describes what respondents felt it 
was like being in hospital and then re-entering the community. For 
example, in two accounts respondents talked about needing to keep links 
with the hospital before completely re-entering their old life. Others gave 
constructions of the difficulties of orientating themselves to the ‘world 
outside’ after being in hospital. 
 
QS15, Line 533 (Male, Black African) 
Resp:  Just me coming out of hospital and trying to get back into society. It was 
like – it kind of brought me down again. Confidence. 
 
The largest part of this parallel was called ‘the prison parallel’. 
Here respondents constructed their experiences of being in hospital as 
similar to being ‘locked away’. Conversely leaving hospital was construed 
as either escaping or finally gaining their freedom.  
 
QS17, Lines 182-189 (Female, Black Caribbean) 
Int: Can I ask you, do you remember? Well the first time you went into  
 hospital your Mum and your Aunt took you really didn't they? And  
 the second time, did you go on your own or did your Mum take  you?  
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Resp: I think every time... Do you know what it is yeah? It's like, my Mum 
called the police. Because back in the day you could police and  they 
could section you. They could take you straight there. It was without you 
being seen by a psychiatrist. But I think the second time I think I was at 
my Mum's house and she just called them and they came and took me. 
And that happened a good three times, I've been taken from my Mum's 
house. We're risking the ratings and everything. Proper.  
 
Int: Did you live with your Mum for a...? 
 
Resp: Yeah. And every time she thinks I'm going funny. Or call the psychiatrist 
to come and see me. And obviously because I've got a record, they 
automatically think, yeah, yeah. That's why I escaped from hospital one 
time and I didn't go back. 
 
Int: Because you have a record? 
 
Resp: No not record. I mean... because...the mental.. 
 




Constructions of punishment and force also formed part of this 
theme.  
 
QS13, Lines 225-226, (Male, Black Caribbean) 
Int: You said when you started smoking again and your mum would notice, 
and so then she'd take you to hospital.  Do you think those times that 
you needed to be in hospital? 
 
Resp: Yes, because I need to understand that smoking weed is not good is it?  
So it's like going to jail, you do a crime you've got to do the time haven't 
you?  So the same thing. 
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Behaving how the hospital expected you to or following the rules 
was a prominent feature for six respondents who talked about their 
experience of being hospitalised as is evident in the following extracts. 
 
QS15 Lines 486-489 (Male Black African) 
Int: And how would you describe your experience of being there, in your own 
words? 
 
Resp:  At first it was scary, but then I started to get more understanding as the 
years went on. They’re just there to help you. 
 
Int: How did you feel you were treated by the people there? 
 
Resp: At first I thought I was [inaudible], but then they just see you and they’re 
restraining me all the time, and I got angrier and [inaudible]. As the 
years went on I started to have more of an understanding about why 
they was doing that, and I started to go by the rules, then things got 
better. 
 
Eighteen of the respondents had been hospitalised at some point 
since their initial episode of ‘illness’. Table 53 shows that ten of those 
respondents had at least one compulsory admission. Regardless of 
whether a respondent was compulsorily admitted or not, they still saw 
hospital as an institution which they had been forcibly placed. 
Respondents gave constructions of having to ‘serve their time’ there 
before they were released. 
 
Table 53: Respondents who paralleled hospitalisation to prison by 
respondents who had had a compulsory admission 







Hospitalisation compared to prison 
(n=16) 














The findings of the quantitative study showed that for patients with 
White or Black Caribbean ethnicity those with comorbidity had a 
significantly higher likelihood of having a compulsory admission than 
those with no drug use. This pattern was not observed in Black Africans. 
There were no notable differences in respondents from the qualitative 
study by ethnicity and compulsory admission, however all but one of the 
females had a compulsory admission. Use of the theme prison parallel 
was equally spread across ethnic groups and by gender.  
 
9.7.1.2 The role of hospitalisation 
 
Sixteen of the respondents expressed views about the role or 
usefulness of hospitalisation. Six respondents felt that hospital did not 
provide any form of support or help (mostly prompted responses) to 
them however the remaining respondents who experienced 
hospitalisation gave at least one way that hospital helped them in their 
recovery process. Table 54 summarises the uses described by the 
respondents. Resting from the stresses of life was one of the most 
common perceived uses or benefits of being hospitalised (n=6) and was 
elicited only in prompted form.   
 






 prompted unprompted 
 n % n % 
Usefulness of hospital (n=16)    
Think about things 








































Table 55: Usefulness of hospital by respondents who had had a 
compulsory admission 
 Ever had compulsory admission
 
 
 No  Yes 


















Interestingly of the ten respondents that found hospital useful over 
half had been sectioned at least once during their illness. This suggests 
that even when a patient is hospitalised against their will, they may see 
the overall benefit of being in hospital afterwards. 
 
 
9.7.2 Who: Constructions of who gives support and who is 
responsible for the treatment journey and recovery process 
All respondents gave constructions of who had supported them or 
should be responsible for supporting them through their treatment 
journey and recovery process. There were four main sources of support 
described by the respondents: Health services; spiritual or alternative 
means; local communities; and self-support. The majority of respondents 
(n=12) believed that mental health services was the right place for them 
to receive treatment and six respondents actively used mental health 
services as part of their larger coping strategy. All of the responses under 
this theme were prompted. 
 
Despite all of the respondents having been given a diagnosis of 
comorbid substance use disorder in the first arm of the PhD study only 
nine of them had had contact with substance abuse treatment services. 
Of these nine only five respondents actually felt drug or alcohol treatment 









Eight respondents described turning to spiritual or alternative 
forms of support during their treatment or recovery process. The majority 
of these respondents were from a Black ethnic group (n=6). None of 
them however felt that this was a permanent source of support for them. 
 
All but five respondents talked about the role that they themselves 
played in their recovery process and these constructions were elicited in 
only unprompted form. The role that the respondent played was 
constructed in several ways: the strength they had to evoke during their 
recovery; having to rely on themselves because they did not have others 
as a source of support; initiating interventions themselves; and the 
coping strategies they employed during recovery. I will discuss this in 
more detail below in the discussion of the theme on mastery and 
involvement in the treatment journey. 
 
Family and friends were also seen as a support. Fourteen 
respondents felt that their family member’s involvement in their 
treatment and recovery was a source of support. However respondents 
typically gave both positive and negative examples of family involvement. 
Additionally seven respondents gave constructions of not wanting to put 
upon their family or understanding that family members had their own 
problems. Two respondents talked about not having anyone to talk to. 
 
 prompted unprompted 
 n % n % 
Sources of support (n=19)    
Health services (n=13) 
     Mental health services 
     Drug treatment services 
     GP 
Wider society (n=4) 
Family or friends (n=14) 
Spiritual/Alternative (n=8) 
     Church/Bible 











































Eight respondents spoke of the role of their GP.  In all but one 
account GPs were approached as an initial resource, in a crisis and often 
because of persuasion by family members who were trying to help them 
at the time. Four of the respondents gave unprompted descriptions of the 
role that wider society or social systems should play in supporting people 
with mental health. These constructions often included the belief that 
larger social institutions such as the police, education and health systems 
as well as local community should play a role in supporting and 
monitoring people who have mental illness or who are at risk of having a 




9.7.2.1 Credibility, professionalism and trust in the treatment 
process 
 
Although the  hospital and community mental health staff were not 
a primary focus of research questions and did not form part of the topic 
guide, nearly all of the respondents who talked about their experiences of 
hospital, mental health or drug treatment services talked about the staff 
members involved in their treatment. Experiences were very mixed; most 
respondents experienced good and bad health professionals; some 
respondents (n=7) felt that staff members (often specific people) had 
been very helpful and supportive; others gave constructions of feeling 
that at times they were not understood, respected or supported (n=9). 
Consistency in health professionals was also very important (n=9). 
Regardless of whether they had positive or negative perceptions of the 
health professionals that treated them they all gave constructions of the 
credibility of health professionals as part of their overall construction of 





9.7.2.2 Family roles and involvement 
 
As we saw in section 9.7.2, 14 respondents believed family and/or 
friends to be a source of support in their treatment and recovery journey. 
The majority (n=9) of respondents gave construction of the involvement 
of family members and significant others as sometimes positive and 
some negatives.  
 
Positive involvement on the whole included family members giving 
emotional and practical support (such as talking about problems with 
respondents or providing physical care), but also included encouragement 
to seek help and paying attention to changes in the mental state of the 
respondent.  
 
QS14 Lines 474-481 (Female, Black Caribbean) 




Int: How long have you been together? 
 
Resp: It is about eight years.   Yes, about eight years. 
 
Int: And is he a support to you? 
 
Resp: He’s a fucking arsehole!  No, he’s all right!   He knows about my illness 
and everything else.  He would never let me smoke weed again.  He 
would tell me if I was getting unwell or whatever. 
 
Int: Do you talk to him about stuff – about your feelings or thoughts? 
 
Resp: Yes, we used to.  But there is nothing really to talk about because my 
thoughts are all right.   If I am stressed out or upset then I will let him 
know.   
 
Interestingly, negative involvement was mostly related to 
monitoring the respondents behaviour and in a number of the 
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respondents’ accounts (n=3) was associated with taking away control 
and mastery in recovery (including normalisation of the respondents’ life 
post illness episode).  While in two respondents’ accounts behaviour 
monitoring created a situation where the respondents did not want to talk 
to family members for fear of being re-hospitalised.  
 






Support from family and friends was considered important but 
good relationships irrespective of the respondents’ experiences and 
problems were key. For one respondent (QS1) this was being able to talk 
to his mum when he had his experiences and after he left hospital but he 
also described the importance of their continued good dynamic after his 
initial episode. This continued support was built upon the pre-existing 
family structure and relationship the respondent had with his mum. 
 
This can be contrasted with respondents who did not have or want 
support from their family. For example respondent QS11 had lost his 
parents just before his initial psychotic episode and although fairly close 
with his siblings he described not wanting to put upon. He did not have a 
strong pre-existing familial support system to draw on in a time of crisis. 
Subsequently he gives an ambivalent construction of the support his 
siblings gave him.  
 
QS11 Lines 106-111 (Male, Black African) 
Int: And do you feel that they [the respondent’s brothers and sisters] 
supported you when you were in hospital?  
 
Resp: Yes and no. Yes and no. You know what I mean, you know cos remember 
they've got their own lives to lead as well. And remember two of my 
brother have had a nervous break-down as well. 
  
 n % 
Family Involvement (n=19) 
Family involvement considered positive 










This respondent and respondent QS14 both constructed the 
involvement of at least one family member as (at least in part) 
undesirable at least once in their accounts. Interestingly both of these 
respondents had family members with a history of psychosis. 
 
 
9.7.3 What: Constructions of what is useful, needed and strived 
for in the treatment journey and recovery process 
As part of respondents constructions of their recovery and 
treatment pathways, respondents described what they felt had been 
useful or what they felt they had needed for recovery. Three types of 
support were identified: Psychological; social; and medical. Constructions 
of the usefulness of support systems and processes needed for recovery 
came mostly in prompted forms (with the exception of psychological 
support) as questions relating the usefulness of hospital and community 
services had been directly asked during the interview. In addition, the 
majority of respondents detailed other forms of support and recovery 
processes, as well as give indications of what mental health professionals 
helped them with during their time as both an inpatient and outpatient.  
 
Table 58 shows the types of help and support that mental health 
professionals, friends and family gave respondents, as well as the range 
of recovery processes that the individuals evoked themselves. Help and 
support given from treatment services came in the form of formal 
therapy from counsellors or psychologists for seven respondents. 
Similarly 13 of the respondents identified that help from health 
professionals to understand or cope with the causes of their experiences, 
such as bereavement or drug use, was a useful form of support. In terms 
of support that health professionals, friends and family could provide, 
talking through the problems (n=14), economic support in the form of 
help with paying bills and getting benefits (n=3) and generally having 
other people around so they do not being by yourself (n=6) were all 
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mentioned.  Equally 16 of the 19 respondents identified taking 
medication as a way of helping them recover from illness experiences. 
 
Table 58: Types of support and means for recovery 
 
 
One of the categories of psychological support that was elicited in 
accounts was psychological therapy. This construction was found in 
prompted form in accounts (n=7).  
 
In exploring the relationship between perception of experiences 
and the identification of therapy as a useful tool in treatment and 
recovery, the majority (n=5) of respondents who felt they had a mental 
illness did not identify therapy as useful or potentially useful. For the 
majority of respondents who did not feel that their experiences 
constituted a mental illness, therapy was mentioned as a beneficial 
treatment in their account (n=4,). Additionally, 14 respondents identified 
talking about problems as a useful mechanism for coping or as a source 
of support but not all of these respondents felt this had to be done in the 





 prompted unprompted 
 n % n % 
Types of support (n=19)    
Psychological (n=19) 
     Therapy 
     Talking about problems 
     Change in thinking process 
     Dealing with the causes of experiences 
Social/Practical (n=14) 
    Practical support 
    Not being by yourself 
    Economic support 
Medical (n=16) 














































Table 59: Relationship between usefulness of talking about problems 
and having therapy  
 Talking about problems useful 
  
 Yes  No 
 N %  n % 















The sub-section below addresses how respondents constructed 
their own personal aims in treatment and recovery. While the topic guide 
did not ask specific question about goals in recovery, all respondents 
constructed the psychological, social and medical ways support was given 
or needed in the treatment journey and recovery process. These types of 
support all had one goal for respondents: Being normal. 
 
Normality was constructed in two ways. The first involved  
constructions of the benefits of doing ‘normal’ things such as using the 
gym while in hospital or having a CPN help you begin to interact with the 
‘world outside’ while on leave. The second involved the respondents’ 
descriptions of trying to return their emotions or behaviour to state they 
were in before they were ill: the true or normal version of themselves. 
This was done through involvement in ‘normal’ activities. This was 
evident in QS4’s account when he described the weeks following his 
admission to hospital as the beginning of getting back to ‘being myself 
again’ ‘Doing normal things’ was an important indicator of mastery in the 
recovery process.  
 
QS14, Lines 241-242 (Female, Black Caribbean) 
 
Int: What do you think makes you better? 
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Resp: When I start doing something with myself – like going to college.  I have 
done a lot of courses – or started them.  When I am low, that is what I 
normally do: go to college, meet people, force myself to get out and have 
a routine.  That is what gets me better – having a routine.  Something to 
do.  Yes. 
 
 
9.7.4 The role of The Self: Constructions of mastery in treatment 
and recovery 
The research questions that have been outlined in Chapter 6 and 
the beginning of this chapter are concerned with uncovering how 
respondents with an 8-12 year history of psychosis and comorbid 
substance use construct their experiences. The themes that have been 
discussed above have aimed at detailing the constructions and patterns 
of constructions in respondents from different ethnic backgrounds, and 
have specifically focused on psychotic experiences and substance use. We 
have also looked at how respondents with comorbidity construct their 
experiences of mental health and substance use disorder treatment 
services which included unpacking the things that were salient to them in 
the treatment and recovery process. 
 
In all respondents accounts it was clear where they placed ‘the 
self’, this often manifested in what role they felt they had to play in their 
recovery process and forms an important part of understanding the 
constructions of experiences given so far. 
 
 
9.7.4.1 Active and passive involvement and control in the 
treatment and recovery process 
 
When respondents talked about their experiences of hospital and 
other treatment services which have been discussed in the above 
sections they spoke of the role they felt they themselves should or did 
play in their own recovery process. Mastery in the recovery process can 
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albeit crudely split into two camps; active involvement, and passive 
involvement. At different times, nearly all respondents gave descriptions 
of active or passive involvement in their treatment pathway, symptom 
management or substance use (n=17). 
 
Table 60: Involvement in the treatment process 
 
 prompted unprompted 
 n % n % 












Active involvement in the recovery process included respondents 
initiating contact with services for the things they were experiencing or 
whether they were involved in the medical aspects of their treatment.  
The latter included having control over the medication they received as 
well as researching and trialling alternative means of treatment such as 
herbal remedies.  The majority of the respondents felt that they had 
taken an active role in their recovery process (n=16).  
 
Initiating interventions was the main theme under active 
involvement. In 10 of the 19 accounts, initiating an intervention was 
discussed. These types of constructions did not vary by ethnicity, but 
only one of these accounts was from a female respondent. Respondents 
were asked questions about what happened around the time of their first 
contact with services, as well as if they had ever sought out help for their 
experiences or drug use. Four respondents gave prompted constructions 
of initiating interventions for themselves, but there were also examples 
from six of the respondents that were unprompted. 
 
QS11 Lines 38-41 (Male, Black African) 
Resp: So I’m on the right course. And during this period, I’ve completed ruts.  
The six step detox. I’ve applied to go into rehab so that I can come out 
equipped with tools to maintain abstinence and also to help me change 
my behaviour and attitude and make personal choices and social 
interactions and confidence and all these sorts of things. So this is the 
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only time throughout my whole time of committing offences and using 
drugs that I personally, not the system, I personally have driven myself 
to the point where I’m saying enough is enough.  
 
Challenging treatment procedures and individual staff members 
was another theme that was elicited in accounts  about  treatment. Data 
under this theme included examples where the respondent was 
deliberately difficult and challenged staff either actively 
(verbally/physically) or passively (not doing things they were asked to 
do). In many of these constructions, respondents were speaking about 
challenging the medication they were expected to take, and often 
challenging the system or individual health professionals happened when 
they were first in hospital and/or suffering acutely from their psychotic 
experiences. Respondents also gave examples of being challenging after 




QS6 Lines 61-66 (Male, Black Caribbean) 
 
Resp: When I first went in it was alright, I met new people and whatever.  And I 
started to feel a bit better in myself. I had some ups and downs with the 
staff, with their attitude and the way they were approaching me.  So I 
kind of like, maybe I should have just settled down a bit.  I kind of like 
aggravated things. 
 
Int: Like what, what do you mean? 
 
Resp: Well, there was an incident where I was in the smoking room with a 
friend, one of the other patients.  And the patient slammed the door 
behind the staff.  And then the staff came and said “Who slammed the 
door?” You know raising his voice.  And “Who kicked the door?  You’re 
here on a prison section - we’ll send you back to prison.” 
 
Int: The staff said that? 
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Resp: Yes.  And after that I kind of like, every time we had a meeting or 
anything I would start saying things about the staff.  About they’re not 
treating us right, and things.  I just got into arguments all the time with 
the staff really.  Two or three.  And the same staff that I had the 
arguments with were quite helpful anyway. 
 
Eight respondents described behaving in a challenging way while in 
hospital or in contact with mental health practitioners. Only a handful saw 
this as a bad thing in retrospect, instead they often justified the 
behaviour. As seen in Table 61, only two of the respondents were White. 
This is consistent with studies that have looked at ethnic differences in 
health service utilisation and who have argued that Black patients are 
often seen to be more aggressive and may be more likely than whites to 
refuse procedures recommended by their physicians (McBean & Gornick, 





Table 61: Challenging treatment by ethnicity 
 

































Related to challenging treatment processes was a theme at the 
heart of the over-arching theme mastery: control in the treatment and 
recovery process. This theme related to whether respondents had felt 
they had control, or should have had control, over aspects of the 
recovery process from formal inpatient and outpatient treatment to 
individual coping strategies for symptom management. It included 
respondents’ conceptions of their decision making processes and having 
ownership of their recovery (e.g. control over whether or not to take 
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medication and subsequently have control over their symptoms, 
experiences or medication side effects).  
 
All respondents gave constructions of the importance of control in 
treatment, regardless of whether they had active or passive responses to 
their treatment, management of psychotic experiences or substance use. 
Fourteen of the respondents detailed control over the medication they 
received (mostly not wanting to take it) as an important aspect of control 
in treatment. The need for control was mostly related the need for 
empowerment in a situation where they had no control, such as in 
hospital on section. However, in 4 accounts (two females and two males) 
the decision not to take medication was taken to protect another aspect 
of their self and their life choices, namely having children. 
 
QS14 Lines 199-200 (Female, Black Caribbean) 
Int:  ...And you had been taking your medication regularly? 
 
Resp: Not really, no.  Because when I was – because in 2006 I didn’t take any.  
I wanted to fall pregnant with her, so I am on and off with it.  I take - at 
the moment I am not taking any sodium sulphate, or whatever it’s called, 
because I am hoping to fall pregnant again, so I can’t take that whilst I 
am doing that.  So I am just on Olanzapine but a very low dose – 5 ml.  
But I find that that is all right for me, so when I talk about my 
medication, whether or not I do get pregnant or whatever, because I 
don’t think… in the past I have been on 25mls of Olanzapine or 1000mls 
of sodium sulphate, but I don’t believe that is necessary.   Because some 
days I won’t take it and I am all right.  So, I believe that that should be 
reviewed in the next three months or something.   
 
Two themes that related to more passive involvement in the 
recovery process where, ‘resigning yourself’ and ‘…because the 
professionals said so’. In both these themes respondents talked about 
taking more of a back seat in the recovery process. Respondents who 
gave constructions of ‘getting on with it’ or ‘resigning themselves’ (n=12) 
were nearly always talking about being in hospital or being on 
medication. In many accounts it was after initially challenging the 
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treatment service or the type of medication prescribed or even family 
that they became almost defeated and gave in. 
 
QS17 Lines 115-116 (Female, Black Caribbean) 
Int: Four weeks. And then you went to a community service after that.  
 How did you find that? 
 
Resp: I didn't find it very helpful. Not very, not too much. I was seeing a 
psychiatrist in Streatham. And I was like, I just went, I won't be in there. 
I was young. I was  seventeen, eighteen. Just turned eighteen. I just 
wanted to get my life back on track. I weren't feeling going and being a 
mental patient. I still don't like it but, well, what  could I do? 
 
QS2 (Female, White) and QS6 (Male, Black Caribbean) along with 
four other respondents, had strong constructions throughout their whole 
account of settling into treatment because of the trust they had in mental 
health professionals, particularly their psychiatrists.  From this theme it 
was clear that respondents believed ‘The doctors know what they are 
doing’ and you must trust that they are correct.  
 
QS2 Lines 710-723 (Female, White) 
Int:  Was there any type of help either medication or therapy or something 
else any other type of help that you would have liked to have got then 
that you didn’t perhaps? 
 
Resp:  You know I was completely unaware of it I would no not really. Not really. 
 
Int:  Ok. 
 
Resp:  Not really no very much trusted the system. 
 
Int:  Yeah. 
 
Resp:  And the you know the medical yeah I completely did again quite used to  
so I, I belong to that well that sort of people that thing that the doctor is 
there to help you and they will help you. 
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Int:  Yeah. 
 
Resp:  And do anything to help you. 
 
Int:  Yeah. 
 
Resp: Otherwise they would never have sworn that oath I don’t know if you live  




Resp:  And that’s what you see. 
 
Int:  No that makes sense. 
 
Resp:  That’s what you expect from everybody from all the doctors and I was 
pretty sure and I was never given the reason to believe differently never 
so. 
 
For a few of the respondents however ‘because the health 
professionals told me’ was conceptualised as them having to do 




9.7.4.2 Understanding my experiences 
 
Constructions of mastery were related to understanding illness 
experiences and mental illness as well as its relationship to substance 
use. All respondents elicited constructions of the importance of 
understanding their experiences (both illness and substance use) during 
their treatment and recovery.  
 
Understanding experiences was not considered the same as 
‘insight’ into illness. For all respondents understanding their experiences 
meant making sense of them within their own model (i.e. not necessarily 
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a psychiatric model). Being able to judge when symptoms were 
reappearing or knowing how to manage experiences both formed part of 
understanding their illness. 
 
QS17 Lines 225-226 (Female, Black Caribbean) 
Int: Do you feel that the psychiatrists or nursing staff or key workers helped 
kind of explain to you what they mean by 'bi-polar?' 
 
Resp: They've tried to tell me but it just goes in one ear and comes out the  
 other. I just know when I'm manic, I'm manic.  
 
Understanding experiences typically fell into two categories: 
understanding the cause of their experiences; and understanding the 
effects of substance use on their experiences. In both of these 
constructions health service staff were often the providers of information, 
however nearly all respondents who were hospitalised had trouble 
recalling whether this information had been given to them during their 
admission.  
 
QS4 Lines 246-248 (Male, White) 
Int: …what did you think was going on with you why did you think you needed 
to go to hospital. did you think…? 
 
Resp: Because I needed to sort of like get help to find out why, why, why this 
all happened and what the causes were and stuff and having someone to 
talk to and, and the support really. 
 
Understanding experiences was also considered something that 
respondents had to learn for themselves, either by researching their 
illness and its relationship to substance use or just being emotionally 
ready to hear information that health service staff gave them about their 
experiences and the negative effects of drug use. 
 
QS9 Lines 328-329 (Male, White) 
Int: Can I ask you actually, before you came into hospital the first time, did 
you have any kind of perception about what mental illness was? 
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Resp: Yes.  I didn't think at the time when they said "Oh you've got mental 
health issues."  I just thought “No, I haven't got mental health issues.”  
Because I didn't class taking drugs as a mental health illness; but then 
when I looked into more I realised what it actually does to you, it affects 
your mental state, then it all sort of clicked. 
 
Table 62: Understanding experience 
  
 n % 
Understanding experiences (n=19) 
Information about illness experiences 







For all respondents constructions of wanting information about 
their illness experiences or information about the relationship between 




Coping strategies formed a part of the constructions of treatment 
experiences and recovery for 18 of the 19 respondents. It should be 
noted that coping strategies were not directly asked about in the 
interview topic guide, and coping strategies were elicited as a secondary 
element of other thematic constructions, such as substance use 
behaviours and views relating to the usefulness of treatment services and 





The second phase of the qualitative study aimed to uncover 
constructions of psychotic illness experiences and substance use in a 
sample of individuals with a clinical diagnosis of comorbid psychosis and 
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drug or alcohol use disorders. From detailed thematic analyses of 19 
accounts it was found that individuals with comorbidity used a variety of 
mechanisms to describe their mental illness, substance use and 
treatment experiences. These included: 
 ‘When’ in time the description of the experience was located (e.g. 
what they thought at the time or what they think now);  
 ‘What’ feature of the experience or event was the respondent 
describing and focusing on in their account (e.g. how they felt or 
what they did); and  
 ‘How’ (or through what lens) the respondent created or gave the 
account of that experience or event (e.g. were they 
intellectualising their experiences or justifying their mental illness 
related behaviours)?  
 
Analysis of these accounts showed that individuals with comorbidity 
constructed their experiences of ‘psychosis’ and drug and alcohol use as 
separate but related. Just less than half of the sample believed they 
currently had or had experienced in the past a mental illness. A minority 
of the respondents who did not construct their psychotic experiences as a 
mental illness did however believe that they had been suffering from 
depression (which was not considered to be a mental illness).  
 
Lay models of causation of psychotic and other illness experiences 
were elicited in all accounts and broadly fell into four frameworks: 
Emotional/psychological; biological; spiritual; or a combination of the 
above. The majority of respondents used a combination causation 
framework (n=10) of illness experience and many respondents had 
different frameworks of causation for their initial episode of illness and 
subsequent episodes of illness.  
 
The most common combinations of aetiological frameworks were 
life events or stress in addition to substance use for respondent’s initial 
episode of illness and substance use and or medication non-compliance 
for illness relapse or exacerbation of symptoms. Black Caribbean 
respondents tended to use emotional or biological frameworks whereas 
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White respondents tended to have combined frameworks. Black British 
respondents used all frameworks except biological and they were the only 
ethnic group to use a spiritual framework.  
 
Causes of initiation of substance use were conceptualised in three 
main ways: psycho-social; physical; and situational. However this was 
not a major theme in accounts. There were three thematic constructions 
of continuation or cessation after respondents’ first episode of psychosis: 
Psychological; Economic/Legal; and Social. The psychological 
constructions of substance use after the initial episode of illness or 
mental health experience were closely linked with themes around 
mastery and involvement in the treatment and recovery process. The 
perception of cannabis use as not being problematic was also an 
important theme.  
 
The relationship between psychotic and mental illness experiences 
and substance use was a major theme in all accounts: the relationship 
between cannabis use and paranoia being the most prominent 
construction. Nearly half of the respondents spoke about their drug use 
and experiences of paranoia. Using substances to self-medicate was a 
theme that related closely to constructions of coping and over half of the 
respondents detailed using drugs or alcohol in this way at some point 
since their first episode.  
 
In answering the research question how individuals with 
comorbidity of psychosis and substance use disorders constructed their 
experiences of mental health and substance abuse treatment services the 
qualitative study found  that support  could come from several sources: 
including Mental health services, drug treatment services, GP, Wider 
society/local community, Family or friends, Church or from oneself.  
 
Most respondents felt mental health services (including 
hospitalisation) were a useful form of support. There were no notable 
differences in respondents by ethnicity and compulsory admission, 
however all but one of the females had had a compulsory admission. 
 370 
Despite hospitalisation being seen as useful it was often related to the 
feeling of being imprisoned. 
 
Types of support was categorised in three broad ways: 
Psychological; Social/Practical; and Medical. The majority of respondents 
drew support in all three categories and 14 of the 19 respondents felt 
talking about problems was a useful therapeutic tool.  
 
Many respondents believed having mental health services give 
them information about drugs was useful but mastering your addiction 
yourself was considered key. This often meant initiating treatment 
yourself despite it being offered by mental health services or GPs. For 
respondents that continued substance use this was done on the basis 
that they could stop if they wanted (i.e. may not have a problem) and so 
did not need help regardless of whether they saw a relationship between 
their symptoms and drug use. 
 
A number of respondents described the role of their family in their 
treatment and recovery process. Involvement on the whole was 
considered positive although perceptions at the time of experiences 
differed from those viewed retrospectively.  
 
The role of self and mastery in substance use, treatment 
experiences and recovery from illness was a salient theme and returning 
to ‘Normality’ featured heavily in accounts. Many respondents also draw 
comparisons both explicitly and implicitly between their own illness 










Chapter Summary 9.   
Chapter Summary 
 
Aims of the Chapter: 
 






 Individuals with comorbidity used a variety of account mechanisms 
to construct their mental illness, substance use and treatment 
experiences 
 A key construction throughout all accounts was lay models of illness 
aetiology 
 The relationship between psychotic and mental illness experiences 
and substance use was a major theme in all accounts: the 
relationship between cannabis use and paranoia being the most 
prominent construction. 
 Individuals with comorbidity constructed their experiences of 
‘psychosis’ and drug and alcohol use as separate but related 
 Using substances to self-medicate was a theme that related closely 
to constructions of coping 
 Support networks were constructed as coming from several 
sources: including Mental health services, drug treatment services, 
GP, Wider society/local community, Family or friends, Church or 
from oneself.  
 Perceptions of the role of family and friends was on the whole 
positive but current percpetions of involvement often differed from 
retrospective percetions 
 Mastery and returing to ‘normal’ was a key theme in the treatment 
and recovery process 
 Comparisons both explicitly and implicitly between individuals own 
illness experiences and that of other patients were often drawn. 
 Expereinces of services were mostly constructed as a useful form 




CHAPTER 10: DISCUSSION 
 
10.1 SUMMARY OF FINDINGS 
10.1.1 Quantitative results summary: 
The findings from the quantitative investigation support the 
hypothesis that the prevalence of comorbid substance use disorders 
(SUD) in individuals with an 8-12 year history of psychosis differ 
according to ethnic group and that the prevalence of comorbid substance 
use disorders is lower in Black Africans compared to Whites. However, 
the findings did not support the hypothesis that the prevalence of 
comorbidity is higher in Black Caribbeans compared to Whites. 
 
When drugs and alcohol were looked at separately, significantly 
less drug and alcohol use as well as drug and alcohol use disorders (DUD 
and AUD) were found in Black African patients compared to White and 
Black Caribbean patients when potential confounders were adjusted for. 
Black Caribbans did not have an increased prevalence of DUD and AUD. 
Interestingly after adjustment, risk for drug use and use disorders in the 
Black Caribbean patients had a trend for being lower than in White 
patients. Risk for alcohol use and use disorders were significantly less 
likely in Black Caribbean patients compared to White patients.   
 
The second hypothesis that comorbidity is negatively associated 
with psychotic relapse and hospital admission in all ethnic groups was not 
supported.  
 
Despite the negative finding relating to prevalence of comorbid 
SUDs in Black Caribbean patients, a trend of increased likelihood for 
negative outcomes (i.e. episodic or neither episodic nor continuous illness 
course, increased frequency of psychotic relapse, increased frequency of 
hospital admission and compulsory hospital admission), was found in 
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Black Caribbean patients with DUD. This pattern was not found in White 
patients. These findings did not reach statistical significance however.  
 
Interestingly significantly lower risk for psychotic relapse in the 
comorbid DUD group was found in White patients and significantly lower 
risk for psychotic relapse was found in the alcohol use groups for Black 
Caribbeans. Black Caribbeans were also significantly less likely to have 
had several hospital admissions if they were alcohol users compared to 
never using alcohol. 
 
Not surprisingly White patients with comorbid AUD showed a trend 
of higher rates/risk for negative outcomes (i.e. increased frequency of 
psychotic relapse, increased frequency of hospital admission and 
compulsory hospital admission) compared with patients from Black ethnic 
groups. These findings unfortunately failed to reach statistical 
significance. White patients with comorbid DUD however, were 
significantly more likely to have had a compulsory hospital admission (OR 
4.435, CI 1.398-14.062, p= 0.011). 
 
Black Africans who had a low prevalence of both drug and alcohol 
use disorders had significantly lower rates of psychotic relapse in the 
alcohol use and comorbid alcohol use disorder group (compared to non-
users) (RR 0.162, CI 0.057-0.463, p= 0.001). Black Africans were also 
less likely to have frequent hospital admissions (comorbid DUD; alcohol 
use; and comorbid AUD) and compulsory hospital admissions (comorbid 
AUD only). This pattern was not observed in Black Caribbean or White 
patients. However these differences were only significant for frequency of 
hospital admission in the alcohol comorbid group (Alcohol use: RR 0.624, 







10.1.2 Qualitative results summary: 
The second phase of the qualitative study aimed to uncover 
constructions of psychotic illness experiences and substance use in a 
sample of individuals with a clinical diagnosis of comorbid psychosis and 
drug or alcohol use disorders. It aimed to both describe if and how the 
problem of comorbidity differs for ethnic minorities in psychotic 
populations and to identify conceptualisations illness and substance use. 
The study also aimed to explore the impact comorbidity might have on 
attitudes towards the perceived usefulness of treatment approaches 
(namely hospitalisation, community treatment) and the role family, 
friends and alternative forms of support play in the recovery process. 
 
From detailed thematic analyses of 19 accounts it was found that 
individuals with comorbidity used a variety of mechanisms to describe 
their mental illness, substance use and treatment experiences. These 
included: 
 ‘When’ in time the description of the experience was located (e.g. 
what they thought at the time or what they think now);  
 ‘What’ feature of the experience or event was the respondent 
describing and focusing on in their account (e.g. how they felt or 
what they did); and  
 ‘How’ (or through what lens) the respondent created or gave the 
account of that experience or event (e.g. were they 
intellectualising their experiences or justifying their mental illness 
related behaviours)?  
 
Just less than half of the sample believed they currently had or had 
experienced in the past a mental illness. A minority of the respondents 
who didn’t construct their psychosis related experiences as a mental 
illness did however believe that they had been suffering from depression 
(which was not considered to be a mental illness).  
 
Lay models of causation of psychotic and other illness experiences 
were elicited in all accounts. The majority of respondents used a 
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combination causation framework (n=10) of illness experience and many 
respondents had different frameworks of causation for their initial 
episode of illness and subsequent episodes of illness. Black Caribbean 
respondents tended to use emotional or biological frameworks whereas 
White respondents tended to have combined frameworks.  
 
Reasons for initiation of substance use as well as changes in 
substance use were elicited in most accounts. There were no observed 
differences in gender, ethnicity, or whether respondents saw themselves 
as having a problem with substances in the frameworks of substance use 
initiation. The psychological constructions of substance use after the 
initial episode of illness or mental health experience were closely linked 
with themes around mastery and involvement in the treatment and 
recovery process.  
 
The relationship between psychotic and mental illness experiences and 
substance use was a major theme in all accounts; the relationship 
between cannabis use and paranoia being the most prominent 
construction. Nearly half of the respondents spoke about their drug use 
and experiences of paranoia. Using substances to self-medicate was a 
theme that related closely to constructions of coping and over half of the 
respondents detailed using drugs or alcohol in this way at some point  
since their first episode. 
 
The perception of cannabis use as not being problematic was also an 
important theme but was not always related to decisions to give up 
cannabis use. Many respondents believed having mental health services 
give them information about drugs was useful but mastering their 
addiction themselves was considered key. Seeing a relationship between 
relapse or symptom reoccurrence and substance use was related to 
respondents’ decisions to stop using substances but this was tempered 
by a desire to continue using cannabis socially. Understanding the 
relationship between illness experiences and substance use was salient to 
most respondents but this tended to happen over time.  
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Support was considered to come from several sources: including 
mental health services, drug treatment services, GP, wider society/local 
community, family or friends, church or from oneself. Many respondents 
felt mental health services were a useful form of support but the majority 
gave constructions of the role they themselves played in their recovery. 
Hospital was mostly seen as useful. There were no notable differences in 
respondents from the qualitative study by ethnicity and compulsory 
admission, however all but one of the women had had a compulsory 
admission. A theme relating to the feeling of being imprisoned was 
associated with hospitalisation.  
 
Types of support was categorised in three broad ways: psychological, 
social/practical; and medical. The majority of respondents drew support 
in all three categories and most felt talking about problems was a useful 
therapeutic tool. A number of respondents described the role of their 
family in their treatment and recovery process. Involvement on the whole 
was considered positive although many had mixed feelings.  
 
The role of self and mastery in substance use, treatment experiences 
and recovery from illness was a salient theme and returning to 
‘Normality’ featured heavily in accounts. Many respondents also draw 
comparisons both explicitly and implicitly between their own illness 
experiences and that of other patients. 
 
 
10.2 METHODOLOGICAL LIMITATIONS 
10.2.1 General 
A major strength of the AESOP-10 study which the first phase of 
the PhD utilised data from, was that it was a large epidemiological study. 
Participant identification and recruitment procedures were standardised 
and data for the main outcome variables (diagnosis of psychotic illness 
and substance use disorders) were collected and collated using three 
different sources: patient interview, key informant (usually family 
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member) and clinical records. These were then assessed against ICD-10 
criteria (following consensus meetings).  
 
However, there are limitations to this phase of the PhD study that 
should be noted. Despite recruiting large numbers of FEP patients for the 
AESOP baseline study, and achieving a 90.4% follow-up rate for the 
AESOP-10 study, sample size was a limitation. A relatively small number 
of participants were diagnosed with a substance use disorder and 
numbers of patients with a substance use disorder from Black African 
ethnic groups were tiny (n=6). This meant that is was not possible to 
conduct some of the adjusted statistical tests for Black African patients 
that were necessary to determine differences by ethnic group and to 
accurately address the study hypotheses. This has an impact on the 
generalisability of the study and reliability of results. 
  
Differences in the sample characteristics between the two study 
centres were explored in sections 8.2 and 8.3. These differences might 
suggest data from each centre should be analysed separately and 
questions about pooling the data are raised.  As the PhD involved only 
two study centres there was insufficient data to treat centres as clusters. 
For completeness and transparency stratified analyses by study centre 
were conducted alongside pooled whole sample analyses and stratified 
analyses by ethnic group to explore the effect comorbid substance use 
disorders has on risk for negative outcome.  
 
Differences in the risk for relapse and hospital admission between 
non-substance users and those with comorbid diagnosis were found 
between the two study centres.  These differences are most likely to do 
with differences in the ethnic distribution of the London and Nottingham 
samples however other sample differences (which may not have been 
measured) may have been present.  Although the significantly smaller 
proportions of patients from both of the Black ethnic groups in the 
Nottingham sample meant data from both study centres needed to be 
pooled the stark study centre differences in the odds and rate ratios for 
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negative outcome highlight the limitation of pooling data and should be 
noted when interpreting the findings.  
 
Furthermore it would be fair to argue that a better measure of 
frequency of compulsory admission would be to look at the rates of 
compulsory admission. However, a limitation of this study is that the data 
for legal status on admission to hospital was limited meaning that it was 
only possibly to look at compulsory admission in terms of its presence or 




The final sample for phase one of the PhD study excluded patients 
with a follow-up of less than eight years and patients that had moved 
abroad or died. The included sample had significantly less White males 
than the excluded sample. In addition analyses of the excluded sample 
showed that patients that had moved abroad tended to be from Black 
African ethnic groups. These differences are likely to have led to some 
selection bias. 
 
Although substance use was measured using three sources in the 
AESOP-10 study information relating to drug use parameters, for 
example, frequency, quantity, duration and type (e.g. type of drug that 
was misused) of use were not available. It would have been of particular 
interest to investigate this in order to ascertain whether there is an 
association between quantity and frequency of substance misuse and 
negative outcome over time as demonstrated in studies looking at dose-
response of cannabis and psychotic relapse (Linszen et al., 1994). 
Additionally it is possible that certain ethnic groups tend to have longer 
periods of substance use disorder or misuse certain types of drugs. Those 
differences may have explained differences in clinical outcome. 
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In addition the lack of corroboration of self-reported drug use and 
drug use identified through examination of clinical records with biological 
techniques such as hair or urine analyses may have led to bias (for 
example social views about drug use in certain ethnic groups may lead to 
increased or decreased likelihood of drug use disclosure). Previous 
studies have shown that hair analysis in patients with schizophrenia is a 
well-tolerated, sensitive test for substance use disorders and has several 
advantages over questionnaires and urine analysis for clinical and 
research purposes (McPhillips, Kelly, Barnes, Duke, Gene-Cos & Clark, 
1997). 
 
Although corroborated in the majority of cases by self-reported 
information, data relating to frequency of hospital and compulsory 
hospital admission were also limited. Information from clinical records 
was sometimes incomplete in relation to legal status on admission. A 
subsequent limitation of this study is that the data for compulsory 
admission over the follow-up period was limited the presence or absence 
of a compulsory admission and frequency of compulsory of admissions 




Due to smaller than predicted numbers of patients with comorbid 
substance use disorders in the ASEOP-10 study a second power analysis 
calculation was performed to estimate the study power of the final 
sample.  Looking at prevalence of comorbid alcohol use disorders (AUD), 
tests with a 0.05 two-sided significance level were found to have 98% 
power to detect the difference between White patients (Group 1) with 
64% prevalence of comorbid AUD and Black African patients (Group 2) 
with 14% prevalence of comorbid AUD (unadjusted odds ratio of 0.093) 
when the sample sizes were 42 and 21, respectively (a total sample size 
of 63, which included those with no alcohol use and those with comorbid 
AUD). The study was found to have high statistical power in the alcohol 
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use group however power may not have been so high in the drug use 
group and subsequently may have increased the chance of a false 




Confounding involves error in the interpretation. Confounders 
(which are factors that have a relationship with both the independent and 
dependent variables) if known, are often dealt with by stratification or 
adjustment in analyses. Confounders in the PhD study were selected 
based on previous research in this area.  
 
Indicators of social disadvantage (e.g. housing, employment and 
education) and medication compliance were measured in the AESOP-10 
study using the WHO Life Chart. However data was often limited and 
incomplete. A limitation of the findings relating to negative outcome was 
that measures of social deprivation, which has been associated with 
ethnicity (Brugha et al., 2004), substance use (Peck & Plant, 1986) and 
risk for psychotic illness (Harrison et al., 1995) as well as medication 
compliance were not controlled for. 
 
 
10.2.5 Reverse causality 
A major limitation of the PhD study relates to the nature of the 
data collected on substance use. The Life Chart gave an overall measure 
of drug or alcohol use in the lifetime before follow-up. Several issue with 
this need to be highlighted. 
 
Firstly although information about the periods of substance use 
were collected for patients that scored for abuse or dependence a high 
proportion of this data was missing making meaningful analysis by ethnic 
groups could not be conducted. This leaves us with the unanswered 
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question, are their ethnic differences in the prevalence of substance use 
disorders prior to onset vs. after onset of psychotic illness?  
 
Secondly, causality is also an issue here. We cannot make any 
inferences about causality without knowing first knowing whether a SUD 
preceded onset of psychotic illness or not. In addition, if there are ethnic 
differences in prevalence of SUDs before and after the onset of psychotic 
illness then do these difference account for ethnic differences in 
frequency of hospital admission (including frequency and likelihood of 
compulsory admission), illness course type and frequency of psychotic 
relapse? It is possible that certain groups of patients who experienced 
multiple hospital admissions or multiple relapses did so because of on-
going and sustained substance misuse and once this is controlled for the 
ethnic differences may vanish. 
 
 
10.2.6 Methodological considerations of mixed method and 
qualitative research 
 
Reliability and validity are realist research evaluation criteria and 
so have often been considered inappropriate for evaluating qualitative 
research (Kelle & Laurie, 1995). The philosophical approach that PhD 
study took however was a subtle form of realism. Subtle realism as I 
discussed in Chapter 5 combines realist ontology with a constructivist or 
idealist epistemology. This theoretical combination is compatible with 
both quantitative and qualitative enquiry and facilitates the use of both 
these research methods in a mixed method design. Silverman (1993) 
proposes a number procedures within a subtle realist framework that can 
increase the validity of qualitative research; careful case selection, on-
going hypothesis testing, inductive analysis, and quantifying through 
counting. He also proposes that reliability can be addressed through 
standardised methods for taking down field notes and transcribing taped 
interviews and by having peers review the data analysis.  
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In addition Corbin and Strauss (1990) argue that there are several 
criterion from which qualitative research can be evaluated including:  
 Interrelating the  collection and analysis;  
 considering concepts an basic units of analysis (i.e. data is a 
conceptualisation of events not events themselves);  
 developing and interrelating categories;  
 using a constant comparison method (i.e. an incident is noted, 
and should be compared against other incidents for similarities 
and differences);  
 making sure patterns and variations should be accounted for 
and process (breaking a phenomenon down into stages, or 
steps), built into the theory; and writing theoretical memos  
(Corbin & Strauss, 1990) 
 
A number of these procedures were undertaken during data 
collection and analyses including; piloting of the interview topic guide, 
making reflexive field notes and memos, using experienced organisations 
to transcribe the interview data; involving co-coders in the analysis 
process; and developing categories and highlighting typologies of themes 
by respondent characteristics in order to propose theory. 
 
Moreover, reliability and validity are concerned with knowledge 
creation. As mentioned in Chapter 5, Hamilton (2002) has offered an 
alternative definition of knowledge: beliefs in which one can have 
reasonable confidence in their validity or truth. This definition falls in line 
with what Hammersley (1992) considers a ‘common sense’ 
understanding and consensual notion of what constitutes social 
knowledge. This standpoint is particularly useful when judging the validity 
or truth of such knowledge generated through research findings.  
 
Hammersley (1990; 1992), has argued however that while the 
same criteria should be applied to both qualitative and quantitative 
research, there are some problems with the conventional criteria of 
 383 
validity and reliability and that some modifications should be made. 
Validity for example, in part derives from the way a sample was selected.  
 
Many of the limitations of the qualitative study were the product of 
the design which was largely determined by the timing of recruitment for 
the AESOP-10 study. The study used convenience sampling which may 
increase the likelihood of selection bias. A larger number of interviews 
with equal numbers of men and women and ethnic backgrounds as well 
as different age groups may have allowed for some degree of theoretical 
saturation. However  the number of eligible patients from the AESOP-10 
study that had been traced and assessed at the time of recruiting for the 
qualitative study was small and subsequently a smaller than anticipated 
number of eligible patients were approached for the qualitative study. 
The final sample was biased towards young men from White and Black 
ethnic backgrounds.  
 
The PhD qualitative study was partly exploratory in design and as 
I’ve highlighted, based on convenience sampling.  Interpretation of 
studies that use purposive or convenience sampling are limited to the 
population under study and it is important to bear this in mind when 
coming to conclusions about the study findings (Bernard, 2006). In other 




10.3 FINDINGS FROM BOTH STUDIES IN RELATION TO 
PREVIOUS LITERATURE: CONNECTING THE DATA AND 
GENERATING HYPOTHESES 
 
One of the main aims of the qualitative study was to explore  
constructions of psychotic illness and substance use in persons with 
comorbidity. In exploring constructions the aim was to, in part, to explain 
(or generate hypotheses about), if there were ethnic differences in 
prevalence and outcome of comorbidity, why those differences may exist. 
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The study also aimed to help uncover some of the complexities of the 
lived experience of people with both disorders as well as highlight the 
need for further areas of investigation around clinical and service use 
outcomes, experiences of health services and the role social networks 
play in outcome and recovery.  
  
 
10.3.1 Prevalence of comorbidity 
As with many of the studies reviewed in this thesis, the PhD study 
found ethnic differences in prevalence of comorbidity.  Slightly lower 
rates of drug use and drug use disorders were found in Black Caribbean 
patients compared to White patients. This finding is similar to that of 
Cantwell et al., (1999), however rates were only marginally lower and 
these did not reach statistical significance. These findings may be 
explained by changing patterns in types of drugs used or alternatively by 
an increase in overall drug use disorders in psychiatric patients from a 
Black Caribbean ethnicity.  
 
It is noteworthy that most other studies have failed to look at 
differences beyond the crude ‘Black’ and ‘White’ divide (e.g. Copeland et 
al., 2003; Ahuja et al., 2007; Strakowski et al., 1992) and differences 
between Black Caribbean and Black African groups were only explored in 
three studies in the PhD study systematic review. Consequently, the 
finding that Black African patients have a significantly lower prevalence of 
substance use disorder compared to White and Black Caribbean patient is 
a novel one.  The small sample size in the Black African group should be 
noted when interpreting this finding however. In addition the study 
supported findings by Miles et al. (2003) that alcohol use disorders were 
more prominent in White ethnic groups. Similarly this finding was 
observed in an earlier study by Cantwell et al. (1999). 
 
Studies such as Afuwape et al., (2006) have found equivalent rates 
of drug use disorder in White and Black Caribbean patients with 
psychosis. A similar observation was found in the PhD study however 
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after controlling for age, gender, diagnosis and study centre lower rates 
of comorbid DUD were observed compared to Whites.   
 
Although the difference between Black Caribbean and White 
patients risk for drug use disorders was not statistically significant the 
prevalence of drug use disorders in Black Caribbean patients was 
observed to be much higher (40%) in this study than in other U.K studies 
which estimated prevalence between six and seven per cent (Cantwell et 
al., 1999; Afuwape et al., 2006). This may be due to the study not 
separating out Black patients that were British born. A study by Afuwape 
at al. found that when Black African and Black Caribbean groups were 
split into those who were British born and not, the Black British born 
patients had significantly higher prevalence (40%) of comorbidity than 
any other ethnic group (White = 6% and Black Caribbean = 7%), 
(Afuwape et al., 2006). 
 
The qualitative study did not find any definitive observable 
differences between Black Caribbean and Black African individuals that 
might help explain the difference in prevalence of comorbidity. Moreover 
the samples of Black African patients in both phases of the PhD study 
were also too small to make any meaningful conclusions. 
 
However findings from the qualitative study do highlight further 
questions around the relationship between comorbidity and ethnicity. In 
critique of one of the prominent theoretical models of comorbidity 
aetiology, drug use in the qualitative study (which was already present in 
most of the respondents) was constructed as one of the main causes of 
mental illness experiences.   
 
We have seen that Black African and Black Caribbean groups have 
been found to have elevated risk for psychotic disorders (Fearon et al., 
2006). In addition research has shown that in the general population 
drug use can be higher in some ethnic groups. If drug use was the sole 
cause of psychotic illness and Black Africans we would expect to see 
higher levels of substance use in Black African and Black Caribbean 
 386 
groups. This was obviously not found in the quantitative study. Other 
factors such as negative events may also play a part in risk for psychotic 
illness however how these factors are interrelated with substance use 
needs further exploration. 
 
How far does the aetiology of substance use help explain the 
aetiology of comorbidity? And leading on from that, could ethnic 
differences in the reasons for substance use help explain ethnic 
differences in prevalence of comorbidity? 
 
Despite substance use being constructed as a causal factor in 
illness experiences, many of the respondents in the qualitative study 
described the initiation of substance use in response to what could be 
considered prodromal symptoms, such as depression. Others described 
initiation of a substitute substance as a way of managing other illness 
experiences such as psychotic phenomena (self-medication). Many 
respondents, however, described their early substance use in relation to 
situational factors suggesting initiation of substance use in comorbid 
populations is similar to that found in the general population. This finding 
is similar to that of Bradizza & Stasiewicz (2003).  
 
These findings highlight the need to explore substance use course 
in relation to psychotic illness course. Because patterns of drug use 
before and after the initial index of illness were not explored in the first 
phase of the study and were not categorisable in the second phase of the 
study, it is difficult to unpick the role non-problematic drug use plays in 
risk for comorbid diagnosis. Although there were no observed ethnic 
differences in respondents’ accounts of initiation of substances it is 
possible that ethnic differences in substance use patterns may play a role 
in explaining prevalence of diagnosable comorbid substance use.  
 
One factor that is noteworthy in the discussion of ethnic 
differences in the relationship between substance use initiation and the 
risk for comorbidity is that, although cannabis use was not explicitly 
examined in the first phase of the study it was a significant theme in the 
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qualitative study. Moreover, data relating to the type of drug that led to 
comorbid diagnosis was not available in the quantitative study.  Cannabis 
was found to be the most common drug used in the qualitative study and 
a proportion of respondents experienced problematic cannabis use. 
However, reasons for continuation and cessation of cannabis were 
different from cessation and continuation of other drugs or alcohol. In 
addition, although no ethnic differences in the use of cannabis were 
found it is possible that reasons for the initiation of cannabis use may 
differ by ethnicity.  
 
A further question raised by the qualitative study is what role does 
social disadvantage play in ethnic differences in the risk for comorbidity? 
Detailed constructions of how respondents conceptualised their own 
ethnicity were summarised in section 9.2.2.  These constructions were 
framed within a person’s nationality, colour or religion. Furthermore all 
respondents gave constructions of the difficulties leading up to their first 
episode of psychosis and questions around unfair treatment were also 
asked of all respondents.  
 
Constructions of social disadvantage (for example difficulties with 
education, housing or occupation) were not expressed in any of the 
accounts in relation to larger constructions of ethnicity or as direct 
reasons for either illness experiences or substance use. Instead, general 
‘stress’ and individual negative life events (such as losing a family 
member or friend) had much more prominence in accounts of illness 
aetiology and substance use. Interestingly however, difficulties with 
social relationships (most commonly intimate relationships) did form part 
of constructions of illness aetiology, substance use initiation and changes 
in substance use. As well as pointing to the obvious role of larger social 
networks in health beliefs, relationship status and social networks have 
been shown to be an indicator of social disadvantage (Morgan et al., 
2008). 
 
The role social disadvantage plays in the increased risk of minority 
groups having mental illness or substance use was discussed in section 
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2.3.4. Delineating this relationship was not a primary objective of the 
PhD study. However this relationship warrants further discussion. While 
Black Caribbeans have a higher risk for psychotic illness and cannabis 
use, findings from phase one of the study have shown that Black 
Caribbean patients do not have higher risk for comorbid substance use 
disorders than White patients. Equally Black African patients had 
significantly lower rates of risk for comorbidity compared to White 
patients. While social disadvantage may play a role in overall risk for 
comorbidity, these findings call into question social disadvantage as a 
mediating factor in the risk for comorbidity in minority groups (i.e. that 
social disadvantage which is more prominent in minority groups explains 
higher risk in minority groups for comorbidity). 
 
Although social disadvantage may play a role in substance use 
problems, it is likely that individual life events and negative experiences 
and eventually self medication for mental illness symptoms may play a 
bigger role. These factors may not be more prominent in any one ethnic 
group. Consequently, reasons for ethnic differences in comorbidity and 
outcome remain unexplained. 
 
 
10.3.2 Comorbidity, ethnicity and negative outcome: 
Psychotic relapse 
A question raised by the quantitative study is why were substance 
use and substance use disorders in some ethnic groups found to be 
protective for having further psychotic relapses? The PhD study failed to 
measure differences between patients who had substance use disorder 
before their first episode of illness and those who developed them after.  
In a review of comorbid substance use disorders in patients with 
psychosis, Wisdom et al. (2011) observed that in many of the studies 
patients who adopted abstinence reduced their rates of relapse, whereas 
those who continued to abuse substances experienced increased rates of 
relapse. This observation would only help explain findings in the PhD 
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study where substance use was protective but comorbid SUD wasn’t (as 
was the trend observed for Black Caribbeans in the drug group).  
 
Similar to observations in a study by Drake et al., (2011), Wisdom 
et al. (2011) argued that it is possible that a significant proportion of 
patients who were using or abusing alcohol and other drugs before or just 
after their FEP may have reduced their substance use or became 
abstinent as a result of the trauma of a psychotic experience itself and/or 
the education they received about preventing relapses. With the 
increasing use and abuse of cannabis (in the general population and 
within psychotic patient populations) and an increasing body of 
knowledge suggesting a causal relationship between cannabis and 
psychotic illness, observations such as these may help explain patterns of 
relapse found in the PhD study.  
 
One important note is that equivalent rates of relapse between 
drug users, those with comorbid DUDs and non-drug users found in the 
whole sample are explained by the higher rates of risk in Black 
Caribbeans and lower rates of risk in White patients. A failing of the study 
is that relapse rates in the Black African group only were not able to be 
examined.  
 
Findings from the qualitative phase of the PhD study show that 
substance use (in particular illicit drug use) was firmly built into lay 
models of causation for the first episode of psychosis (initial illness 
experiences) as well as models of causation for illness relapse 
(subsequent illness experiences) in patients with comorbidity. These 
models may help explain ethnic differences in the rates of relapse found 
in the first phase of the study in a couple of ways.  
 
Firstly, for a large proportion of respondents substance use was 
constructed as related to self-medicating symptoms leading up to first 
contact with services. These findings are similar to those of Bradizza and 
Stasiewicz (2003) (which examineddifferences between patients with 
SUD only and those with psychosis and SUD), who found self-
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management and mastery of psychosocial stresses through self-
medication of substances was key. Although the qualitative study 
observed this behaviour across all ethnic groups with both drug and 
alcohol use disorders it is conceivable that certain groups of patients are 
more likely to use substances in this way. 
 
Secondly, and in contrast to observations found in the above 
studies (Drake et al., 2011; Wisdom et al., 2011), continuation of 
substance use was found in many respondents for some or most of the 
time period since their first episode. Cannabis (the most popular drug of 
choice), in particular, was considered fundamentally different from other 
drugs and despite many respondents having an awareness of the 
relationship between cannabis, paranoia and their mental illness 
experiences, discontinuation of this particular drug was (in many cases) 
not desired. The quantitative study failed to separate out cannabis use 
from other drug use and evidence has shown increase in comorbid 
cannabis use disorders in psychotic populations (Donoghue et al, 2011), 
which has significant implications because of the relationship between 
cannabis and psychotic illness. Although there were no observed 
differences in the continuation of cannabis use by ethnicity in the 
qualitative study, continuation of cannabis use may go some way to 
explaining higher rates of relapse in comorbid populations despite 
individuals constructing drug use as one of the causal factors in illness 
experiences. 
 
It should be noted that in the qualitative study respondents 
constructed reduction or cessation of substance use as taking time and 
change in substance use behaviour was related to two factors: firstly 
understanding the relationship between substance use and symptoms 
themselves (mastery); and secondly being ready to cut down or stop. 
Attitudes to drug use and health belief in larger cultural and immediate 
social networks as well as objective and subjective perceptions of social 
disadvantage are also likely to play their part. However, explanations for 
ethnic differences in rates of psychotic relapse point more towards choice 
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of substance than indicators of social disadvantage.  Especially as certain 
minority group ethnicity may indeed be protective (e.g. Black African). 
 
Turning lastly to illness course, the findings from both studies beg 
the question, why would comorbidity be related to illness course? A trend 
of a slight increased risk for episodic or neither illness course type was 
found in patients with comorbid DUD and decreased risk for these two 
illness course types in patients with comorbid AUD (these findings were 
not statistically significant).  
 
A study by Goswami et al., (2003) which looked at illness course in 
schizophrenic patients in relation to substance use course found that 
substance use course did not lead to poor illness course in schizophrenia. 
However, substance use increase did precede exacerbation of 
schizophrenia symptoms at first episode. Conversely decrease in 
substances did not lead to an increase or decrease of illness symptoms.  
 
A critique of comparing this study to the PhD study is that firstly, it 
had very small sample (n=22) and secondly illness course was 
categorised as total time (in months) either psychotic, non-psychotic or 
in remission rather than by the pattern off illness course. It is plausible 
that substance use (which may go through periods of cessation as well as 
abusive use) over the course of a person’s psychotic illness may lead to 
increased frequency of relapse and hinder remission from previous 
episodes. This pattern of use would ultimaley result in an episodic type 
illness course which was observed in the quantitative study. 
 
 
Hospitalisation, sectioning, the criminal justice system and the role of the 
family 
Findings from the quantitative phase of the PhD show that patients 
in the Black African group who had comorbid AUD were found to have 
significantly lower rates of hospital admission than non-users. Equally 
this pattern was observed in Black Caribbean patients with alcohol use. 
This finding is in complete contrast to the unadjusted findings of Afuwape 
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et al. (2006), as part of the UK COMO study which found higher levels of 
admissions in Black African patients with comorbidity. Although the desire 
to continue to use cannabis after the index episode was found across all 
ethnic groups in the qualitative study, it is conceivable that this, 
alongside fear of rehospitalisation under section and the subsequent loss 
of power, control and feelings of being ‘normal’ experienced during 
previous admissions may go some way to explain why certain people who 
experienced comorbid SUDs (and may have experienced family or health 
professional monitoring of their drug use) avoid voluntary hospitalisation. 
 
White patients with comorbidity however had significantly higher 
likelihood of having a compulsory admission than those with no drug use. 
This pattern was also observed in Black Caribbeans but not Black 
Africans. This finding again is somewhat different to the study by 
Afuwape et al. who found Black British patients with comorbidity to have 
the highest rates of compulsory admission and may be explained by a 
higher proportion of Black British patients in the Black Caribbean group 
than in the Black African group in the PhD study.  
 
There were no notable differences in respondents from the 
qualitative study by ethnicity and compulsory admission, however all but 
one of the women had had a compulsory admission. Constructions of 
hospitalisation as being similar to being in prison were equally spread 
across ethnic groups and men and women, and the majority of 
respondents saw hospitalisation this way. What this does tell us is that 
regardless of ethnicity (or gender) whether a patient is hospitalised under 
section or not the feeling that they are ‘under lock and key’ is 
experienced. The qualitative study also highlights that even when 
patients experience sectioning the overall benefits of hospitalisation is 
still felt, albeit retrospectively. 
 
Wisdom et al. (2011) found in their review of comorbid psychosis 
and substance use that one study reported significant differences in 
involuntary hospitalisations and arrests between drug abusers and non-
abusers at baseline; however these differences were no longer significant 
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at follow-up (Archie et al., 2007). This may have been explained by 
patients becoming abstinent after their FEP which in turn reduced their 
rates of hospitalisation, whereas those who continued to abuse 
substances experienced increased rates of hospitalisation. As with the 
findings for comorbidity and psychotic relapse, the PhD study failed to 
measure differences between patients who had substance use disorder 
before their first episode of illness and those who developed them after, 
so this relationship could not be tested.   
 
According to Zola’s (1973) model of help-seeking, people may 
draw upon 'lay referral' systems (family, friends ) or engage in 'self-
medication' or alternative therapies instead of or in addition to seeking 
help from professional medical services. What this model as well as 
similar models of help-seeking highlight is how culturally-shaped beliefs 
about illness in individuals as well as the conceptualisation of illness by 
significant others both play a part in the ultimate responses to illness and 
decisions to seek help (Morgan et al., 2004). Findings from the 
qualitative study which uncovered constructions of self-medication as a 
reason for initiating substance use before and after FEP highlight how 
substance use could be considered an alternative to hospital. 
 
Factors significantly associated with compulsory admission in a 
study by Cole et al. (1995) were absence of GP or family/friends 
involvement. Burnett et al. (1999) similarly found that sociodemographic 
and service related factors were the most important in pathways to care 
at first contact. In the qualitative study for this PhD respondents 
described the role of their family in their treatment and recovery process.  
 
Some respondents gave constructions of not wanting to rely on 
family to support them because of feelings of guilt. Substance use was 
sometimes hidden from family members and some of the respondents 
from Black ethnic groups’ constructed worry about the burden on family, 
disliking family interference in the treatment process or acceptance of 
family members needing to lead their own lives as reasons for reduced 
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family involvement. Moreover, of the six respondents that had had 
contact with the criminal justice system during their illness (either in 
relation to or separate from hospitalisation), four were from Black ethnic 
backgrounds.  
 
Although the frequency of these constructions was small and 
negative constructions of family involvement were mainly from Black 
Caribbean as well as Black African individuals, the findings may help 
explain higher rates of risk for compulsory admission in general as well as 
ethnic differences in service utilisation. 
 
However,  four respondents in particular spoke of their families as 
being a constant source of support during the initial stages of illness as 
well as subsequent episodes. Support during their treatment was part of 
this but relationships irrespective of the respondents illness were key. 
Being able to talk to family about problems, having family pay attention 
to indicators of illness relapse were all seen as positive in many accounts 
and in some cases preferable to hospitalisation and could arguably affect 
whether a person is admitted to hospital on a compulsory basis. In 
addition, respondents spoke of the role of their GP played.  In all of these 
accounts GP’s were approached as an initial resource, in a crisis but 
mostly by family members who were trying to help them at the time.  
 
Thinking again about health belief models that involve social 
networks, and as I mentioned above, it is possible that the aetiological 
models of a person’s illness or general beliefs around psychotic illness 
and substance use held by ‘significant others’ could go some way to 
explaining rates of compulsory admission in certain demographic groups.  
 
For example, the hypothesis that comorbidity is associated with 
compulsory hospital admission was supported, but as with any hospital 
admission and psychotic relapse the relationship did differ by ethnic 
group. All patients, as well as patients in the White only and Black 
Caribbean only groups who were drug users or had comorbid drug or 
alcohol use disorders were more likely to have had a compulsory 
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admission. It was only patients in the Black Caribbean group with 
comorbid drug use disorders however that had significantly higher rates 
of compulsory hospital admissions compared with patients with no drug 
use. This pattern was not observed in Black African patients who were 
less likely to have had a compulsory admission.  
 
Studies have shown higher rates of compulsory admission in Black 
Caribbean patients with psychotic disorders (Bhui et al., 2003; Morgan et 
al., 2005. Morgan et al. (2004) have argued that these higher rates could 
be explained by differences in the way Black Caribbean and White 
families respond to mental illness and may not only hinder voluntary 
help-seeking but increase the involvement of the criminal justice system 
in a an individual’s pathway to care. This argument would likely explain 
higher rates of compulsory admission in Black patients with comorbid 
substance use disorders. 
 
In general the findings from the quantitative study showed a trend 
of greater risk of admission, compulsory admission and psychotic relapse 
in Black Caribbean patients with comorbidity despite the fact the 
prevalence of drug use disorders was equivalent to those from White 
ethnic groups. This finding is most likely explained by the interactions 
Black Caribbean patients have with their immediate socio-cultural 
environment (Morgan et al., 2004), and/or interactions with available 
health care services as well as perceived discriminatory behaviour within 
these services (Bhui et al., 2003). 
 
Do social networks play a role in likelihood of hospitalisation? From 
the qualitative study it is clear that some psychosis patients try to avoid 
family involvement because of illness and drug use monitoring due to 
fear of forced intervention. This may result in reduced voluntary 
hospitalisation. Interestingly constructions of initiating interventions for 




10.3.3 Constructions of psychotic illness, substance use and 
the treatment and recovery process 
As Kinderman et al. (2006) found, ‘self’ was a salient feature of 
understanding illness in the qualitative phase of the PhD study. This 
finding is also in line with many of the studies reviewed by Boydell et al., 
(2010) who found that achieving identity through understanding 
psychotic experience was salient in young persons with FEP. Separation 
between ill behaviours and normal behaviours as well as describing 
similarities and differences between themselves and other patients were 
important aspects if illness constructions in the qualitative study.  
 
Furthermore, the experience of loss in patients with comorbidity 
was built into lay models of causation of illness experiences (which often 
included bereavement), a finding that is similar to that of Bradizza and 
Stasiewicz (2003). As I discussed above models of aetiology were 
prominent in PhD study respondents’ constructions. Similar to several of 
the studies outlined in the systematic review by Boydell et al. (2010) 
respondents tended to adopt multiple explanations over the course of 
their illness. 
 
A number of respondents constructed their mental illness type 
experiences as depression and of equal importance they did not consider 
depression to be a mental illness. With more and more public awareness 
of depression this finding may indicate that people are happy to admit to 
a problem that is not considered a mental illness because it is more 
socially acceptable. 
 
Bradizza and Stasiewicz (2003), who looked at differences between 
patients with psychosis and SUD and SUD only found that despite 
negative effects of substance use such as symptom worsening, patients 
with comorbidity may continue using substances and that substance use 
in psychotic populations can be just as enjoyable as it is in the general 
population. A similar finding was observed in this study.  
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Constructions of substance use after the initial episode of illness 
highlighted a perceived relationship between drug use and music scene 
which may have played a factor in both continuation and cessation of 
drug use. Cessation of cannabis use in particular was often considered 
difficult. In line with Becker and Maimon (1983) and Rosenbock et al.’s 
(1988) health belief model the respondents gave constructions of 
reducing or stopping cannabis use when they were ready; when they saw 
it as beneficial (often after several attempts of encouragement to 
discontinue use from mental health service practitioners); and when the 
difficulty was not greater than what was to be gained (e.g., retaining 
custody of children or reducing likelihood of readmission to hospital). 
 
Moreover, in line with Leventhal’s Self Regulatory Theory many 
respondents detailed being given medical advice about the negative 
effects of drug use on their mental health, however drug use cessation 
was only taken up when respondents were interested in improving their 
own health. 
 
In addition to constructions of substance use as a self-medication 
strategy that has been noted in both epidemiological and sociological 
literatures (Khantzian, 1985 & 1997; Bradizza & Stasiewicz, 2003) this 
study found that substances were most often used in social situations and 
related to the desire to reaffirm social relationships. Coping strategies 
were also an important reason for initiating substance use and this is in 
line with findings from a recent study by Archie at al. (2013). 
 
As Kinderman et al. (2006) noted patients may construct their 
illness behaviours as an extension of their personality and this was true 
for a number of respondents in the qualitative study (for example 
thinking or worrying more than usual, or getting angry because they 
have a temper). This may be important in understanding how patients 
relate to family, other paints and staff when first in hospital if they feel 
their behaviour has been misidentified by family and professionals. 
Challenging behaviour on the ward could arguably be explained by 
understandable frustration and fear at being compulsorily hospitalised 
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rather than continued psychotic symptomatology, and uncovering 
patients own constructions of illness behaviours may help engagement 
with mental health services. 
 
In line with a study by Warfa et al. (2006), this study also found 
that mental health issues were addressed more thoroughly than 
substance abuse issues in patients with comorbidity and patients often 
used alternate means of support such as church and alternative medicine 
as part of their larger coping strategy and support network.  
 
 
10.4 CONCLUSIONS, IMPLICATIONS AND FUTURE 
RESEARCH 
 
There are a number of strengths and limitations of this PhD study. 
In conclusion though, mixed method design involving large longitudinal 
epidemiological and qualitative studies are an appropriate way of 
investigating the relationship betweenpyschosis and substance use.  A 
subtle realist philosophical approach is a useful way of bridging the gap 
between the two seemingly opposing research processes. Assuming a 
definition of knowledge as beliefs in which one can have reasonable 
confidence in their validity or truth, the study has attempted to generate 
knowledge by representing a truth that can be judged in relation to what 
is already known.  
 
However larger sample sizes in future qualitative research in this 
area may be useful for uncovering more detailed ethnic difference in 
constructions of illness, substance use and treatment experiences in 
patients with comorbidity. 
 
What the above findings collectively tell us is that ethnic differences 
in the prevalence of comorbidity are likely in populations of patients with 
psychosis.Patients with comorbidity are more likely to have  certain 
negative outcomes however the extent of the negative effect comorbidity 
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has on these outcomes is likely to be greater in Black Caribbean patients 
with drug use disorders and White British with alcohol use disorders. For 
illness course type, relapse and hospital admission, drug use could be 
considered protective. These negative outcomes may be explained to 
some degree by constructions and models of illness, help-seeking 
(particularly the use drugs to self-medicate), mastery and the role of 
professional medical services and the family.  
 
Offering talking based treatments are likely to be of benefit to this 
population particularly if they are focused around causes of illness and 
substance use. Patients with a clinical diagnosis of a comorbid substance 
use disorder may see they have a problem with drugs but may not 
necessarily feel they have an addiction and this distinction may be salient 
to them.  
 
Moreover patients may feel that stopping or cutting down substance 
use should be directed by themselves and determination through their 
own desire. Having mental health services involved (for example giving 
information about drugs) may be considered useful but mastering 
problems with substances may be seen as key. This may mean patients 
initiating treatment themselves despite being offered help by mental 
health services or GP’s. Treating professionals may need to consider that 
patients may feel and indeed may be in control of their substance use 
including patients that see a relationship (casual or otherwise) between 
their substance use and symptoms.  
 
Patient constructions of the relationship between cannabis and 
paranoia may help explain drug use behaviours. Paranoia as a side effect 
of using cannabis was often given in this PhD study and paranoid 
experiences were in some cases explained in this way rather than as a 
symptom of mental illness. In reality it is possible for both to be true. 
Moreover drug use as a cause of experiences was found to exist in illness 




This finding may have strong treatment implications suggesting that 
someone does not necessarily have to subscribe to a psychiatric 
framework of illness to perceive a causal relationship between their drug 
use and their paranoid symptoms. If paranoid symptoms are framed 
within negative effects of drug use rather than symptoms of mental 
illness this might be a more acceptable model of understanding and more 
likely to give way to a change in health behaviour. Additionally looking at 
models of illness causation and how these may change over a patient’s 
illness career may be useful when working therapeutically with certain 
patients. 
 
An important factor for clinicians to consider is that for some 
patients, lack of trust over cessation of drug use could be considered 
damaging to the relationship between patient and treating health 
professional. Additionally, at the core of continued or discontinued drug 
use is the individual themselves. An approach much like drug treatment 
agencies which focus on clients being ready for change may be more 
useful in encouraging discontinuation of substance use particularly when 
patients may see help from mental health services (rather than drug 
treatment services) as preferable. Additionally the involvement of family 
members in the treatment and recovery journey of patients may need to 
be considered based on pre-existing familial relationships. 
 
Several areas for further investigation have been identified in this 
study including: 
 Patterns of substance use course in relation to illness course. 
 Whether the role of social networks play a part in higher risk 
of negative outcomes in minority populations with comorbid 
diagnoses. 
 Whether patients constructions of illness aetiology or 
substance use initiation may help explain risk for comorbid 
psychosis and substance use disorders. 




Further research into the patterns of substance use over time in this 
population is needed to explain reasons for ethnic differences in 
prevalence and negative outcomes of patients with comorbidity. Further 
epidemiological research examining substance use patterns in comorbid 
populations as individuals age as well as further qualitative research 
comparing constructions of illness, substance use and treatment 
experiences in psychosis patients with and without diagnosed comorbidity 






























Chapter Summary 10.   
Chapter Summary 
 
Aims of the Chapter: 
To discuss the strengths and limitations of the PhD study. To discuss the findings 
from both arms of the study in relation to previous research. To discuss future 
research areas highlighted by the both studies but particularly the qualitative 




 The hypothesis that the prevalence of comorbid substance use disorders 
in individuals with an 8-12 year history of psychosis will differ according 
to ethnic grou was supported. 
 Risk for comorbidyt was found to be lower in Black African patients 
compared to White patients. However risk for comorbidity in Black 
Caribbean patients was not found to be higher. 
 The hypothesis that in all ethnic groups, comorbid substance use disorder 
will be associated with:  
 a) more frequent relapses and  
 b) more compulsory admissions  
independent of potential confounders, including age, gender, diagnosis 
and study centre was not supported 
 In relation to the research question how do individuals with comorbidity 
of psychosis and substance use disorders construct their experiences of 
‘psychosis’ and drug and alcohol use 8-12 years after their first episode? 
The PhD study found that several account devices are used to construct 
experience. Aetiology of illness is a key to understanding ones 
expereinces as is general feelings of mastery and returing to ‘normal’. 
Individuals with comorbidity may construct their experiences of 
‘psychosis’ and drug and alcohol use as separate but related and often 
use substances to self-medicate 
 With regard to the second hypothesis: How do individuals with 
comorbidity of psychosis and substance use disorders construct their 
experiences of mental health and substance abuse treatment services? 
Primary and secondary care health services play a part in the larger 
support network of individuals 
 The perceived role of family, friends and other social support networks in 
the treatment process for ‘psychosis’ and substance use disorder was 
largely positive but current percpetions of involvement often differed from 
retrospective percetions. Expereinces of services were mostly constructed 
as a useful form of support (including hospitalisation). 
 There are a number of strengths and limitations of this PhD study, 
however, mixed method design involving large longitudinal 
epidemiological and qualitative studies are an appropriate way of 
investigating the relationship between pyschosis and substance use.  A 
subtle realist philosophical approach is a useful way of bridging the gap 
between the two seemingly opposing research processes 
 Further epidemiological and qualitative research into the changing 
patterns of substance use over a time in psychotic populations are 
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QUALITATIVE STUDY OF ETHNICITY, MENTAL 
HEALTH AND SUBSTANCE USE  
 
Please read this carefully if you are interested in participating in our 
research project.  You may like to discuss it with your friends or 
family.  A researcher will explain what the study involves but please 
ask questions if you do not understand anything or if you would like 
more information. Your participation is entirely voluntary.  
 
Participant Information Sheet 
 
About ten years ago you made contact with mental health services for 
the first time and very kindly agreed to take part in some interviews 
and assessments as a participant in the ‘AESOP’ study.  Recently the 
‘AESOP’ team re-contacted you as part of their follow-up study and 
were again very grateful for your time and help.  
 
Why have I been invited? 
 
We are now contacting you and other people who participated in the 
‘AESOP’ study to ask if you would be interested in joining an 
additional research project.  Participation is completely voluntary, and 
will not affect any treatment or care you are receiving, in any way.  
For this, we would like to invite you to take part in a one off face-to-
face interview with one of our researchers, to discuss your 
experiences since you first made contact with services and your 
perceptions on the quality of mental health and substance abuse 
care, both in general and from your own experience. 
 
What is this research for? 
 
The aim of the research is to find out about the experiences of people 
who made contact with mental health services (and drug treatment 
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people who have used mental health (and drug treatment services) 
services perceive the role of those services. 
 
 
What would taking part in the research involve? 
 
As we said before your participation is completely voluntary. If you 
are interested in taking part the researcher will then ask you to sign a 
consent form. 
   
The interview will last for no more than an hour and a half. It will be 
held in an interview room in the Psychological Medicine and 
Psychiatry Department at the Institute of Psychiatry.  You will receive 
£15, in appreciation of your time.   
 
The interview would be very informal. The person who would 
interview you is Jo Hart, who is a researcher at the Institute of 
Psychiatry.   She is totally independent of the services that you may 
receive care from now or have received care from in the past. 
 
Anything you say in the interview will be confidential.  With your 
permission the interview will be audio-taped.  The tape will be 
transcribed by an administrator working for the team.  When the tape 
is transcribed you will not be identified by name but by a code 
number. The tape will be kept securely and destroyed at the end of 
the project.  We will analyse the transcript on computers in the 
department.  If you decide to withdraw from the study any tape or 
notes made of the interview would then be destroyed, and would not 
be used in the study. Any comments from the interview that we quote 
in our final report will be anonymised.   
 
 
What are the possible benefits, disadvantages and risks of  
taking part? 
 
The interviewer will ask you about your experiences of mental illness 
and drug use, which are sensitive topics. However, the interview 
would always be in your control: you could end it at any time, and you 
could ‘skip’ questions if you wanted to.  If you decided after the 
interview that you didn’t want to be in this study after all, you can tell 
the researcher.   
 
There will be no direct benefit to you in taking part in the project, but 
we hope you will feel it is worthwhile, and that your contribution may 
help to improve the care offered to other people in the future.   
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If you feel you might agree to be interviewed, what should you 
do next? 
 
If you would like to participate in the study, you would like to ask any 
questions or want to find out about anything else at all, please 
telephone Jo Hart on 07779729589 (see further contact details 
below).  If she is not there when you call, please leave a message 
and she will call you back as soon as she can. 
 
If you decide to participate you are still free to withdraw from the 
study at any time, without giving a reason.  Withdrawal from the study 
will not affect any treatment or care you are receiving. 
 
We are happy to send you a copy of the report if you would like one.  
It is hoped that the results of the study will be published in a mental 
health journal.  The study is funded by the Medical Research Council 
as part of the interviewers PhD. The project has been approved by 
the Bexley & Greenwich NHS Research Ethics Committee. 
 
If, you decide to participate in the study and have a concern about 
any aspect of it, please speak to Jo Hart who will do her best to 
respond to your concerns (07779729589).  If you remain unhappy 
and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from Patient Advice 
& Liaison Services (PALS) at the Maudsley (0800 731 2864).  In the 
event of you suffering any adverse effects as a consequence of your 
participation in this project, you may be compensated through the 
King’s College London’s ‘No Fault’ Compensation Scheme. 
 
  For further information about the project please contact:  
  Jo Hart, PO Box 63, Institute of Psychiatry, De Crespigny Park, 
  London, SE5 8AF.  Tel: 07779729589   E-mail: jo.hart@iop.kcl.ac.uk 
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Participant Identification Number for this project: 
 
          CONSENT FORM 
 
 
           Title of Project:   QUALITATIVE STUDY OF ETHNICITY, MENTAL HEALTH  
AND SUBSTANCE USE  
Name of Researcher:          
                                                                     Please initial box 
1. I confirm that I have read and understand the Participant  
Information Sheet dated ……… (version …) for the above  
project.  I have had the opportunity to consider the  
information, ask questions and have had these answered  
satisfactorily. 
 
2. I understand that my participation is voluntary and  
that I am free to withdraw at any time without giving any  
reason, and without my medical care or legal rights being  
affected.  
 
3. I consent to the interview being audio-taped.     
     
 
 
4. I consent to information and quotations from the transcript  
of the interview being published in the final report  
(confidentiality and anonymity will be maintained and  
it will not be possible to identify you from the publication). 
 
5. I agree to take part in the above project.   
 
 
_____________________ ___________            ______________________ 
Name of Participant Date            Signature 
 
___________________ __________  ____________________ 




I do/don’t* want to be sent a copy of the report on this study  
*(delete as appropriate) 
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Ethnicity, Comorbidity and Treatment Service Use 
 
 
This is not a structured interview schedule, but a semi-structured topic guide for 
prospective interviews with people who made contact with South London and 
Maudsley services for mental health (and substance use) problems between 1997 and 
2000.  It is unlikely that all interviews will cover all topics.  The order, in which 
topics are covered will in part, be lead by the participants themselves. Questions / 
topics which are highlighted in bold are likely to come into all accounts: questions / 





Thank you for agreeing to take part in this research (Go through information sheet 
and consent form. Establish consent for tape recording). 
 
I would like to talk to you about some of your experiences over the last 10 years. I 
would also like to ask you about your experiences of mental health (and substance 
treatment) services and find out in your opinion what role they play (if any) in 
helping you with the things you have been experiencing over the last 10 years. 
 
Defining ethnicity: 
o 1. How would you define your ethnicity or your ethnic group? 
POSSIBLE PROBES: 
 Get details of where they were born  
 Get details of where their parents were born 
 Briefly explore family relationships. 
 
Experiences of mental illness:: 
 
o 2.The first thing I want to ask you about is how it was you came into contact 
with the Mental Health Services for the very first time in?’ 
POSSIBLE PROBES: 
 Start with the events leading up to their first contact with services.  
 Get details of what happened just prior to admission including how the 
person felt about each event they discuss. 
 
 
o 3.‘Did you experienced any problems or difficulties in your life around that 
time?’ 
POSSIBLE PROBES: 
 Gage information about any problems they had been experiencing before 
that event (either social, physical or mental) 




o  4. Whose idea was it to go to [name of hospital]? Did any friends or family go 
with you? 
POSSIBLE PROBES: 
 Ask if any friends or family were involved in the decision to seek help or 
in the admission itself. 
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 If they haven’t already covered this, ask them to give specific details of 
the admission (i.e. who assessed them; how long they were in hospital 
for) 
 Find out if the CJS was involved and how they felt about that. 
 
o 5. Did you think you needed to go to hospital at that time? 
POSSIBLE PROBES: 
 Find out if the patient felt they needed treatment for the problems they 
were experiencing. 
 Were they prescribed medication and did they take it (if not why not)? 
 
 
o 6. Had you ever experienced any of these things (use patients own words) in 
your life before going into hospital? 
POSSIBLE PROBES: 
 Find out if they had experienced any of the things described before the 
time they made contact with mental health service for the first time? 
 
 
o 7. Have you had any of these experiences since that time? 
POSSIBLE PROBES: 
 Get detail about any similar experiences they have had since there first 
contact with mental health services (e.g. when did they start, how long 
did thy last etc) 
 Did they make contact with services for these experiences, and what was 
the outcome of this (if not why not)? 




o 8. How do you feel when you experience these things, and what do you think is 
the reason for these experiences? 
POSSIBLE PROBES: 
 Find out whether they feel these experiences were because of mental 
illness 




o 9. Before you had these experiences what did you know or think about mental 
illness 
POSSIBLE PROBES: 
 Find out what they think mental illness is. 
 What did their family/friends know about mental illness before they made 
contact with services (e.g other family members with mental illness, 




Experiences of substance use: 
 
o 10. When we interviewed you last you told our researchers that you (used to) 




 Find out if when they first started using substances and the reasons for 
that 
 Find out how much they were using, whether they still use substances and 
how much they currently use 
 Where they used, in what situations (alone or with friends). 
 
 
o 11. Have there ever been points in your life when you’ve used less often or more 
often than your normal amount? 
POSSIBLE PROBES: 
 Gage whether the patient has had periods of substance abuse, dependence 
or abstinence (i.e when their use became more than recreational) 
 Try to elicit reasons for the possible change in usage of their substance(s) 
of choice and whether the situations they used in changed as well 
 Find out whether they felt at any point in their life that their substance use 
was a problem for them or other people (friends/family) and was change 
in frequency/severity of substance use related to this? 
 
o 12. Have you ever experienced any health problems in relation to your 
substance use 
POSSIBLE PROBES: 
 Ask if they have ever experienced any health problems (this can include 
mental health problems e.g. depression, as well as physical health 
problem e.g. infections from needles, injuries while intoxicated) which 
they or others have attributed to substance use 
 How did they feel about these problems and did they speak to anyone or 
do anything to help stop or alleviate these problems 
 
o 13. Did you ever want to stop your substance use or did you ever seek help for 
your substance use? 
POSSIBLE PROBES: 
 Find out if they have ever considered or actually sought help (e.g. GP, 
mental health or substance service, or other services or agencies) for their 
substance use 
 What were the reasons for this (e.g. to stop/reduce substance use, manage 
other problems associated with substance use) 
 Who did they contact and when did they contact them 
 If they never considered or actually sought help why was that? 
 
o 14. Did you ever have any contact with the police because of drug use? 
POSSIBLE PROBES: 
 Find out if they have ever had contact with the CJS while taking/dealing 
drugs either while alone or in a group 
 
 
ASK ONLY IF PATIENT CONSIDERED OR ACTUALLY SOUGHT HELP FOR 
SUBSTANCE USE 
 
o 15. What was the outcome of considering/seeking help for your substance use? 
POSSIBLE PROBES: 
 Ask whether they got a referral / presented to substance abuse treatment 
services 
 If they only considered seeking help why didn’t they? 
 Get details about any period of treatment they received 
 If nothing came of seeking help find out why? 
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 Have they ever tried or been asked (by friends, family or health 
professionals) to seek help (again) since that first time they considered 
/sought help? 
 If they haven’t already covered this, gage whether mental health services 
facilitated them seeking help for substance use (e.g. referral while I 
hospital or with a community team or detoxification) 
 
 
o 16. Did you ever speak to family members/friends about your substance use 
POSSIBLE PROBES: 
 Find out whether they have confided in family and/or friends and whether 
they found this helpful 
 Find out what their family thought of (their) drug taking. Use this as an 
opportunity to get details of family structure, their upbringing and cultural 
beliefs.  
 Ask whether their substance use has caused any problems in their 
relationships with family or friends 
 Were/are any family members or friends involved in helping them 
monitor their substance use (e.g. contact with treatment services or 
helping them directly) 
 
 
o 17. Have you ever felt your substance use was related to any of the things you 
have experienced (use patients own words) in the past? 
POSSIBLE PROBES: 
 Ask if they feel that some of their experiences were a consequence of, 
made worse or better by their substance use? 
 Gage information about substance use patterns whilst they were having 
these experiences and the reasons for that. 
 
 
Experiences and perceptions of mental health and substance abuse treatment services: 
 
o 18. How would you describe your experience of mental health services 
POSSIBLE PROBES: 
 Find out how they felt they were treated by mental health professionals 
 Ask if they were able to see friends and family while in hospital 
 If they received treatment in the community ask whether they find/found 
their care co-coordinator helpful 
 What did they expect from mental health services 
 If they haven’t covered this already, ask if the mental health professionals 
help them with their substance use 
 Did they experience any unfair treatment and why do they think they 
were treated that way. 
 
 
o 19. Do you think being in hospital or being in contact with mental health 
services was/is useful for you 
POSSIBLE PROBES: 
 If not previously discussed, gage whether they feel mental health services 
have helped them with some of their experiences and/or if they are useful 
for people with those type of experiences at all 
 Ask if the patient thinks that some other intervention of form of help 




o 20. How would you describe your experience of substance abuse treatment 
services 
POSSIBLE PROBES: 
 Find out how they felt they were treated by substance abuse treatment 
professionals 
 If they were in a detox unit were friends and family ale to visit? 
 If they have received treatment  in the community ask whether they 
find/found their care co-ordinator helpful 
 What did they expect from services 
 If they haven’t covered this already, ask if the substance abuse treatment 
professionals help them with any of the experiences they have descried 
earlier (use patients own words) 
 Did they experience any unfair treatment and why do they think they 
were treated that way. 
 
 
o 21. Have you ever sought help from other types of people/services/agencies for 
problems with substance use or and of the experiences you’ve described (e.g. 
church, community services or natural remedies)? 
POSSIBLE PROBES: 
 Gage whether patient has contacted any community or spiritual 
groups/services 
 How did you find out about [name of support]? When did you contact 
them 
 Ask if they found this useful 
 
Current activities and future plans: 
 
o 22. How do you spend your days now?  Has that changed since you first 
were in hospital? 
POSSIBLE PROBES: 
 Ask if they are working / studying presently? 
 Do they see their friends and family more or less than they use to? 
 Have they had to change their lifestyle because of their drug use or the 
experiences they have described? 




APPENDIX 2: SEARCH TERMS FOR SYSTEMATIC 




1. Drug use terms combined with ‘OR’. 
Drug addiction, drug abuse, drug dependence, drug misuse, alcoholism, 
alcohol abuse, alcohol dependence, alcohol misuse, substance abuse, 
substance abuse, substance dependence, substance misuse, substance 




2. Psychotic disorder search terms combined with ‘OR’ 
Schizo*, psychosis, psychoses, psychotic, acute psychosis, depressive 
psychosis, manic depressive psychosis, paranoid psychosis, alcohol 
psychosis, manic psychosis, or affective psychosis, bipolar disorder 
 
 
3. Ethnicity terms combined with ‘OR’ 
Ethnic differences, ethnic and racial groups, minority, racial aspects, 
ethnic group, ethnic*, African Caribbean, African American, Black 
Caribbean, Asian, Asian American , British Asian, Chinese, Indian, Indian 
American, Pakistan*, racial*, race, 
 
 
Search items 1, 2 and 3 were combined with ‘AND’ 
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APPENDIX 3: COMPARISON OF CONDITIONAL 















LCS 2.6 number of psychotic episodes 
comorbid drug use 3 levels Mean N Variance 
No drug use 1.6282 78 2.315 
Drug use 1.6327 49 3.404 
Drug use disorder 1.7500 36 5.850 
Total 1.6564 163 3.375 











LCS 2.6 number of psychotic episodes 
comorbid alcohol use 3 
levels 
Mean N Variance 
No alcohol use 2.2500 32 5.290 
Alcohol use 1.4771 109 2.770 
Alcohol use disorder 1.6957 23 3.858 
Total 1.6585 164 3.453 


















LCS 3.1a total number of hospital admissions at follow-up (t3) 
comorbid drug use 3 levels Mean N Variance 
No drug use 3.1667 126 11.708 
Drug use 2.9875 80 8.772 
Drug use disorder 4.3226 62 12.878 
Total 3.3806 268 11.293 











LCS 3.1a total number of hospital admissions at follow-up (t3) 
comorbid alcohol use 3 
levels 
Mean N Variance 
No alcohol use 4.5000 56 23.782 
Alcohol use 3.0060 168 7.635 
Alcohol use disorder 3.4444 45 10.162 
Total 3.3903 269 11.657 




APPENDIX 4: CODING FRAMEWORKS FOR PHASE 
TWO QUALITATIVE STUDY 
 
 
Coder 1 (respondent QS6 only) 
 
The benefits of hospitalisation  
 change in thinking ‘knowing not set fires’  
 change in and mood 
 
Living context theme  
 relates to risk factors (low education, homeless, ethnicity) 
 
Change in drug use theme 
 moves from immature  ‘I can stop whenever to’, ‘I see there is a 
need’ 
 support for quitting  
 
Is drug use separate from mental health? 
 
Prior knowledge of mental illness 
 
Recognising symptoms 








Psychosis as illness 
 Unwell 
 Suffering from illness 
 ‘Had to be sectioned’ 
 Personal vs. professional symptom description 
 
Symptoms 
 External vs. internal origin – ‘it was happening to me’ 
 Description of symptoms as psychosis, mentally ill? Proper 
psychosis? 
 Attribution of cause – external vs. internal 
 
Significant life events 
 Unsettled – housing, job, loss, moving 
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Agency vs. passivity 
 
Drug use 
 Drug use at time of treatment 
 Description of drug use – why use, perceived dependence 
 Drugs as normality 
 Effects of drug use on self (mental/physical/practical) 
 Perceived link to episode/MH 
 Current vs. historic views drug use 
 Drug use during hospitalisation 
 Attention to drug use as part of treatment 
 Drug cessation vs. maintenance 
 Coping and drug use 
 
Hospitalisation 
 Involvement vs. being done to – passivity vs. agency, 
contradictions and consistencies 
 Perceived reasons for admittance 
 Frustration 
 Hindsight vs. historic views 
 Impact of treatment vs. impact of hospitalisation  
 Staff as friends/allies/enemies 
 Dissociation from other patients – patients as ‘other’, special 
 Playing the game, acting out 
 Inside vs. outside 
 Leaving/re-entering community 
 Post-discharge care and continuity 
 
Treatment 
 Credibility of staff 
 Suspicion 
 Doctors/psychiatrists as authority – deferential, external locus 
 Willing treatment vs. being sectioned 
 Perceived need for treatment 
 Awareness of consequences 
 
Medication 
 Adherence  
 Drug use (recreational) vs. medication 
 Specific vs. vague knowledge (knew exact drug and dosage but 




 Support from family/friends – prior to episode/involvement with 
treatment/accessing treatment/post-discharge 
 Support from medical staff – psychiatrist vs. nurses 
 Church/religion 
 Local authority/council  
 
Views about the self 
 Identity 
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 Self esteem/mastery 
 Self-centredness 
 Ambition/hope 
 Current circumstance/mind set 
 
Trajectories 
 Events leading up to hospitalisation, impact of drug use and 






Defining the experiences 
 Terms (psychiatric vs. lay) 
 definitions / conceptualisations (physical vs. behavioural 
o  acting out (on purpose as opposed to not being able to help 
the way you behave) 
 emotional / psychological 
o personality change 








Causes of the experiences 
 located in wider society (responsibility with other) 
o economic 
o institutional 
 located in immediate social setting (responsibility with other) 
o family 
o childhood experience 
o financial problems / unemployed 
o interpersonal problems at work 
 located in individual (responsibility with self) 
o biological 
o drug abuse 
o psychosocial (stress, relationship breakdown) 
  




   
Drug taking 
 positive experience 
 negative experience 
 related to my illness / not related to my illness 
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Treatment 
 usefulness: needed / not needed (could do table on this)  
 positive experience / negative experience (could do table on this) 
 what: what they got / what they would have wanted 
 definition (what was treatment defined as i.e. the provider) 
o treatment services 
o family support (recognising the person is ill, taking them to 
the hospital, having someone to talk to / care for you 
 responsibility 
o active / passive participation  
 
Treatment and recovery 
 What (what type of treatment is useful) 
o Medical (medication) 
o Physical (Have a rest, Detox from drugs) 
o Psychological / Emotional (Emotional support / Talking) 
o Practical / social (Getting back routine, Getting job 




 Who (who should provide treatment) 
o The individual (self) 
o Local community / institution 
 Mental health services 
 Drug treatment services 
 Criminal justice service 
 Family 
 Wider Society 
 How (how is treatment provided and recovery made) 
o goal 
 psychological 
 be myself again 
 being a different person (better) 
 social / economic 
 rest Power struggles 
o Causes of experiences 
o Forcibly made to detox 
 
 Why (Why is treatment needed; for purpose does it function; who 
benefits) 
o Social (Better my relationships) 
o Psychological (Be a better person) 











Final Coding Framework 
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